#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Abnormal resting-state functional connectivity in the orbitofrontal cortex of heroin users and its relationship with anxiety: a pilot fNIRS study
1-1	0-8	Abnormal	_	
1-2	9-22	resting-state	_	
1-3	23-33	functional	_	
1-4	34-46	connectivity	_	
1-5	47-49	in	_	
1-6	50-53	the	_	
1-7	54-67	orbitofrontal	_	
1-8	68-74	cortex	_	
1-9	75-77	of	_	
1-10	78-84	heroin	_	
1-11	85-90	users	_	
1-12	91-94	and	_	
1-13	95-98	its	_	
1-14	99-111	relationship	_	
1-15	112-116	with	_	
1-16	117-124	anxiety	_	
1-17	124-125	:	_	
1-18	126-127	a	_	
1-19	128-133	pilot	_	
1-20	134-139	fNIRS	_	
1-21	140-145	study	_	

#Text=Drug addiction is widely linked to the orbitofrontal cortex (OFC), which is essential for regulating reward-related behaviors, emotional responses, and anxiety. Over the past two decades, neuroimaging has provided significant contributions revealing functional and structural alternations in the brains of drug addicts. However, the underlying neural mechanism in the OFC and its correlates with drug addiction and anxiety still require further elucidation. We first presented a pilot investigation to examine local networks in OFC regions through resting-state functional connectivity (rsFC) using functional near-infrared spectroscopy (fNIRS) from eight abstinent addicts in a heroin-dependent group (HD) and seven subjects in a control group (CG). We discovered that the HDs manifested enhanced interhemispheric correlation and rsFC. Moreover, small-worldness was explored in the brain networks. In addition to the altered rsFC in the OFC networks, our examinations demonstrated associations in the functional connectivity between the left inferior frontal gyrus and other OFC regions related to anxiety in the HDs. The study provides important preliminary evidence of the complex OFC networks in heroin addiction and suggests neural correlates of anxiety. It opens a window in application of fNIRS to predict psychiatric trajectories and may create new insights into neural adaptations resulting from chronic opiate intake.
2-1	146-150	Drug	_	
2-2	151-160	addiction	_	
2-3	161-163	is	_	
2-4	164-170	widely	_	
2-5	171-177	linked	_	
2-6	178-180	to	_	
2-7	181-184	the	_	
2-8	185-198	orbitofrontal	_	
2-9	199-205	cortex	_	
2-10	206-207	(	_	
2-11	207-210	OFC	_	
2-12	210-211	)	_	
2-13	211-212	,	_	
2-14	213-218	which	_	
2-15	219-221	is	_	
2-16	222-231	essential	_	
2-17	232-235	for	_	
2-18	236-246	regulating	_	
2-19	247-261	reward-related	_	
2-20	262-271	behaviors	_	
2-21	271-272	,	_	
2-22	273-282	emotional	_	
2-23	283-292	responses	_	
2-24	292-293	,	_	
2-25	294-297	and	_	
2-26	298-305	anxiety	_	
2-27	305-306	.	_	
2-28	307-311	Over	_	
2-29	312-315	the	_	
2-30	316-320	past	_	
2-31	321-324	two	_	
2-32	325-332	decades	_	
2-33	332-333	,	_	
2-34	334-346	neuroimaging	_	
2-35	347-350	has	_	
2-36	351-359	provided	_	
2-37	360-371	significant	_	
2-38	372-385	contributions	_	
2-39	386-395	revealing	_	
2-40	396-406	functional	_	
2-41	407-410	and	_	
2-42	411-421	structural	_	
2-43	422-434	alternations	_	
2-44	435-437	in	_	
2-45	438-441	the	_	
2-46	442-448	brains	_	
2-47	449-451	of	_	
2-48	452-456	drug	_	
2-49	457-464	addicts	_	
2-50	464-465	.	_	
2-51	466-473	However	_	
2-52	473-474	,	_	
2-53	475-478	the	_	
2-54	479-489	underlying	_	
2-55	490-496	neural	_	
2-56	497-506	mechanism	_	
2-57	507-509	in	_	
2-58	510-513	the	_	
2-59	514-517	OFC	_	
2-60	518-521	and	_	
2-61	522-525	its	_	
2-62	526-536	correlates	_	
2-63	537-541	with	_	
2-64	542-546	drug	_	
2-65	547-556	addiction	_	
2-66	557-560	and	_	
2-67	561-568	anxiety	_	
2-68	569-574	still	_	
2-69	575-582	require	_	
2-70	583-590	further	_	
2-71	591-602	elucidation	_	
2-72	602-603	.	_	
2-73	604-606	We	_	
2-74	607-612	first	_	
2-75	613-622	presented	_	
2-76	623-624	a	_	
2-77	625-630	pilot	_	
2-78	631-644	investigation	_	
2-79	645-647	to	_	
2-80	648-655	examine	_	
2-81	656-661	local	_	
2-82	662-670	networks	_	
2-83	671-673	in	_	
2-84	674-677	OFC	_	
2-85	678-685	regions	_	
2-86	686-693	through	_	
2-87	694-707	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#ClinicalRiskStatus[1]|http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder[2]|http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[3]	
2-88	708-718	functional	http://maven.renci.org/NeuroBridge/neurobridge#ClinicalRiskStatus[1]|http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder[2]|http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[3]	
2-89	719-731	connectivity	http://maven.renci.org/NeuroBridge/neurobridge#ClinicalRiskStatus[1]|http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder[2]|http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[3]	
2-90	732-733	(	http://maven.renci.org/NeuroBridge/neurobridge#ClinicalRiskStatus[1]|http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder[2]|http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[3]	
2-91	733-737	rsFC	http://maven.renci.org/NeuroBridge/neurobridge#ClinicalRiskStatus[1]|http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder[2]|http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[3]	
2-92	737-738	)	http://maven.renci.org/NeuroBridge/neurobridge#ClinicalRiskStatus[1]|http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder[2]|http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[3]	
2-93	739-744	using	_	
2-94	745-755	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy[4]	
2-95	756-769	near-infrared	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy[4]	
2-96	770-782	spectroscopy	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy[4]	
2-97	783-784	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy[4]	
2-98	784-789	fNIRS	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy[4]	
2-99	789-790	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy[4]	
2-100	791-795	from	_	
2-101	796-801	eight	_	
2-102	802-811	abstinent	_	
2-103	812-819	addicts	_	
2-104	820-822	in	_	
2-105	823-824	a	_	
2-106	825-841	heroin-dependent	_	
2-107	842-847	group	_	
2-108	848-849	(	_	
2-109	849-851	HD	_	
2-110	851-852	)	_	
2-111	853-856	and	_	
2-112	857-862	seven	_	
2-113	863-871	subjects	_	
2-114	872-874	in	_	
2-115	875-876	a	_	
2-116	877-884	control	_	
2-117	885-890	group	_	
2-118	891-892	(	_	
2-119	892-894	CG	_	
2-120	894-895	)	_	
2-121	895-896	.	_	
2-122	897-899	We	_	
2-123	900-910	discovered	_	
2-124	911-915	that	_	
2-125	916-919	the	_	
2-126	920-923	HDs	_	
2-127	924-934	manifested	_	
2-128	935-943	enhanced	_	
2-129	944-960	interhemispheric	_	
2-130	961-972	correlation	_	
2-131	973-976	and	_	
2-132	977-981	rsFC	_	
2-133	981-982	.	_	
2-134	983-991	Moreover	_	
2-135	991-992	,	_	
2-136	993-1008	small-worldness	_	
2-137	1009-1012	was	_	
2-138	1013-1021	explored	_	
2-139	1022-1024	in	_	
2-140	1025-1028	the	_	
2-141	1029-1034	brain	_	
2-142	1035-1043	networks	_	
2-143	1043-1044	.	_	
2-144	1045-1047	In	_	
2-145	1048-1056	addition	_	
2-146	1057-1059	to	_	
2-147	1060-1063	the	_	
2-148	1064-1071	altered	_	
2-149	1072-1076	rsFC	_	
2-150	1077-1079	in	_	
2-151	1080-1083	the	_	
2-152	1084-1087	OFC	_	
2-153	1088-1096	networks	_	
2-154	1096-1097	,	_	
2-155	1098-1101	our	_	
2-156	1102-1114	examinations	_	
2-157	1115-1127	demonstrated	_	
2-158	1128-1140	associations	_	
2-159	1141-1143	in	_	
2-160	1144-1147	the	_	
2-161	1148-1158	functional	_	
2-162	1159-1171	connectivity	_	
2-163	1172-1179	between	_	
2-164	1180-1183	the	_	
2-165	1184-1188	left	_	
2-166	1189-1197	inferior	_	
2-167	1198-1205	frontal	_	
2-168	1206-1211	gyrus	_	
2-169	1212-1215	and	_	
2-170	1216-1221	other	_	
2-171	1222-1225	OFC	_	
2-172	1226-1233	regions	_	
2-173	1234-1241	related	_	
2-174	1242-1244	to	_	
2-175	1245-1252	anxiety	_	
2-176	1253-1255	in	_	
2-177	1256-1259	the	_	
2-178	1260-1263	HDs	_	
2-179	1263-1264	.	_	
2-180	1265-1268	The	_	
2-181	1269-1274	study	_	
2-182	1275-1283	provides	_	
2-183	1284-1293	important	_	
2-184	1294-1305	preliminary	_	
2-185	1306-1314	evidence	_	
2-186	1315-1317	of	_	
2-187	1318-1321	the	_	
2-188	1322-1329	complex	_	
2-189	1330-1333	OFC	_	
2-190	1334-1342	networks	_	
2-191	1343-1345	in	_	
2-192	1346-1352	heroin	_	
2-193	1353-1362	addiction	_	
2-194	1363-1366	and	_	
2-195	1367-1375	suggests	_	
2-196	1376-1382	neural	_	
2-197	1383-1393	correlates	_	
2-198	1394-1396	of	_	
2-199	1397-1404	anxiety	_	
2-200	1404-1405	.	_	
2-201	1406-1408	It	_	
2-202	1409-1414	opens	_	
2-203	1415-1416	a	_	
2-204	1417-1423	window	_	
2-205	1424-1426	in	_	
2-206	1427-1438	application	_	
2-207	1439-1441	of	_	
2-208	1442-1447	fNIRS	_	
2-209	1448-1450	to	_	
2-210	1451-1458	predict	_	
2-211	1459-1470	psychiatric	_	
2-212	1471-1483	trajectories	_	
2-213	1484-1487	and	_	
2-214	1488-1491	may	_	
2-215	1492-1498	create	_	
2-216	1499-1502	new	_	
2-217	1503-1511	insights	_	
2-218	1512-1516	into	_	
2-219	1517-1523	neural	_	
2-220	1524-1535	adaptations	_	
2-221	1536-1545	resulting	_	
2-222	1546-1550	from	_	
2-223	1551-1558	chronic	_	
2-224	1559-1565	opiate	_	
2-225	1566-1572	intake	_	
2-226	1572-1573	.	_	

#Text=Drug addiction is a neuropsychiatric disorder characterized by compulsive drug-seeking and drug-taking behaviors despite adverse consequences. As one of the most frequently abused drugs, heroin is widely recognized to be associated with dire societal consequences, undermined industrial and social advancement, increased crime, violence, insecurity and the spread of transmitted diseases like HIV or hepatitis C virus. As a result, identifying the neurobiological mechanisms underlying heroin addiction will have substantial implications for the medical, psychological and legal management of drug addicts, as well as for the fundamental understanding of addictive behaviors.
3-1	1574-1578	Drug	_	
3-2	1579-1588	addiction	_	
3-3	1589-1591	is	_	
3-4	1592-1593	a	_	
3-5	1594-1610	neuropsychiatric	_	
3-6	1611-1619	disorder	_	
3-7	1620-1633	characterized	_	
3-8	1634-1636	by	_	
3-9	1637-1647	compulsive	_	
3-10	1648-1660	drug-seeking	_	
3-11	1661-1664	and	_	
3-12	1665-1676	drug-taking	_	
3-13	1677-1686	behaviors	_	
3-14	1687-1694	despite	_	
3-15	1695-1702	adverse	_	
3-16	1703-1715	consequences	_	
3-17	1715-1716	.	_	
3-18	1717-1719	As	_	
3-19	1720-1723	one	_	
3-20	1724-1726	of	_	
3-21	1727-1730	the	_	
3-22	1731-1735	most	_	
3-23	1736-1746	frequently	_	
3-24	1747-1753	abused	_	
3-25	1754-1759	drugs	_	
3-26	1759-1760	,	_	
3-27	1761-1767	heroin	_	
3-28	1768-1770	is	_	
3-29	1771-1777	widely	_	
3-30	1778-1788	recognized	_	
3-31	1789-1791	to	_	
3-32	1792-1794	be	_	
3-33	1795-1805	associated	_	
3-34	1806-1810	with	_	
3-35	1811-1815	dire	_	
3-36	1816-1824	societal	_	
3-37	1825-1837	consequences	_	
3-38	1837-1838	,	_	
3-39	1839-1849	undermined	_	
3-40	1850-1860	industrial	_	
3-41	1861-1864	and	_	
3-42	1865-1871	social	_	
3-43	1872-1883	advancement	_	
3-44	1883-1884	,	_	
3-45	1885-1894	increased	_	
3-46	1895-1900	crime	_	
3-47	1900-1901	,	_	
3-48	1902-1910	violence	_	
3-49	1910-1911	,	_	
3-50	1912-1922	insecurity	_	
3-51	1923-1926	and	_	
3-52	1927-1930	the	_	
3-53	1931-1937	spread	_	
3-54	1938-1940	of	_	
3-55	1941-1952	transmitted	_	
3-56	1953-1961	diseases	_	
3-57	1962-1966	like	_	
3-58	1967-1970	HIV	_	
3-59	1971-1973	or	_	
3-60	1974-1983	hepatitis	_	
3-61	1984-1985	C	_	
3-62	1986-1991	virus	_	
3-63	1991-1992	.	_	
3-64	1993-1995	As	_	
3-65	1996-1997	a	_	
3-66	1998-2004	result	_	
3-67	2004-2005	,	_	
3-68	2006-2017	identifying	_	
3-69	2018-2021	the	_	
3-70	2022-2037	neurobiological	_	
3-71	2038-2048	mechanisms	_	
3-72	2049-2059	underlying	_	
3-73	2060-2066	heroin	_	
3-74	2067-2076	addiction	_	
3-75	2077-2081	will	_	
3-76	2082-2086	have	_	
3-77	2087-2098	substantial	_	
3-78	2099-2111	implications	_	
3-79	2112-2115	for	_	
3-80	2116-2119	the	_	
3-81	2120-2127	medical	_	
3-82	2127-2128	,	_	
3-83	2129-2142	psychological	_	
3-84	2143-2146	and	_	
3-85	2147-2152	legal	_	
3-86	2153-2163	management	_	
3-87	2164-2166	of	_	
3-88	2167-2171	drug	_	
3-89	2172-2179	addicts	_	
3-90	2179-2180	,	_	
3-91	2181-2183	as	_	
3-92	2184-2188	well	_	
3-93	2189-2191	as	_	
3-94	2192-2195	for	_	
3-95	2196-2199	the	_	
3-96	2200-2211	fundamental	_	
3-97	2212-2225	understanding	_	
3-98	2226-2228	of	_	
3-99	2229-2238	addictive	_	
3-100	2239-2248	behaviors	_	
3-101	2248-2249	.	_	

#Text=In a normal brain, the orbitofrontal cortex (OFC), as part of the prefrontal cortex (PFC), plays an essential role in executive functions and inhibitory decision making, especially in the formulation and use of outcome expectancies related to reward. The OFC mediates environmental stimuli, affective information, and emotional and social responses, such as demonstrating empathy, acessesing one’s own and other individuals’ thoughts and predicting future consequnces and actions. In contrast, well-documented neuroimaging studies of substance use disorders have provided accumulating evidence that disregulations in the decision-making functions of the OFC of an addict’s brain are closely associated with addictive traits, such as craving, salience, repeat drug use, and relapse.
4-1	2250-2252	In	_	
4-2	2253-2254	a	_	
4-3	2255-2261	normal	_	
4-4	2262-2267	brain	_	
4-5	2267-2268	,	_	
4-6	2269-2272	the	_	
4-7	2273-2286	orbitofrontal	_	
4-8	2287-2293	cortex	_	
4-9	2294-2295	(	_	
4-10	2295-2298	OFC	_	
4-11	2298-2299	)	_	
4-12	2299-2300	,	_	
4-13	2301-2303	as	_	
4-14	2304-2308	part	_	
4-15	2309-2311	of	_	
4-16	2312-2315	the	_	
4-17	2316-2326	prefrontal	_	
4-18	2327-2333	cortex	_	
4-19	2334-2335	(	_	
4-20	2335-2338	PFC	_	
4-21	2338-2339	)	_	
4-22	2339-2340	,	_	
4-23	2341-2346	plays	_	
4-24	2347-2349	an	_	
4-25	2350-2359	essential	_	
4-26	2360-2364	role	_	
4-27	2365-2367	in	_	
4-28	2368-2377	executive	_	
4-29	2378-2387	functions	_	
4-30	2388-2391	and	_	
4-31	2392-2402	inhibitory	_	
4-32	2403-2411	decision	_	
4-33	2412-2418	making	_	
4-34	2418-2419	,	_	
4-35	2420-2430	especially	_	
4-36	2431-2433	in	_	
4-37	2434-2437	the	_	
4-38	2438-2449	formulation	_	
4-39	2450-2453	and	_	
4-40	2454-2457	use	_	
4-41	2458-2460	of	_	
4-42	2461-2468	outcome	_	
4-43	2469-2481	expectancies	_	
4-44	2482-2489	related	_	
4-45	2490-2492	to	_	
4-46	2493-2499	reward	_	
4-47	2499-2500	.	_	
4-48	2501-2504	The	_	
4-49	2505-2508	OFC	_	
4-50	2509-2517	mediates	_	
4-51	2518-2531	environmental	_	
4-52	2532-2539	stimuli	_	
4-53	2539-2540	,	_	
4-54	2541-2550	affective	_	
4-55	2551-2562	information	_	
4-56	2562-2563	,	_	
4-57	2564-2567	and	_	
4-58	2568-2577	emotional	_	
4-59	2578-2581	and	_	
4-60	2582-2588	social	_	
4-61	2589-2598	responses	_	
4-62	2598-2599	,	_	
4-63	2600-2604	such	_	
4-64	2605-2607	as	_	
4-65	2608-2621	demonstrating	_	
4-66	2622-2629	empathy	_	
4-67	2629-2630	,	_	
4-68	2631-2641	acessesing	_	
4-69	2642-2645	one	_	
4-70	2645-2646	’	_	
4-71	2646-2647	s	_	
4-72	2648-2651	own	_	
4-73	2652-2655	and	_	
4-74	2656-2661	other	_	
4-75	2662-2673	individuals	_	
4-76	2673-2674	’	_	
4-77	2675-2683	thoughts	_	
4-78	2684-2687	and	_	
4-79	2688-2698	predicting	_	
4-80	2699-2705	future	_	
4-81	2706-2717	consequnces	_	
4-82	2718-2721	and	_	
4-83	2722-2729	actions	_	
4-84	2729-2730	.	_	
4-85	2731-2733	In	_	
4-86	2734-2742	contrast	_	
4-87	2742-2743	,	_	
4-88	2744-2759	well-documented	_	
4-89	2760-2772	neuroimaging	_	
4-90	2773-2780	studies	_	
4-91	2781-2783	of	_	
4-92	2784-2793	substance	_	
4-93	2794-2797	use	_	
4-94	2798-2807	disorders	_	
4-95	2808-2812	have	_	
4-96	2813-2821	provided	_	
4-97	2822-2834	accumulating	_	
4-98	2835-2843	evidence	_	
4-99	2844-2848	that	_	
4-100	2849-2863	disregulations	_	
4-101	2864-2866	in	_	
4-102	2867-2870	the	_	
4-103	2871-2886	decision-making	_	
4-104	2887-2896	functions	_	
4-105	2897-2899	of	_	
4-106	2900-2903	the	_	
4-107	2904-2907	OFC	_	
4-108	2908-2910	of	_	
4-109	2911-2913	an	_	
4-110	2914-2920	addict	_	
4-111	2920-2921	’	_	
4-112	2921-2922	s	_	
4-113	2923-2928	brain	_	
4-114	2929-2932	are	_	
4-115	2933-2940	closely	_	
4-116	2941-2951	associated	_	
4-117	2952-2956	with	_	
4-118	2957-2966	addictive	_	
4-119	2967-2973	traits	_	
4-120	2973-2974	,	_	
4-121	2975-2979	such	_	
4-122	2980-2982	as	_	
4-123	2983-2990	craving	_	
4-124	2990-2991	,	_	
4-125	2992-3000	salience	_	
4-126	3000-3001	,	_	
4-127	3002-3008	repeat	_	
4-128	3009-3013	drug	_	
4-129	3014-3017	use	_	
4-130	3017-3018	,	_	
4-131	3019-3022	and	_	
4-132	3023-3030	relapse	_	
4-133	3030-3031	.	_	

#Text=While task-based neuroimaging studies have provided convincing evidence that acute and/or chronic exposure to drugs of abuse can cause both short- and long-term consequences within delineated brain areas as well as essential insights into the neuroplastic adaptations resulting from drug exposure, these findings have failed to consistently described substantial brain activities in the OFC and their relationship to a particular drug. For example, previous studies attempting to detect different OFC activations in patients with methamphetamine and cocaine use disorders, both involving stimulants, these findings were not consistent. Paulus et al. demonstrated decreased task-related activity in the right OFC of methamphetamine users, whereas Bolla et al. reported increased brain activity in cocaine users. A more comprehensive strategy is needed to explain the underlying neural mechanisms in addiction to various drugs. The type of drug of abuse, the stage of the abuser, and other essential elements, such as comorbid anxiety or depression, and co-dependence on other substances, such as nicotine, should be considered and accounted in studies in order to better understand the essentiality of reward, anticipation, and cognition in the OFC networks. This may ultimately provide tools to predict relapse in individuals trying to recover from addiction.
5-1	3032-3037	While	_	
5-2	3038-3048	task-based	_	
5-3	3049-3061	neuroimaging	_	
5-4	3062-3069	studies	_	
5-5	3070-3074	have	_	
5-6	3075-3083	provided	_	
5-7	3084-3094	convincing	_	
5-8	3095-3103	evidence	_	
5-9	3104-3108	that	_	
5-10	3109-3114	acute	_	
5-11	3115-3118	and	_	
5-12	3118-3119	/	_	
5-13	3119-3121	or	_	
5-14	3122-3129	chronic	_	
5-15	3130-3138	exposure	_	
5-16	3139-3141	to	_	
5-17	3142-3147	drugs	_	
5-18	3148-3150	of	_	
5-19	3151-3156	abuse	_	
5-20	3157-3160	can	_	
5-21	3161-3166	cause	_	
5-22	3167-3171	both	_	
5-23	3172-3177	short	_	
5-24	3177-3178	-	_	
5-25	3179-3182	and	_	
5-26	3183-3192	long-term	_	
5-27	3193-3205	consequences	_	
5-28	3206-3212	within	_	
5-29	3213-3223	delineated	_	
5-30	3224-3229	brain	_	
5-31	3230-3235	areas	_	
5-32	3236-3238	as	_	
5-33	3239-3243	well	_	
5-34	3244-3246	as	_	
5-35	3247-3256	essential	_	
5-36	3257-3265	insights	_	
5-37	3266-3270	into	_	
5-38	3271-3274	the	_	
5-39	3275-3287	neuroplastic	_	
5-40	3288-3299	adaptations	_	
5-41	3300-3309	resulting	_	
5-42	3310-3314	from	_	
5-43	3315-3319	drug	_	
5-44	3320-3328	exposure	_	
5-45	3328-3329	,	_	
5-46	3330-3335	these	_	
5-47	3336-3344	findings	_	
5-48	3345-3349	have	_	
5-49	3350-3356	failed	_	
5-50	3357-3359	to	_	
5-51	3360-3372	consistently	_	
5-52	3373-3382	described	_	
5-53	3383-3394	substantial	_	
5-54	3395-3400	brain	_	
5-55	3401-3411	activities	_	
5-56	3412-3414	in	_	
5-57	3415-3418	the	_	
5-58	3419-3422	OFC	_	
5-59	3423-3426	and	_	
5-60	3427-3432	their	_	
5-61	3433-3445	relationship	_	
5-62	3446-3448	to	_	
5-63	3449-3450	a	_	
5-64	3451-3461	particular	_	
5-65	3462-3466	drug	_	
5-66	3466-3467	.	_	
5-67	3468-3471	For	_	
5-68	3472-3479	example	_	
5-69	3479-3480	,	_	
5-70	3481-3489	previous	_	
5-71	3490-3497	studies	_	
5-72	3498-3508	attempting	_	
5-73	3509-3511	to	_	
5-74	3512-3518	detect	_	
5-75	3519-3528	different	_	
5-76	3529-3532	OFC	_	
5-77	3533-3544	activations	_	
5-78	3545-3547	in	_	
5-79	3548-3556	patients	_	
5-80	3557-3561	with	_	
5-81	3562-3577	methamphetamine	_	
5-82	3578-3581	and	_	
5-83	3582-3589	cocaine	_	
5-84	3590-3593	use	_	
5-85	3594-3603	disorders	_	
5-86	3603-3604	,	_	
5-87	3605-3609	both	_	
5-88	3610-3619	involving	_	
5-89	3620-3630	stimulants	_	
5-90	3630-3631	,	_	
5-91	3632-3637	these	_	
5-92	3638-3646	findings	_	
5-93	3647-3651	were	_	
5-94	3652-3655	not	_	
5-95	3656-3666	consistent	_	
5-96	3666-3667	.	_	
5-97	3668-3674	Paulus	_	
5-98	3675-3677	et	_	
5-99	3678-3680	al	_	
5-100	3680-3681	.	_	
5-101	3682-3694	demonstrated	_	
5-102	3695-3704	decreased	_	
5-103	3705-3717	task-related	_	
5-104	3718-3726	activity	_	
5-105	3727-3729	in	_	
5-106	3730-3733	the	_	
5-107	3734-3739	right	_	
5-108	3740-3743	OFC	_	
5-109	3744-3746	of	_	
5-110	3747-3762	methamphetamine	_	
5-111	3763-3768	users	_	
5-112	3768-3769	,	_	
5-113	3770-3777	whereas	_	
5-114	3778-3783	Bolla	_	
5-115	3784-3786	et	_	
5-116	3787-3789	al	_	
5-117	3789-3790	.	_	
5-118	3791-3799	reported	_	
5-119	3800-3809	increased	_	
5-120	3810-3815	brain	_	
5-121	3816-3824	activity	_	
5-122	3825-3827	in	_	
5-123	3828-3835	cocaine	_	
5-124	3836-3841	users	_	
5-125	3841-3842	.	_	
5-126	3843-3844	A	_	
5-127	3845-3849	more	_	
5-128	3850-3863	comprehensive	_	
5-129	3864-3872	strategy	_	
5-130	3873-3875	is	_	
5-131	3876-3882	needed	_	
5-132	3883-3885	to	_	
5-133	3886-3893	explain	_	
5-134	3894-3897	the	_	
5-135	3898-3908	underlying	_	
5-136	3909-3915	neural	_	
5-137	3916-3926	mechanisms	_	
5-138	3927-3929	in	_	
5-139	3930-3939	addiction	_	
5-140	3940-3942	to	_	
5-141	3943-3950	various	_	
5-142	3951-3956	drugs	_	
5-143	3956-3957	.	_	
5-144	3958-3961	The	_	
5-145	3962-3966	type	_	
5-146	3967-3969	of	_	
5-147	3970-3974	drug	_	
5-148	3975-3977	of	_	
5-149	3978-3983	abuse	_	
5-150	3983-3984	,	_	
5-151	3985-3988	the	_	
5-152	3989-3994	stage	_	
5-153	3995-3997	of	_	
5-154	3998-4001	the	_	
5-155	4002-4008	abuser	_	
5-156	4008-4009	,	_	
5-157	4010-4013	and	_	
5-158	4014-4019	other	_	
5-159	4020-4029	essential	_	
5-160	4030-4038	elements	_	
5-161	4038-4039	,	_	
5-162	4040-4044	such	_	
5-163	4045-4047	as	_	
5-164	4048-4056	comorbid	_	
5-165	4057-4064	anxiety	_	
5-166	4065-4067	or	_	
5-167	4068-4078	depression	_	
5-168	4078-4079	,	_	
5-169	4080-4083	and	_	
5-170	4084-4097	co-dependence	_	
5-171	4098-4100	on	_	
5-172	4101-4106	other	_	
5-173	4107-4117	substances	_	
5-174	4117-4118	,	_	
5-175	4119-4123	such	_	
5-176	4124-4126	as	_	
5-177	4127-4135	nicotine	_	
5-178	4135-4136	,	_	
5-179	4137-4143	should	_	
5-180	4144-4146	be	_	
5-181	4147-4157	considered	_	
5-182	4158-4161	and	_	
5-183	4162-4171	accounted	_	
5-184	4172-4174	in	_	
5-185	4175-4182	studies	_	
5-186	4183-4185	in	_	
5-187	4186-4191	order	_	
5-188	4192-4194	to	_	
5-189	4195-4201	better	_	
5-190	4202-4212	understand	_	
5-191	4213-4216	the	_	
5-192	4217-4229	essentiality	_	
5-193	4230-4232	of	_	
5-194	4233-4239	reward	_	
5-195	4239-4240	,	_	
5-196	4241-4253	anticipation	_	
5-197	4253-4254	,	_	
5-198	4255-4258	and	_	
5-199	4259-4268	cognition	_	
5-200	4269-4271	in	_	
5-201	4272-4275	the	_	
5-202	4276-4279	OFC	_	
5-203	4280-4288	networks	_	
5-204	4288-4289	.	_	
5-205	4290-4294	This	_	
5-206	4295-4298	may	_	
5-207	4299-4309	ultimately	_	
5-208	4310-4317	provide	_	
5-209	4318-4323	tools	_	
5-210	4324-4326	to	_	
5-211	4327-4334	predict	_	
5-212	4335-4342	relapse	_	
5-213	4343-4345	in	_	
5-214	4346-4357	individuals	_	
5-215	4358-4364	trying	_	
5-216	4365-4367	to	_	
5-217	4368-4375	recover	_	
5-218	4376-4380	from	_	
5-219	4381-4390	addiction	_	
5-220	4390-4391	.	_	

#Text=One previous study found that anxiety can be a predictor of relapse. Recently, an additional study demonstrated that anxiety produced by environmental stressors played an essential role in the connectivity among the OFC, inferior frontal gyrus, ventromedial PFC, and amygdala; this anxiety was linked to a range of impaired goal-directed psychiatric disorders, such as addiction. Drug addiction involves deficits in controlling drug-seeking and drug-taking behaviors via inhibitory decision making – a function that presumably depends on connectivity within the OFC cortical network. Thus, in the present study we hypothesized that alterations in the OFC correlated with anxiety in heroin addiction.
6-1	4392-4395	One	_	
6-2	4396-4404	previous	_	
6-3	4405-4410	study	_	
6-4	4411-4416	found	_	
6-5	4417-4421	that	_	
6-6	4422-4429	anxiety	_	
6-7	4430-4433	can	_	
6-8	4434-4436	be	_	
6-9	4437-4438	a	_	
6-10	4439-4448	predictor	_	
6-11	4449-4451	of	_	
6-12	4452-4459	relapse	_	
6-13	4459-4460	.	_	
6-14	4461-4469	Recently	_	
6-15	4469-4470	,	_	
6-16	4471-4473	an	_	
6-17	4474-4484	additional	_	
6-18	4485-4490	study	_	
6-19	4491-4503	demonstrated	_	
6-20	4504-4508	that	_	
6-21	4509-4516	anxiety	_	
6-22	4517-4525	produced	_	
6-23	4526-4528	by	_	
6-24	4529-4542	environmental	_	
6-25	4543-4552	stressors	_	
6-26	4553-4559	played	_	
6-27	4560-4562	an	_	
6-28	4563-4572	essential	_	
6-29	4573-4577	role	_	
6-30	4578-4580	in	_	
6-31	4581-4584	the	_	
6-32	4585-4597	connectivity	_	
6-33	4598-4603	among	_	
6-34	4604-4607	the	_	
6-35	4608-4611	OFC	_	
6-36	4611-4612	,	_	
6-37	4613-4621	inferior	_	
6-38	4622-4629	frontal	_	
6-39	4630-4635	gyrus	_	
6-40	4635-4636	,	_	
6-41	4637-4649	ventromedial	_	
6-42	4650-4653	PFC	_	
6-43	4653-4654	,	_	
6-44	4655-4658	and	_	
6-45	4659-4667	amygdala	_	
6-46	4667-4668	;	_	
6-47	4669-4673	this	_	
6-48	4674-4681	anxiety	_	
6-49	4682-4685	was	_	
6-50	4686-4692	linked	_	
6-51	4693-4695	to	_	
6-52	4696-4697	a	_	
6-53	4698-4703	range	_	
6-54	4704-4706	of	_	
6-55	4707-4715	impaired	_	
6-56	4716-4729	goal-directed	_	
6-57	4730-4741	psychiatric	_	
6-58	4742-4751	disorders	_	
6-59	4751-4752	,	_	
6-60	4753-4757	such	_	
6-61	4758-4760	as	_	
6-62	4761-4770	addiction	_	
6-63	4770-4771	.	_	
6-64	4772-4776	Drug	_	
6-65	4777-4786	addiction	_	
6-66	4787-4795	involves	_	
6-67	4796-4804	deficits	_	
6-68	4805-4807	in	_	
6-69	4808-4819	controlling	_	
6-70	4820-4832	drug-seeking	_	
6-71	4833-4836	and	_	
6-72	4837-4848	drug-taking	_	
6-73	4849-4858	behaviors	_	
6-74	4859-4862	via	_	
6-75	4863-4873	inhibitory	_	
6-76	4874-4882	decision	_	
6-77	4883-4889	making	_	
6-78	4890-4891	–	_	
6-79	4892-4893	a	_	
6-80	4894-4902	function	_	
6-81	4903-4907	that	_	
6-82	4908-4918	presumably	_	
6-83	4919-4926	depends	_	
6-84	4927-4929	on	_	
6-85	4930-4942	connectivity	_	
6-86	4943-4949	within	_	
6-87	4950-4953	the	_	
6-88	4954-4957	OFC	_	
6-89	4958-4966	cortical	_	
6-90	4967-4974	network	_	
6-91	4974-4975	.	_	
6-92	4976-4980	Thus	_	
6-93	4980-4981	,	_	
6-94	4982-4984	in	_	
6-95	4985-4988	the	_	
6-96	4989-4996	present	_	
6-97	4997-5002	study	_	
6-98	5003-5005	we	_	
6-99	5006-5018	hypothesized	_	
6-100	5019-5023	that	_	
6-101	5024-5035	alterations	_	
6-102	5036-5038	in	_	
6-103	5039-5042	the	_	
6-104	5043-5046	OFC	_	
6-105	5047-5057	correlated	_	
6-106	5058-5062	with	_	
6-107	5063-5070	anxiety	_	
6-108	5071-5073	in	_	
6-109	5074-5080	heroin	_	
6-110	5081-5090	addiction	_	
6-111	5090-5091	.	_	

#Text=Recently, there has been growing evidence that resting-state functional connectivity (rsFC) can provide significant insight and may be a biomarker for the early detection of impaired neural circuitry underlying diverse neuropsychiatric disorders. The theory is that neurons synchronized at rest are synaptically bound to defined, straightforward, or multiple interconnected regions and therefore create credible and logical functional networks. Furthermore, the strength of these functional networks at rest can predict accurate behavioral responses and the sequential arousal of the same brain regions when tasks are being performed.
7-1	5092-5100	Recently	_	
7-2	5100-5101	,	_	
7-3	5102-5107	there	_	
7-4	5108-5111	has	_	
7-5	5112-5116	been	_	
7-6	5117-5124	growing	_	
7-7	5125-5133	evidence	_	
7-8	5134-5138	that	_	
7-9	5139-5152	resting-state	_	
7-10	5153-5163	functional	_	
7-11	5164-5176	connectivity	_	
7-12	5177-5178	(	_	
7-13	5178-5182	rsFC	_	
7-14	5182-5183	)	_	
7-15	5184-5187	can	_	
7-16	5188-5195	provide	_	
7-17	5196-5207	significant	_	
7-18	5208-5215	insight	_	
7-19	5216-5219	and	_	
7-20	5220-5223	may	_	
7-21	5224-5226	be	_	
7-22	5227-5228	a	_	
7-23	5229-5238	biomarker	_	
7-24	5239-5242	for	_	
7-25	5243-5246	the	_	
7-26	5247-5252	early	_	
7-27	5253-5262	detection	_	
7-28	5263-5265	of	_	
7-29	5266-5274	impaired	_	
7-30	5275-5281	neural	_	
7-31	5282-5291	circuitry	_	
7-32	5292-5302	underlying	_	
7-33	5303-5310	diverse	_	
7-34	5311-5327	neuropsychiatric	_	
7-35	5328-5337	disorders	_	
7-36	5337-5338	.	_	
7-37	5339-5342	The	_	
7-38	5343-5349	theory	_	
7-39	5350-5352	is	_	
7-40	5353-5357	that	_	
7-41	5358-5365	neurons	_	
7-42	5366-5378	synchronized	_	
7-43	5379-5381	at	_	
7-44	5382-5386	rest	_	
7-45	5387-5390	are	_	
7-46	5391-5403	synaptically	_	
7-47	5404-5409	bound	_	
7-48	5410-5412	to	_	
7-49	5413-5420	defined	_	
7-50	5420-5421	,	_	
7-51	5422-5437	straightforward	_	
7-52	5437-5438	,	_	
7-53	5439-5441	or	_	
7-54	5442-5450	multiple	_	
7-55	5451-5465	interconnected	_	
7-56	5466-5473	regions	_	
7-57	5474-5477	and	_	
7-58	5478-5487	therefore	_	
7-59	5488-5494	create	_	
7-60	5495-5503	credible	_	
7-61	5504-5507	and	_	
7-62	5508-5515	logical	_	
7-63	5516-5526	functional	_	
7-64	5527-5535	networks	_	
7-65	5535-5536	.	_	
7-66	5537-5548	Furthermore	_	
7-67	5548-5549	,	_	
7-68	5550-5553	the	_	
7-69	5554-5562	strength	_	
7-70	5563-5565	of	_	
7-71	5566-5571	these	_	
7-72	5572-5582	functional	_	
7-73	5583-5591	networks	_	
7-74	5592-5594	at	_	
7-75	5595-5599	rest	_	
7-76	5600-5603	can	_	
7-77	5604-5611	predict	_	
7-78	5612-5620	accurate	_	
7-79	5621-5631	behavioral	_	
7-80	5632-5641	responses	_	
7-81	5642-5645	and	_	
7-82	5646-5649	the	_	
7-83	5650-5660	sequential	_	
7-84	5661-5668	arousal	_	
7-85	5669-5671	of	_	
7-86	5672-5675	the	_	
7-87	5676-5680	same	_	
7-88	5681-5686	brain	_	
7-89	5687-5694	regions	_	
7-90	5695-5699	when	_	
7-91	5700-5705	tasks	_	
7-92	5706-5709	are	_	
7-93	5710-5715	being	_	
7-94	5716-5725	performed	_	
7-95	5725-5726	.	_	

#Text=More importantly, functional near-infrared spectroscopy (fNIRS), a rapidly growing non-invasive neuroimaging technique, offers good temporal resolution and provides quantitative hemodynamic information regarding both oxyhemoglobin (HbO) and deoxyhemoglobin (Hb). fNIRS has been implemented in the form of a wearable device capable of intuitively monitoring brain activity in real-life conditions, it has shown promise over the past few decades to support rsFC studies in both healthy individuals and psychiatric patients with depression, attention deficit/hyperactive disorder, and autism, suggesting that alterations in rsFC strength has potential as a biomarker to examine different psychiatric disorder trajectories. Recently, the use of fNIRS to assess functional connectivity has been extended to psychiatric patients with arachnophobia and children with psychopathology risk.
8-1	5727-5731	More	_	
8-2	5732-5743	importantly	_	
8-3	5743-5744	,	_	
8-4	5745-5755	functional	_	
8-5	5756-5769	near-infrared	_	
8-6	5770-5782	spectroscopy	_	
8-7	5783-5784	(	_	
8-8	5784-5789	fNIRS	_	
8-9	5789-5790	)	_	
8-10	5790-5791	,	_	
8-11	5792-5793	a	_	
8-12	5794-5801	rapidly	_	
8-13	5802-5809	growing	_	
8-14	5810-5822	non-invasive	_	
8-15	5823-5835	neuroimaging	_	
8-16	5836-5845	technique	_	
8-17	5845-5846	,	_	
8-18	5847-5853	offers	_	
8-19	5854-5858	good	_	
8-20	5859-5867	temporal	_	
8-21	5868-5878	resolution	_	
8-22	5879-5882	and	_	
8-23	5883-5891	provides	_	
8-24	5892-5904	quantitative	_	
8-25	5905-5916	hemodynamic	_	
8-26	5917-5928	information	_	
8-27	5929-5938	regarding	_	
8-28	5939-5943	both	_	
8-29	5944-5957	oxyhemoglobin	_	
8-30	5958-5959	(	_	
8-31	5959-5962	HbO	_	
8-32	5962-5963	)	_	
8-33	5964-5967	and	_	
8-34	5968-5983	deoxyhemoglobin	_	
8-35	5984-5985	(	_	
8-36	5985-5987	Hb	_	
8-37	5987-5988	)	_	
8-38	5988-5989	.	_	
8-39	5990-5995	fNIRS	_	
8-40	5996-5999	has	_	
8-41	6000-6004	been	_	
8-42	6005-6016	implemented	_	
8-43	6017-6019	in	_	
8-44	6020-6023	the	_	
8-45	6024-6028	form	_	
8-46	6029-6031	of	_	
8-47	6032-6033	a	_	
8-48	6034-6042	wearable	_	
8-49	6043-6049	device	_	
8-50	6050-6057	capable	_	
8-51	6058-6060	of	_	
8-52	6061-6072	intuitively	_	
8-53	6073-6083	monitoring	_	
8-54	6084-6089	brain	_	
8-55	6090-6098	activity	_	
8-56	6099-6101	in	_	
8-57	6102-6111	real-life	_	
8-58	6112-6122	conditions	_	
8-59	6122-6123	,	_	
8-60	6124-6126	it	_	
8-61	6127-6130	has	_	
8-62	6131-6136	shown	_	
8-63	6137-6144	promise	_	
8-64	6145-6149	over	_	
8-65	6150-6153	the	_	
8-66	6154-6158	past	_	
8-67	6159-6162	few	_	
8-68	6163-6170	decades	_	
8-69	6171-6173	to	_	
8-70	6174-6181	support	_	
8-71	6182-6186	rsFC	_	
8-72	6187-6194	studies	_	
8-73	6195-6197	in	_	
8-74	6198-6202	both	_	
8-75	6203-6210	healthy	_	
8-76	6211-6222	individuals	_	
8-77	6223-6226	and	_	
8-78	6227-6238	psychiatric	_	
8-79	6239-6247	patients	_	
8-80	6248-6252	with	_	
8-81	6253-6263	depression	_	
8-82	6263-6264	,	_	
8-83	6265-6274	attention	_	
8-84	6275-6282	deficit	_	
8-85	6282-6283	/	_	
8-86	6283-6294	hyperactive	_	
8-87	6295-6303	disorder	_	
8-88	6303-6304	,	_	
8-89	6305-6308	and	_	
8-90	6309-6315	autism	_	
8-91	6315-6316	,	_	
8-92	6317-6327	suggesting	_	
8-93	6328-6332	that	_	
8-94	6333-6344	alterations	_	
8-95	6345-6347	in	_	
8-96	6348-6352	rsFC	_	
8-97	6353-6361	strength	_	
8-98	6362-6365	has	_	
8-99	6366-6375	potential	_	
8-100	6376-6378	as	_	
8-101	6379-6380	a	_	
8-102	6381-6390	biomarker	_	
8-103	6391-6393	to	_	
8-104	6394-6401	examine	_	
8-105	6402-6411	different	_	
8-106	6412-6423	psychiatric	_	
8-107	6424-6432	disorder	_	
8-108	6433-6445	trajectories	_	
8-109	6445-6446	.	_	
8-110	6447-6455	Recently	_	
8-111	6455-6456	,	_	
8-112	6457-6460	the	_	
8-113	6461-6464	use	_	
8-114	6465-6467	of	_	
8-115	6468-6473	fNIRS	_	
8-116	6474-6476	to	_	
8-117	6477-6483	assess	_	
8-118	6484-6494	functional	_	
8-119	6495-6507	connectivity	_	
8-120	6508-6511	has	_	
8-121	6512-6516	been	_	
8-122	6517-6525	extended	_	
8-123	6526-6528	to	_	
8-124	6529-6540	psychiatric	_	
8-125	6541-6549	patients	_	
8-126	6550-6554	with	_	
8-127	6555-6568	arachnophobia	_	
8-128	6569-6572	and	_	
8-129	6573-6581	children	_	
8-130	6582-6586	with	_	
8-131	6587-6602	psychopathology	_	
8-132	6603-6607	risk	_	
8-133	6607-6608	.	_	

#Text=To the best of our knowledge, no investigations have been conducted using fNIRS measurements to identify the OFC activation network patterns and the rsFC of individuals with heroin addiction. Although this pilot study is not sufficient to provide full verification of the above stated hypotheses, the objectives of our experimental investigation are multi-fold: (1) to explore the neural networks generated within and between the particular OFC brain regions when an individual with heroin addiction is at rest; (2) to examine whether rsFC in the OFC is increased or decreased by focusing on abstinent heroin addicts; and (3) to investigate correlations with anxiety in local OFC networks. This pilot study used resting-state fNIRS in a small sample of abstinent heroin-dependent (HD) individuals in order to identify novel neural correlates of opioid addiction and anxiety in the OFC system.
9-1	6609-6611	To	_	
9-2	6612-6615	the	_	
9-3	6616-6620	best	_	
9-4	6621-6623	of	_	
9-5	6624-6627	our	_	
9-6	6628-6637	knowledge	_	
9-7	6637-6638	,	_	
9-8	6639-6641	no	_	
9-9	6642-6656	investigations	_	
9-10	6657-6661	have	_	
9-11	6662-6666	been	_	
9-12	6667-6676	conducted	_	
9-13	6677-6682	using	_	
9-14	6683-6688	fNIRS	_	
9-15	6689-6701	measurements	_	
9-16	6702-6704	to	_	
9-17	6705-6713	identify	_	
9-18	6714-6717	the	_	
9-19	6718-6721	OFC	_	
9-20	6722-6732	activation	_	
9-21	6733-6740	network	_	
9-22	6741-6749	patterns	_	
9-23	6750-6753	and	_	
9-24	6754-6757	the	_	
9-25	6758-6762	rsFC	_	
9-26	6763-6765	of	_	
9-27	6766-6777	individuals	_	
9-28	6778-6782	with	_	
9-29	6783-6789	heroin	_	
9-30	6790-6799	addiction	_	
9-31	6799-6800	.	_	
9-32	6801-6809	Although	_	
9-33	6810-6814	this	_	
9-34	6815-6820	pilot	_	
9-35	6821-6826	study	_	
9-36	6827-6829	is	_	
9-37	6830-6833	not	_	
9-38	6834-6844	sufficient	_	
9-39	6845-6847	to	_	
9-40	6848-6855	provide	_	
9-41	6856-6860	full	_	
9-42	6861-6873	verification	_	
9-43	6874-6876	of	_	
9-44	6877-6880	the	_	
9-45	6881-6886	above	_	
9-46	6887-6893	stated	_	
9-47	6894-6904	hypotheses	_	
9-48	6904-6905	,	_	
9-49	6906-6909	the	_	
9-50	6910-6920	objectives	_	
9-51	6921-6923	of	_	
9-52	6924-6927	our	_	
9-53	6928-6940	experimental	_	
9-54	6941-6954	investigation	_	
9-55	6955-6958	are	_	
9-56	6959-6969	multi-fold	_	
9-57	6969-6970	:	_	
9-58	6971-6972	(	_	
9-59	6972-6973	1	_	
9-60	6973-6974	)	_	
9-61	6975-6977	to	_	
9-62	6978-6985	explore	_	
9-63	6986-6989	the	_	
9-64	6990-6996	neural	_	
9-65	6997-7005	networks	_	
9-66	7006-7015	generated	_	
9-67	7016-7022	within	_	
9-68	7023-7026	and	_	
9-69	7027-7034	between	_	
9-70	7035-7038	the	_	
9-71	7039-7049	particular	_	
9-72	7050-7053	OFC	_	
9-73	7054-7059	brain	_	
9-74	7060-7067	regions	_	
9-75	7068-7072	when	_	
9-76	7073-7075	an	_	
9-77	7076-7086	individual	_	
9-78	7087-7091	with	_	
9-79	7092-7098	heroin	_	
9-80	7099-7108	addiction	_	
9-81	7109-7111	is	_	
9-82	7112-7114	at	_	
9-83	7115-7119	rest	_	
9-84	7119-7120	;	_	
9-85	7121-7122	(	_	
9-86	7122-7123	2	_	
9-87	7123-7124	)	_	
9-88	7125-7127	to	_	
9-89	7128-7135	examine	_	
9-90	7136-7143	whether	_	
9-91	7144-7148	rsFC	_	
9-92	7149-7151	in	_	
9-93	7152-7155	the	_	
9-94	7156-7159	OFC	_	
9-95	7160-7162	is	_	
9-96	7163-7172	increased	_	
9-97	7173-7175	or	_	
9-98	7176-7185	decreased	_	
9-99	7186-7188	by	_	
9-100	7189-7197	focusing	_	
9-101	7198-7200	on	_	
9-102	7201-7210	abstinent	_	
9-103	7211-7217	heroin	_	
9-104	7218-7225	addicts	_	
9-105	7225-7226	;	_	
9-106	7227-7230	and	_	
9-107	7231-7232	(	_	
9-108	7232-7233	3	_	
9-109	7233-7234	)	_	
9-110	7235-7237	to	_	
9-111	7238-7249	investigate	_	
9-112	7250-7262	correlations	_	
9-113	7263-7267	with	_	
9-114	7268-7275	anxiety	_	
9-115	7276-7278	in	_	
9-116	7279-7284	local	_	
9-117	7285-7288	OFC	_	
9-118	7289-7297	networks	_	
9-119	7297-7298	.	_	
9-120	7299-7303	This	_	
9-121	7304-7309	pilot	_	
9-122	7310-7315	study	_	
9-123	7316-7320	used	_	
9-124	7321-7334	resting-state	_	
9-125	7335-7340	fNIRS	_	
9-126	7341-7343	in	_	
9-127	7344-7345	a	_	
9-128	7346-7351	small	_	
9-129	7352-7358	sample	_	
9-130	7359-7361	of	_	
9-131	7362-7371	abstinent	_	
9-132	7372-7388	heroin-dependent	_	
9-133	7389-7390	(	_	
9-134	7390-7392	HD	_	
9-135	7392-7393	)	_	
9-136	7394-7405	individuals	_	
9-137	7406-7408	in	_	
9-138	7409-7414	order	_	
9-139	7415-7417	to	_	
9-140	7418-7426	identify	_	
9-141	7427-7432	novel	_	
9-142	7433-7439	neural	_	
9-143	7440-7450	correlates	_	
9-144	7451-7453	of	_	
9-145	7454-7460	opioid	_	
9-146	7461-7470	addiction	_	
9-147	7471-7474	and	_	
9-148	7475-7482	anxiety	_	
9-149	7483-7485	in	_	
9-150	7486-7489	the	_	
9-151	7490-7493	OFC	_	
9-152	7494-7500	system	_	
9-153	7500-7501	.	_	

#Text=Results
10-1	7502-7509	Results	_	

#Text=Interhemispheric correlations
11-1	7510-7526	Interhemispheric	_	
11-2	7527-7539	correlations	_	

#Text=The results of the interhemispheric correlation analysis are shown in Fig. 1. The HbO and Hb signals were examined to explore the long-distance brain connectivity through the intravascular events between the hemispheres. Compared with the control group subjects (CGs), the study group (HDs) manifested enhanced overall functional connectivity between the left and right hemispheres, including all the channels that covered the lOFC and mOFC regions (see Supplementary Table S2). Specifically, the results of Student’s t-test showed that, compared with the CGs, the HDs exhibited significantly higher overall left-right correlation values for HbO (rHD = 0.857 ± 0.024, rCG = 0.751 ± 0.046, p = 0.016) and significantly higher HbO values in the lOFC (rHD = 0.871 ± 0.017, rCG = 0.678 ± 0.070, p = 0.033). More importantly, the HDs also showed significantly greater overall interhemispheric correlation values for Hb than the CGs (rHD = 0.727 ± 0.039, rCG = 0.590 ± 0.027, p = 0.012) and in the mOFC (rHD = 0.919 ± 0.016, rCG = 0.787 ± 0.047, p = 0.012) and lOFC regions (rHD = 0.625 ± 0.050, rCG = 0.476 ± 0.047, p = 0.049). In contrast, the HbO values in the mOFC regions (p = 0.206) did not show a significant difference between the groups.
12-1	7540-7543	The	_	
12-2	7544-7551	results	_	
12-3	7552-7554	of	_	
12-4	7555-7558	the	_	
12-5	7559-7575	interhemispheric	_	
12-6	7576-7587	correlation	_	
12-7	7588-7596	analysis	_	
12-8	7597-7600	are	_	
12-9	7601-7606	shown	_	
12-10	7607-7609	in	_	
12-11	7610-7613	Fig	_	
12-12	7613-7614	.	_	
12-13	7615-7616	1	_	
12-14	7616-7617	.	_	
12-15	7618-7621	The	_	
12-16	7622-7625	HbO	_	
12-17	7626-7629	and	_	
12-18	7630-7632	Hb	_	
12-19	7633-7640	signals	_	
12-20	7641-7645	were	_	
12-21	7646-7654	examined	_	
12-22	7655-7657	to	_	
12-23	7658-7665	explore	_	
12-24	7666-7669	the	_	
12-25	7670-7683	long-distance	_	
12-26	7684-7689	brain	_	
12-27	7690-7702	connectivity	_	
12-28	7703-7710	through	_	
12-29	7711-7714	the	_	
12-30	7715-7728	intravascular	_	
12-31	7729-7735	events	_	
12-32	7736-7743	between	_	
12-33	7744-7747	the	_	
12-34	7748-7759	hemispheres	_	
12-35	7759-7760	.	_	
12-36	7761-7769	Compared	_	
12-37	7770-7774	with	_	
12-38	7775-7778	the	_	
12-39	7779-7786	control	http://www.ukp.informatik.tu-darmstadt.de/inception/1.0#node1f7tpjks8x1[5]	
12-40	7787-7792	group	http://www.ukp.informatik.tu-darmstadt.de/inception/1.0#node1f7tpjks8x1[5]	
12-41	7793-7801	subjects	http://www.ukp.informatik.tu-darmstadt.de/inception/1.0#node1f7tpjks8x1[5]	
12-42	7802-7803	(	http://www.ukp.informatik.tu-darmstadt.de/inception/1.0#node1f7tpjks8x1[5]	
12-43	7803-7806	CGs	http://www.ukp.informatik.tu-darmstadt.de/inception/1.0#node1f7tpjks8x1[5]	
12-44	7806-7807	)	http://www.ukp.informatik.tu-darmstadt.de/inception/1.0#node1f7tpjks8x1[5]	
12-45	7807-7808	,	_	
12-46	7809-7812	the	_	
12-47	7813-7818	study	_	
12-48	7819-7824	group	_	
12-49	7825-7826	(	_	
12-50	7826-7829	HDs	_	
12-51	7829-7830	)	_	
12-52	7831-7841	manifested	_	
12-53	7842-7850	enhanced	_	
12-54	7851-7858	overall	_	
12-55	7859-7869	functional	_	
12-56	7870-7882	connectivity	_	
12-57	7883-7890	between	_	
12-58	7891-7894	the	_	
12-59	7895-7899	left	_	
12-60	7900-7903	and	_	
12-61	7904-7909	right	_	
12-62	7910-7921	hemispheres	_	
12-63	7921-7922	,	_	
12-64	7923-7932	including	_	
12-65	7933-7936	all	_	
12-66	7937-7940	the	_	
12-67	7941-7949	channels	_	
12-68	7950-7954	that	_	
12-69	7955-7962	covered	_	
12-70	7963-7966	the	_	
12-71	7967-7971	lOFC	_	
12-72	7972-7975	and	_	
12-73	7976-7980	mOFC	_	
12-74	7981-7988	regions	_	
12-75	7989-7990	(	_	
12-76	7990-7993	see	_	
12-77	7994-8007	Supplementary	_	
12-78	8008-8013	Table	_	
12-79	8014-8016	S2	_	
12-80	8016-8017	)	_	
12-81	8017-8018	.	_	
12-82	8019-8031	Specifically	_	
12-83	8031-8032	,	_	
12-84	8033-8036	the	_	
12-85	8037-8044	results	_	
12-86	8045-8047	of	_	
12-87	8048-8055	Student	_	
12-88	8055-8056	’	_	
12-89	8056-8057	s	_	
12-90	8058-8064	t-test	_	
12-91	8065-8071	showed	_	
12-92	8072-8076	that	_	
12-93	8076-8077	,	_	
12-94	8078-8086	compared	_	
12-95	8087-8091	with	_	
12-96	8092-8095	the	_	
12-97	8096-8099	CGs	_	
12-98	8099-8100	,	_	
12-99	8101-8104	the	_	
12-100	8105-8108	HDs	_	
12-101	8109-8118	exhibited	_	
12-102	8119-8132	significantly	_	
12-103	8133-8139	higher	_	
12-104	8140-8147	overall	_	
12-105	8148-8158	left-right	_	
12-106	8159-8170	correlation	_	
12-107	8171-8177	values	_	
12-108	8178-8181	for	_	
12-109	8182-8185	HbO	_	
12-110	8186-8187	(	_	
12-111	8187-8190	rHD	_	
12-112	8191-8192	=	_	
12-113	8193-8198	0.857	_	
12-114	8199-8200	±	_	
12-115	8201-8206	0.024	_	
12-116	8206-8207	,	_	
12-117	8208-8211	rCG	_	
12-118	8212-8213	=	_	
12-119	8214-8219	0.751	_	
12-120	8220-8221	±	_	
12-121	8222-8227	0.046	_	
12-122	8227-8228	,	_	
12-123	8229-8230	p	_	
12-124	8231-8232	=	_	
12-125	8233-8238	0.016	_	
12-126	8238-8239	)	_	
12-127	8240-8243	and	_	
12-128	8244-8257	significantly	_	
12-129	8258-8264	higher	_	
12-130	8265-8268	HbO	_	
12-131	8269-8275	values	_	
12-132	8276-8278	in	_	
12-133	8279-8282	the	_	
12-134	8283-8287	lOFC	_	
12-135	8288-8289	(	_	
12-136	8289-8292	rHD	_	
12-137	8293-8294	=	_	
12-138	8295-8300	0.871	_	
12-139	8301-8302	±	_	
12-140	8303-8308	0.017	_	
12-141	8308-8309	,	_	
12-142	8310-8313	rCG	_	
12-143	8314-8315	=	_	
12-144	8316-8321	0.678	_	
12-145	8322-8323	±	_	
12-146	8324-8329	0.070	_	
12-147	8329-8330	,	_	
12-148	8331-8332	p	_	
12-149	8333-8334	=	_	
12-150	8335-8340	0.033	_	
12-151	8340-8341	)	_	
12-152	8341-8342	.	_	
12-153	8343-8347	More	_	
12-154	8348-8359	importantly	_	
12-155	8359-8360	,	_	
12-156	8361-8364	the	_	
12-157	8365-8368	HDs	_	
12-158	8369-8373	also	_	
12-159	8374-8380	showed	_	
12-160	8381-8394	significantly	_	
12-161	8395-8402	greater	_	
12-162	8403-8410	overall	_	
12-163	8411-8427	interhemispheric	_	
12-164	8428-8439	correlation	_	
12-165	8440-8446	values	_	
12-166	8447-8450	for	_	
12-167	8451-8453	Hb	_	
12-168	8454-8458	than	_	
12-169	8459-8462	the	_	
12-170	8463-8466	CGs	_	
12-171	8467-8468	(	_	
12-172	8468-8471	rHD	_	
12-173	8472-8473	=	_	
12-174	8474-8479	0.727	_	
12-175	8480-8481	±	_	
12-176	8482-8487	0.039	_	
12-177	8487-8488	,	_	
12-178	8489-8492	rCG	_	
12-179	8493-8494	=	_	
12-180	8495-8500	0.590	_	
12-181	8501-8502	±	_	
12-182	8503-8508	0.027	_	
12-183	8508-8509	,	_	
12-184	8510-8511	p	_	
12-185	8512-8513	=	_	
12-186	8514-8519	0.012	_	
12-187	8519-8520	)	_	
12-188	8521-8524	and	_	
12-189	8525-8527	in	_	
12-190	8528-8531	the	_	
12-191	8532-8536	mOFC	_	
12-192	8537-8538	(	_	
12-193	8538-8541	rHD	_	
12-194	8542-8543	=	_	
12-195	8544-8549	0.919	_	
12-196	8550-8551	±	_	
12-197	8552-8557	0.016	_	
12-198	8557-8558	,	_	
12-199	8559-8562	rCG	_	
12-200	8563-8564	=	_	
12-201	8565-8570	0.787	_	
12-202	8571-8572	±	_	
12-203	8573-8578	0.047	_	
12-204	8578-8579	,	_	
12-205	8580-8581	p	_	
12-206	8582-8583	=	_	
12-207	8584-8589	0.012	_	
12-208	8589-8590	)	_	
12-209	8591-8594	and	_	
12-210	8595-8599	lOFC	_	
12-211	8600-8607	regions	_	
12-212	8608-8609	(	_	
12-213	8609-8612	rHD	_	
12-214	8613-8614	=	_	
12-215	8615-8620	0.625	_	
12-216	8621-8622	±	_	
12-217	8623-8628	0.050	_	
12-218	8628-8629	,	_	
12-219	8630-8633	rCG	_	
12-220	8634-8635	=	_	
12-221	8636-8641	0.476	_	
12-222	8642-8643	±	_	
12-223	8644-8649	0.047	_	
12-224	8649-8650	,	_	
12-225	8651-8652	p	_	
12-226	8653-8654	=	_	
12-227	8655-8660	0.049	_	
12-228	8660-8661	)	_	
12-229	8661-8662	.	_	
12-230	8663-8665	In	_	
12-231	8666-8674	contrast	_	
12-232	8674-8675	,	_	
12-233	8676-8679	the	_	
12-234	8680-8683	HbO	_	
12-235	8684-8690	values	_	
12-236	8691-8693	in	_	
12-237	8694-8697	the	_	
12-238	8698-8702	mOFC	_	
12-239	8703-8710	regions	_	
12-240	8711-8712	(	_	
12-241	8712-8713	p	_	
12-242	8714-8715	=	_	
12-243	8716-8721	0.206	_	
12-244	8721-8722	)	_	
12-245	8723-8726	did	_	
12-246	8727-8730	not	_	
12-247	8731-8735	show	_	
12-248	8736-8737	a	_	
12-249	8738-8749	significant	_	
12-250	8750-8760	difference	_	
12-251	8761-8768	between	_	
12-252	8769-8772	the	_	
12-253	8773-8779	groups	_	
12-254	8779-8780	.	_	

#Text=Seed-based localizer results
13-1	8781-8791	Seed-based	_	
13-2	8792-8801	localizer	_	
13-3	8802-8809	results	_	

#Text=For simplicity, the HbO signals from all the channels across all the subjects were analyzed and reported in the remainder of the study. Seed channels were selected primarily based on brain activation in the gambling localizer task. Among all the channels covering the OFC regions, channel 11 in the left hemisphere and channel 4 in the right hemisphere were identified to have the most notable gambling task-induced HbO changes. Therefore, with symmetric localization, the OFC seed channels for rsFC analysis were selected and localized at channels 11 and 12 for the left hemisphere and channels 4 and 1 for the right hemisphere. To illustrate resting-state low-frequency fluctuations, resting-state time courses from the seed channels (i.e., channels 11 and 4) of one subject from each group are displayed in Supplementary Figure S3.
14-1	8810-8813	For	_	
14-2	8814-8824	simplicity	_	
14-3	8824-8825	,	_	
14-4	8826-8829	the	_	
14-5	8830-8833	HbO	_	
14-6	8834-8841	signals	_	
14-7	8842-8846	from	_	
14-8	8847-8850	all	_	
14-9	8851-8854	the	_	
14-10	8855-8863	channels	_	
14-11	8864-8870	across	_	
14-12	8871-8874	all	_	
14-13	8875-8878	the	_	
14-14	8879-8887	subjects	_	
14-15	8888-8892	were	_	
14-16	8893-8901	analyzed	_	
14-17	8902-8905	and	_	
14-18	8906-8914	reported	_	
14-19	8915-8917	in	_	
14-20	8918-8921	the	_	
14-21	8922-8931	remainder	_	
14-22	8932-8934	of	_	
14-23	8935-8938	the	_	
14-24	8939-8944	study	_	
14-25	8944-8945	.	_	
14-26	8946-8950	Seed	_	
14-27	8951-8959	channels	_	
14-28	8960-8964	were	_	
14-29	8965-8973	selected	_	
14-30	8974-8983	primarily	_	
14-31	8984-8989	based	_	
14-32	8990-8992	on	_	
14-33	8993-8998	brain	_	
14-34	8999-9009	activation	_	
14-35	9010-9012	in	_	
14-36	9013-9016	the	_	
14-37	9017-9025	gambling	_	
14-38	9026-9035	localizer	_	
14-39	9036-9040	task	_	
14-40	9040-9041	.	_	
14-41	9042-9047	Among	_	
14-42	9048-9051	all	_	
14-43	9052-9055	the	_	
14-44	9056-9064	channels	_	
14-45	9065-9073	covering	_	
14-46	9074-9077	the	_	
14-47	9078-9081	OFC	_	
14-48	9082-9089	regions	_	
14-49	9089-9090	,	_	
14-50	9091-9098	channel	_	
14-51	9099-9101	11	_	
14-52	9102-9104	in	_	
14-53	9105-9108	the	_	
14-54	9109-9113	left	_	
14-55	9114-9124	hemisphere	_	
14-56	9125-9128	and	_	
14-57	9129-9136	channel	_	
14-58	9137-9138	4	_	
14-59	9139-9141	in	_	
14-60	9142-9145	the	_	
14-61	9146-9151	right	_	
14-62	9152-9162	hemisphere	_	
14-63	9163-9167	were	_	
14-64	9168-9178	identified	_	
14-65	9179-9181	to	_	
14-66	9182-9186	have	_	
14-67	9187-9190	the	_	
14-68	9191-9195	most	_	
14-69	9196-9203	notable	_	
14-70	9204-9212	gambling	_	
14-71	9213-9225	task-induced	_	
14-72	9226-9229	HbO	_	
14-73	9230-9237	changes	_	
14-74	9237-9238	.	_	
14-75	9239-9248	Therefore	_	
14-76	9248-9249	,	_	
14-77	9250-9254	with	_	
14-78	9255-9264	symmetric	_	
14-79	9265-9277	localization	_	
14-80	9277-9278	,	_	
14-81	9279-9282	the	_	
14-82	9283-9286	OFC	_	
14-83	9287-9291	seed	_	
14-84	9292-9300	channels	_	
14-85	9301-9304	for	_	
14-86	9305-9309	rsFC	_	
14-87	9310-9318	analysis	_	
14-88	9319-9323	were	_	
14-89	9324-9332	selected	_	
14-90	9333-9336	and	_	
14-91	9337-9346	localized	_	
14-92	9347-9349	at	_	
14-93	9350-9358	channels	_	
14-94	9359-9361	11	_	
14-95	9362-9365	and	_	
14-96	9366-9368	12	_	
14-97	9369-9372	for	_	
14-98	9373-9376	the	_	
14-99	9377-9381	left	_	
14-100	9382-9392	hemisphere	_	
14-101	9393-9396	and	_	
14-102	9397-9405	channels	_	
14-103	9406-9407	4	_	
14-104	9408-9411	and	_	
14-105	9412-9413	1	_	
14-106	9414-9417	for	_	
14-107	9418-9421	the	_	
14-108	9422-9427	right	_	
14-109	9428-9438	hemisphere	_	
14-110	9438-9439	.	_	
14-111	9440-9442	To	_	
14-112	9443-9453	illustrate	_	
14-113	9454-9467	resting-state	_	
14-114	9468-9481	low-frequency	_	
14-115	9482-9494	fluctuations	_	
14-116	9494-9495	,	_	
14-117	9496-9509	resting-state	_	
14-118	9510-9514	time	_	
14-119	9515-9522	courses	_	
14-120	9523-9527	from	_	
14-121	9528-9531	the	_	
14-122	9532-9536	seed	_	
14-123	9537-9545	channels	_	
14-124	9546-9547	(	_	
14-125	9547-9550	i.e	_	
14-126	9550-9551	.	_	
14-127	9551-9552	,	_	
14-128	9553-9561	channels	_	
14-129	9562-9564	11	_	
14-130	9565-9568	and	_	
14-131	9569-9570	4	_	
14-132	9570-9571	)	_	
14-133	9572-9574	of	_	
14-134	9575-9578	one	_	
14-135	9579-9586	subject	_	
14-136	9587-9591	from	_	
14-137	9592-9596	each	_	
14-138	9597-9602	group	_	
14-139	9603-9606	are	_	
14-140	9607-9616	displayed	_	
14-141	9617-9619	in	_	
14-142	9620-9633	Supplementary	_	
14-143	9634-9640	Figure	_	
14-144	9641-9643	S3	_	
14-145	9643-9644	.	_	

#Text=Functional connectivity measurement: seed-based correlation results
15-1	9645-9655	Functional	_	
15-2	9656-9668	connectivity	_	
15-3	9669-9680	measurement	_	
15-4	9680-9681	:	_	
15-5	9682-9692	seed-based	_	
15-6	9693-9704	correlation	_	
15-7	9705-9712	results	_	

#Text=Group-level results of seed-based rsFC maps are shown in Fig. 2. By estimating the strength of pairwise relationships between the selected seed channels and the channels covering other OFC regions for both the HDs and CGs, seed-based rsFCs were observed between bilateral and within ipsilateral OFC regions. Bilaterally to the right seed regions, considerable correlations in the left regions were shown in channels 10–12 (covering the contralateral OFC regions) in the HDs.
16-1	9713-9724	Group-level	_	
16-2	9725-9732	results	_	
16-3	9733-9735	of	_	
16-4	9736-9746	seed-based	_	
16-5	9747-9751	rsFC	_	
16-6	9752-9756	maps	_	
16-7	9757-9760	are	_	
16-8	9761-9766	shown	_	
16-9	9767-9769	in	_	
16-10	9770-9773	Fig	_	
16-11	9773-9774	.	_	
16-12	9775-9776	2	_	
16-13	9776-9777	.	_	
16-14	9778-9780	By	_	
16-15	9781-9791	estimating	_	
16-16	9792-9795	the	_	
16-17	9796-9804	strength	_	
16-18	9805-9807	of	_	
16-19	9808-9816	pairwise	_	
16-20	9817-9830	relationships	_	
16-21	9831-9838	between	_	
16-22	9839-9842	the	_	
16-23	9843-9851	selected	_	
16-24	9852-9856	seed	_	
16-25	9857-9865	channels	_	
16-26	9866-9869	and	_	
16-27	9870-9873	the	_	
16-28	9874-9882	channels	_	
16-29	9883-9891	covering	_	
16-30	9892-9897	other	_	
16-31	9898-9901	OFC	_	
16-32	9902-9909	regions	_	
16-33	9910-9913	for	_	
16-34	9914-9918	both	_	
16-35	9919-9922	the	_	
16-36	9923-9926	HDs	_	
16-37	9927-9930	and	_	
16-38	9931-9934	CGs	_	
16-39	9934-9935	,	_	
16-40	9936-9946	seed-based	_	
16-41	9947-9952	rsFCs	_	
16-42	9953-9957	were	_	
16-43	9958-9966	observed	_	
16-44	9967-9974	between	_	
16-45	9975-9984	bilateral	_	
16-46	9985-9988	and	_	
16-47	9989-9995	within	_	
16-48	9996-10007	ipsilateral	_	
16-49	10008-10011	OFC	_	
16-50	10012-10019	regions	_	
16-51	10019-10020	.	_	
16-52	10021-10032	Bilaterally	_	
16-53	10033-10035	to	_	
16-54	10036-10039	the	_	
16-55	10040-10045	right	_	
16-56	10046-10050	seed	_	
16-57	10051-10058	regions	_	
16-58	10058-10059	,	_	
16-59	10060-10072	considerable	_	
16-60	10073-10085	correlations	_	
16-61	10086-10088	in	_	
16-62	10089-10092	the	_	
16-63	10093-10097	left	_	
16-64	10098-10105	regions	_	
16-65	10106-10110	were	_	
16-66	10111-10116	shown	_	
16-67	10117-10119	in	_	
16-68	10120-10128	channels	_	
16-69	10129-10131	10	_	
16-70	10131-10132	–	_	
16-71	10132-10134	12	_	
16-72	10135-10136	(	_	
16-73	10136-10144	covering	_	
16-74	10145-10148	the	_	
16-75	10149-10162	contralateral	_	
16-76	10163-10166	OFC	_	
16-77	10167-10174	regions	_	
16-78	10174-10175	)	_	
16-79	10176-10178	in	_	
16-80	10179-10182	the	_	
16-81	10183-10186	HDs	_	
16-82	10186-10187	.	_	

#Text=Ipsilaterally within the left seed regions, a considerable correlation was observed in channel 10 in the HDs but not in the CGs. Interestingly, for seed channel 12, both groups displayed a considerable correlation with ipsilateral channel 8, covering the left mOFC, but not for seed channel 11.
17-1	10188-10201	Ipsilaterally	_	
17-2	10202-10208	within	_	
17-3	10209-10212	the	_	
17-4	10213-10217	left	_	
17-5	10218-10222	seed	_	
17-6	10223-10230	regions	_	
17-7	10230-10231	,	_	
17-8	10232-10233	a	_	
17-9	10234-10246	considerable	_	
17-10	10247-10258	correlation	_	
17-11	10259-10262	was	_	
17-12	10263-10271	observed	_	
17-13	10272-10274	in	_	
17-14	10275-10282	channel	_	
17-15	10283-10285	10	_	
17-16	10286-10288	in	_	
17-17	10289-10292	the	_	
17-18	10293-10296	HDs	_	
17-19	10297-10300	but	_	
17-20	10301-10304	not	_	
17-21	10305-10307	in	_	
17-22	10308-10311	the	_	
17-23	10312-10315	CGs	_	
17-24	10315-10316	.	_	
17-25	10317-10330	Interestingly	_	
17-26	10330-10331	,	_	
17-27	10332-10335	for	_	
17-28	10336-10340	seed	_	
17-29	10341-10348	channel	_	
17-30	10349-10351	12	_	
17-31	10351-10352	,	_	
17-32	10353-10357	both	_	
17-33	10358-10364	groups	_	
17-34	10365-10374	displayed	_	
17-35	10375-10376	a	_	
17-36	10377-10389	considerable	_	
17-37	10390-10401	correlation	_	
17-38	10402-10406	with	_	
17-39	10407-10418	ipsilateral	_	
17-40	10419-10426	channel	_	
17-41	10427-10428	8	_	
17-42	10428-10429	,	_	
17-43	10430-10438	covering	_	
17-44	10439-10442	the	_	
17-45	10443-10447	left	_	
17-46	10448-10452	mOFC	_	
17-47	10452-10453	,	_	
17-48	10454-10457	but	_	
17-49	10458-10461	not	_	
17-50	10462-10465	for	_	
17-51	10466-10470	seed	_	
17-52	10471-10478	channel	_	
17-53	10479-10481	11	_	
17-54	10481-10482	.	_	

#Text=Functional connectivity measurement: whole-brain correlation results
18-1	10483-10493	Functional	_	
18-2	10494-10506	connectivity	_	
18-3	10507-10518	measurement	_	
18-4	10518-10519	:	_	
18-5	10520-10531	whole-brain	_	
18-6	10532-10543	correlation	_	
18-7	10544-10551	results	_	

#Text=Using resting-state fNIRS data, a mean group-level correlation matrix was obtained in the CGs, and its network topological attributes were compared with the HDs. Before generating network topological properties, we used the foremost 5% of the connections (correlation coefficient values >0.87; mean correlation = 0.75) calculated in the CGs (method details in Niu et al.) because this allowed us to examine the absolute network organization of the controls for comparison with the study group, the HDs. Group-level HbO-based connectivity patterns for both the HDs and CGs by whole-brain analysis are shown in Fig. 3, where the nodes represent the channels and the edges represent the connectivity between the nodes. The HD and CG connectivity matrices are shown in Fig. 3A and B, respectively. The HD brain networks (Fig. 3C) demonstrated more edges in the OFC system than the CG brain networks (Fig. 3D) overall, but not within mOFC regions. Though, the HD network showed an especially strong connection between channels 6 and 8, which covered the right and left mOFCs, respectively.
19-1	10552-10557	Using	_	
19-2	10558-10571	resting-state	_	
19-3	10572-10577	fNIRS	_	
19-4	10578-10582	data	_	
19-5	10582-10583	,	_	
19-6	10584-10585	a	_	
19-7	10586-10590	mean	_	
19-8	10591-10602	group-level	_	
19-9	10603-10614	correlation	_	
19-10	10615-10621	matrix	_	
19-11	10622-10625	was	_	
19-12	10626-10634	obtained	_	
19-13	10635-10637	in	_	
19-14	10638-10641	the	_	
19-15	10642-10645	CGs	_	
19-16	10645-10646	,	_	
19-17	10647-10650	and	_	
19-18	10651-10654	its	_	
19-19	10655-10662	network	_	
19-20	10663-10674	topological	_	
19-21	10675-10685	attributes	_	
19-22	10686-10690	were	_	
19-23	10691-10699	compared	_	
19-24	10700-10704	with	_	
19-25	10705-10708	the	_	
19-26	10709-10712	HDs	_	
19-27	10712-10713	.	_	
19-28	10714-10720	Before	_	
19-29	10721-10731	generating	_	
19-30	10732-10739	network	_	
19-31	10740-10751	topological	_	
19-32	10752-10762	properties	_	
19-33	10762-10763	,	_	
19-34	10764-10766	we	_	
19-35	10767-10771	used	_	
19-36	10772-10775	the	_	
19-37	10776-10784	foremost	_	
19-38	10785-10787	5%	_	
19-39	10788-10790	of	_	
19-40	10791-10794	the	_	
19-41	10795-10806	connections	_	
19-42	10807-10808	(	_	
19-43	10808-10819	correlation	_	
19-44	10820-10831	coefficient	_	
19-45	10832-10838	values	_	
19-46	10839-10840	>	_	
19-47	10840-10844	0.87	_	
19-48	10844-10845	;	_	
19-49	10846-10850	mean	_	
19-50	10851-10862	correlation	_	
19-51	10863-10864	=	_	
19-52	10865-10869	0.75	_	
19-53	10869-10870	)	_	
19-54	10871-10881	calculated	_	
19-55	10882-10884	in	_	
19-56	10885-10888	the	_	
19-57	10889-10892	CGs	_	
19-58	10893-10894	(	_	
19-59	10894-10900	method	_	
19-60	10901-10908	details	_	
19-61	10909-10911	in	_	
19-62	10912-10915	Niu	_	
19-63	10916-10918	et	_	
19-64	10919-10921	al	_	
19-65	10921-10922	.	_	
19-66	10922-10923	)	_	
19-67	10924-10931	because	_	
19-68	10932-10936	this	_	
19-69	10937-10944	allowed	_	
19-70	10945-10947	us	_	
19-71	10948-10950	to	_	
19-72	10951-10958	examine	_	
19-73	10959-10962	the	_	
19-74	10963-10971	absolute	_	
19-75	10972-10979	network	_	
19-76	10980-10992	organization	_	
19-77	10993-10995	of	_	
19-78	10996-10999	the	_	
19-79	11000-11008	controls	_	
19-80	11009-11012	for	_	
19-81	11013-11023	comparison	_	
19-82	11024-11028	with	_	
19-83	11029-11032	the	_	
19-84	11033-11038	study	_	
19-85	11039-11044	group	_	
19-86	11044-11045	,	_	
19-87	11046-11049	the	_	
19-88	11050-11053	HDs	_	
19-89	11053-11054	.	_	
19-90	11055-11066	Group-level	_	
19-91	11067-11076	HbO-based	_	
19-92	11077-11089	connectivity	_	
19-93	11090-11098	patterns	_	
19-94	11099-11102	for	_	
19-95	11103-11107	both	_	
19-96	11108-11111	the	_	
19-97	11112-11115	HDs	_	
19-98	11116-11119	and	_	
19-99	11120-11123	CGs	_	
19-100	11124-11126	by	_	
19-101	11127-11138	whole-brain	_	
19-102	11139-11147	analysis	_	
19-103	11148-11151	are	_	
19-104	11152-11157	shown	_	
19-105	11158-11160	in	_	
19-106	11161-11164	Fig	_	
19-107	11164-11165	.	_	
19-108	11166-11167	3	_	
19-109	11167-11168	,	_	
19-110	11169-11174	where	_	
19-111	11175-11178	the	_	
19-112	11179-11184	nodes	_	
19-113	11185-11194	represent	_	
19-114	11195-11198	the	_	
19-115	11199-11207	channels	_	
19-116	11208-11211	and	_	
19-117	11212-11215	the	_	
19-118	11216-11221	edges	_	
19-119	11222-11231	represent	_	
19-120	11232-11235	the	_	
19-121	11236-11248	connectivity	_	
19-122	11249-11256	between	_	
19-123	11257-11260	the	_	
19-124	11261-11266	nodes	_	
19-125	11266-11267	.	_	
19-126	11268-11271	The	_	
19-127	11272-11274	HD	_	
19-128	11275-11278	and	_	
19-129	11279-11281	CG	_	
19-130	11282-11294	connectivity	_	
19-131	11295-11303	matrices	_	
19-132	11304-11307	are	_	
19-133	11308-11313	shown	_	
19-134	11314-11316	in	_	
19-135	11317-11320	Fig	_	
19-136	11320-11321	.	_	
19-137	11322-11324	3A	_	
19-138	11325-11328	and	_	
19-139	11329-11330	B	_	
19-140	11330-11331	,	_	
19-141	11332-11344	respectively	_	
19-142	11344-11345	.	_	
19-143	11346-11349	The	_	
19-144	11350-11352	HD	_	
19-145	11353-11358	brain	_	
19-146	11359-11367	networks	_	
19-147	11368-11369	(	_	
19-148	11369-11372	Fig	_	
19-149	11372-11373	.	_	
19-150	11374-11376	3C	_	
19-151	11376-11377	)	_	
19-152	11378-11390	demonstrated	_	
19-153	11391-11395	more	_	
19-154	11396-11401	edges	_	
19-155	11402-11404	in	_	
19-156	11405-11408	the	_	
19-157	11409-11412	OFC	_	
19-158	11413-11419	system	_	
19-159	11420-11424	than	_	
19-160	11425-11428	the	_	
19-161	11429-11431	CG	_	
19-162	11432-11437	brain	_	
19-163	11438-11446	networks	_	
19-164	11447-11448	(	_	
19-165	11448-11451	Fig	_	
19-166	11451-11452	.	_	
19-167	11453-11455	3D	_	
19-168	11455-11456	)	_	
19-169	11457-11464	overall	_	
19-170	11464-11465	,	_	
19-171	11466-11469	but	_	
19-172	11470-11473	not	_	
19-173	11474-11480	within	_	
19-174	11481-11485	mOFC	_	
19-175	11486-11493	regions	_	
19-176	11493-11494	.	_	
19-177	11495-11501	Though	_	
19-178	11501-11502	,	_	
19-179	11503-11506	the	_	
19-180	11507-11509	HD	_	
19-181	11510-11517	network	_	
19-182	11518-11524	showed	_	
19-183	11525-11527	an	_	
19-184	11528-11538	especially	_	
19-185	11539-11545	strong	_	
19-186	11546-11556	connection	_	
19-187	11557-11564	between	_	
19-188	11565-11573	channels	_	
19-189	11574-11575	6	_	
19-190	11576-11579	and	_	
19-191	11580-11581	8	_	
19-192	11581-11582	,	_	
19-193	11583-11588	which	_	
19-194	11589-11596	covered	_	
19-195	11597-11600	the	_	
19-196	11601-11606	right	_	
19-197	11607-11610	and	_	
19-198	11611-11615	left	_	
19-199	11616-11621	mOFCs	_	
19-200	11621-11622	,	_	
19-201	11623-11635	respectively	_	
19-202	11635-11636	.	_	

#Text=Next, we quantified the connectivity strength, σ, which is the average connectivity of a node in each network in the OFC system. We calculated the column mean of the HbO-based connectivity matrices, and group results are shown in Fig. 4. Group-level analysis demonstrates that the rsFC strengths in the HDs are remarkably (p < 0.001) higher in channels 9, 10, and 3. Channels 1, 2, 4, 5, 6, 8, 11, and 12 in the HDs also demonstrate greater connectivity strengths than in the CGs (see Supplementary Table S4).
20-1	11637-11641	Next	_	
20-2	11641-11642	,	_	
20-3	11643-11645	we	_	
20-4	11646-11656	quantified	_	
20-5	11657-11660	the	_	
20-6	11661-11673	connectivity	_	
20-7	11674-11682	strength	_	
20-8	11682-11683	,	_	
20-9	11684-11685	σ	_	
20-10	11685-11686	,	_	
20-11	11687-11692	which	_	
20-12	11693-11695	is	_	
20-13	11696-11699	the	_	
20-14	11700-11707	average	_	
20-15	11708-11720	connectivity	_	
20-16	11721-11723	of	_	
20-17	11724-11725	a	_	
20-18	11726-11730	node	_	
20-19	11731-11733	in	_	
20-20	11734-11738	each	_	
20-21	11739-11746	network	_	
20-22	11747-11749	in	_	
20-23	11750-11753	the	_	
20-24	11754-11757	OFC	_	
20-25	11758-11764	system	_	
20-26	11764-11765	.	_	
20-27	11766-11768	We	_	
20-28	11769-11779	calculated	_	
20-29	11780-11783	the	_	
20-30	11784-11790	column	_	
20-31	11791-11795	mean	_	
20-32	11796-11798	of	_	
20-33	11799-11802	the	_	
20-34	11803-11812	HbO-based	_	
20-35	11813-11825	connectivity	_	
20-36	11826-11834	matrices	_	
20-37	11834-11835	,	_	
20-38	11836-11839	and	_	
20-39	11840-11845	group	_	
20-40	11846-11853	results	_	
20-41	11854-11857	are	_	
20-42	11858-11863	shown	_	
20-43	11864-11866	in	_	
20-44	11867-11870	Fig	_	
20-45	11870-11871	.	_	
20-46	11872-11873	4	_	
20-47	11873-11874	.	_	
20-48	11875-11886	Group-level	_	
20-49	11887-11895	analysis	_	
20-50	11896-11908	demonstrates	_	
20-51	11909-11913	that	_	
20-52	11914-11917	the	_	
20-53	11918-11922	rsFC	_	
20-54	11923-11932	strengths	_	
20-55	11933-11935	in	_	
20-56	11936-11939	the	_	
20-57	11940-11943	HDs	_	
20-58	11944-11947	are	_	
20-59	11948-11958	remarkably	_	
20-60	11959-11960	(	_	
20-61	11960-11961	p	_	
20-62	11962-11963	<	_	
20-63	11964-11969	0.001	_	
20-64	11969-11970	)	_	
20-65	11971-11977	higher	_	
20-66	11978-11980	in	_	
20-67	11981-11989	channels	_	
20-68	11990-11991	9	_	
20-69	11991-11992	,	_	
20-70	11993-11995	10	_	
20-71	11995-11996	,	_	
20-72	11997-12000	and	_	
20-73	12001-12002	3	_	
20-74	12002-12003	.	_	
20-75	12004-12012	Channels	_	
20-76	12013-12014	1	_	
20-77	12014-12015	,	_	
20-78	12016-12017	2	_	
20-79	12017-12018	,	_	
20-80	12019-12020	4	_	
20-81	12020-12021	,	_	
20-82	12022-12023	5	_	
20-83	12023-12024	,	_	
20-84	12025-12026	6	_	
20-85	12026-12027	,	_	
20-86	12028-12029	8	_	
20-87	12029-12030	,	_	
20-88	12031-12033	11	_	
20-89	12033-12034	,	_	
20-90	12035-12038	and	_	
20-91	12039-12041	12	_	
20-92	12042-12044	in	_	
20-93	12045-12048	the	_	
20-94	12049-12052	HDs	_	
20-95	12053-12057	also	_	
20-96	12058-12069	demonstrate	_	
20-97	12070-12077	greater	_	
20-98	12078-12090	connectivity	_	
20-99	12091-12100	strengths	_	
20-100	12101-12105	than	_	
20-101	12106-12108	in	_	
20-102	12109-12112	the	_	
20-103	12113-12116	CGs	_	
20-104	12117-12118	(	_	
20-105	12118-12121	see	_	
20-106	12122-12135	Supplementary	_	
20-107	12136-12141	Table	_	
20-108	12142-12144	S4	_	
20-109	12144-12145	)	_	
20-110	12145-12146	.	_	

#Text=Mapping the small-world properties of brain networks in heroin addiction
21-1	12147-12154	Mapping	_	
21-2	12155-12158	the	_	
21-3	12159-12170	small-world	_	
21-4	12171-12181	properties	_	
21-5	12182-12184	of	_	
21-6	12185-12190	brain	_	
21-7	12191-12199	networks	_	
21-8	12200-12202	in	_	
21-9	12203-12209	heroin	_	
21-10	12210-12219	addiction	_	

#Text=For subsequent network analyses, the correlation matrices were thresholded into both HD and CG brain networks over the entire range of sparsity, S, from 0 to 1. As a function of sparsity, the clustering coefficient, characteristic path length, local efficiency, and global efficiency are profiled in Fig. 5. For brain networks of the HDs and CGs, the clustering coefficients increased (Fig. 5A) but the characteristic path lengths decreased (Fig. 5B) as sparsity increased. These patterns are consistent with previous findings. Moreover, clustering coefficients in the HDs (Fig. 5A) were significantly greater than in the CGs over sparsity ranges between 0.11 and 0.24 (0.0001 < p < 0.03), between 0.49 and 0.65 (0.004 < p < 0.012), and between 0.82 and 0.87 (0.001 < p < 0.049). Conversely, the characteristic path lengths of the brain network were significantly larger in the HDs (Fig. 5B) than in the CGs over sparsity ranges between 0.13 and 0.39 (0.001 < p < 0.047) and between 0.57 and 0.77 (0.007 < p < 0.01).
22-1	12220-12223	For	_	
22-2	12224-12234	subsequent	_	
22-3	12235-12242	network	_	
22-4	12243-12251	analyses	_	
22-5	12251-12252	,	_	
22-6	12253-12256	the	_	
22-7	12257-12268	correlation	_	
22-8	12269-12277	matrices	_	
22-9	12278-12282	were	_	
22-10	12283-12294	thresholded	_	
22-11	12295-12299	into	_	
22-12	12300-12304	both	_	
22-13	12305-12307	HD	_	
22-14	12308-12311	and	_	
22-15	12312-12314	CG	_	
22-16	12315-12320	brain	_	
22-17	12321-12329	networks	_	
22-18	12330-12334	over	_	
22-19	12335-12338	the	_	
22-20	12339-12345	entire	_	
22-21	12346-12351	range	_	
22-22	12352-12354	of	_	
22-23	12355-12363	sparsity	_	
22-24	12363-12364	,	_	
22-25	12365-12366	S	_	
22-26	12366-12367	,	_	
22-27	12368-12372	from	_	
22-28	12373-12374	0	_	
22-29	12375-12377	to	_	
22-30	12378-12379	1	_	
22-31	12379-12380	.	_	
22-32	12381-12383	As	_	
22-33	12384-12385	a	_	
22-34	12386-12394	function	_	
22-35	12395-12397	of	_	
22-36	12398-12406	sparsity	_	
22-37	12406-12407	,	_	
22-38	12408-12411	the	_	
22-39	12412-12422	clustering	_	
22-40	12423-12434	coefficient	_	
22-41	12434-12435	,	_	
22-42	12436-12450	characteristic	_	
22-43	12451-12455	path	_	
22-44	12456-12462	length	_	
22-45	12462-12463	,	_	
22-46	12464-12469	local	_	
22-47	12470-12480	efficiency	_	
22-48	12480-12481	,	_	
22-49	12482-12485	and	_	
22-50	12486-12492	global	_	
22-51	12493-12503	efficiency	_	
22-52	12504-12507	are	_	
22-53	12508-12516	profiled	_	
22-54	12517-12519	in	_	
22-55	12520-12523	Fig	_	
22-56	12523-12524	.	_	
22-57	12525-12526	5	_	
22-58	12526-12527	.	_	
22-59	12528-12531	For	_	
22-60	12532-12537	brain	_	
22-61	12538-12546	networks	_	
22-62	12547-12549	of	_	
22-63	12550-12553	the	_	
22-64	12554-12557	HDs	_	
22-65	12558-12561	and	_	
22-66	12562-12565	CGs	_	
22-67	12565-12566	,	_	
22-68	12567-12570	the	_	
22-69	12571-12581	clustering	_	
22-70	12582-12594	coefficients	_	
22-71	12595-12604	increased	_	
22-72	12605-12606	(	_	
22-73	12606-12609	Fig	_	
22-74	12609-12610	.	_	
22-75	12611-12613	5A	_	
22-76	12613-12614	)	_	
22-77	12615-12618	but	_	
22-78	12619-12622	the	_	
22-79	12623-12637	characteristic	_	
22-80	12638-12642	path	_	
22-81	12643-12650	lengths	_	
22-82	12651-12660	decreased	_	
22-83	12661-12662	(	_	
22-84	12662-12665	Fig	_	
22-85	12665-12666	.	_	
22-86	12667-12669	5B	_	
22-87	12669-12670	)	_	
22-88	12671-12673	as	_	
22-89	12674-12682	sparsity	_	
22-90	12683-12692	increased	_	
22-91	12692-12693	.	_	
22-92	12694-12699	These	_	
22-93	12700-12708	patterns	_	
22-94	12709-12712	are	_	
22-95	12713-12723	consistent	_	
22-96	12724-12728	with	_	
22-97	12729-12737	previous	_	
22-98	12738-12746	findings	_	
22-99	12746-12747	.	_	
22-100	12748-12756	Moreover	_	
22-101	12756-12757	,	_	
22-102	12758-12768	clustering	_	
22-103	12769-12781	coefficients	_	
22-104	12782-12784	in	_	
22-105	12785-12788	the	_	
22-106	12789-12792	HDs	_	
22-107	12793-12794	(	_	
22-108	12794-12797	Fig	_	
22-109	12797-12798	.	_	
22-110	12799-12801	5A	_	
22-111	12801-12802	)	_	
22-112	12803-12807	were	_	
22-113	12808-12821	significantly	_	
22-114	12822-12829	greater	_	
22-115	12830-12834	than	_	
22-116	12835-12837	in	_	
22-117	12838-12841	the	_	
22-118	12842-12845	CGs	_	
22-119	12846-12850	over	_	
22-120	12851-12859	sparsity	_	
22-121	12860-12866	ranges	_	
22-122	12867-12874	between	_	
22-123	12875-12879	0.11	_	
22-124	12880-12883	and	_	
22-125	12884-12888	0.24	_	
22-126	12889-12890	(	_	
22-127	12890-12896	0.0001	_	
22-128	12897-12898	<	_	
22-129	12899-12900	p	_	
22-130	12901-12902	<	_	
22-131	12903-12907	0.03	_	
22-132	12907-12908	)	_	
22-133	12908-12909	,	_	
22-134	12910-12917	between	_	
22-135	12918-12922	0.49	_	
22-136	12923-12926	and	_	
22-137	12927-12931	0.65	_	
22-138	12932-12933	(	_	
22-139	12933-12938	0.004	_	
22-140	12939-12940	<	_	
22-141	12941-12942	p	_	
22-142	12943-12944	<	_	
22-143	12945-12950	0.012	_	
22-144	12950-12951	)	_	
22-145	12951-12952	,	_	
22-146	12953-12956	and	_	
22-147	12957-12964	between	_	
22-148	12965-12969	0.82	_	
22-149	12970-12973	and	_	
22-150	12974-12978	0.87	_	
22-151	12979-12980	(	_	
22-152	12980-12985	0.001	_	
22-153	12986-12987	<	_	
22-154	12988-12989	p	_	
22-155	12990-12991	<	_	
22-156	12992-12997	0.049	_	
22-157	12997-12998	)	_	
22-158	12998-12999	.	_	
22-159	13000-13010	Conversely	_	
22-160	13010-13011	,	_	
22-161	13012-13015	the	_	
22-162	13016-13030	characteristic	_	
22-163	13031-13035	path	_	
22-164	13036-13043	lengths	_	
22-165	13044-13046	of	_	
22-166	13047-13050	the	_	
22-167	13051-13056	brain	_	
22-168	13057-13064	network	_	
22-169	13065-13069	were	_	
22-170	13070-13083	significantly	_	
22-171	13084-13090	larger	_	
22-172	13091-13093	in	_	
22-173	13094-13097	the	_	
22-174	13098-13101	HDs	_	
22-175	13102-13103	(	_	
22-176	13103-13106	Fig	_	
22-177	13106-13107	.	_	
22-178	13108-13110	5B	_	
22-179	13110-13111	)	_	
22-180	13112-13116	than	_	
22-181	13117-13119	in	_	
22-182	13120-13123	the	_	
22-183	13124-13127	CGs	_	
22-184	13128-13132	over	_	
22-185	13133-13141	sparsity	_	
22-186	13142-13148	ranges	_	
22-187	13149-13156	between	_	
22-188	13157-13161	0.13	_	
22-189	13162-13165	and	_	
22-190	13166-13170	0.39	_	
22-191	13171-13172	(	_	
22-192	13172-13177	0.001	_	
22-193	13178-13179	<	_	
22-194	13180-13181	p	_	
22-195	13182-13183	<	_	
22-196	13184-13189	0.047	_	
22-197	13189-13190	)	_	
22-198	13191-13194	and	_	
22-199	13195-13202	between	_	
22-200	13203-13207	0.57	_	
22-201	13208-13211	and	_	
22-202	13212-13216	0.77	_	
22-203	13217-13218	(	_	
22-204	13218-13223	0.007	_	
22-205	13224-13225	<	_	
22-206	13226-13227	p	_	
22-207	13228-13229	<	_	
22-208	13230-13234	0.01	_	
22-209	13234-13235	)	_	
22-210	13235-13236	.	_	

#Text=Next, we compared the HD brain network to the CG brain network. With respect to the CG brain network, as Fig. 5C shows, the normalized clustering coefficient, γ, was larger than 1, and the normalized characteristic path length, λ, was approximately 1. These features demonstrate that the HD brain network showed high levels of clustering with a low average path length compared with the CG brain network.
23-1	13237-13241	Next	_	
23-2	13241-13242	,	_	
23-3	13243-13245	we	_	
23-4	13246-13254	compared	_	
23-5	13255-13258	the	_	
23-6	13259-13261	HD	_	
23-7	13262-13267	brain	_	
23-8	13268-13275	network	_	
23-9	13276-13278	to	_	
23-10	13279-13282	the	_	
23-11	13283-13285	CG	_	
23-12	13286-13291	brain	_	
23-13	13292-13299	network	_	
23-14	13299-13300	.	_	
23-15	13301-13305	With	_	
23-16	13306-13313	respect	_	
23-17	13314-13316	to	_	
23-18	13317-13320	the	_	
23-19	13321-13323	CG	_	
23-20	13324-13329	brain	_	
23-21	13330-13337	network	_	
23-22	13337-13338	,	_	
23-23	13339-13341	as	_	
23-24	13342-13345	Fig	_	
23-25	13345-13346	.	_	
23-26	13347-13349	5C	_	
23-27	13350-13355	shows	_	
23-28	13355-13356	,	_	
23-29	13357-13360	the	_	
23-30	13361-13371	normalized	_	
23-31	13372-13382	clustering	_	
23-32	13383-13394	coefficient	_	
23-33	13394-13395	,	_	
23-34	13396-13397	γ	_	
23-35	13397-13398	,	_	
23-36	13399-13402	was	_	
23-37	13403-13409	larger	_	
23-38	13410-13414	than	_	
23-39	13415-13416	1	_	
23-40	13416-13417	,	_	
23-41	13418-13421	and	_	
23-42	13422-13425	the	_	
23-43	13426-13436	normalized	_	
23-44	13437-13451	characteristic	_	
23-45	13452-13456	path	_	
23-46	13457-13463	length	_	
23-47	13463-13464	,	_	
23-48	13465-13466	λ	_	
23-49	13466-13467	,	_	
23-50	13468-13471	was	_	
23-51	13472-13485	approximately	_	
23-52	13486-13487	1	_	
23-53	13487-13488	.	_	
23-54	13489-13494	These	_	
23-55	13495-13503	features	_	
23-56	13504-13515	demonstrate	_	
23-57	13516-13520	that	_	
23-58	13521-13524	the	_	
23-59	13525-13527	HD	_	
23-60	13528-13533	brain	_	
23-61	13534-13541	network	_	
23-62	13542-13548	showed	_	
23-63	13549-13553	high	_	
23-64	13554-13560	levels	_	
23-65	13561-13563	of	_	
23-66	13564-13574	clustering	_	
23-67	13575-13579	with	_	
23-68	13580-13581	a	_	
23-69	13582-13585	low	_	
23-70	13586-13593	average	_	
23-71	13594-13598	path	_	
23-72	13599-13605	length	_	
23-73	13606-13614	compared	_	
23-74	13615-13619	with	_	
23-75	13620-13623	the	_	
23-76	13624-13626	CG	_	
23-77	13627-13632	brain	_	
23-78	13633-13640	network	_	
23-79	13640-13641	.	_	

#Text=For the efficiency measurement, the values of local efficiency (Fig. 5D) and global efficiency (Fig. 5E) derived from the brain networks in the HDs and CGs increased as sparsity increased. The HD brain network showed significantly higher local efficiency in wide sparsity ranges (0.1 < S < 0.24, 0.022 < p < 0.044; 0.49 < S < 0.56, 0.018 < p < 0.05; 0.58 < S < 0.78, 0.0001 < p < 0.05; 0.82 < S < 0.87, 0.001 < p < 0.05), and lower global efficiency (0.13 < S < 0.22, 0.0001 < p < 0.016; 0.25 < S < 0.39, 0.023 < p < 0.041) than the CG brain network. These data suggested that, compared with the CGs, the signal processing in the OFC system of the HDs may be more locally efficient but less globally efficient, particularly in the sparsity ranges from 0.13 to 0.22. It was noted that the local and the global efficiency values in the HD brain network were higher than those of the CGs in the sparsity range between approximately 0.56 and 0.78, suggesting that the concurrence may allow the HD network to balance localized processing, fault tolerance, and large-scale functional integration over this range. In the sparsity range between 0.40 and 0.46, there may be similar implications to the CG network due to the concurrence of significantly (0.018 < p < 0.05) higher local efficiency and considerably higher global efficiency.
24-1	13642-13645	For	_	
24-2	13646-13649	the	_	
24-3	13650-13660	efficiency	_	
24-4	13661-13672	measurement	_	
24-5	13672-13673	,	_	
24-6	13674-13677	the	_	
24-7	13678-13684	values	_	
24-8	13685-13687	of	_	
24-9	13688-13693	local	_	
24-10	13694-13704	efficiency	_	
24-11	13705-13706	(	_	
24-12	13706-13709	Fig	_	
24-13	13709-13710	.	_	
24-14	13711-13713	5D	_	
24-15	13713-13714	)	_	
24-16	13715-13718	and	_	
24-17	13719-13725	global	_	
24-18	13726-13736	efficiency	_	
24-19	13737-13738	(	_	
24-20	13738-13741	Fig	_	
24-21	13741-13742	.	_	
24-22	13743-13745	5E	_	
24-23	13745-13746	)	_	
24-24	13747-13754	derived	_	
24-25	13755-13759	from	_	
24-26	13760-13763	the	_	
24-27	13764-13769	brain	_	
24-28	13770-13778	networks	_	
24-29	13779-13781	in	_	
24-30	13782-13785	the	_	
24-31	13786-13789	HDs	_	
24-32	13790-13793	and	_	
24-33	13794-13797	CGs	_	
24-34	13798-13807	increased	_	
24-35	13808-13810	as	_	
24-36	13811-13819	sparsity	_	
24-37	13820-13829	increased	_	
24-38	13829-13830	.	_	
24-39	13831-13834	The	_	
24-40	13835-13837	HD	_	
24-41	13838-13843	brain	_	
24-42	13844-13851	network	_	
24-43	13852-13858	showed	_	
24-44	13859-13872	significantly	_	
24-45	13873-13879	higher	_	
24-46	13880-13885	local	_	
24-47	13886-13896	efficiency	_	
24-48	13897-13899	in	_	
24-49	13900-13904	wide	_	
24-50	13905-13913	sparsity	_	
24-51	13914-13920	ranges	_	
24-52	13921-13922	(	_	
24-53	13922-13925	0.1	_	
24-54	13926-13927	<	_	
24-55	13928-13929	S	_	
24-56	13930-13931	<	_	
24-57	13932-13936	0.24	_	
24-58	13936-13937	,	_	
24-59	13938-13943	0.022	_	
24-60	13944-13945	<	_	
24-61	13946-13947	p	_	
24-62	13948-13949	<	_	
24-63	13950-13955	0.044	_	
24-64	13955-13956	;	_	
24-65	13957-13961	0.49	_	
24-66	13962-13963	<	_	
24-67	13964-13965	S	_	
24-68	13966-13967	<	_	
24-69	13968-13972	0.56	_	
24-70	13972-13973	,	_	
24-71	13974-13979	0.018	_	
24-72	13980-13981	<	_	
24-73	13982-13983	p	_	
24-74	13984-13985	<	_	
24-75	13986-13990	0.05	_	
24-76	13990-13991	;	_	
24-77	13992-13996	0.58	_	
24-78	13997-13998	<	_	
24-79	13999-14000	S	_	
24-80	14001-14002	<	_	
24-81	14003-14007	0.78	_	
24-82	14007-14008	,	_	
24-83	14009-14015	0.0001	_	
24-84	14016-14017	<	_	
24-85	14018-14019	p	_	
24-86	14020-14021	<	_	
24-87	14022-14026	0.05	_	
24-88	14026-14027	;	_	
24-89	14028-14032	0.82	_	
24-90	14033-14034	<	_	
24-91	14035-14036	S	_	
24-92	14037-14038	<	_	
24-93	14039-14043	0.87	_	
24-94	14043-14044	,	_	
24-95	14045-14050	0.001	_	
24-96	14051-14052	<	_	
24-97	14053-14054	p	_	
24-98	14055-14056	<	_	
24-99	14057-14061	0.05	_	
24-100	14061-14062	)	_	
24-101	14062-14063	,	_	
24-102	14064-14067	and	_	
24-103	14068-14073	lower	_	
24-104	14074-14080	global	_	
24-105	14081-14091	efficiency	_	
24-106	14092-14093	(	_	
24-107	14093-14097	0.13	_	
24-108	14098-14099	<	_	
24-109	14100-14101	S	_	
24-110	14102-14103	<	_	
24-111	14104-14108	0.22	_	
24-112	14108-14109	,	_	
24-113	14110-14116	0.0001	_	
24-114	14117-14118	<	_	
24-115	14119-14120	p	_	
24-116	14121-14122	<	_	
24-117	14123-14128	0.016	_	
24-118	14128-14129	;	_	
24-119	14130-14134	0.25	_	
24-120	14135-14136	<	_	
24-121	14137-14138	S	_	
24-122	14139-14140	<	_	
24-123	14141-14145	0.39	_	
24-124	14145-14146	,	_	
24-125	14147-14152	0.023	_	
24-126	14153-14154	<	_	
24-127	14155-14156	p	_	
24-128	14157-14158	<	_	
24-129	14159-14164	0.041	_	
24-130	14164-14165	)	_	
24-131	14166-14170	than	_	
24-132	14171-14174	the	_	
24-133	14175-14177	CG	_	
24-134	14178-14183	brain	_	
24-135	14184-14191	network	_	
24-136	14191-14192	.	_	
24-137	14193-14198	These	_	
24-138	14199-14203	data	_	
24-139	14204-14213	suggested	_	
24-140	14214-14218	that	_	
24-141	14218-14219	,	_	
24-142	14220-14228	compared	_	
24-143	14229-14233	with	_	
24-144	14234-14237	the	_	
24-145	14238-14241	CGs	_	
24-146	14241-14242	,	_	
24-147	14243-14246	the	_	
24-148	14247-14253	signal	_	
24-149	14254-14264	processing	_	
24-150	14265-14267	in	_	
24-151	14268-14271	the	_	
24-152	14272-14275	OFC	_	
24-153	14276-14282	system	_	
24-154	14283-14285	of	_	
24-155	14286-14289	the	_	
24-156	14290-14293	HDs	_	
24-157	14294-14297	may	_	
24-158	14298-14300	be	_	
24-159	14301-14305	more	_	
24-160	14306-14313	locally	_	
24-161	14314-14323	efficient	_	
24-162	14324-14327	but	_	
24-163	14328-14332	less	_	
24-164	14333-14341	globally	_	
24-165	14342-14351	efficient	_	
24-166	14351-14352	,	_	
24-167	14353-14365	particularly	_	
24-168	14366-14368	in	_	
24-169	14369-14372	the	_	
24-170	14373-14381	sparsity	_	
24-171	14382-14388	ranges	_	
24-172	14389-14393	from	_	
24-173	14394-14398	0.13	_	
24-174	14399-14401	to	_	
24-175	14402-14406	0.22	_	
24-176	14406-14407	.	_	
24-177	14408-14410	It	_	
24-178	14411-14414	was	_	
24-179	14415-14420	noted	_	
24-180	14421-14425	that	_	
24-181	14426-14429	the	_	
24-182	14430-14435	local	_	
24-183	14436-14439	and	_	
24-184	14440-14443	the	_	
24-185	14444-14450	global	_	
24-186	14451-14461	efficiency	_	
24-187	14462-14468	values	_	
24-188	14469-14471	in	_	
24-189	14472-14475	the	_	
24-190	14476-14478	HD	_	
24-191	14479-14484	brain	_	
24-192	14485-14492	network	_	
24-193	14493-14497	were	_	
24-194	14498-14504	higher	_	
24-195	14505-14509	than	_	
24-196	14510-14515	those	_	
24-197	14516-14518	of	_	
24-198	14519-14522	the	_	
24-199	14523-14526	CGs	_	
24-200	14527-14529	in	_	
24-201	14530-14533	the	_	
24-202	14534-14542	sparsity	_	
24-203	14543-14548	range	_	
24-204	14549-14556	between	_	
24-205	14557-14570	approximately	_	
24-206	14571-14575	0.56	_	
24-207	14576-14579	and	_	
24-208	14580-14584	0.78	_	
24-209	14584-14585	,	_	
24-210	14586-14596	suggesting	_	
24-211	14597-14601	that	_	
24-212	14602-14605	the	_	
24-213	14606-14617	concurrence	_	
24-214	14618-14621	may	_	
24-215	14622-14627	allow	_	
24-216	14628-14631	the	_	
24-217	14632-14634	HD	_	
24-218	14635-14642	network	_	
24-219	14643-14645	to	_	
24-220	14646-14653	balance	_	
24-221	14654-14663	localized	_	
24-222	14664-14674	processing	_	
24-223	14674-14675	,	_	
24-224	14676-14681	fault	_	
24-225	14682-14691	tolerance	_	
24-226	14691-14692	,	_	
24-227	14693-14696	and	_	
24-228	14697-14708	large-scale	_	
24-229	14709-14719	functional	_	
24-230	14720-14731	integration	_	
24-231	14732-14736	over	_	
24-232	14737-14741	this	_	
24-233	14742-14747	range	_	
24-234	14747-14748	.	_	
24-235	14749-14751	In	_	
24-236	14752-14755	the	_	
24-237	14756-14764	sparsity	_	
24-238	14765-14770	range	_	
24-239	14771-14778	between	_	
24-240	14779-14783	0.40	_	
24-241	14784-14787	and	_	
24-242	14788-14792	0.46	_	
24-243	14792-14793	,	_	
24-244	14794-14799	there	_	
24-245	14800-14803	may	_	
24-246	14804-14806	be	_	
24-247	14807-14814	similar	_	
24-248	14815-14827	implications	_	
24-249	14828-14830	to	_	
24-250	14831-14834	the	_	
24-251	14835-14837	CG	_	
24-252	14838-14845	network	_	
24-253	14846-14849	due	_	
24-254	14850-14852	to	_	
24-255	14853-14856	the	_	
24-256	14857-14868	concurrence	_	
24-257	14869-14871	of	_	
24-258	14872-14885	significantly	_	
24-259	14886-14887	(	_	
24-260	14887-14892	0.018	_	
24-261	14893-14894	<	_	
24-262	14895-14896	p	_	
24-263	14897-14898	<	_	
24-264	14899-14903	0.05	_	
24-265	14903-14904	)	_	
24-266	14905-14911	higher	_	
24-267	14912-14917	local	_	
24-268	14918-14928	efficiency	_	
24-269	14929-14932	and	_	
24-270	14933-14945	considerably	_	
24-271	14946-14952	higher	_	
24-272	14953-14959	global	_	
24-273	14960-14970	efficiency	_	
24-274	14970-14971	.	_	

#Text=Figure 5F shows that the normalized local efficiency with respect to the CG network, γE, was larger than 1 and that the normalized global efficiency, λE, was approximately 1. These patterns suggested that, compared with the CG brain network, the HD brain network is approximately equivalently efficient in distributed signal processing and yet more efficient in local signal processing in the OFC system. Note that there was an inconsistent pattern of global efficiency (Fig. 5E) at the sparsity threshold of 0.45, suggesting that, at values less than the threshold, the HD network having lower global efficiency had weaker “small-world” attributes.
25-1	14972-14978	Figure	_	
25-2	14979-14981	5F	_	
25-3	14982-14987	shows	_	
25-4	14988-14992	that	_	
25-5	14993-14996	the	_	
25-6	14997-15007	normalized	_	
25-7	15008-15013	local	_	
25-8	15014-15024	efficiency	_	
25-9	15025-15029	with	_	
25-10	15030-15037	respect	_	
25-11	15038-15040	to	_	
25-12	15041-15044	the	_	
25-13	15045-15047	CG	_	
25-14	15048-15055	network	_	
25-15	15055-15056	,	_	
25-16	15057-15059	γE	_	
25-17	15059-15060	,	_	
25-18	15061-15064	was	_	
25-19	15065-15071	larger	_	
25-20	15072-15076	than	_	
25-21	15077-15078	1	_	
25-22	15079-15082	and	_	
25-23	15083-15087	that	_	
25-24	15088-15091	the	_	
25-25	15092-15102	normalized	_	
25-26	15103-15109	global	_	
25-27	15110-15120	efficiency	_	
25-28	15120-15121	,	_	
25-29	15122-15124	λE	_	
25-30	15124-15125	,	_	
25-31	15126-15129	was	_	
25-32	15130-15143	approximately	_	
25-33	15144-15145	1	_	
25-34	15145-15146	.	_	
25-35	15147-15152	These	_	
25-36	15153-15161	patterns	_	
25-37	15162-15171	suggested	_	
25-38	15172-15176	that	_	
25-39	15176-15177	,	_	
25-40	15178-15186	compared	_	
25-41	15187-15191	with	_	
25-42	15192-15195	the	_	
25-43	15196-15198	CG	_	
25-44	15199-15204	brain	_	
25-45	15205-15212	network	_	
25-46	15212-15213	,	_	
25-47	15214-15217	the	_	
25-48	15218-15220	HD	_	
25-49	15221-15226	brain	_	
25-50	15227-15234	network	_	
25-51	15235-15237	is	_	
25-52	15238-15251	approximately	_	
25-53	15252-15264	equivalently	_	
25-54	15265-15274	efficient	_	
25-55	15275-15277	in	_	
25-56	15278-15289	distributed	_	
25-57	15290-15296	signal	_	
25-58	15297-15307	processing	_	
25-59	15308-15311	and	_	
25-60	15312-15315	yet	_	
25-61	15316-15320	more	_	
25-62	15321-15330	efficient	_	
25-63	15331-15333	in	_	
25-64	15334-15339	local	_	
25-65	15340-15346	signal	_	
25-66	15347-15357	processing	_	
25-67	15358-15360	in	_	
25-68	15361-15364	the	_	
25-69	15365-15368	OFC	_	
25-70	15369-15375	system	_	
25-71	15375-15376	.	_	
25-72	15377-15381	Note	_	
25-73	15382-15386	that	_	
25-74	15387-15392	there	_	
25-75	15393-15396	was	_	
25-76	15397-15399	an	_	
25-77	15400-15412	inconsistent	_	
25-78	15413-15420	pattern	_	
25-79	15421-15423	of	_	
25-80	15424-15430	global	_	
25-81	15431-15441	efficiency	_	
25-82	15442-15443	(	_	
25-83	15443-15446	Fig	_	
25-84	15446-15447	.	_	
25-85	15448-15450	5E	_	
25-86	15450-15451	)	_	
25-87	15452-15454	at	_	
25-88	15455-15458	the	_	
25-89	15459-15467	sparsity	_	
25-90	15468-15477	threshold	_	
25-91	15478-15480	of	_	
25-92	15481-15485	0.45	_	
25-93	15485-15486	,	_	
25-94	15487-15497	suggesting	_	
25-95	15498-15502	that	_	
25-96	15502-15503	,	_	
25-97	15504-15506	at	_	
25-98	15507-15513	values	_	
25-99	15514-15518	less	_	
25-100	15519-15523	than	_	
25-101	15524-15527	the	_	
25-102	15528-15537	threshold	_	
25-103	15537-15538	,	_	
25-104	15539-15542	the	_	
25-105	15543-15545	HD	_	
25-106	15546-15553	network	_	
25-107	15554-15560	having	_	
25-108	15561-15566	lower	_	
25-109	15567-15573	global	_	
25-110	15574-15584	efficiency	_	
25-111	15585-15588	had	_	
25-112	15589-15595	weaker	_	
25-113	15596-15597	“	_	
25-114	15597-15608	small-world	_	
25-115	15608-15609	”	_	
25-116	15610-15620	attributes	_	
25-117	15620-15621	.	_	

#Text=Furthermore, both the HD and CG brain networks were compared to their random networks. With respect to their random networks, the normalized values of these small-world properties (profiled in Supplementary Figure S5) suggested that both the HD and CG brain networks are small-world. The measure of network small-worldness showed a significance (p = 0.019) at the sparsity of 0.14 between groups. While examining the intuitive normalization method, where the HD brain network was compared to the CG brain network, and the classical normalization method, where the HD brain network was compared to random network, we found that the metrics were significantly (pFDR < 0.05) different at a few short sparsity ranges (0.49 < S < 0.50; 0.79 < S < 0.80; 0.82 < S < 0.83). The measures of small-world characteristics are displayed in Supplementary Figure S6.
26-1	15622-15633	Furthermore	_	
26-2	15633-15634	,	_	
26-3	15635-15639	both	_	
26-4	15640-15643	the	_	
26-5	15644-15646	HD	_	
26-6	15647-15650	and	_	
26-7	15651-15653	CG	_	
26-8	15654-15659	brain	_	
26-9	15660-15668	networks	_	
26-10	15669-15673	were	_	
26-11	15674-15682	compared	_	
26-12	15683-15685	to	_	
26-13	15686-15691	their	_	
26-14	15692-15698	random	_	
26-15	15699-15707	networks	_	
26-16	15707-15708	.	_	
26-17	15709-15713	With	_	
26-18	15714-15721	respect	_	
26-19	15722-15724	to	_	
26-20	15725-15730	their	_	
26-21	15731-15737	random	_	
26-22	15738-15746	networks	_	
26-23	15746-15747	,	_	
26-24	15748-15751	the	_	
26-25	15752-15762	normalized	_	
26-26	15763-15769	values	_	
26-27	15770-15772	of	_	
26-28	15773-15778	these	_	
26-29	15779-15790	small-world	_	
26-30	15791-15801	properties	_	
26-31	15802-15803	(	_	
26-32	15803-15811	profiled	_	
26-33	15812-15814	in	_	
26-34	15815-15828	Supplementary	_	
26-35	15829-15835	Figure	_	
26-36	15836-15838	S5	_	
26-37	15838-15839	)	_	
26-38	15840-15849	suggested	_	
26-39	15850-15854	that	_	
26-40	15855-15859	both	_	
26-41	15860-15863	the	_	
26-42	15864-15866	HD	_	
26-43	15867-15870	and	_	
26-44	15871-15873	CG	_	
26-45	15874-15879	brain	_	
26-46	15880-15888	networks	_	
26-47	15889-15892	are	_	
26-48	15893-15904	small-world	_	
26-49	15904-15905	.	_	
26-50	15906-15909	The	_	
26-51	15910-15917	measure	_	
26-52	15918-15920	of	_	
26-53	15921-15928	network	_	
26-54	15929-15944	small-worldness	_	
26-55	15945-15951	showed	_	
26-56	15952-15953	a	_	
26-57	15954-15966	significance	_	
26-58	15967-15968	(	_	
26-59	15968-15969	p	_	
26-60	15970-15971	=	_	
26-61	15972-15977	0.019	_	
26-62	15977-15978	)	_	
26-63	15979-15981	at	_	
26-64	15982-15985	the	_	
26-65	15986-15994	sparsity	_	
26-66	15995-15997	of	_	
26-67	15998-16002	0.14	_	
26-68	16003-16010	between	_	
26-69	16011-16017	groups	_	
26-70	16017-16018	.	_	
26-71	16019-16024	While	_	
26-72	16025-16034	examining	_	
26-73	16035-16038	the	_	
26-74	16039-16048	intuitive	_	
26-75	16049-16062	normalization	_	
26-76	16063-16069	method	_	
26-77	16069-16070	,	_	
26-78	16071-16076	where	_	
26-79	16077-16080	the	_	
26-80	16081-16083	HD	_	
26-81	16084-16089	brain	_	
26-82	16090-16097	network	_	
26-83	16098-16101	was	_	
26-84	16102-16110	compared	_	
26-85	16111-16113	to	_	
26-86	16114-16117	the	_	
26-87	16118-16120	CG	_	
26-88	16121-16126	brain	_	
26-89	16127-16134	network	_	
26-90	16134-16135	,	_	
26-91	16136-16139	and	_	
26-92	16140-16143	the	_	
26-93	16144-16153	classical	_	
26-94	16154-16167	normalization	_	
26-95	16168-16174	method	_	
26-96	16174-16175	,	_	
26-97	16176-16181	where	_	
26-98	16182-16185	the	_	
26-99	16186-16188	HD	_	
26-100	16189-16194	brain	_	
26-101	16195-16202	network	_	
26-102	16203-16206	was	_	
26-103	16207-16215	compared	_	
26-104	16216-16218	to	_	
26-105	16219-16225	random	_	
26-106	16226-16233	network	_	
26-107	16233-16234	,	_	
26-108	16235-16237	we	_	
26-109	16238-16243	found	_	
26-110	16244-16248	that	_	
26-111	16249-16252	the	_	
26-112	16253-16260	metrics	_	
26-113	16261-16265	were	_	
26-114	16266-16279	significantly	_	
26-115	16280-16281	(	_	
26-116	16281-16285	pFDR	_	
26-117	16286-16287	<	_	
26-118	16288-16292	0.05	_	
26-119	16292-16293	)	_	
26-120	16294-16303	different	_	
26-121	16304-16306	at	_	
26-122	16307-16308	a	_	
26-123	16309-16312	few	_	
26-124	16313-16318	short	_	
26-125	16319-16327	sparsity	_	
26-126	16328-16334	ranges	_	
26-127	16335-16336	(	_	
26-128	16336-16340	0.49	_	
26-129	16341-16342	<	_	
26-130	16343-16344	S	_	
26-131	16345-16346	<	_	
26-132	16347-16351	0.50	_	
26-133	16351-16352	;	_	
26-134	16353-16357	0.79	_	
26-135	16358-16359	<	_	
26-136	16360-16361	S	_	
26-137	16362-16363	<	_	
26-138	16364-16368	0.80	_	
26-139	16368-16369	;	_	
26-140	16370-16374	0.82	_	
26-141	16375-16376	<	_	
26-142	16377-16378	S	_	
26-143	16379-16380	<	_	
26-144	16381-16385	0.83	_	
26-145	16385-16386	)	_	
26-146	16386-16387	.	_	
26-147	16388-16391	The	_	
26-148	16392-16400	measures	_	
26-149	16401-16403	of	_	
26-150	16404-16415	small-world	_	
26-151	16416-16431	characteristics	_	
26-152	16432-16435	are	_	
26-153	16436-16445	displayed	_	
26-154	16446-16448	in	_	
26-155	16449-16462	Supplementary	_	
26-156	16463-16469	Figure	_	
26-157	16470-16472	S6	_	
26-158	16472-16473	.	_	

#Text=Regression analysis
27-1	16474-16484	Regression	_	
27-2	16485-16493	analysis	_	

#Text=Linear regression analyses were conducted to investigate the associations between the STAI scores after controlling for the covariates of age, IQ, education years, and daily consumption of cigarettes, and functional connectivity based on the seed channels (i.e., the stimuli-induced activated channels 11 and 4 from the localizer task in our study). There were significant (pFDR < 0.05) associations between the STAI scores and functional connectivity in the seed channel 11, but no significant association in the seed channel 4 was observed between groups. Connectivity t-maps are shown in Fig. 6A where the seed channel 11 is in red, and the channels with significant regression are shown and colored. Figure 6B–E show that the STAI scores after controlling for the covariates, were proportionally related to enhanced functional connectivity between the seed channel 11 (covering the left inferior frontal gyrus, orbital part), and channel 1 (covering the right middle frontal gyrus, orbital part; Fig. 6B), channel 6 (covering the right mOFC; Fig. 6C), channel 8 (covering the left mOFC; Fig. 6D), and channel 9 (covering the left superior frontal gyrus, orbital part; Fig. 6E). No significant differences between the groups in the variables age, years of education, years of smoking, daily consumption of cigarettes, and the effect of medication status were observed. Our results showed that the HDs had significantly (p < 0.05, Table 1) higher anxiety (STAI) scores than the CGs.
28-1	16494-16500	Linear	_	
28-2	16501-16511	regression	_	
28-3	16512-16520	analyses	_	
28-4	16521-16525	were	_	
28-5	16526-16535	conducted	_	
28-6	16536-16538	to	_	
28-7	16539-16550	investigate	_	
28-8	16551-16554	the	_	
28-9	16555-16567	associations	_	
28-10	16568-16575	between	_	
28-11	16576-16579	the	_	
28-12	16580-16584	STAI	_	
28-13	16585-16591	scores	_	
28-14	16592-16597	after	_	
28-15	16598-16609	controlling	_	
28-16	16610-16613	for	_	
28-17	16614-16617	the	_	
28-18	16618-16628	covariates	_	
28-19	16629-16631	of	_	
28-20	16632-16635	age	_	
28-21	16635-16636	,	_	
28-22	16637-16639	IQ	_	
28-23	16639-16640	,	_	
28-24	16641-16650	education	_	
28-25	16651-16656	years	_	
28-26	16656-16657	,	_	
28-27	16658-16661	and	_	
28-28	16662-16667	daily	_	
28-29	16668-16679	consumption	_	
28-30	16680-16682	of	_	
28-31	16683-16693	cigarettes	_	
28-32	16693-16694	,	_	
28-33	16695-16698	and	_	
28-34	16699-16709	functional	_	
28-35	16710-16722	connectivity	_	
28-36	16723-16728	based	_	
28-37	16729-16731	on	_	
28-38	16732-16735	the	_	
28-39	16736-16740	seed	_	
28-40	16741-16749	channels	_	
28-41	16750-16751	(	_	
28-42	16751-16754	i.e	_	
28-43	16754-16755	.	_	
28-44	16755-16756	,	_	
28-45	16757-16760	the	_	
28-46	16761-16776	stimuli-induced	_	
28-47	16777-16786	activated	_	
28-48	16787-16795	channels	_	
28-49	16796-16798	11	_	
28-50	16799-16802	and	_	
28-51	16803-16804	4	_	
28-52	16805-16809	from	_	
28-53	16810-16813	the	_	
28-54	16814-16823	localizer	_	
28-55	16824-16828	task	_	
28-56	16829-16831	in	_	
28-57	16832-16835	our	_	
28-58	16836-16841	study	_	
28-59	16841-16842	)	_	
28-60	16842-16843	.	_	
28-61	16844-16849	There	_	
28-62	16850-16854	were	_	
28-63	16855-16866	significant	_	
28-64	16867-16868	(	_	
28-65	16868-16872	pFDR	_	
28-66	16873-16874	<	_	
28-67	16875-16879	0.05	_	
28-68	16879-16880	)	_	
28-69	16881-16893	associations	_	
28-70	16894-16901	between	_	
28-71	16902-16905	the	_	
28-72	16906-16910	STAI	_	
28-73	16911-16917	scores	_	
28-74	16918-16921	and	_	
28-75	16922-16932	functional	_	
28-76	16933-16945	connectivity	_	
28-77	16946-16948	in	_	
28-78	16949-16952	the	_	
28-79	16953-16957	seed	_	
28-80	16958-16965	channel	_	
28-81	16966-16968	11	_	
28-82	16968-16969	,	_	
28-83	16970-16973	but	_	
28-84	16974-16976	no	_	
28-85	16977-16988	significant	_	
28-86	16989-17000	association	_	
28-87	17001-17003	in	_	
28-88	17004-17007	the	_	
28-89	17008-17012	seed	_	
28-90	17013-17020	channel	_	
28-91	17021-17022	4	_	
28-92	17023-17026	was	_	
28-93	17027-17035	observed	_	
28-94	17036-17043	between	_	
28-95	17044-17050	groups	_	
28-96	17050-17051	.	_	
28-97	17052-17064	Connectivity	_	
28-98	17065-17071	t-maps	_	
28-99	17072-17075	are	_	
28-100	17076-17081	shown	_	
28-101	17082-17084	in	_	
28-102	17085-17088	Fig	_	
28-103	17088-17089	.	_	
28-104	17090-17092	6A	_	
28-105	17093-17098	where	_	
28-106	17099-17102	the	_	
28-107	17103-17107	seed	_	
28-108	17108-17115	channel	_	
28-109	17116-17118	11	_	
28-110	17119-17121	is	_	
28-111	17122-17124	in	_	
28-112	17125-17128	red	_	
28-113	17128-17129	,	_	
28-114	17130-17133	and	_	
28-115	17134-17137	the	_	
28-116	17138-17146	channels	_	
28-117	17147-17151	with	_	
28-118	17152-17163	significant	_	
28-119	17164-17174	regression	_	
28-120	17175-17178	are	_	
28-121	17179-17184	shown	_	
28-122	17185-17188	and	_	
28-123	17189-17196	colored	_	
28-124	17196-17197	.	_	
28-125	17198-17204	Figure	_	
28-126	17205-17209	6B–E	_	
28-127	17210-17214	show	_	
28-128	17215-17219	that	_	
28-129	17220-17223	the	_	
28-130	17224-17228	STAI	_	
28-131	17229-17235	scores	_	
28-132	17236-17241	after	_	
28-133	17242-17253	controlling	_	
28-134	17254-17257	for	_	
28-135	17258-17261	the	_	
28-136	17262-17272	covariates	_	
28-137	17272-17273	,	_	
28-138	17274-17278	were	_	
28-139	17279-17293	proportionally	_	
28-140	17294-17301	related	_	
28-141	17302-17304	to	_	
28-142	17305-17313	enhanced	_	
28-143	17314-17324	functional	_	
28-144	17325-17337	connectivity	_	
28-145	17338-17345	between	_	
28-146	17346-17349	the	_	
28-147	17350-17354	seed	_	
28-148	17355-17362	channel	_	
28-149	17363-17365	11	_	
28-150	17366-17367	(	_	
28-151	17367-17375	covering	_	
28-152	17376-17379	the	_	
28-153	17380-17384	left	_	
28-154	17385-17393	inferior	_	
28-155	17394-17401	frontal	_	
28-156	17402-17407	gyrus	_	
28-157	17407-17408	,	_	
28-158	17409-17416	orbital	_	
28-159	17417-17421	part	_	
28-160	17421-17422	)	_	
28-161	17422-17423	,	_	
28-162	17424-17427	and	_	
28-163	17428-17435	channel	_	
28-164	17436-17437	1	_	
28-165	17438-17439	(	_	
28-166	17439-17447	covering	_	
28-167	17448-17451	the	_	
28-168	17452-17457	right	_	
28-169	17458-17464	middle	_	
28-170	17465-17472	frontal	_	
28-171	17473-17478	gyrus	_	
28-172	17478-17479	,	_	
28-173	17480-17487	orbital	_	
28-174	17488-17492	part	_	
28-175	17492-17493	;	_	
28-176	17494-17497	Fig	_	
28-177	17497-17498	.	_	
28-178	17499-17501	6B	_	
28-179	17501-17502	)	_	
28-180	17502-17503	,	_	
28-181	17504-17511	channel	_	
28-182	17512-17513	6	_	
28-183	17514-17515	(	_	
28-184	17515-17523	covering	_	
28-185	17524-17527	the	_	
28-186	17528-17533	right	_	
28-187	17534-17538	mOFC	_	
28-188	17538-17539	;	_	
28-189	17540-17543	Fig	_	
28-190	17543-17544	.	_	
28-191	17545-17547	6C	_	
28-192	17547-17548	)	_	
28-193	17548-17549	,	_	
28-194	17550-17557	channel	_	
28-195	17558-17559	8	_	
28-196	17560-17561	(	_	
28-197	17561-17569	covering	_	
28-198	17570-17573	the	_	
28-199	17574-17578	left	_	
28-200	17579-17583	mOFC	_	
28-201	17583-17584	;	_	
28-202	17585-17588	Fig	_	
28-203	17588-17589	.	_	
28-204	17590-17592	6D	_	
28-205	17592-17593	)	_	
28-206	17593-17594	,	_	
28-207	17595-17598	and	_	
28-208	17599-17606	channel	_	
28-209	17607-17608	9	_	
28-210	17609-17610	(	_	
28-211	17610-17618	covering	_	
28-212	17619-17622	the	_	
28-213	17623-17627	left	_	
28-214	17628-17636	superior	_	
28-215	17637-17644	frontal	_	
28-216	17645-17650	gyrus	_	
28-217	17650-17651	,	_	
28-218	17652-17659	orbital	_	
28-219	17660-17664	part	_	
28-220	17664-17665	;	_	
28-221	17666-17669	Fig	_	
28-222	17669-17670	.	_	
28-223	17671-17673	6E	_	
28-224	17673-17674	)	_	
28-225	17674-17675	.	_	
28-226	17676-17678	No	_	
28-227	17679-17690	significant	_	
28-228	17691-17702	differences	_	
28-229	17703-17710	between	_	
28-230	17711-17714	the	_	
28-231	17715-17721	groups	_	
28-232	17722-17724	in	_	
28-233	17725-17728	the	_	
28-234	17729-17738	variables	_	
28-235	17739-17742	age	_	
28-236	17742-17743	,	_	
28-237	17744-17749	years	_	
28-238	17750-17752	of	_	
28-239	17753-17762	education	_	
28-240	17762-17763	,	_	
28-241	17764-17769	years	_	
28-242	17770-17772	of	_	
28-243	17773-17780	smoking	_	
28-244	17780-17781	,	_	
28-245	17782-17787	daily	_	
28-246	17788-17799	consumption	_	
28-247	17800-17802	of	_	
28-248	17803-17813	cigarettes	_	
28-249	17813-17814	,	_	
28-250	17815-17818	and	_	
28-251	17819-17822	the	_	
28-252	17823-17829	effect	_	
28-253	17830-17832	of	_	
28-254	17833-17843	medication	_	
28-255	17844-17850	status	_	
28-256	17851-17855	were	_	
28-257	17856-17864	observed	_	
28-258	17864-17865	.	_	
28-259	17866-17869	Our	_	
28-260	17870-17877	results	_	
28-261	17878-17884	showed	_	
28-262	17885-17889	that	_	
28-263	17890-17893	the	_	
28-264	17894-17897	HDs	_	
28-265	17898-17901	had	_	
28-266	17902-17915	significantly	_	
28-267	17916-17917	(	_	
28-268	17917-17918	p	_	
28-269	17919-17920	<	_	
28-270	17921-17925	0.05	_	
28-271	17925-17926	,	_	
28-272	17927-17932	Table	_	
28-273	17933-17934	1	_	
28-274	17934-17935	)	_	
28-275	17936-17942	higher	_	
28-276	17943-17950	anxiety	_	
28-277	17951-17952	(	_	
28-278	17952-17956	STAI	_	
28-279	17956-17957	)	_	
28-280	17958-17964	scores	_	
28-281	17965-17969	than	_	
28-282	17970-17973	the	_	
28-283	17974-17977	CGs	_	
28-284	17977-17978	.	_	

#Text=Discussion
29-1	17979-17989	Discussion	_	

#Text=In this study, we utilized resting-state fNIRS measurements to characterize the cortical networks in the OFC regions in chronic heroin users in an abstinent stage. In particular, the alterations in the functional connectivity within the OFC were investigated and the question of whether anxiety is linked to the OFC networks was also examined. We discovered that the HDs who used heroin for over twenty years and who managed to stay abstinent for more than three months up to ten years exhibited manifold significant differences compared to the CGs. Overall, our findings demonstrated that the HDs showed increased interhemispheric correlations, enhanced resting-state functional connectivity, and unique network organizations in the OFC. Moreover, our group-level analysis demonstrated that the connectivity associations between the left inferior frontal gyrus seed and four OFC regions were linked to anxiety scores. We did not find evidence for associations with other seed channels in our study, nor did we find any significant differences across the participants’ demographic characteristics. Here, we consider the significant differences in the OFC networks between the HDs and the CGs from the perspective of the rsFC in turn.
30-1	17990-17992	In	_	
30-2	17993-17997	this	_	
30-3	17998-18003	study	_	
30-4	18003-18004	,	_	
30-5	18005-18007	we	_	
30-6	18008-18016	utilized	_	
30-7	18017-18030	resting-state	_	
30-8	18031-18036	fNIRS	_	
30-9	18037-18049	measurements	_	
30-10	18050-18052	to	_	
30-11	18053-18065	characterize	_	
30-12	18066-18069	the	_	
30-13	18070-18078	cortical	_	
30-14	18079-18087	networks	_	
30-15	18088-18090	in	_	
30-16	18091-18094	the	_	
30-17	18095-18098	OFC	_	
30-18	18099-18106	regions	_	
30-19	18107-18109	in	_	
30-20	18110-18117	chronic	_	
30-21	18118-18124	heroin	_	
30-22	18125-18130	users	_	
30-23	18131-18133	in	_	
30-24	18134-18136	an	_	
30-25	18137-18146	abstinent	_	
30-26	18147-18152	stage	_	
30-27	18152-18153	.	_	
30-28	18154-18156	In	_	
30-29	18157-18167	particular	_	
30-30	18167-18168	,	_	
30-31	18169-18172	the	_	
30-32	18173-18184	alterations	_	
30-33	18185-18187	in	_	
30-34	18188-18191	the	_	
30-35	18192-18202	functional	_	
30-36	18203-18215	connectivity	_	
30-37	18216-18222	within	_	
30-38	18223-18226	the	_	
30-39	18227-18230	OFC	_	
30-40	18231-18235	were	_	
30-41	18236-18248	investigated	_	
30-42	18249-18252	and	_	
30-43	18253-18256	the	_	
30-44	18257-18265	question	_	
30-45	18266-18268	of	_	
30-46	18269-18276	whether	_	
30-47	18277-18284	anxiety	_	
30-48	18285-18287	is	_	
30-49	18288-18294	linked	_	
30-50	18295-18297	to	_	
30-51	18298-18301	the	_	
30-52	18302-18305	OFC	_	
30-53	18306-18314	networks	_	
30-54	18315-18318	was	_	
30-55	18319-18323	also	_	
30-56	18324-18332	examined	_	
30-57	18332-18333	.	_	
30-58	18334-18336	We	_	
30-59	18337-18347	discovered	_	
30-60	18348-18352	that	_	
30-61	18353-18356	the	_	
30-62	18357-18360	HDs	_	
30-63	18361-18364	who	_	
30-64	18365-18369	used	_	
30-65	18370-18376	heroin	_	
30-66	18377-18380	for	_	
30-67	18381-18385	over	_	
30-68	18386-18392	twenty	_	
30-69	18393-18398	years	_	
30-70	18399-18402	and	_	
30-71	18403-18406	who	_	
30-72	18407-18414	managed	_	
30-73	18415-18417	to	_	
30-74	18418-18422	stay	_	
30-75	18423-18432	abstinent	_	
30-76	18433-18436	for	_	
30-77	18437-18441	more	_	
30-78	18442-18446	than	_	
30-79	18447-18452	three	_	
30-80	18453-18459	months	_	
30-81	18460-18462	up	_	
30-82	18463-18465	to	_	
30-83	18466-18469	ten	_	
30-84	18470-18475	years	_	
30-85	18476-18485	exhibited	_	
30-86	18486-18494	manifold	_	
30-87	18495-18506	significant	_	
30-88	18507-18518	differences	_	
30-89	18519-18527	compared	_	
30-90	18528-18530	to	_	
30-91	18531-18534	the	_	
30-92	18535-18538	CGs	_	
30-93	18538-18539	.	_	
30-94	18540-18547	Overall	_	
30-95	18547-18548	,	_	
30-96	18549-18552	our	_	
30-97	18553-18561	findings	_	
30-98	18562-18574	demonstrated	_	
30-99	18575-18579	that	_	
30-100	18580-18583	the	_	
30-101	18584-18587	HDs	_	
30-102	18588-18594	showed	_	
30-103	18595-18604	increased	_	
30-104	18605-18621	interhemispheric	_	
30-105	18622-18634	correlations	_	
30-106	18634-18635	,	_	
30-107	18636-18644	enhanced	_	
30-108	18645-18658	resting-state	_	
30-109	18659-18669	functional	_	
30-110	18670-18682	connectivity	_	
30-111	18682-18683	,	_	
30-112	18684-18687	and	_	
30-113	18688-18694	unique	_	
30-114	18695-18702	network	_	
30-115	18703-18716	organizations	_	
30-116	18717-18719	in	_	
30-117	18720-18723	the	_	
30-118	18724-18727	OFC	_	
30-119	18727-18728	.	_	
30-120	18729-18737	Moreover	_	
30-121	18737-18738	,	_	
30-122	18739-18742	our	_	
30-123	18743-18754	group-level	_	
30-124	18755-18763	analysis	_	
30-125	18764-18776	demonstrated	_	
30-126	18777-18781	that	_	
30-127	18782-18785	the	_	
30-128	18786-18798	connectivity	_	
30-129	18799-18811	associations	_	
30-130	18812-18819	between	_	
30-131	18820-18823	the	_	
30-132	18824-18828	left	_	
30-133	18829-18837	inferior	_	
30-134	18838-18845	frontal	_	
30-135	18846-18851	gyrus	_	
30-136	18852-18856	seed	_	
30-137	18857-18860	and	_	
30-138	18861-18865	four	_	
30-139	18866-18869	OFC	_	
30-140	18870-18877	regions	_	
30-141	18878-18882	were	_	
30-142	18883-18889	linked	_	
30-143	18890-18892	to	_	
30-144	18893-18900	anxiety	_	
30-145	18901-18907	scores	_	
30-146	18907-18908	.	_	
30-147	18909-18911	We	_	
30-148	18912-18915	did	_	
30-149	18916-18919	not	_	
30-150	18920-18924	find	_	
30-151	18925-18933	evidence	_	
30-152	18934-18937	for	_	
30-153	18938-18950	associations	_	
30-154	18951-18955	with	_	
30-155	18956-18961	other	_	
30-156	18962-18966	seed	_	
30-157	18967-18975	channels	_	
30-158	18976-18978	in	_	
30-159	18979-18982	our	_	
30-160	18983-18988	study	_	
30-161	18988-18989	,	_	
30-162	18990-18993	nor	_	
30-163	18994-18997	did	_	
30-164	18998-19000	we	_	
30-165	19001-19005	find	_	
30-166	19006-19009	any	_	
30-167	19010-19021	significant	_	
30-168	19022-19033	differences	_	
30-169	19034-19040	across	_	
30-170	19041-19044	the	_	
30-171	19045-19057	participants	_	
30-172	19057-19058	’	_	
30-173	19059-19070	demographic	_	
30-174	19071-19086	characteristics	_	
30-175	19086-19087	.	_	
30-176	19088-19092	Here	_	
30-177	19092-19093	,	_	
30-178	19094-19096	we	_	
30-179	19097-19105	consider	_	
30-180	19106-19109	the	_	
30-181	19110-19121	significant	_	
30-182	19122-19133	differences	_	
30-183	19134-19136	in	_	
30-184	19137-19140	the	_	
30-185	19141-19144	OFC	_	
30-186	19145-19153	networks	_	
30-187	19154-19161	between	_	
30-188	19162-19165	the	_	
30-189	19166-19169	HDs	_	
30-190	19170-19173	and	_	
30-191	19174-19177	the	_	
30-192	19178-19181	CGs	_	
30-193	19182-19186	from	_	
30-194	19187-19190	the	_	
30-195	19191-19202	perspective	_	
30-196	19203-19205	of	_	
30-197	19206-19209	the	_	
30-198	19210-19214	rsFC	_	
30-199	19215-19217	in	_	
30-200	19218-19222	turn	_	
30-201	19222-19223	.	_	

#Text=With respect to the connectivity patterns of the HDs, our analyses demonstrated enhanced resting-state functional connectivity within and between the regions of interest (ROIs) in the OFC. First, our seed-based analysis estimated and detected different strength in pairwise relationships between the seeds, which were determined in our unbiased localizer task experiment, and other OFC regions. Second, our whole-brain analysis identified more connectivity patterns as indicated by increased number of edges within the region of the right lOFC (i.e., the right middle frontal gyrus and the right superior frontal gyrus, orbital part) and between the right and the left superior frontal gyri, as well as between the right and the left middle frontal gyri in the orbital part of the brain. In contrast, compared with the CG whole-brain connectivity map, the HDs showed less connectivity patterns as indicated by reduced number of edges within the mOFC. The result was consistent with our interhemispheric correlation finding where no significant intravascular events (i.e., the changes in HbO and Hb) were observed in the mOFC, which is believed to be responsible for empathic activity and is involved in emotion.
31-1	19224-19228	With	_	
31-2	19229-19236	respect	_	
31-3	19237-19239	to	_	
31-4	19240-19243	the	_	
31-5	19244-19256	connectivity	_	
31-6	19257-19265	patterns	_	
31-7	19266-19268	of	_	
31-8	19269-19272	the	_	
31-9	19273-19276	HDs	_	
31-10	19276-19277	,	_	
31-11	19278-19281	our	_	
31-12	19282-19290	analyses	_	
31-13	19291-19303	demonstrated	_	
31-14	19304-19312	enhanced	_	
31-15	19313-19326	resting-state	_	
31-16	19327-19337	functional	_	
31-17	19338-19350	connectivity	_	
31-18	19351-19357	within	_	
31-19	19358-19361	and	_	
31-20	19362-19369	between	_	
31-21	19370-19373	the	_	
31-22	19374-19381	regions	_	
31-23	19382-19384	of	_	
31-24	19385-19393	interest	_	
31-25	19394-19395	(	_	
31-26	19395-19399	ROIs	_	
31-27	19399-19400	)	_	
31-28	19401-19403	in	_	
31-29	19404-19407	the	_	
31-30	19408-19411	OFC	_	
31-31	19411-19412	.	_	
31-32	19413-19418	First	_	
31-33	19418-19419	,	_	
31-34	19420-19423	our	_	
31-35	19424-19434	seed-based	_	
31-36	19435-19443	analysis	_	
31-37	19444-19453	estimated	_	
31-38	19454-19457	and	_	
31-39	19458-19466	detected	_	
31-40	19467-19476	different	_	
31-41	19477-19485	strength	_	
31-42	19486-19488	in	_	
31-43	19489-19497	pairwise	_	
31-44	19498-19511	relationships	_	
31-45	19512-19519	between	_	
31-46	19520-19523	the	_	
31-47	19524-19529	seeds	_	
31-48	19529-19530	,	_	
31-49	19531-19536	which	_	
31-50	19537-19541	were	_	
31-51	19542-19552	determined	_	
31-52	19553-19555	in	_	
31-53	19556-19559	our	_	
31-54	19560-19568	unbiased	_	
31-55	19569-19578	localizer	_	
31-56	19579-19583	task	_	
31-57	19584-19594	experiment	_	
31-58	19594-19595	,	_	
31-59	19596-19599	and	_	
31-60	19600-19605	other	_	
31-61	19606-19609	OFC	_	
31-62	19610-19617	regions	_	
31-63	19617-19618	.	_	
31-64	19619-19625	Second	_	
31-65	19625-19626	,	_	
31-66	19627-19630	our	_	
31-67	19631-19642	whole-brain	_	
31-68	19643-19651	analysis	_	
31-69	19652-19662	identified	_	
31-70	19663-19667	more	_	
31-71	19668-19680	connectivity	_	
31-72	19681-19689	patterns	_	
31-73	19690-19692	as	_	
31-74	19693-19702	indicated	_	
31-75	19703-19705	by	_	
31-76	19706-19715	increased	_	
31-77	19716-19722	number	_	
31-78	19723-19725	of	_	
31-79	19726-19731	edges	_	
31-80	19732-19738	within	_	
31-81	19739-19742	the	_	
31-82	19743-19749	region	_	
31-83	19750-19752	of	_	
31-84	19753-19756	the	_	
31-85	19757-19762	right	_	
31-86	19763-19767	lOFC	_	
31-87	19768-19769	(	_	
31-88	19769-19772	i.e	_	
31-89	19772-19773	.	_	
31-90	19773-19774	,	_	
31-91	19775-19778	the	_	
31-92	19779-19784	right	_	
31-93	19785-19791	middle	_	
31-94	19792-19799	frontal	_	
31-95	19800-19805	gyrus	_	
31-96	19806-19809	and	_	
31-97	19810-19813	the	_	
31-98	19814-19819	right	_	
31-99	19820-19828	superior	_	
31-100	19829-19836	frontal	_	
31-101	19837-19842	gyrus	_	
31-102	19842-19843	,	_	
31-103	19844-19851	orbital	_	
31-104	19852-19856	part	_	
31-105	19856-19857	)	_	
31-106	19858-19861	and	_	
31-107	19862-19869	between	_	
31-108	19870-19873	the	_	
31-109	19874-19879	right	_	
31-110	19880-19883	and	_	
31-111	19884-19887	the	_	
31-112	19888-19892	left	_	
31-113	19893-19901	superior	_	
31-114	19902-19909	frontal	_	
31-115	19910-19914	gyri	_	
31-116	19914-19915	,	_	
31-117	19916-19918	as	_	
31-118	19919-19923	well	_	
31-119	19924-19926	as	_	
31-120	19927-19934	between	_	
31-121	19935-19938	the	_	
31-122	19939-19944	right	_	
31-123	19945-19948	and	_	
31-124	19949-19952	the	_	
31-125	19953-19957	left	_	
31-126	19958-19964	middle	_	
31-127	19965-19972	frontal	_	
31-128	19973-19977	gyri	_	
31-129	19978-19980	in	_	
31-130	19981-19984	the	_	
31-131	19985-19992	orbital	_	
31-132	19993-19997	part	_	
31-133	19998-20000	of	_	
31-134	20001-20004	the	_	
31-135	20005-20010	brain	_	
31-136	20010-20011	.	_	
31-137	20012-20014	In	_	
31-138	20015-20023	contrast	_	
31-139	20023-20024	,	_	
31-140	20025-20033	compared	_	
31-141	20034-20038	with	_	
31-142	20039-20042	the	_	
31-143	20043-20045	CG	_	
31-144	20046-20057	whole-brain	_	
31-145	20058-20070	connectivity	_	
31-146	20071-20074	map	_	
31-147	20074-20075	,	_	
31-148	20076-20079	the	_	
31-149	20080-20083	HDs	_	
31-150	20084-20090	showed	_	
31-151	20091-20095	less	_	
31-152	20096-20108	connectivity	_	
31-153	20109-20117	patterns	_	
31-154	20118-20120	as	_	
31-155	20121-20130	indicated	_	
31-156	20131-20133	by	_	
31-157	20134-20141	reduced	_	
31-158	20142-20148	number	_	
31-159	20149-20151	of	_	
31-160	20152-20157	edges	_	
31-161	20158-20164	within	_	
31-162	20165-20168	the	_	
31-163	20169-20173	mOFC	_	
31-164	20173-20174	.	_	
31-165	20175-20178	The	_	
31-166	20179-20185	result	_	
31-167	20186-20189	was	_	
31-168	20190-20200	consistent	_	
31-169	20201-20205	with	_	
31-170	20206-20209	our	_	
31-171	20210-20226	interhemispheric	_	
31-172	20227-20238	correlation	_	
31-173	20239-20246	finding	_	
31-174	20247-20252	where	_	
31-175	20253-20255	no	_	
31-176	20256-20267	significant	_	
31-177	20268-20281	intravascular	_	
31-178	20282-20288	events	_	
31-179	20289-20290	(	_	
31-180	20290-20293	i.e	_	
31-181	20293-20294	.	_	
31-182	20294-20295	,	_	
31-183	20296-20299	the	_	
31-184	20300-20307	changes	_	
31-185	20308-20310	in	_	
31-186	20311-20314	HbO	_	
31-187	20315-20318	and	_	
31-188	20319-20321	Hb	_	
31-189	20321-20322	)	_	
31-190	20323-20327	were	_	
31-191	20328-20336	observed	_	
31-192	20337-20339	in	_	
31-193	20340-20343	the	_	
31-194	20344-20348	mOFC	_	
31-195	20348-20349	,	_	
31-196	20350-20355	which	_	
31-197	20356-20358	is	_	
31-198	20359-20367	believed	_	
31-199	20368-20370	to	_	
31-200	20371-20373	be	_	
31-201	20374-20385	responsible	_	
31-202	20386-20389	for	_	
31-203	20390-20398	empathic	_	
31-204	20399-20407	activity	_	
31-205	20408-20411	and	_	
31-206	20412-20414	is	_	
31-207	20415-20423	involved	_	
31-208	20424-20426	in	_	
31-209	20427-20434	emotion	_	
31-210	20434-20435	.	_	

#Text=Similar to the connectivity patterns, our graph-theory analysis further showed a striking phenomenon: the HDs displayed stronger connections in almost all of the channels covering the ROIs of the OFC regions than the CGs in our study. For example, the superior and the middle frontal gyri in the OFC in the left hemisphere and the superior frontal gyrus in the right hemisphere of the HDs displayed distinct overall connectivity strength.
32-1	20436-20443	Similar	_	
32-2	20444-20446	to	_	
32-3	20447-20450	the	_	
32-4	20451-20463	connectivity	_	
32-5	20464-20472	patterns	_	
32-6	20472-20473	,	_	
32-7	20474-20477	our	_	
32-8	20478-20490	graph-theory	_	
32-9	20491-20499	analysis	_	
32-10	20500-20507	further	_	
32-11	20508-20514	showed	_	
32-12	20515-20516	a	_	
32-13	20517-20525	striking	_	
32-14	20526-20536	phenomenon	_	
32-15	20536-20537	:	_	
32-16	20538-20541	the	_	
32-17	20542-20545	HDs	_	
32-18	20546-20555	displayed	_	
32-19	20556-20564	stronger	_	
32-20	20565-20576	connections	_	
32-21	20577-20579	in	_	
32-22	20580-20586	almost	_	
32-23	20587-20590	all	_	
32-24	20591-20593	of	_	
32-25	20594-20597	the	_	
32-26	20598-20606	channels	_	
32-27	20607-20615	covering	_	
32-28	20616-20619	the	_	
32-29	20620-20624	ROIs	_	
32-30	20625-20627	of	_	
32-31	20628-20631	the	_	
32-32	20632-20635	OFC	_	
32-33	20636-20643	regions	_	
32-34	20644-20648	than	_	
32-35	20649-20652	the	_	
32-36	20653-20656	CGs	_	
32-37	20657-20659	in	_	
32-38	20660-20663	our	_	
32-39	20664-20669	study	_	
32-40	20669-20670	.	_	
32-41	20671-20674	For	_	
32-42	20675-20682	example	_	
32-43	20682-20683	,	_	
32-44	20684-20687	the	_	
32-45	20688-20696	superior	_	
32-46	20697-20700	and	_	
32-47	20701-20704	the	_	
32-48	20705-20711	middle	_	
32-49	20712-20719	frontal	_	
32-50	20720-20724	gyri	_	
32-51	20725-20727	in	_	
32-52	20728-20731	the	_	
32-53	20732-20735	OFC	_	
32-54	20736-20738	in	_	
32-55	20739-20742	the	_	
32-56	20743-20747	left	_	
32-57	20748-20758	hemisphere	_	
32-58	20759-20762	and	_	
32-59	20763-20766	the	_	
32-60	20767-20775	superior	_	
32-61	20776-20783	frontal	_	
32-62	20784-20789	gyrus	_	
32-63	20790-20792	in	_	
32-64	20793-20796	the	_	
32-65	20797-20802	right	_	
32-66	20803-20813	hemisphere	_	
32-67	20814-20816	of	_	
32-68	20817-20820	the	_	
32-69	20821-20824	HDs	_	
32-70	20825-20834	displayed	_	
32-71	20835-20843	distinct	_	
32-72	20844-20851	overall	_	
32-73	20852-20864	connectivity	_	
32-74	20865-20873	strength	_	
32-75	20873-20874	.	_	

#Text=These heterogeneous connectivity patterns within different regions of the OFC between the HDs and CGs indicated that the enhanced connectivity in these regions may manifest a neurobiological alternation in heroin addiction. Although this fNIRS-based rsFC result is novel, a number of previous “brain at rest” imaging or metabolic studies have reported the hypofunctionality of OFC in psychoactive-dependent individuals during late withdrawal (>7 days) and prolonged abstinence. For example, some neuroimaging studies using fMRI and PET have reported predominantly lower activity in the mOFC and the left OFC in abstinent alcoholics. Moreover, previous PET studies have shown lower metabolic rates in the right OFC and the left dorsolateral PFC in cocaine users, lower dopamine receptor availability in the OFC, and lower dopamine transporter density in the OFC in methamphetamine users. In contrast, one perfusion MRI study observed no significant differences in the OFC in their long-abstinent methamphetamine subjects with the control group. Taken together, these heterogeneous findings need further investigations to unfold the nature of the alternations in the rsFC circuitry of the OFC in drug addiction. More importantly, these studies, which used a lorazepam challenge, did not address heroin or opioid-related addiction. Interestingly, it is noted that the observed enhanced connectivity in the OFC bears an impressive resemblance to two recent advanced rsFC fMRI studies, that showed stronger functional connectivity between the lOFC and the mOFC, as well as between the OFC and the nucleus accumbens (NAc) in abstinent heroin addicts than in healthy controls.
33-1	20875-20880	These	_	
33-2	20881-20894	heterogeneous	_	
33-3	20895-20907	connectivity	_	
33-4	20908-20916	patterns	_	
33-5	20917-20923	within	_	
33-6	20924-20933	different	_	
33-7	20934-20941	regions	_	
33-8	20942-20944	of	_	
33-9	20945-20948	the	_	
33-10	20949-20952	OFC	_	
33-11	20953-20960	between	_	
33-12	20961-20964	the	_	
33-13	20965-20968	HDs	_	
33-14	20969-20972	and	_	
33-15	20973-20976	CGs	_	
33-16	20977-20986	indicated	_	
33-17	20987-20991	that	_	
33-18	20992-20995	the	_	
33-19	20996-21004	enhanced	_	
33-20	21005-21017	connectivity	_	
33-21	21018-21020	in	_	
33-22	21021-21026	these	_	
33-23	21027-21034	regions	_	
33-24	21035-21038	may	_	
33-25	21039-21047	manifest	_	
33-26	21048-21049	a	_	
33-27	21050-21065	neurobiological	_	
33-28	21066-21077	alternation	_	
33-29	21078-21080	in	_	
33-30	21081-21087	heroin	_	
33-31	21088-21097	addiction	_	
33-32	21097-21098	.	_	
33-33	21099-21107	Although	_	
33-34	21108-21112	this	_	
33-35	21113-21124	fNIRS-based	_	
33-36	21125-21129	rsFC	_	
33-37	21130-21136	result	_	
33-38	21137-21139	is	_	
33-39	21140-21145	novel	_	
33-40	21145-21146	,	_	
33-41	21147-21148	a	_	
33-42	21149-21155	number	_	
33-43	21156-21158	of	_	
33-44	21159-21167	previous	_	
33-45	21168-21169	“	_	
33-46	21169-21174	brain	_	
33-47	21175-21177	at	_	
33-48	21178-21182	rest	_	
33-49	21182-21183	”	_	
33-50	21184-21191	imaging	_	
33-51	21192-21194	or	_	
33-52	21195-21204	metabolic	_	
33-53	21205-21212	studies	_	
33-54	21213-21217	have	_	
33-55	21218-21226	reported	_	
33-56	21227-21230	the	_	
33-57	21231-21248	hypofunctionality	_	
33-58	21249-21251	of	_	
33-59	21252-21255	OFC	_	
33-60	21256-21258	in	_	
33-61	21259-21281	psychoactive-dependent	_	
33-62	21282-21293	individuals	_	
33-63	21294-21300	during	_	
33-64	21301-21305	late	_	
33-65	21306-21316	withdrawal	_	
33-66	21317-21318	(	_	
33-67	21318-21319	>	_	
33-68	21319-21320	7	_	
33-69	21321-21325	days	_	
33-70	21325-21326	)	_	
33-71	21327-21330	and	_	
33-72	21331-21340	prolonged	_	
33-73	21341-21351	abstinence	_	
33-74	21351-21352	.	_	
33-75	21353-21356	For	_	
33-76	21357-21364	example	_	
33-77	21364-21365	,	_	
33-78	21366-21370	some	_	
33-79	21371-21383	neuroimaging	_	
33-80	21384-21391	studies	_	
33-81	21392-21397	using	_	
33-82	21398-21402	fMRI	_	
33-83	21403-21406	and	_	
33-84	21407-21410	PET	_	
33-85	21411-21415	have	_	
33-86	21416-21424	reported	_	
33-87	21425-21438	predominantly	_	
33-88	21439-21444	lower	_	
33-89	21445-21453	activity	_	
33-90	21454-21456	in	_	
33-91	21457-21460	the	_	
33-92	21461-21465	mOFC	_	
33-93	21466-21469	and	_	
33-94	21470-21473	the	_	
33-95	21474-21478	left	_	
33-96	21479-21482	OFC	_	
33-97	21483-21485	in	_	
33-98	21486-21495	abstinent	_	
33-99	21496-21506	alcoholics	_	
33-100	21506-21507	.	_	
33-101	21508-21516	Moreover	_	
33-102	21516-21517	,	_	
33-103	21518-21526	previous	_	
33-104	21527-21530	PET	_	
33-105	21531-21538	studies	_	
33-106	21539-21543	have	_	
33-107	21544-21549	shown	_	
33-108	21550-21555	lower	_	
33-109	21556-21565	metabolic	_	
33-110	21566-21571	rates	_	
33-111	21572-21574	in	_	
33-112	21575-21578	the	_	
33-113	21579-21584	right	_	
33-114	21585-21588	OFC	_	
33-115	21589-21592	and	_	
33-116	21593-21596	the	_	
33-117	21597-21601	left	_	
33-118	21602-21614	dorsolateral	_	
33-119	21615-21618	PFC	_	
33-120	21619-21621	in	_	
33-121	21622-21629	cocaine	_	
33-122	21630-21635	users	_	
33-123	21635-21636	,	_	
33-124	21637-21642	lower	_	
33-125	21643-21651	dopamine	_	
33-126	21652-21660	receptor	_	
33-127	21661-21673	availability	_	
33-128	21674-21676	in	_	
33-129	21677-21680	the	_	
33-130	21681-21684	OFC	_	
33-131	21684-21685	,	_	
33-132	21686-21689	and	_	
33-133	21690-21695	lower	_	
33-134	21696-21704	dopamine	_	
33-135	21705-21716	transporter	_	
33-136	21717-21724	density	_	
33-137	21725-21727	in	_	
33-138	21728-21731	the	_	
33-139	21732-21735	OFC	_	
33-140	21736-21738	in	_	
33-141	21739-21754	methamphetamine	_	
33-142	21755-21760	users	_	
33-143	21760-21761	.	_	
33-144	21762-21764	In	_	
33-145	21765-21773	contrast	_	
33-146	21773-21774	,	_	
33-147	21775-21778	one	_	
33-148	21779-21788	perfusion	_	
33-149	21789-21792	MRI	_	
33-150	21793-21798	study	_	
33-151	21799-21807	observed	_	
33-152	21808-21810	no	_	
33-153	21811-21822	significant	_	
33-154	21823-21834	differences	_	
33-155	21835-21837	in	_	
33-156	21838-21841	the	_	
33-157	21842-21845	OFC	_	
33-158	21846-21848	in	_	
33-159	21849-21854	their	_	
33-160	21855-21869	long-abstinent	_	
33-161	21870-21885	methamphetamine	_	
33-162	21886-21894	subjects	_	
33-163	21895-21899	with	_	
33-164	21900-21903	the	_	
33-165	21904-21911	control	_	
33-166	21912-21917	group	_	
33-167	21917-21918	.	_	
33-168	21919-21924	Taken	_	
33-169	21925-21933	together	_	
33-170	21933-21934	,	_	
33-171	21935-21940	these	_	
33-172	21941-21954	heterogeneous	_	
33-173	21955-21963	findings	_	
33-174	21964-21968	need	_	
33-175	21969-21976	further	_	
33-176	21977-21991	investigations	_	
33-177	21992-21994	to	_	
33-178	21995-22001	unfold	_	
33-179	22002-22005	the	_	
33-180	22006-22012	nature	_	
33-181	22013-22015	of	_	
33-182	22016-22019	the	_	
33-183	22020-22032	alternations	_	
33-184	22033-22035	in	_	
33-185	22036-22039	the	_	
33-186	22040-22044	rsFC	_	
33-187	22045-22054	circuitry	_	
33-188	22055-22057	of	_	
33-189	22058-22061	the	_	
33-190	22062-22065	OFC	_	
33-191	22066-22068	in	_	
33-192	22069-22073	drug	_	
33-193	22074-22083	addiction	_	
33-194	22083-22084	.	_	
33-195	22085-22089	More	_	
33-196	22090-22101	importantly	_	
33-197	22101-22102	,	_	
33-198	22103-22108	these	_	
33-199	22109-22116	studies	_	
33-200	22116-22117	,	_	
33-201	22118-22123	which	_	
33-202	22124-22128	used	_	
33-203	22129-22130	a	_	
33-204	22131-22140	lorazepam	_	
33-205	22141-22150	challenge	_	
33-206	22150-22151	,	_	
33-207	22152-22155	did	_	
33-208	22156-22159	not	_	
33-209	22160-22167	address	_	
33-210	22168-22174	heroin	_	
33-211	22175-22177	or	_	
33-212	22178-22192	opioid-related	_	
33-213	22193-22202	addiction	_	
33-214	22202-22203	.	_	
33-215	22204-22217	Interestingly	_	
33-216	22217-22218	,	_	
33-217	22219-22221	it	_	
33-218	22222-22224	is	_	
33-219	22225-22230	noted	_	
33-220	22231-22235	that	_	
33-221	22236-22239	the	_	
33-222	22240-22248	observed	_	
33-223	22249-22257	enhanced	_	
33-224	22258-22270	connectivity	_	
33-225	22271-22273	in	_	
33-226	22274-22277	the	_	
33-227	22278-22281	OFC	_	
33-228	22282-22287	bears	_	
33-229	22288-22290	an	_	
33-230	22291-22301	impressive	_	
33-231	22302-22313	resemblance	_	
33-232	22314-22316	to	_	
33-233	22317-22320	two	_	
33-234	22321-22327	recent	_	
33-235	22328-22336	advanced	_	
33-236	22337-22341	rsFC	_	
33-237	22342-22346	fMRI	_	
33-238	22347-22354	studies	_	
33-239	22354-22355	,	_	
33-240	22356-22360	that	_	
33-241	22361-22367	showed	_	
33-242	22368-22376	stronger	_	
33-243	22377-22387	functional	_	
33-244	22388-22400	connectivity	_	
33-245	22401-22408	between	_	
33-246	22409-22412	the	_	
33-247	22413-22417	lOFC	_	
33-248	22418-22421	and	_	
33-249	22422-22425	the	_	
33-250	22426-22430	mOFC	_	
33-251	22430-22431	,	_	
33-252	22432-22434	as	_	
33-253	22435-22439	well	_	
33-254	22440-22442	as	_	
33-255	22443-22450	between	_	
33-256	22451-22454	the	_	
33-257	22455-22458	OFC	_	
33-258	22459-22462	and	_	
33-259	22463-22466	the	_	
33-260	22467-22474	nucleus	_	
33-261	22475-22484	accumbens	_	
33-262	22485-22486	(	_	
33-263	22486-22489	NAc	_	
33-264	22489-22490	)	_	
33-265	22491-22493	in	_	
33-266	22494-22503	abstinent	_	
33-267	22504-22510	heroin	_	
33-268	22511-22518	addicts	_	
33-269	22519-22523	than	_	
33-270	22524-22526	in	_	
33-271	22527-22534	healthy	_	
33-272	22535-22543	controls	_	
33-273	22543-22544	.	_	

#Text=Although the functional significance of enhanced connectivity in the OFC in heroin addiction is unknown, the findings in this study may provide additional data regarding possible trajectories within the OFC regions in heroin addiction. Some theories have suggested that enhancement in the brain connectivity may be explained in the context of adapted incentive salience for the drug and drug-related stimuli. For example, if the brain area is rendered hypersensitive (i.e., sensitized), the brain system would cause pathological incentive motivation (i.e., the desire/wanting) for drugs. Correspondingly, Wilcox et al. reported enhanced functional connectivity between the ventromedial PFC (including a portion of the OFC) and ventral striatum (including a portion of NAc) in abstinent cocaine users. Tambini et al., however, suggested that the enhancement may be related to memory of recent experiences. Regardless of whether or not it is pathological, the enhanced functional connectivity implies alternations in the OFC networks in people with chronic heroin dependence. Future research is necessary to unravel the neural mechanisms of the aberrant rsFC and neural adaptions in the OFC in opioid dependence, while considering a restless connectivity over different drug-medicating cohorts.
34-1	22545-22553	Although	_	
34-2	22554-22557	the	_	
34-3	22558-22568	functional	_	
34-4	22569-22581	significance	_	
34-5	22582-22584	of	_	
34-6	22585-22593	enhanced	_	
34-7	22594-22606	connectivity	_	
34-8	22607-22609	in	_	
34-9	22610-22613	the	_	
34-10	22614-22617	OFC	_	
34-11	22618-22620	in	_	
34-12	22621-22627	heroin	_	
34-13	22628-22637	addiction	_	
34-14	22638-22640	is	_	
34-15	22641-22648	unknown	_	
34-16	22648-22649	,	_	
34-17	22650-22653	the	_	
34-18	22654-22662	findings	_	
34-19	22663-22665	in	_	
34-20	22666-22670	this	_	
34-21	22671-22676	study	_	
34-22	22677-22680	may	_	
34-23	22681-22688	provide	_	
34-24	22689-22699	additional	_	
34-25	22700-22704	data	_	
34-26	22705-22714	regarding	_	
34-27	22715-22723	possible	_	
34-28	22724-22736	trajectories	_	
34-29	22737-22743	within	_	
34-30	22744-22747	the	_	
34-31	22748-22751	OFC	_	
34-32	22752-22759	regions	_	
34-33	22760-22762	in	_	
34-34	22763-22769	heroin	_	
34-35	22770-22779	addiction	_	
34-36	22779-22780	.	_	
34-37	22781-22785	Some	_	
34-38	22786-22794	theories	_	
34-39	22795-22799	have	_	
34-40	22800-22809	suggested	_	
34-41	22810-22814	that	_	
34-42	22815-22826	enhancement	_	
34-43	22827-22829	in	_	
34-44	22830-22833	the	_	
34-45	22834-22839	brain	_	
34-46	22840-22852	connectivity	_	
34-47	22853-22856	may	_	
34-48	22857-22859	be	_	
34-49	22860-22869	explained	_	
34-50	22870-22872	in	_	
34-51	22873-22876	the	_	
34-52	22877-22884	context	_	
34-53	22885-22887	of	_	
34-54	22888-22895	adapted	_	
34-55	22896-22905	incentive	_	
34-56	22906-22914	salience	_	
34-57	22915-22918	for	_	
34-58	22919-22922	the	_	
34-59	22923-22927	drug	_	
34-60	22928-22931	and	_	
34-61	22932-22944	drug-related	_	
34-62	22945-22952	stimuli	_	
34-63	22952-22953	.	_	
34-64	22954-22957	For	_	
34-65	22958-22965	example	_	
34-66	22965-22966	,	_	
34-67	22967-22969	if	_	
34-68	22970-22973	the	_	
34-69	22974-22979	brain	_	
34-70	22980-22984	area	_	
34-71	22985-22987	is	_	
34-72	22988-22996	rendered	_	
34-73	22997-23011	hypersensitive	_	
34-74	23012-23013	(	_	
34-75	23013-23016	i.e	_	
34-76	23016-23017	.	_	
34-77	23017-23018	,	_	
34-78	23019-23029	sensitized	_	
34-79	23029-23030	)	_	
34-80	23030-23031	,	_	
34-81	23032-23035	the	_	
34-82	23036-23041	brain	_	
34-83	23042-23048	system	_	
34-84	23049-23054	would	_	
34-85	23055-23060	cause	_	
34-86	23061-23073	pathological	_	
34-87	23074-23083	incentive	_	
34-88	23084-23094	motivation	_	
34-89	23095-23096	(	_	
34-90	23096-23099	i.e	_	
34-91	23099-23100	.	_	
34-92	23100-23101	,	_	
34-93	23102-23105	the	_	
34-94	23106-23112	desire	_	
34-95	23112-23113	/	_	
34-96	23113-23120	wanting	_	
34-97	23120-23121	)	_	
34-98	23122-23125	for	_	
34-99	23126-23131	drugs	_	
34-100	23131-23132	.	_	
34-101	23133-23148	Correspondingly	_	
34-102	23148-23149	,	_	
34-103	23150-23156	Wilcox	_	
34-104	23157-23159	et	_	
34-105	23160-23162	al	_	
34-106	23162-23163	.	_	
34-107	23164-23172	reported	_	
34-108	23173-23181	enhanced	_	
34-109	23182-23192	functional	_	
34-110	23193-23205	connectivity	_	
34-111	23206-23213	between	_	
34-112	23214-23217	the	_	
34-113	23218-23230	ventromedial	_	
34-114	23231-23234	PFC	_	
34-115	23235-23236	(	_	
34-116	23236-23245	including	_	
34-117	23246-23247	a	_	
34-118	23248-23255	portion	_	
34-119	23256-23258	of	_	
34-120	23259-23262	the	_	
34-121	23263-23266	OFC	_	
34-122	23266-23267	)	_	
34-123	23268-23271	and	_	
34-124	23272-23279	ventral	_	
34-125	23280-23288	striatum	_	
34-126	23289-23290	(	_	
34-127	23290-23299	including	_	
34-128	23300-23301	a	_	
34-129	23302-23309	portion	_	
34-130	23310-23312	of	_	
34-131	23313-23316	NAc	_	
34-132	23316-23317	)	_	
34-133	23318-23320	in	_	
34-134	23321-23330	abstinent	_	
34-135	23331-23338	cocaine	_	
34-136	23339-23344	users	_	
34-137	23344-23345	.	_	
34-138	23346-23353	Tambini	_	
34-139	23354-23356	et	_	
34-140	23357-23359	al	_	
34-141	23359-23360	.	_	
34-142	23360-23361	,	_	
34-143	23362-23369	however	_	
34-144	23369-23370	,	_	
34-145	23371-23380	suggested	_	
34-146	23381-23385	that	_	
34-147	23386-23389	the	_	
34-148	23390-23401	enhancement	_	
34-149	23402-23405	may	_	
34-150	23406-23408	be	_	
34-151	23409-23416	related	_	
34-152	23417-23419	to	_	
34-153	23420-23426	memory	_	
34-154	23427-23429	of	_	
34-155	23430-23436	recent	_	
34-156	23437-23448	experiences	_	
34-157	23448-23449	.	_	
34-158	23450-23460	Regardless	_	
34-159	23461-23463	of	_	
34-160	23464-23471	whether	_	
34-161	23472-23474	or	_	
34-162	23475-23478	not	_	
34-163	23479-23481	it	_	
34-164	23482-23484	is	_	
34-165	23485-23497	pathological	_	
34-166	23497-23498	,	_	
34-167	23499-23502	the	_	
34-168	23503-23511	enhanced	_	
34-169	23512-23522	functional	_	
34-170	23523-23535	connectivity	_	
34-171	23536-23543	implies	_	
34-172	23544-23556	alternations	_	
34-173	23557-23559	in	_	
34-174	23560-23563	the	_	
34-175	23564-23567	OFC	_	
34-176	23568-23576	networks	_	
34-177	23577-23579	in	_	
34-178	23580-23586	people	_	
34-179	23587-23591	with	_	
34-180	23592-23599	chronic	_	
34-181	23600-23606	heroin	_	
34-182	23607-23617	dependence	_	
34-183	23617-23618	.	_	
34-184	23619-23625	Future	_	
34-185	23626-23634	research	_	
34-186	23635-23637	is	_	
34-187	23638-23647	necessary	_	
34-188	23648-23650	to	_	
34-189	23651-23658	unravel	_	
34-190	23659-23662	the	_	
34-191	23663-23669	neural	_	
34-192	23670-23680	mechanisms	_	
34-193	23681-23683	of	_	
34-194	23684-23687	the	_	
34-195	23688-23696	aberrant	_	
34-196	23697-23701	rsFC	_	
34-197	23702-23705	and	_	
34-198	23706-23712	neural	_	
34-199	23713-23722	adaptions	_	
34-200	23723-23725	in	_	
34-201	23726-23729	the	_	
34-202	23730-23733	OFC	_	
34-203	23734-23736	in	_	
34-204	23737-23743	opioid	_	
34-205	23744-23754	dependence	_	
34-206	23754-23755	,	_	
34-207	23756-23761	while	_	
34-208	23762-23773	considering	_	
34-209	23774-23775	a	_	
34-210	23776-23784	restless	_	
34-211	23785-23797	connectivity	_	
34-212	23798-23802	over	_	
34-213	23803-23812	different	_	
34-214	23813-23828	drug-medicating	_	
34-215	23829-23836	cohorts	_	
34-216	23836-23837	.	_	

#Text=With respect to anxiety scores, our regression analysis showed enhanced functional connectivity between the left inferior frontal gyrus seed and four OFC regions: the right middle frontal gyrus, the right and the left mOFCs, and the left superior frontal gyrus in the HDs. The left inferior frontal gyrus, which was partially covered by channel 11, is critical for inhibitory control. The strong associations observed between this inhibitory region and the others may imply disruption between the OFC and amygdala linked to anxiety. One task-based neuroimaging study has supported the idea that the level of anxiety predicts the connectivity between the amygdala and medial PFC, particularly the dorsal and ventral medial PFC, which plays a critical role in executive functions. In addition to the exhibited increased functional connectivity within the OFC in the HDs who were more anxious than the CGs, our observations supported the hypotheses that there may be reduced connectivity between the amygdala and mPFC, as well as the connectivity between the OFC and PFC in the individuals with heroin addiction. These assumptions help provide an explanation for the addictive phenomenon observed when an addict fails to resist impulsive desires to seek and consume drugs despite serious harmful consequences.
35-1	23838-23842	With	_	
35-2	23843-23850	respect	_	
35-3	23851-23853	to	_	
35-4	23854-23861	anxiety	_	
35-5	23862-23868	scores	_	
35-6	23868-23869	,	_	
35-7	23870-23873	our	_	
35-8	23874-23884	regression	_	
35-9	23885-23893	analysis	_	
35-10	23894-23900	showed	_	
35-11	23901-23909	enhanced	_	
35-12	23910-23920	functional	_	
35-13	23921-23933	connectivity	_	
35-14	23934-23941	between	_	
35-15	23942-23945	the	_	
35-16	23946-23950	left	_	
35-17	23951-23959	inferior	_	
35-18	23960-23967	frontal	_	
35-19	23968-23973	gyrus	_	
35-20	23974-23978	seed	_	
35-21	23979-23982	and	_	
35-22	23983-23987	four	_	
35-23	23988-23991	OFC	_	
35-24	23992-23999	regions	_	
35-25	23999-24000	:	_	
35-26	24001-24004	the	_	
35-27	24005-24010	right	_	
35-28	24011-24017	middle	_	
35-29	24018-24025	frontal	_	
35-30	24026-24031	gyrus	_	
35-31	24031-24032	,	_	
35-32	24033-24036	the	_	
35-33	24037-24042	right	_	
35-34	24043-24046	and	_	
35-35	24047-24050	the	_	
35-36	24051-24055	left	_	
35-37	24056-24061	mOFCs	_	
35-38	24061-24062	,	_	
35-39	24063-24066	and	_	
35-40	24067-24070	the	_	
35-41	24071-24075	left	_	
35-42	24076-24084	superior	_	
35-43	24085-24092	frontal	_	
35-44	24093-24098	gyrus	_	
35-45	24099-24101	in	_	
35-46	24102-24105	the	_	
35-47	24106-24109	HDs	_	
35-48	24109-24110	.	_	
35-49	24111-24114	The	_	
35-50	24115-24119	left	_	
35-51	24120-24128	inferior	_	
35-52	24129-24136	frontal	_	
35-53	24137-24142	gyrus	_	
35-54	24142-24143	,	_	
35-55	24144-24149	which	_	
35-56	24150-24153	was	_	
35-57	24154-24163	partially	_	
35-58	24164-24171	covered	_	
35-59	24172-24174	by	_	
35-60	24175-24182	channel	_	
35-61	24183-24185	11	_	
35-62	24185-24186	,	_	
35-63	24187-24189	is	_	
35-64	24190-24198	critical	_	
35-65	24199-24202	for	_	
35-66	24203-24213	inhibitory	_	
35-67	24214-24221	control	_	
35-68	24221-24222	.	_	
35-69	24223-24226	The	_	
35-70	24227-24233	strong	_	
35-71	24234-24246	associations	_	
35-72	24247-24255	observed	_	
35-73	24256-24263	between	_	
35-74	24264-24268	this	_	
35-75	24269-24279	inhibitory	_	
35-76	24280-24286	region	_	
35-77	24287-24290	and	_	
35-78	24291-24294	the	_	
35-79	24295-24301	others	_	
35-80	24302-24305	may	_	
35-81	24306-24311	imply	_	
35-82	24312-24322	disruption	_	
35-83	24323-24330	between	_	
35-84	24331-24334	the	_	
35-85	24335-24338	OFC	_	
35-86	24339-24342	and	_	
35-87	24343-24351	amygdala	_	
35-88	24352-24358	linked	_	
35-89	24359-24361	to	_	
35-90	24362-24369	anxiety	_	
35-91	24369-24370	.	_	
35-92	24371-24374	One	_	
35-93	24375-24385	task-based	_	
35-94	24386-24398	neuroimaging	_	
35-95	24399-24404	study	_	
35-96	24405-24408	has	_	
35-97	24409-24418	supported	_	
35-98	24419-24422	the	_	
35-99	24423-24427	idea	_	
35-100	24428-24432	that	_	
35-101	24433-24436	the	_	
35-102	24437-24442	level	_	
35-103	24443-24445	of	_	
35-104	24446-24453	anxiety	_	
35-105	24454-24462	predicts	_	
35-106	24463-24466	the	_	
35-107	24467-24479	connectivity	_	
35-108	24480-24487	between	_	
35-109	24488-24491	the	_	
35-110	24492-24500	amygdala	_	
35-111	24501-24504	and	_	
35-112	24505-24511	medial	_	
35-113	24512-24515	PFC	_	
35-114	24515-24516	,	_	
35-115	24517-24529	particularly	_	
35-116	24530-24533	the	_	
35-117	24534-24540	dorsal	_	
35-118	24541-24544	and	_	
35-119	24545-24552	ventral	_	
35-120	24553-24559	medial	_	
35-121	24560-24563	PFC	_	
35-122	24563-24564	,	_	
35-123	24565-24570	which	_	
35-124	24571-24576	plays	_	
35-125	24577-24578	a	_	
35-126	24579-24587	critical	_	
35-127	24588-24592	role	_	
35-128	24593-24595	in	_	
35-129	24596-24605	executive	_	
35-130	24606-24615	functions	_	
35-131	24615-24616	.	_	
35-132	24617-24619	In	_	
35-133	24620-24628	addition	_	
35-134	24629-24631	to	_	
35-135	24632-24635	the	_	
35-136	24636-24645	exhibited	_	
35-137	24646-24655	increased	_	
35-138	24656-24666	functional	_	
35-139	24667-24679	connectivity	_	
35-140	24680-24686	within	_	
35-141	24687-24690	the	_	
35-142	24691-24694	OFC	_	
35-143	24695-24697	in	_	
35-144	24698-24701	the	_	
35-145	24702-24705	HDs	_	
35-146	24706-24709	who	_	
35-147	24710-24714	were	_	
35-148	24715-24719	more	_	
35-149	24720-24727	anxious	_	
35-150	24728-24732	than	_	
35-151	24733-24736	the	_	
35-152	24737-24740	CGs	_	
35-153	24740-24741	,	_	
35-154	24742-24745	our	_	
35-155	24746-24758	observations	_	
35-156	24759-24768	supported	_	
35-157	24769-24772	the	_	
35-158	24773-24783	hypotheses	_	
35-159	24784-24788	that	_	
35-160	24789-24794	there	_	
35-161	24795-24798	may	_	
35-162	24799-24801	be	_	
35-163	24802-24809	reduced	_	
35-164	24810-24822	connectivity	_	
35-165	24823-24830	between	_	
35-166	24831-24834	the	_	
35-167	24835-24843	amygdala	_	
35-168	24844-24847	and	_	
35-169	24848-24852	mPFC	_	
35-170	24852-24853	,	_	
35-171	24854-24856	as	_	
35-172	24857-24861	well	_	
35-173	24862-24864	as	_	
35-174	24865-24868	the	_	
35-175	24869-24881	connectivity	_	
35-176	24882-24889	between	_	
35-177	24890-24893	the	_	
35-178	24894-24897	OFC	_	
35-179	24898-24901	and	_	
35-180	24902-24905	PFC	_	
35-181	24906-24908	in	_	
35-182	24909-24912	the	_	
35-183	24913-24924	individuals	_	
35-184	24925-24929	with	_	
35-185	24930-24936	heroin	_	
35-186	24937-24946	addiction	_	
35-187	24946-24947	.	_	
35-188	24948-24953	These	_	
35-189	24954-24965	assumptions	_	
35-190	24966-24970	help	_	
35-191	24971-24978	provide	_	
35-192	24979-24981	an	_	
35-193	24982-24993	explanation	_	
35-194	24994-24997	for	_	
35-195	24998-25001	the	_	
35-196	25002-25011	addictive	_	
35-197	25012-25022	phenomenon	_	
35-198	25023-25031	observed	_	
35-199	25032-25036	when	_	
35-200	25037-25039	an	_	
35-201	25040-25046	addict	_	
35-202	25047-25052	fails	_	
35-203	25053-25055	to	_	
35-204	25056-25062	resist	_	
35-205	25063-25072	impulsive	_	
35-206	25073-25080	desires	_	
35-207	25081-25083	to	_	
35-208	25084-25088	seek	_	
35-209	25089-25092	and	_	
35-210	25093-25100	consume	_	
35-211	25101-25106	drugs	_	
35-212	25107-25114	despite	_	
35-213	25115-25122	serious	_	
35-214	25123-25130	harmful	_	
35-215	25131-25143	consequences	_	
35-216	25143-25144	.	_	

#Text=OFC functioning is known to be essential for social cognition processes. Interestingly, the topological findings provided by our study demonstrated that the relationship between network topology and the function of social cognition is an important question that remains unsolved. When considered together with previous evidence, the predictability of certain connections by monitoring the level of anxiety could be helpful in predicting relapses. It thus points to future directions; that is, investigating the neural mechanisms underlying heroin addiction in a social setting. First, is enhanced connectivity the outcome of addicts’ anxious state and traits in their environments? Second, how are the neural networks linked to social cognition, such as empathy and other processes, such as moral decisions and emotion control? Third, is enhancement the result of a therapeutic process (e.g., remaining abstinent)? The answers to these questions could be tremendously helpful in the development of psycho-social-behavioral intervention and treatment programs.
36-1	25145-25148	OFC	_	
36-2	25149-25160	functioning	_	
36-3	25161-25163	is	_	
36-4	25164-25169	known	_	
36-5	25170-25172	to	_	
36-6	25173-25175	be	_	
36-7	25176-25185	essential	_	
36-8	25186-25189	for	_	
36-9	25190-25196	social	_	
36-10	25197-25206	cognition	_	
36-11	25207-25216	processes	_	
36-12	25216-25217	.	_	
36-13	25218-25231	Interestingly	_	
36-14	25231-25232	,	_	
36-15	25233-25236	the	_	
36-16	25237-25248	topological	_	
36-17	25249-25257	findings	_	
36-18	25258-25266	provided	_	
36-19	25267-25269	by	_	
36-20	25270-25273	our	_	
36-21	25274-25279	study	_	
36-22	25280-25292	demonstrated	_	
36-23	25293-25297	that	_	
36-24	25298-25301	the	_	
36-25	25302-25314	relationship	_	
36-26	25315-25322	between	_	
36-27	25323-25330	network	_	
36-28	25331-25339	topology	_	
36-29	25340-25343	and	_	
36-30	25344-25347	the	_	
36-31	25348-25356	function	_	
36-32	25357-25359	of	_	
36-33	25360-25366	social	_	
36-34	25367-25376	cognition	_	
36-35	25377-25379	is	_	
36-36	25380-25382	an	_	
36-37	25383-25392	important	_	
36-38	25393-25401	question	_	
36-39	25402-25406	that	_	
36-40	25407-25414	remains	_	
36-41	25415-25423	unsolved	_	
36-42	25423-25424	.	_	
36-43	25425-25429	When	_	
36-44	25430-25440	considered	_	
36-45	25441-25449	together	_	
36-46	25450-25454	with	_	
36-47	25455-25463	previous	_	
36-48	25464-25472	evidence	_	
36-49	25472-25473	,	_	
36-50	25474-25477	the	_	
36-51	25478-25492	predictability	_	
36-52	25493-25495	of	_	
36-53	25496-25503	certain	_	
36-54	25504-25515	connections	_	
36-55	25516-25518	by	_	
36-56	25519-25529	monitoring	_	
36-57	25530-25533	the	_	
36-58	25534-25539	level	_	
36-59	25540-25542	of	_	
36-60	25543-25550	anxiety	_	
36-61	25551-25556	could	_	
36-62	25557-25559	be	_	
36-63	25560-25567	helpful	_	
36-64	25568-25570	in	_	
36-65	25571-25581	predicting	_	
36-66	25582-25590	relapses	_	
36-67	25590-25591	.	_	
36-68	25592-25594	It	_	
36-69	25595-25599	thus	_	
36-70	25600-25606	points	_	
36-71	25607-25609	to	_	
36-72	25610-25616	future	_	
36-73	25617-25627	directions	_	
36-74	25627-25628	;	_	
36-75	25629-25633	that	_	
36-76	25634-25636	is	_	
36-77	25636-25637	,	_	
36-78	25638-25651	investigating	_	
36-79	25652-25655	the	_	
36-80	25656-25662	neural	_	
36-81	25663-25673	mechanisms	_	
36-82	25674-25684	underlying	_	
36-83	25685-25691	heroin	_	
36-84	25692-25701	addiction	_	
36-85	25702-25704	in	_	
36-86	25705-25706	a	_	
36-87	25707-25713	social	_	
36-88	25714-25721	setting	_	
36-89	25721-25722	.	_	
36-90	25723-25728	First	_	
36-91	25728-25729	,	_	
36-92	25730-25732	is	_	
36-93	25733-25741	enhanced	_	
36-94	25742-25754	connectivity	_	
36-95	25755-25758	the	_	
36-96	25759-25766	outcome	_	
36-97	25767-25769	of	_	
36-98	25770-25777	addicts	_	
36-99	25777-25778	’	_	
36-100	25779-25786	anxious	_	
36-101	25787-25792	state	_	
36-102	25793-25796	and	_	
36-103	25797-25803	traits	_	
36-104	25804-25806	in	_	
36-105	25807-25812	their	_	
36-106	25813-25825	environments	_	
36-107	25825-25826	?	_	
36-108	25827-25833	Second	_	
36-109	25833-25834	,	_	
36-110	25835-25838	how	_	
36-111	25839-25842	are	_	
36-112	25843-25846	the	_	
36-113	25847-25853	neural	_	
36-114	25854-25862	networks	_	
36-115	25863-25869	linked	_	
36-116	25870-25872	to	_	
36-117	25873-25879	social	_	
36-118	25880-25889	cognition	_	
36-119	25889-25890	,	_	
36-120	25891-25895	such	_	
36-121	25896-25898	as	_	
36-122	25899-25906	empathy	_	
36-123	25907-25910	and	_	
36-124	25911-25916	other	_	
36-125	25917-25926	processes	_	
36-126	25926-25927	,	_	
36-127	25928-25932	such	_	
36-128	25933-25935	as	_	
36-129	25936-25941	moral	_	
36-130	25942-25951	decisions	_	
36-131	25952-25955	and	_	
36-132	25956-25963	emotion	_	
36-133	25964-25971	control	_	
36-134	25971-25972	?	_	
36-135	25973-25978	Third	_	
36-136	25978-25979	,	_	
36-137	25980-25982	is	_	
36-138	25983-25994	enhancement	_	
36-139	25995-25998	the	_	
36-140	25999-26005	result	_	
36-141	26006-26008	of	_	
36-142	26009-26010	a	_	
36-143	26011-26022	therapeutic	_	
36-144	26023-26030	process	_	
36-145	26031-26032	(	_	
36-146	26032-26035	e.g	_	
36-147	26035-26036	.	_	
36-148	26036-26037	,	_	
36-149	26038-26047	remaining	_	
36-150	26048-26057	abstinent	_	
36-151	26057-26058	)	_	
36-152	26058-26059	?	_	
36-153	26060-26063	The	_	
36-154	26064-26071	answers	_	
36-155	26072-26074	to	_	
36-156	26075-26080	these	_	
36-157	26081-26090	questions	_	
36-158	26091-26096	could	_	
36-159	26097-26099	be	_	
36-160	26100-26112	tremendously	_	
36-161	26113-26120	helpful	_	
36-162	26121-26123	in	_	
36-163	26124-26127	the	_	
36-164	26128-26139	development	_	
36-165	26140-26142	of	_	
36-166	26143-26167	psycho-social-behavioral	_	
36-167	26168-26180	intervention	_	
36-168	26181-26184	and	_	
36-169	26185-26194	treatment	_	
36-170	26195-26203	programs	_	
36-171	26203-26204	.	_	

#Text=As current advances in rs-fNIRS have been shown to be a valid and supportive tool for investigating the rsFC in normal and pathological conditions, our study also validated fNIRS as an additional neuroimaging method available to examine cortical mechanisms underlying addiction. Unlike fMRIs, fNIRS has higher temporal resolution, and thus it allows precise quantification of the network parameters and measures when and which OFC regions were consuming oxygen. Using fNIRS, perhaps another remarkable finding was that a small-worldness architecture was quantified and observed in the brain networks of the HDs and CGs, providing a profile of clustering coefficients and characteristic path lengths over an entire range of sparsity thresholds. Moreover, our exploratory work produced evidence that the HD network was “small-world” with respect to the CGs, suggesting that the HD brain network acquires non-control and non-random construction. Though, the new normalization method is experimental, and thus the results from the method should be read with caution and should be served as additional information to the ones from the traditional method.
37-1	26205-26207	As	_	
37-2	26208-26215	current	_	
37-3	26216-26224	advances	_	
37-4	26225-26227	in	_	
37-5	26228-26236	rs-fNIRS	_	
37-6	26237-26241	have	_	
37-7	26242-26246	been	_	
37-8	26247-26252	shown	_	
37-9	26253-26255	to	_	
37-10	26256-26258	be	_	
37-11	26259-26260	a	_	
37-12	26261-26266	valid	_	
37-13	26267-26270	and	_	
37-14	26271-26281	supportive	_	
37-15	26282-26286	tool	_	
37-16	26287-26290	for	_	
37-17	26291-26304	investigating	_	
37-18	26305-26308	the	_	
37-19	26309-26313	rsFC	_	
37-20	26314-26316	in	_	
37-21	26317-26323	normal	_	
37-22	26324-26327	and	_	
37-23	26328-26340	pathological	_	
37-24	26341-26351	conditions	_	
37-25	26351-26352	,	_	
37-26	26353-26356	our	_	
37-27	26357-26362	study	_	
37-28	26363-26367	also	_	
37-29	26368-26377	validated	_	
37-30	26378-26383	fNIRS	_	
37-31	26384-26386	as	_	
37-32	26387-26389	an	_	
37-33	26390-26400	additional	_	
37-34	26401-26413	neuroimaging	_	
37-35	26414-26420	method	_	
37-36	26421-26430	available	_	
37-37	26431-26433	to	_	
37-38	26434-26441	examine	_	
37-39	26442-26450	cortical	_	
37-40	26451-26461	mechanisms	_	
37-41	26462-26472	underlying	_	
37-42	26473-26482	addiction	_	
37-43	26482-26483	.	_	
37-44	26484-26490	Unlike	_	
37-45	26491-26496	fMRIs	_	
37-46	26496-26497	,	_	
37-47	26498-26503	fNIRS	_	
37-48	26504-26507	has	_	
37-49	26508-26514	higher	_	
37-50	26515-26523	temporal	_	
37-51	26524-26534	resolution	_	
37-52	26534-26535	,	_	
37-53	26536-26539	and	_	
37-54	26540-26544	thus	_	
37-55	26545-26547	it	_	
37-56	26548-26554	allows	_	
37-57	26555-26562	precise	_	
37-58	26563-26577	quantification	_	
37-59	26578-26580	of	_	
37-60	26581-26584	the	_	
37-61	26585-26592	network	_	
37-62	26593-26603	parameters	_	
37-63	26604-26607	and	_	
37-64	26608-26616	measures	_	
37-65	26617-26621	when	_	
37-66	26622-26625	and	_	
37-67	26626-26631	which	_	
37-68	26632-26635	OFC	_	
37-69	26636-26643	regions	_	
37-70	26644-26648	were	_	
37-71	26649-26658	consuming	_	
37-72	26659-26665	oxygen	_	
37-73	26665-26666	.	_	
37-74	26667-26672	Using	_	
37-75	26673-26678	fNIRS	_	
37-76	26678-26679	,	_	
37-77	26680-26687	perhaps	_	
37-78	26688-26695	another	_	
37-79	26696-26706	remarkable	_	
37-80	26707-26714	finding	_	
37-81	26715-26718	was	_	
37-82	26719-26723	that	_	
37-83	26724-26725	a	_	
37-84	26726-26741	small-worldness	_	
37-85	26742-26754	architecture	_	
37-86	26755-26758	was	_	
37-87	26759-26769	quantified	_	
37-88	26770-26773	and	_	
37-89	26774-26782	observed	_	
37-90	26783-26785	in	_	
37-91	26786-26789	the	_	
37-92	26790-26795	brain	_	
37-93	26796-26804	networks	_	
37-94	26805-26807	of	_	
37-95	26808-26811	the	_	
37-96	26812-26815	HDs	_	
37-97	26816-26819	and	_	
37-98	26820-26823	CGs	_	
37-99	26823-26824	,	_	
37-100	26825-26834	providing	_	
37-101	26835-26836	a	_	
37-102	26837-26844	profile	_	
37-103	26845-26847	of	_	
37-104	26848-26858	clustering	_	
37-105	26859-26871	coefficients	_	
37-106	26872-26875	and	_	
37-107	26876-26890	characteristic	_	
37-108	26891-26895	path	_	
37-109	26896-26903	lengths	_	
37-110	26904-26908	over	_	
37-111	26909-26911	an	_	
37-112	26912-26918	entire	_	
37-113	26919-26924	range	_	
37-114	26925-26927	of	_	
37-115	26928-26936	sparsity	_	
37-116	26937-26947	thresholds	_	
37-117	26947-26948	.	_	
37-118	26949-26957	Moreover	_	
37-119	26957-26958	,	_	
37-120	26959-26962	our	_	
37-121	26963-26974	exploratory	_	
37-122	26975-26979	work	_	
37-123	26980-26988	produced	_	
37-124	26989-26997	evidence	_	
37-125	26998-27002	that	_	
37-126	27003-27006	the	_	
37-127	27007-27009	HD	_	
37-128	27010-27017	network	_	
37-129	27018-27021	was	_	
37-130	27022-27023	“	_	
37-131	27023-27034	small-world	_	
37-132	27034-27035	”	_	
37-133	27036-27040	with	_	
37-134	27041-27048	respect	_	
37-135	27049-27051	to	_	
37-136	27052-27055	the	_	
37-137	27056-27059	CGs	_	
37-138	27059-27060	,	_	
37-139	27061-27071	suggesting	_	
37-140	27072-27076	that	_	
37-141	27077-27080	the	_	
37-142	27081-27083	HD	_	
37-143	27084-27089	brain	_	
37-144	27090-27097	network	_	
37-145	27098-27106	acquires	_	
37-146	27107-27118	non-control	_	
37-147	27119-27122	and	_	
37-148	27123-27133	non-random	_	
37-149	27134-27146	construction	_	
37-150	27146-27147	.	_	
37-151	27148-27154	Though	_	
37-152	27154-27155	,	_	
37-153	27156-27159	the	_	
37-154	27160-27163	new	_	
37-155	27164-27177	normalization	_	
37-156	27178-27184	method	_	
37-157	27185-27187	is	_	
37-158	27188-27200	experimental	_	
37-159	27200-27201	,	_	
37-160	27202-27205	and	_	
37-161	27206-27210	thus	_	
37-162	27211-27214	the	_	
37-163	27215-27222	results	_	
37-164	27223-27227	from	_	
37-165	27228-27231	the	_	
37-166	27232-27238	method	_	
37-167	27239-27245	should	_	
37-168	27246-27248	be	_	
37-169	27249-27253	read	_	
37-170	27254-27258	with	_	
37-171	27259-27266	caution	_	
37-172	27267-27270	and	_	
37-173	27271-27277	should	_	
37-174	27278-27280	be	_	
37-175	27281-27287	served	_	
37-176	27288-27290	as	_	
37-177	27291-27301	additional	_	
37-178	27302-27313	information	_	
37-179	27314-27316	to	_	
37-180	27317-27320	the	_	
37-181	27321-27325	ones	_	
37-182	27326-27330	from	_	
37-183	27331-27334	the	_	
37-184	27335-27346	traditional	_	
37-185	27347-27353	method	_	
37-186	27353-27354	.	_	

#Text=The major findings examined above were primarily based on the abnormal resting state observed in abstinent heroin addicts and the controls using fNIRS. Additional characteristics of functional connectivity in the circuitry associated with addiction, such as reward, anticipation, emotion, and environmental stressors, such as anxiety, remain to be elucidated. Due to the small sizes of our sample without strict control of the alpha-error inflation resulting from manifold analyses and the control for multiple covariates, questions remain regarding to what extent the present findings are linked to the abnormality of brain functions in drug abusers and to what degree the current results are stable and reliable. Therefore, findings presented in this study must be treated with caution until results are confirmed in a larger sample. Forthcoming fNIRS-based work on the rsFC in the remainder of the brain regions involved in opioid dependence, including dependence on prescribed opiates, such as morphine, oxycodone, and fentanyl, is needed to provide a more definitive and meticulous explanation of the current study. Moreover, future studies involving different treatment-/intervention-programs for opioid dependence and behavioral tasks are needed to finalize conclusions, such as examining the task-based functional connectivity and the link between the neuroimaging results and behavioral data, and defining the influences of other drugs available in treatment, such as methadone, buprenorphine, naloxone, and naltrexone, on functional connectivity. We observed that the year of smoking was correlated with anxiety scores, and thus co-dependence on other substances, such as nicotine, and comorbid conditions, such as anxiety, should be carefully taken into account in future studies.
38-1	27355-27358	The	_	
38-2	27359-27364	major	_	
38-3	27365-27373	findings	_	
38-4	27374-27382	examined	_	
38-5	27383-27388	above	_	
38-6	27389-27393	were	_	
38-7	27394-27403	primarily	_	
38-8	27404-27409	based	_	
38-9	27410-27412	on	_	
38-10	27413-27416	the	_	
38-11	27417-27425	abnormal	_	
38-12	27426-27433	resting	_	
38-13	27434-27439	state	_	
38-14	27440-27448	observed	_	
38-15	27449-27451	in	_	
38-16	27452-27461	abstinent	_	
38-17	27462-27468	heroin	_	
38-18	27469-27476	addicts	_	
38-19	27477-27480	and	_	
38-20	27481-27484	the	_	
38-21	27485-27493	controls	_	
38-22	27494-27499	using	_	
38-23	27500-27505	fNIRS	_	
38-24	27505-27506	.	_	
38-25	27507-27517	Additional	_	
38-26	27518-27533	characteristics	_	
38-27	27534-27536	of	_	
38-28	27537-27547	functional	_	
38-29	27548-27560	connectivity	_	
38-30	27561-27563	in	_	
38-31	27564-27567	the	_	
38-32	27568-27577	circuitry	_	
38-33	27578-27588	associated	_	
38-34	27589-27593	with	_	
38-35	27594-27603	addiction	_	
38-36	27603-27604	,	_	
38-37	27605-27609	such	_	
38-38	27610-27612	as	_	
38-39	27613-27619	reward	_	
38-40	27619-27620	,	_	
38-41	27621-27633	anticipation	_	
38-42	27633-27634	,	_	
38-43	27635-27642	emotion	_	
38-44	27642-27643	,	_	
38-45	27644-27647	and	_	
38-46	27648-27661	environmental	_	
38-47	27662-27671	stressors	_	
38-48	27671-27672	,	_	
38-49	27673-27677	such	_	
38-50	27678-27680	as	_	
38-51	27681-27688	anxiety	_	
38-52	27688-27689	,	_	
38-53	27690-27696	remain	_	
38-54	27697-27699	to	_	
38-55	27700-27702	be	_	
38-56	27703-27713	elucidated	_	
38-57	27713-27714	.	_	
38-58	27715-27718	Due	_	
38-59	27719-27721	to	_	
38-60	27722-27725	the	_	
38-61	27726-27731	small	_	
38-62	27732-27737	sizes	_	
38-63	27738-27740	of	_	
38-64	27741-27744	our	_	
38-65	27745-27751	sample	_	
38-66	27752-27759	without	_	
38-67	27760-27766	strict	_	
38-68	27767-27774	control	_	
38-69	27775-27777	of	_	
38-70	27778-27781	the	_	
38-71	27782-27793	alpha-error	_	
38-72	27794-27803	inflation	_	
38-73	27804-27813	resulting	_	
38-74	27814-27818	from	_	
38-75	27819-27827	manifold	_	
38-76	27828-27836	analyses	_	
38-77	27837-27840	and	_	
38-78	27841-27844	the	_	
38-79	27845-27852	control	_	
38-80	27853-27856	for	_	
38-81	27857-27865	multiple	_	
38-82	27866-27876	covariates	_	
38-83	27876-27877	,	_	
38-84	27878-27887	questions	_	
38-85	27888-27894	remain	_	
38-86	27895-27904	regarding	_	
38-87	27905-27907	to	_	
38-88	27908-27912	what	_	
38-89	27913-27919	extent	_	
38-90	27920-27923	the	_	
38-91	27924-27931	present	_	
38-92	27932-27940	findings	_	
38-93	27941-27944	are	_	
38-94	27945-27951	linked	_	
38-95	27952-27954	to	_	
38-96	27955-27958	the	_	
38-97	27959-27970	abnormality	_	
38-98	27971-27973	of	_	
38-99	27974-27979	brain	_	
38-100	27980-27989	functions	_	
38-101	27990-27992	in	_	
38-102	27993-27997	drug	_	
38-103	27998-28005	abusers	_	
38-104	28006-28009	and	_	
38-105	28010-28012	to	_	
38-106	28013-28017	what	_	
38-107	28018-28024	degree	_	
38-108	28025-28028	the	_	
38-109	28029-28036	current	_	
38-110	28037-28044	results	_	
38-111	28045-28048	are	_	
38-112	28049-28055	stable	_	
38-113	28056-28059	and	_	
38-114	28060-28068	reliable	_	
38-115	28068-28069	.	_	
38-116	28070-28079	Therefore	_	
38-117	28079-28080	,	_	
38-118	28081-28089	findings	_	
38-119	28090-28099	presented	_	
38-120	28100-28102	in	_	
38-121	28103-28107	this	_	
38-122	28108-28113	study	_	
38-123	28114-28118	must	_	
38-124	28119-28121	be	_	
38-125	28122-28129	treated	_	
38-126	28130-28134	with	_	
38-127	28135-28142	caution	_	
38-128	28143-28148	until	_	
38-129	28149-28156	results	_	
38-130	28157-28160	are	_	
38-131	28161-28170	confirmed	_	
38-132	28171-28173	in	_	
38-133	28174-28175	a	_	
38-134	28176-28182	larger	_	
38-135	28183-28189	sample	_	
38-136	28189-28190	.	_	
38-137	28191-28202	Forthcoming	_	
38-138	28203-28214	fNIRS-based	_	
38-139	28215-28219	work	_	
38-140	28220-28222	on	_	
38-141	28223-28226	the	_	
38-142	28227-28231	rsFC	_	
38-143	28232-28234	in	_	
38-144	28235-28238	the	_	
38-145	28239-28248	remainder	_	
38-146	28249-28251	of	_	
38-147	28252-28255	the	_	
38-148	28256-28261	brain	_	
38-149	28262-28269	regions	_	
38-150	28270-28278	involved	_	
38-151	28279-28281	in	_	
38-152	28282-28288	opioid	_	
38-153	28289-28299	dependence	_	
38-154	28299-28300	,	_	
38-155	28301-28310	including	_	
38-156	28311-28321	dependence	_	
38-157	28322-28324	on	_	
38-158	28325-28335	prescribed	_	
38-159	28336-28343	opiates	_	
38-160	28343-28344	,	_	
38-161	28345-28349	such	_	
38-162	28350-28352	as	_	
38-163	28353-28361	morphine	_	
38-164	28361-28362	,	_	
38-165	28363-28372	oxycodone	_	
38-166	28372-28373	,	_	
38-167	28374-28377	and	_	
38-168	28378-28386	fentanyl	_	
38-169	28386-28387	,	_	
38-170	28388-28390	is	_	
38-171	28391-28397	needed	_	
38-172	28398-28400	to	_	
38-173	28401-28408	provide	_	
38-174	28409-28410	a	_	
38-175	28411-28415	more	_	
38-176	28416-28426	definitive	_	
38-177	28427-28430	and	_	
38-178	28431-28441	meticulous	_	
38-179	28442-28453	explanation	_	
38-180	28454-28456	of	_	
38-181	28457-28460	the	_	
38-182	28461-28468	current	_	
38-183	28469-28474	study	_	
38-184	28474-28475	.	_	
38-185	28476-28484	Moreover	_	
38-186	28484-28485	,	_	
38-187	28486-28492	future	_	
38-188	28493-28500	studies	_	
38-189	28501-28510	involving	_	
38-190	28511-28520	different	_	
38-191	28521-28530	treatment	_	
38-192	28530-28531	-	_	
38-193	28531-28532	/	_	
38-194	28532-28553	intervention-programs	_	
38-195	28554-28557	for	_	
38-196	28558-28564	opioid	_	
38-197	28565-28575	dependence	_	
38-198	28576-28579	and	_	
38-199	28580-28590	behavioral	_	
38-200	28591-28596	tasks	_	
38-201	28597-28600	are	_	
38-202	28601-28607	needed	_	
38-203	28608-28610	to	_	
38-204	28611-28619	finalize	_	
38-205	28620-28631	conclusions	_	
38-206	28631-28632	,	_	
38-207	28633-28637	such	_	
38-208	28638-28640	as	_	
38-209	28641-28650	examining	_	
38-210	28651-28654	the	_	
38-211	28655-28665	task-based	_	
38-212	28666-28676	functional	_	
38-213	28677-28689	connectivity	_	
38-214	28690-28693	and	_	
38-215	28694-28697	the	_	
38-216	28698-28702	link	_	
38-217	28703-28710	between	_	
38-218	28711-28714	the	_	
38-219	28715-28727	neuroimaging	_	
38-220	28728-28735	results	_	
38-221	28736-28739	and	_	
38-222	28740-28750	behavioral	_	
38-223	28751-28755	data	_	
38-224	28755-28756	,	_	
38-225	28757-28760	and	_	
38-226	28761-28769	defining	_	
38-227	28770-28773	the	_	
38-228	28774-28784	influences	_	
38-229	28785-28787	of	_	
38-230	28788-28793	other	_	
38-231	28794-28799	drugs	_	
38-232	28800-28809	available	_	
38-233	28810-28812	in	_	
38-234	28813-28822	treatment	_	
38-235	28822-28823	,	_	
38-236	28824-28828	such	_	
38-237	28829-28831	as	_	
38-238	28832-28841	methadone	_	
38-239	28841-28842	,	_	
38-240	28843-28856	buprenorphine	_	
38-241	28856-28857	,	_	
38-242	28858-28866	naloxone	_	
38-243	28866-28867	,	_	
38-244	28868-28871	and	_	
38-245	28872-28882	naltrexone	_	
38-246	28882-28883	,	_	
38-247	28884-28886	on	_	
38-248	28887-28897	functional	_	
38-249	28898-28910	connectivity	_	
38-250	28910-28911	.	_	
38-251	28912-28914	We	_	
38-252	28915-28923	observed	_	
38-253	28924-28928	that	_	
38-254	28929-28932	the	_	
38-255	28933-28937	year	_	
38-256	28938-28940	of	_	
38-257	28941-28948	smoking	_	
38-258	28949-28952	was	_	
38-259	28953-28963	correlated	_	
38-260	28964-28968	with	_	
38-261	28969-28976	anxiety	_	
38-262	28977-28983	scores	_	
38-263	28983-28984	,	_	
38-264	28985-28988	and	_	
38-265	28989-28993	thus	_	
38-266	28994-29007	co-dependence	_	
38-267	29008-29010	on	_	
38-268	29011-29016	other	_	
38-269	29017-29027	substances	_	
38-270	29027-29028	,	_	
38-271	29029-29033	such	_	
38-272	29034-29036	as	_	
38-273	29037-29045	nicotine	_	
38-274	29045-29046	,	_	
38-275	29047-29050	and	_	
38-276	29051-29059	comorbid	_	
38-277	29060-29070	conditions	_	
38-278	29070-29071	,	_	
38-279	29072-29076	such	_	
38-280	29077-29079	as	_	
38-281	29080-29087	anxiety	_	
38-282	29087-29088	,	_	
38-283	29089-29095	should	_	
38-284	29096-29098	be	_	
38-285	29099-29108	carefully	_	
38-286	29109-29114	taken	_	
38-287	29115-29119	into	_	
38-288	29120-29127	account	_	
38-289	29128-29130	in	_	
38-290	29131-29137	future	_	
38-291	29138-29145	studies	_	
38-292	29145-29146	.	_	

#Text=In summary, we have presented important exploratory work using fNIRS to study alternations of OFC functional connectivity in heroin addiction. We have demonstrated evidence of enhanced functional connectivity across OFC regions for abstinent heroin abusers. Although preliminary, the findings contribute new data to an emerging literature on the neuropsychological basis of addiction in the OFC and the resting-state mechanism underlying opioid dependence.
39-1	29147-29149	In	_	
39-2	29150-29157	summary	_	
39-3	29157-29158	,	_	
39-4	29159-29161	we	_	
39-5	29162-29166	have	_	
39-6	29167-29176	presented	_	
39-7	29177-29186	important	_	
39-8	29187-29198	exploratory	_	
39-9	29199-29203	work	_	
39-10	29204-29209	using	_	
39-11	29210-29215	fNIRS	_	
39-12	29216-29218	to	_	
39-13	29219-29224	study	_	
39-14	29225-29237	alternations	_	
39-15	29238-29240	of	_	
39-16	29241-29244	OFC	_	
39-17	29245-29255	functional	_	
39-18	29256-29268	connectivity	_	
39-19	29269-29271	in	_	
39-20	29272-29278	heroin	_	
39-21	29279-29288	addiction	_	
39-22	29288-29289	.	_	
39-23	29290-29292	We	_	
39-24	29293-29297	have	_	
39-25	29298-29310	demonstrated	_	
39-26	29311-29319	evidence	_	
39-27	29320-29322	of	_	
39-28	29323-29331	enhanced	_	
39-29	29332-29342	functional	_	
39-30	29343-29355	connectivity	_	
39-31	29356-29362	across	_	
39-32	29363-29366	OFC	_	
39-33	29367-29374	regions	_	
39-34	29375-29378	for	_	
39-35	29379-29388	abstinent	_	
39-36	29389-29395	heroin	_	
39-37	29396-29403	abusers	_	
39-38	29403-29404	.	_	
39-39	29405-29413	Although	_	
39-40	29414-29425	preliminary	_	
39-41	29425-29426	,	_	
39-42	29427-29430	the	_	
39-43	29431-29439	findings	_	
39-44	29440-29450	contribute	_	
39-45	29451-29454	new	_	
39-46	29455-29459	data	_	
39-47	29460-29462	to	_	
39-48	29463-29465	an	_	
39-49	29466-29474	emerging	_	
39-50	29475-29485	literature	_	
39-51	29486-29488	on	_	
39-52	29489-29492	the	_	
39-53	29493-29511	neuropsychological	_	
39-54	29512-29517	basis	_	
39-55	29518-29520	of	_	
39-56	29521-29530	addiction	_	
39-57	29531-29533	in	_	
39-58	29534-29537	the	_	
39-59	29538-29541	OFC	_	
39-60	29542-29545	and	_	
39-61	29546-29549	the	_	
39-62	29550-29563	resting-state	_	
39-63	29564-29573	mechanism	_	
39-64	29574-29584	underlying	_	
39-65	29585-29591	opioid	_	
39-66	29592-29602	dependence	_	
39-67	29602-29603	.	_	

#Text=Methods
40-1	29604-29611	Methods	_	

#Text=Participants
41-1	29612-29624	Participants	_	

#Text=From May 5, 2015 to September 15, 2015, eight abstinent HD individuals were recruited from a local drug rehabilitation treatment center in Macao SAR and seven control subjects from the local community were enrolled with demographic factors matching those of the HDs (i.e., age, education level, IQ, and years of smoking; Table 1). All the subjects were smokers. In order to control for the effects of nicotine, daily cigarette consumption of the CGs was matched with the HDs. The protocol was approved by the Medial Ethics Committee of the University of Macau. The experiments were performed in accordance with the relevant guidelines and regulations in the latest version of the Declaration of Helsinki. After being providing with an informed description of the study procedures, all the participants signed informed consent forms prior to the experiments.
42-1	29625-29629	From	_	
42-2	29630-29633	May	_	
42-3	29634-29635	5	_	
42-4	29635-29636	,	_	
42-5	29637-29641	2015	_	
42-6	29642-29644	to	_	
42-7	29645-29654	September	_	
42-8	29655-29657	15	_	
42-9	29657-29658	,	_	
42-10	29659-29663	2015	_	
42-11	29663-29664	,	_	
42-12	29665-29670	eight	_	
42-13	29671-29680	abstinent	_	
42-14	29681-29683	HD	_	
42-15	29684-29695	individuals	_	
42-16	29696-29700	were	_	
42-17	29701-29710	recruited	_	
42-18	29711-29715	from	_	
42-19	29716-29717	a	_	
42-20	29718-29723	local	_	
42-21	29724-29728	drug	_	
42-22	29729-29743	rehabilitation	_	
42-23	29744-29753	treatment	_	
42-24	29754-29760	center	_	
42-25	29761-29763	in	_	
42-26	29764-29769	Macao	_	
42-27	29770-29773	SAR	_	
42-28	29774-29777	and	_	
42-29	29778-29783	seven	_	
42-30	29784-29791	control	_	
42-31	29792-29800	subjects	_	
42-32	29801-29805	from	_	
42-33	29806-29809	the	_	
42-34	29810-29815	local	_	
42-35	29816-29825	community	_	
42-36	29826-29830	were	_	
42-37	29831-29839	enrolled	_	
42-38	29840-29844	with	_	
42-39	29845-29856	demographic	_	
42-40	29857-29864	factors	_	
42-41	29865-29873	matching	_	
42-42	29874-29879	those	_	
42-43	29880-29882	of	_	
42-44	29883-29886	the	_	
42-45	29887-29890	HDs	_	
42-46	29891-29892	(	_	
42-47	29892-29895	i.e	_	
42-48	29895-29896	.	_	
42-49	29896-29897	,	_	
42-50	29898-29901	age	_	
42-51	29901-29902	,	_	
42-52	29903-29912	education	_	
42-53	29913-29918	level	_	
42-54	29918-29919	,	_	
42-55	29920-29922	IQ	_	
42-56	29922-29923	,	_	
42-57	29924-29927	and	_	
42-58	29928-29933	years	_	
42-59	29934-29936	of	_	
42-60	29937-29944	smoking	_	
42-61	29944-29945	;	_	
42-62	29946-29951	Table	_	
42-63	29952-29953	1	_	
42-64	29953-29954	)	_	
42-65	29954-29955	.	_	
42-66	29956-29959	All	_	
42-67	29960-29963	the	_	
42-68	29964-29972	subjects	_	
42-69	29973-29977	were	_	
42-70	29978-29985	smokers	_	
42-71	29985-29986	.	_	
42-72	29987-29989	In	_	
42-73	29990-29995	order	_	
42-74	29996-29998	to	_	
42-75	29999-30006	control	_	
42-76	30007-30010	for	_	
42-77	30011-30014	the	_	
42-78	30015-30022	effects	_	
42-79	30023-30025	of	_	
42-80	30026-30034	nicotine	_	
42-81	30034-30035	,	_	
42-82	30036-30041	daily	_	
42-83	30042-30051	cigarette	_	
42-84	30052-30063	consumption	_	
42-85	30064-30066	of	_	
42-86	30067-30070	the	_	
42-87	30071-30074	CGs	_	
42-88	30075-30078	was	_	
42-89	30079-30086	matched	_	
42-90	30087-30091	with	_	
42-91	30092-30095	the	_	
42-92	30096-30099	HDs	_	
42-93	30099-30100	.	_	
42-94	30101-30104	The	_	
42-95	30105-30113	protocol	_	
42-96	30114-30117	was	_	
42-97	30118-30126	approved	_	
42-98	30127-30129	by	_	
42-99	30130-30133	the	_	
42-100	30134-30140	Medial	_	
42-101	30141-30147	Ethics	_	
42-102	30148-30157	Committee	_	
42-103	30158-30160	of	_	
42-104	30161-30164	the	_	
42-105	30165-30175	University	_	
42-106	30176-30178	of	_	
42-107	30179-30184	Macau	_	
42-108	30184-30185	.	_	
42-109	30186-30189	The	_	
42-110	30190-30201	experiments	_	
42-111	30202-30206	were	_	
42-112	30207-30216	performed	_	
42-113	30217-30219	in	_	
42-114	30220-30230	accordance	_	
42-115	30231-30235	with	_	
42-116	30236-30239	the	_	
42-117	30240-30248	relevant	_	
42-118	30249-30259	guidelines	_	
42-119	30260-30263	and	_	
42-120	30264-30275	regulations	_	
42-121	30276-30278	in	_	
42-122	30279-30282	the	_	
42-123	30283-30289	latest	_	
42-124	30290-30297	version	_	
42-125	30298-30300	of	_	
42-126	30301-30304	the	_	
42-127	30305-30316	Declaration	_	
42-128	30317-30319	of	_	
42-129	30320-30328	Helsinki	_	
42-130	30328-30329	.	_	
42-131	30330-30335	After	_	
42-132	30336-30341	being	_	
42-133	30342-30351	providing	_	
42-134	30352-30356	with	_	
42-135	30357-30359	an	_	
42-136	30360-30368	informed	_	
42-137	30369-30380	description	_	
42-138	30381-30383	of	_	
42-139	30384-30387	the	_	
42-140	30388-30393	study	_	
42-141	30394-30404	procedures	_	
42-142	30404-30405	,	_	
42-143	30406-30409	all	_	
42-144	30410-30413	the	_	
42-145	30414-30426	participants	_	
42-146	30427-30433	signed	_	
42-147	30434-30442	informed	_	
42-148	30443-30450	consent	_	
42-149	30451-30456	forms	_	
42-150	30457-30462	prior	_	
42-151	30463-30465	to	_	
42-152	30466-30469	the	_	
42-153	30470-30481	experiments	_	
42-154	30481-30482	.	_	

#Text=The inclusion criteria for all the participants were as follows: (1) aged 18–65 years old, (2) right-handed, (3) Cantonese speakers, and (4) normal or corrected-to-normal vision. The exclusion criteria for all the participants were as follows: (1) history of neurological illness or psychiatric disorder other than heroin and nicotine dependence, (2) reported additional use of psychoactive substances at least 72 hours before any measurement, and (3) history of head trauma or brain injury.
43-1	30483-30486	The	_	
43-2	30487-30496	inclusion	_	
43-3	30497-30505	criteria	_	
43-4	30506-30509	for	_	
43-5	30510-30513	all	_	
43-6	30514-30517	the	_	
43-7	30518-30530	participants	_	
43-8	30531-30535	were	_	
43-9	30536-30538	as	_	
43-10	30539-30546	follows	_	
43-11	30546-30547	:	_	
43-12	30548-30549	(	_	
43-13	30549-30550	1	_	
43-14	30550-30551	)	_	
43-15	30552-30556	aged	_	
43-16	30557-30559	18	_	
43-17	30559-30560	–	_	
43-18	30560-30562	65	_	
43-19	30563-30568	years	_	
43-20	30569-30572	old	_	
43-21	30572-30573	,	_	
43-22	30574-30575	(	_	
43-23	30575-30576	2	_	
43-24	30576-30577	)	_	
43-25	30578-30590	right-handed	_	
43-26	30590-30591	,	_	
43-27	30592-30593	(	_	
43-28	30593-30594	3	_	
43-29	30594-30595	)	_	
43-30	30596-30605	Cantonese	_	
43-31	30606-30614	speakers	_	
43-32	30614-30615	,	_	
43-33	30616-30619	and	_	
43-34	30620-30621	(	_	
43-35	30621-30622	4	_	
43-36	30622-30623	)	_	
43-37	30624-30630	normal	_	
43-38	30631-30633	or	_	
43-39	30634-30653	corrected-to-normal	_	
43-40	30654-30660	vision	_	
43-41	30660-30661	.	_	
43-42	30662-30665	The	_	
43-43	30666-30675	exclusion	_	
43-44	30676-30684	criteria	_	
43-45	30685-30688	for	_	
43-46	30689-30692	all	_	
43-47	30693-30696	the	_	
43-48	30697-30709	participants	_	
43-49	30710-30714	were	_	
43-50	30715-30717	as	_	
43-51	30718-30725	follows	_	
43-52	30725-30726	:	_	
43-53	30727-30728	(	_	
43-54	30728-30729	1	_	
43-55	30729-30730	)	_	
43-56	30731-30738	history	_	
43-57	30739-30741	of	_	
43-58	30742-30754	neurological	_	
43-59	30755-30762	illness	_	
43-60	30763-30765	or	_	
43-61	30766-30777	psychiatric	_	
43-62	30778-30786	disorder	_	
43-63	30787-30792	other	_	
43-64	30793-30797	than	_	
43-65	30798-30804	heroin	_	
43-66	30805-30808	and	_	
43-67	30809-30817	nicotine	_	
43-68	30818-30828	dependence	_	
43-69	30828-30829	,	_	
43-70	30830-30831	(	_	
43-71	30831-30832	2	_	
43-72	30832-30833	)	_	
43-73	30834-30842	reported	_	
43-74	30843-30853	additional	_	
43-75	30854-30857	use	_	
43-76	30858-30860	of	_	
43-77	30861-30873	psychoactive	_	
43-78	30874-30884	substances	_	
43-79	30885-30887	at	_	
43-80	30888-30893	least	_	
43-81	30894-30896	72	_	
43-82	30897-30902	hours	_	
43-83	30903-30909	before	_	
43-84	30910-30913	any	_	
43-85	30914-30925	measurement	_	
43-86	30925-30926	,	_	
43-87	30927-30930	and	_	
43-88	30931-30932	(	_	
43-89	30932-30933	3	_	
43-90	30933-30934	)	_	
43-91	30935-30942	history	_	
43-92	30943-30945	of	_	
43-93	30946-30950	head	_	
43-94	30951-30957	trauma	_	
43-95	30958-30960	or	_	
43-96	30961-30966	brain	_	
43-97	30967-30973	injury	_	
43-98	30973-30974	.	_	

#Text=All the HD subjects had a history of more-than-20-years of heroin abuse. Local medical doctors confirmed the diagnoses of drug addiction. All the participants were required to complete a preclinical interview performed by a local psychological counselor prior to inclusion in the study. The Structured Clinical Interview for DSM-IV (SCID) was used in the interview to verify opioid dependence, and the State-Trait Anxiety Inventory (STAI) was adopted to measure the degree of anxiety. None of the HD subjects had received any formal psychotherapeutic training. Information on the subjects’ demographic characteristics is provided in Table 1. After the preclinical interview, a urine sample was collected from each subject for mandatory drug screening to ensure that the subject had not taken any psychoactive drugs other than heroin and methadone before any assessments or recordings. Subjects were compensated with a small fee upon their completion of the experiment. The medication and substance-use status of the subjects is provided in Supplementary Information S7.
44-1	30975-30978	All	_	
44-2	30979-30982	the	_	
44-3	30983-30985	HD	_	
44-4	30986-30994	subjects	_	
44-5	30995-30998	had	_	
44-6	30999-31000	a	_	
44-7	31001-31008	history	_	
44-8	31009-31011	of	_	
44-9	31012-31021	more-than	_	
44-10	31021-31022	-	_	
44-11	31022-31024	20	_	
44-12	31024-31025	-	_	
44-13	31025-31030	years	_	
44-14	31031-31033	of	_	
44-15	31034-31040	heroin	_	
44-16	31041-31046	abuse	_	
44-17	31046-31047	.	_	
44-18	31048-31053	Local	_	
44-19	31054-31061	medical	_	
44-20	31062-31069	doctors	_	
44-21	31070-31079	confirmed	_	
44-22	31080-31083	the	_	
44-23	31084-31093	diagnoses	_	
44-24	31094-31096	of	_	
44-25	31097-31101	drug	_	
44-26	31102-31111	addiction	_	
44-27	31111-31112	.	_	
44-28	31113-31116	All	_	
44-29	31117-31120	the	_	
44-30	31121-31133	participants	_	
44-31	31134-31138	were	_	
44-32	31139-31147	required	_	
44-33	31148-31150	to	_	
44-34	31151-31159	complete	_	
44-35	31160-31161	a	_	
44-36	31162-31173	preclinical	_	
44-37	31174-31183	interview	_	
44-38	31184-31193	performed	_	
44-39	31194-31196	by	_	
44-40	31197-31198	a	_	
44-41	31199-31204	local	_	
44-42	31205-31218	psychological	_	
44-43	31219-31228	counselor	_	
44-44	31229-31234	prior	_	
44-45	31235-31237	to	_	
44-46	31238-31247	inclusion	_	
44-47	31248-31250	in	_	
44-48	31251-31254	the	_	
44-49	31255-31260	study	_	
44-50	31260-31261	.	_	
44-51	31262-31265	The	_	
44-52	31266-31276	Structured	_	
44-53	31277-31285	Clinical	_	
44-54	31286-31295	Interview	_	
44-55	31296-31299	for	_	
44-56	31300-31306	DSM-IV	_	
44-57	31307-31308	(	_	
44-58	31308-31312	SCID	_	
44-59	31312-31313	)	_	
44-60	31314-31317	was	_	
44-61	31318-31322	used	_	
44-62	31323-31325	in	_	
44-63	31326-31329	the	_	
44-64	31330-31339	interview	_	
44-65	31340-31342	to	_	
44-66	31343-31349	verify	_	
44-67	31350-31356	opioid	_	
44-68	31357-31367	dependence	_	
44-69	31367-31368	,	_	
44-70	31369-31372	and	_	
44-71	31373-31376	the	_	
44-72	31377-31388	State-Trait	_	
44-73	31389-31396	Anxiety	_	
44-74	31397-31406	Inventory	_	
44-75	31407-31408	(	_	
44-76	31408-31412	STAI	_	
44-77	31412-31413	)	_	
44-78	31414-31417	was	_	
44-79	31418-31425	adopted	_	
44-80	31426-31428	to	_	
44-81	31429-31436	measure	_	
44-82	31437-31440	the	_	
44-83	31441-31447	degree	_	
44-84	31448-31450	of	_	
44-85	31451-31458	anxiety	_	
44-86	31458-31459	.	_	
44-87	31460-31464	None	_	
44-88	31465-31467	of	_	
44-89	31468-31471	the	_	
44-90	31472-31474	HD	_	
44-91	31475-31483	subjects	_	
44-92	31484-31487	had	_	
44-93	31488-31496	received	_	
44-94	31497-31500	any	_	
44-95	31501-31507	formal	_	
44-96	31508-31525	psychotherapeutic	_	
44-97	31526-31534	training	_	
44-98	31534-31535	.	_	
44-99	31536-31547	Information	_	
44-100	31548-31550	on	_	
44-101	31551-31554	the	_	
44-102	31555-31563	subjects	_	
44-103	31563-31564	’	_	
44-104	31565-31576	demographic	_	
44-105	31577-31592	characteristics	_	
44-106	31593-31595	is	_	
44-107	31596-31604	provided	_	
44-108	31605-31607	in	_	
44-109	31608-31613	Table	_	
44-110	31614-31615	1	_	
44-111	31615-31616	.	_	
44-112	31617-31622	After	_	
44-113	31623-31626	the	_	
44-114	31627-31638	preclinical	_	
44-115	31639-31648	interview	_	
44-116	31648-31649	,	_	
44-117	31650-31651	a	_	
44-118	31652-31657	urine	_	
44-119	31658-31664	sample	_	
44-120	31665-31668	was	_	
44-121	31669-31678	collected	_	
44-122	31679-31683	from	_	
44-123	31684-31688	each	_	
44-124	31689-31696	subject	_	
44-125	31697-31700	for	_	
44-126	31701-31710	mandatory	_	
44-127	31711-31715	drug	_	
44-128	31716-31725	screening	_	
44-129	31726-31728	to	_	
44-130	31729-31735	ensure	_	
44-131	31736-31740	that	_	
44-132	31741-31744	the	_	
44-133	31745-31752	subject	_	
44-134	31753-31756	had	_	
44-135	31757-31760	not	_	
44-136	31761-31766	taken	_	
44-137	31767-31770	any	_	
44-138	31771-31783	psychoactive	_	
44-139	31784-31789	drugs	_	
44-140	31790-31795	other	_	
44-141	31796-31800	than	_	
44-142	31801-31807	heroin	_	
44-143	31808-31811	and	_	
44-144	31812-31821	methadone	_	
44-145	31822-31828	before	_	
44-146	31829-31832	any	_	
44-147	31833-31844	assessments	_	
44-148	31845-31847	or	_	
44-149	31848-31858	recordings	_	
44-150	31858-31859	.	_	
44-151	31860-31868	Subjects	_	
44-152	31869-31873	were	_	
44-153	31874-31885	compensated	_	
44-154	31886-31890	with	_	
44-155	31891-31892	a	_	
44-156	31893-31898	small	_	
44-157	31899-31902	fee	_	
44-158	31903-31907	upon	_	
44-159	31908-31913	their	_	
44-160	31914-31924	completion	_	
44-161	31925-31927	of	_	
44-162	31928-31931	the	_	
44-163	31932-31942	experiment	_	
44-164	31942-31943	.	_	
44-165	31944-31947	The	_	
44-166	31948-31958	medication	_	
44-167	31959-31962	and	_	
44-168	31963-31976	substance-use	_	
44-169	31977-31983	status	_	
44-170	31984-31986	of	_	
44-171	31987-31990	the	_	
44-172	31991-31999	subjects	_	
44-173	32000-32002	is	_	
44-174	32003-32011	provided	_	
44-175	32012-32014	in	_	
44-176	32015-32028	Supplementary	_	
44-177	32029-32040	Information	_	
44-178	32041-32043	S7	_	
44-179	32043-32044	.	_	

#Text=Experimental design
45-1	32045-32057	Experimental	_	
45-2	32058-32064	design	_	

#Text=The subjects were instructed to sit comfortably on a chair in a quiet and dim room. All the subjects underwent two sessions of fNIRS recordings of neural activities of the OFC. The first session was an 11-min resting-state recording followed by the second session, an approximately 3-minute gambling localizer task.
46-1	32065-32068	The	_	
46-2	32069-32077	subjects	_	
46-3	32078-32082	were	_	
46-4	32083-32093	instructed	_	
46-5	32094-32096	to	_	
46-6	32097-32100	sit	_	
46-7	32101-32112	comfortably	_	
46-8	32113-32115	on	_	
46-9	32116-32117	a	_	
46-10	32118-32123	chair	_	
46-11	32124-32126	in	_	
46-12	32127-32128	a	_	
46-13	32129-32134	quiet	_	
46-14	32135-32138	and	_	
46-15	32139-32142	dim	_	
46-16	32143-32147	room	_	
46-17	32147-32148	.	_	
46-18	32149-32152	All	_	
46-19	32153-32156	the	_	
46-20	32157-32165	subjects	_	
46-21	32166-32175	underwent	_	
46-22	32176-32179	two	_	
46-23	32180-32188	sessions	_	
46-24	32189-32191	of	_	
46-25	32192-32197	fNIRS	_	
46-26	32198-32208	recordings	_	
46-27	32209-32211	of	_	
46-28	32212-32218	neural	_	
46-29	32219-32229	activities	_	
46-30	32230-32232	of	_	
46-31	32233-32236	the	_	
46-32	32237-32240	OFC	_	
46-33	32240-32241	.	_	
46-34	32242-32245	The	_	
46-35	32246-32251	first	_	
46-36	32252-32259	session	_	
46-37	32260-32263	was	_	
46-38	32264-32266	an	_	
46-39	32267-32269	11	_	
46-40	32269-32270	-	_	
46-41	32270-32273	min	_	
46-42	32274-32287	resting-state	_	
46-43	32288-32297	recording	_	
46-44	32298-32306	followed	_	
46-45	32307-32309	by	_	
46-46	32310-32313	the	_	
46-47	32314-32320	second	_	
46-48	32321-32328	session	_	
46-49	32328-32329	,	_	
46-50	32330-32332	an	_	
46-51	32333-32346	approximately	_	
46-52	32347-32348	3	_	
46-53	32348-32349	-	_	
46-54	32349-32355	minute	_	
46-55	32356-32364	gambling	_	
46-56	32365-32374	localizer	_	
46-57	32375-32379	task	_	
46-58	32379-32380	.	_	

#Text=During the resting-state session, the subjects were asked to close their eyes, relax their muscles and mind, think of nothing, remain still and make the least possible amount of motion, but to stay awake and alert. After the resting-state recording, the subjects were instructed to open their eyes to conduct a gambling task to retrain the OFC regions for further rsFC analysis.
47-1	32381-32387	During	_	
47-2	32388-32391	the	_	
47-3	32392-32405	resting-state	_	
47-4	32406-32413	session	_	
47-5	32413-32414	,	_	
47-6	32415-32418	the	_	
47-7	32419-32427	subjects	_	
47-8	32428-32432	were	_	
47-9	32433-32438	asked	_	
47-10	32439-32441	to	_	
47-11	32442-32447	close	_	
47-12	32448-32453	their	_	
47-13	32454-32458	eyes	_	
47-14	32458-32459	,	_	
47-15	32460-32465	relax	_	
47-16	32466-32471	their	_	
47-17	32472-32479	muscles	_	
47-18	32480-32483	and	_	
47-19	32484-32488	mind	_	
47-20	32488-32489	,	_	
47-21	32490-32495	think	_	
47-22	32496-32498	of	_	
47-23	32499-32506	nothing	_	
47-24	32506-32507	,	_	
47-25	32508-32514	remain	_	
47-26	32515-32520	still	_	
47-27	32521-32524	and	_	
47-28	32525-32529	make	_	
47-29	32530-32533	the	_	
47-30	32534-32539	least	_	
47-31	32540-32548	possible	_	
47-32	32549-32555	amount	_	
47-33	32556-32558	of	_	
47-34	32559-32565	motion	_	
47-35	32565-32566	,	_	
47-36	32567-32570	but	_	
47-37	32571-32573	to	_	
47-38	32574-32578	stay	_	
47-39	32579-32584	awake	_	
47-40	32585-32588	and	_	
47-41	32589-32594	alert	_	
47-42	32594-32595	.	_	
47-43	32596-32601	After	_	
47-44	32602-32605	the	_	
47-45	32606-32619	resting-state	_	
47-46	32620-32629	recording	_	
47-47	32629-32630	,	_	
47-48	32631-32634	the	_	
47-49	32635-32643	subjects	_	
47-50	32644-32648	were	_	
47-51	32649-32659	instructed	_	
47-52	32660-32662	to	_	
47-53	32663-32667	open	_	
47-54	32668-32673	their	_	
47-55	32674-32678	eyes	_	
47-56	32679-32681	to	_	
47-57	32682-32689	conduct	_	
47-58	32690-32691	a	_	
47-59	32692-32700	gambling	_	
47-60	32701-32705	task	_	
47-61	32706-32708	to	_	
47-62	32709-32716	retrain	_	
47-63	32717-32720	the	_	
47-64	32721-32724	OFC	_	
47-65	32725-32732	regions	_	
47-66	32733-32736	for	_	
47-67	32737-32744	further	_	
47-68	32745-32749	rsFC	_	
47-69	32750-32758	analysis	_	
47-70	32758-32759	.	_	

#Text=In the rsFC analysis, four functional connectivity methods were utilized to generate regional brain networks related to drug addiction, which included: (1) interhemispheric correlation analysis, (2) functional connectivity measurements generated by seed-based and whole-brain correlation analyses, (3) graph-theory network analysis, and (4) linear regression analysis (for experimental design details, see Supplementary Figure S1).
48-1	32760-32762	In	_	
48-2	32763-32766	the	_	
48-3	32767-32771	rsFC	_	
48-4	32772-32780	analysis	_	
48-5	32780-32781	,	_	
48-6	32782-32786	four	_	
48-7	32787-32797	functional	_	
48-8	32798-32810	connectivity	_	
48-9	32811-32818	methods	_	
48-10	32819-32823	were	_	
48-11	32824-32832	utilized	_	
48-12	32833-32835	to	_	
48-13	32836-32844	generate	_	
48-14	32845-32853	regional	_	
48-15	32854-32859	brain	_	
48-16	32860-32868	networks	_	
48-17	32869-32876	related	_	
48-18	32877-32879	to	_	
48-19	32880-32884	drug	_	
48-20	32885-32894	addiction	_	
48-21	32894-32895	,	_	
48-22	32896-32901	which	_	
48-23	32902-32910	included	_	
48-24	32910-32911	:	_	
48-25	32912-32913	(	_	
48-26	32913-32914	1	_	
48-27	32914-32915	)	_	
48-28	32916-32932	interhemispheric	_	
48-29	32933-32944	correlation	_	
48-30	32945-32953	analysis	_	
48-31	32953-32954	,	_	
48-32	32955-32956	(	_	
48-33	32956-32957	2	_	
48-34	32957-32958	)	_	
48-35	32959-32969	functional	_	
48-36	32970-32982	connectivity	_	
48-37	32983-32995	measurements	_	
48-38	32996-33005	generated	_	
48-39	33006-33008	by	_	
48-40	33009-33019	seed-based	_	
48-41	33020-33023	and	_	
48-42	33024-33035	whole-brain	_	
48-43	33036-33047	correlation	_	
48-44	33048-33056	analyses	_	
48-45	33056-33057	,	_	
48-46	33058-33059	(	_	
48-47	33059-33060	3	_	
48-48	33060-33061	)	_	
48-49	33062-33074	graph-theory	_	
48-50	33075-33082	network	_	
48-51	33083-33091	analysis	_	
48-52	33091-33092	,	_	
48-53	33093-33096	and	_	
48-54	33097-33098	(	_	
48-55	33098-33099	4	_	
48-56	33099-33100	)	_	
48-57	33101-33107	linear	_	
48-58	33108-33118	regression	_	
48-59	33119-33127	analysis	_	
48-60	33128-33129	(	_	
48-61	33129-33132	for	_	
48-62	33133-33145	experimental	_	
48-63	33146-33152	design	_	
48-64	33153-33160	details	_	
48-65	33160-33161	,	_	
48-66	33162-33165	see	_	
48-67	33166-33179	Supplementary	_	
48-68	33180-33186	Figure	_	
48-69	33187-33189	S1	_	
48-70	33189-33190	)	_	
48-71	33190-33191	.	_	

#Text=fNIRS data acquisition
49-1	33192-33197	fNIRS	_	
49-2	33198-33202	data	_	
49-3	33203-33214	acquisition	_	

#Text=The experiments were performed using a continuous wave (CW) fNIRS instrument with three sources and eight detectors (CW6 fNIRS system; TechEn Inc, Milford, MA), as shown in Fig. 7. In this system, two CW lights at wavelengths of 690 nm and 830 nm were emitted at each source fiber, which provided sensitive detection of changes in both the HbO and Hb concentrations in the human brain. The configuration of the source-detector pairs is shown in Fig. 7, in which the sources and detectors were connected by optical fibers on the scalp to generate twelve fNIRS measurement channels covering the bilateral and medial OFC regions, which were positioned accurately based on the 10–20 system. Each set of one source and four detectors covered one particular OFC, resulting in four ROIs; i.e., the right lOFC, the left lOFC, the right mOFC, and the left mOFC (see Supplementary Table S2). The MNI coordinates of the channels were estimated using Homer2 (www.homer-fnirs.org/documentation) and its AtlasViewerGUI with the widely adopted automated anatomical labeling (AAL). The three-dimensional locations of the fNIRS probes were also visualized with the NIRS-SPM software (http://bispl.weebly.com/nirs-spm.html#/). The source-detector distance was 30 mm, measuring the brain activity of the cerebral cortex with a penetration depth of 2–3 cm. The sampling rate of our fNIRS system was 50 Hz. Using MATLAB (MathWorks, Inc., Natick, MA, USA) and BrainNet Viewer (https://www.nitrc.org/projects/bnv), statistical outcomes for each channel were shown on the surface of a normalized and a standardized brain.
50-1	33215-33218	The	_	
50-2	33219-33230	experiments	_	
50-3	33231-33235	were	_	
50-4	33236-33245	performed	_	
50-5	33246-33251	using	_	
50-6	33252-33253	a	_	
50-7	33254-33264	continuous	_	
50-8	33265-33269	wave	_	
50-9	33270-33271	(	_	
50-10	33271-33273	CW	_	
50-11	33273-33274	)	_	
50-12	33275-33280	fNIRS	_	
50-13	33281-33291	instrument	_	
50-14	33292-33296	with	_	
50-15	33297-33302	three	_	
50-16	33303-33310	sources	_	
50-17	33311-33314	and	_	
50-18	33315-33320	eight	_	
50-19	33321-33330	detectors	_	
50-20	33331-33332	(	_	
50-21	33332-33335	CW6	_	
50-22	33336-33341	fNIRS	_	
50-23	33342-33348	system	_	
50-24	33348-33349	;	_	
50-25	33350-33356	TechEn	_	
50-26	33357-33360	Inc	_	
50-27	33360-33361	,	_	
50-28	33362-33369	Milford	_	
50-29	33369-33370	,	_	
50-30	33371-33373	MA	_	
50-31	33373-33374	)	_	
50-32	33374-33375	,	_	
50-33	33376-33378	as	_	
50-34	33379-33384	shown	_	
50-35	33385-33387	in	_	
50-36	33388-33391	Fig	_	
50-37	33391-33392	.	_	
50-38	33393-33394	7	_	
50-39	33394-33395	.	_	
50-40	33396-33398	In	_	
50-41	33399-33403	this	_	
50-42	33404-33410	system	_	
50-43	33410-33411	,	_	
50-44	33412-33415	two	_	
50-45	33416-33418	CW	_	
50-46	33419-33425	lights	_	
50-47	33426-33428	at	_	
50-48	33429-33440	wavelengths	_	
50-49	33441-33443	of	_	
50-50	33444-33447	690	_	
50-51	33448-33450	nm	_	
50-52	33451-33454	and	_	
50-53	33455-33458	830	_	
50-54	33459-33461	nm	_	
50-55	33462-33466	were	_	
50-56	33467-33474	emitted	_	
50-57	33475-33477	at	_	
50-58	33478-33482	each	_	
50-59	33483-33489	source	_	
50-60	33490-33495	fiber	_	
50-61	33495-33496	,	_	
50-62	33497-33502	which	_	
50-63	33503-33511	provided	_	
50-64	33512-33521	sensitive	_	
50-65	33522-33531	detection	_	
50-66	33532-33534	of	_	
50-67	33535-33542	changes	_	
50-68	33543-33545	in	_	
50-69	33546-33550	both	_	
50-70	33551-33554	the	_	
50-71	33555-33558	HbO	_	
50-72	33559-33562	and	_	
50-73	33563-33565	Hb	_	
50-74	33566-33580	concentrations	_	
50-75	33581-33583	in	_	
50-76	33584-33587	the	_	
50-77	33588-33593	human	_	
50-78	33594-33599	brain	_	
50-79	33599-33600	.	_	
50-80	33601-33604	The	_	
50-81	33605-33618	configuration	_	
50-82	33619-33621	of	_	
50-83	33622-33625	the	_	
50-84	33626-33641	source-detector	_	
50-85	33642-33647	pairs	_	
50-86	33648-33650	is	_	
50-87	33651-33656	shown	_	
50-88	33657-33659	in	_	
50-89	33660-33663	Fig	_	
50-90	33663-33664	.	_	
50-91	33665-33666	7	_	
50-92	33666-33667	,	_	
50-93	33668-33670	in	_	
50-94	33671-33676	which	_	
50-95	33677-33680	the	_	
50-96	33681-33688	sources	_	
50-97	33689-33692	and	_	
50-98	33693-33702	detectors	_	
50-99	33703-33707	were	_	
50-100	33708-33717	connected	_	
50-101	33718-33720	by	_	
50-102	33721-33728	optical	_	
50-103	33729-33735	fibers	_	
50-104	33736-33738	on	_	
50-105	33739-33742	the	_	
50-106	33743-33748	scalp	_	
50-107	33749-33751	to	_	
50-108	33752-33760	generate	_	
50-109	33761-33767	twelve	_	
50-110	33768-33773	fNIRS	_	
50-111	33774-33785	measurement	_	
50-112	33786-33794	channels	_	
50-113	33795-33803	covering	_	
50-114	33804-33807	the	_	
50-115	33808-33817	bilateral	_	
50-116	33818-33821	and	_	
50-117	33822-33828	medial	_	
50-118	33829-33832	OFC	_	
50-119	33833-33840	regions	_	
50-120	33840-33841	,	_	
50-121	33842-33847	which	_	
50-122	33848-33852	were	_	
50-123	33853-33863	positioned	_	
50-124	33864-33874	accurately	_	
50-125	33875-33880	based	_	
50-126	33881-33883	on	_	
50-127	33884-33887	the	_	
50-128	33888-33890	10	_	
50-129	33890-33891	–	_	
50-130	33891-33893	20	_	
50-131	33894-33900	system	_	
50-132	33900-33901	.	_	
50-133	33902-33906	Each	_	
50-134	33907-33910	set	_	
50-135	33911-33913	of	_	
50-136	33914-33917	one	_	
50-137	33918-33924	source	_	
50-138	33925-33928	and	_	
50-139	33929-33933	four	_	
50-140	33934-33943	detectors	_	
50-141	33944-33951	covered	_	
50-142	33952-33955	one	_	
50-143	33956-33966	particular	_	
50-144	33967-33970	OFC	_	
50-145	33970-33971	,	_	
50-146	33972-33981	resulting	_	
50-147	33982-33984	in	_	
50-148	33985-33989	four	_	
50-149	33990-33994	ROIs	_	
50-150	33994-33995	;	_	
50-151	33996-33999	i.e	_	
50-152	33999-34000	.	_	
50-153	34000-34001	,	_	
50-154	34002-34005	the	_	
50-155	34006-34011	right	_	
50-156	34012-34016	lOFC	_	
50-157	34016-34017	,	_	
50-158	34018-34021	the	_	
50-159	34022-34026	left	_	
50-160	34027-34031	lOFC	_	
50-161	34031-34032	,	_	
50-162	34033-34036	the	_	
50-163	34037-34042	right	_	
50-164	34043-34047	mOFC	_	
50-165	34047-34048	,	_	
50-166	34049-34052	and	_	
50-167	34053-34056	the	_	
50-168	34057-34061	left	_	
50-169	34062-34066	mOFC	_	
50-170	34067-34068	(	_	
50-171	34068-34071	see	_	
50-172	34072-34085	Supplementary	_	
50-173	34086-34091	Table	_	
50-174	34092-34094	S2	_	
50-175	34094-34095	)	_	
50-176	34095-34096	.	_	
50-177	34097-34100	The	_	
50-178	34101-34104	MNI	_	
50-179	34105-34116	coordinates	_	
50-180	34117-34119	of	_	
50-181	34120-34123	the	_	
50-182	34124-34132	channels	_	
50-183	34133-34137	were	_	
50-184	34138-34147	estimated	_	
50-185	34148-34153	using	_	
50-186	34154-34160	Homer2	_	
50-187	34161-34162	(	_	
50-188	34162-34181	www.homer-fnirs.org	_	
50-189	34181-34182	/	_	
50-190	34182-34195	documentation	_	
50-191	34195-34196	)	_	
50-192	34197-34200	and	_	
50-193	34201-34204	its	_	
50-194	34205-34219	AtlasViewerGUI	_	
50-195	34220-34224	with	_	
50-196	34225-34228	the	_	
50-197	34229-34235	widely	_	
50-198	34236-34243	adopted	_	
50-199	34244-34253	automated	_	
50-200	34254-34264	anatomical	_	
50-201	34265-34273	labeling	_	
50-202	34274-34275	(	_	
50-203	34275-34278	AAL	_	
50-204	34278-34279	)	_	
50-205	34279-34280	.	_	
50-206	34281-34284	The	_	
50-207	34285-34302	three-dimensional	_	
50-208	34303-34312	locations	_	
50-209	34313-34315	of	_	
50-210	34316-34319	the	_	
50-211	34320-34325	fNIRS	_	
50-212	34326-34332	probes	_	
50-213	34333-34337	were	_	
50-214	34338-34342	also	_	
50-215	34343-34353	visualized	_	
50-216	34354-34358	with	_	
50-217	34359-34362	the	_	
50-218	34363-34371	NIRS-SPM	_	
50-219	34372-34380	software	_	
50-220	34381-34382	(	_	
50-221	34382-34386	http	_	
50-222	34386-34387	:	_	
50-223	34387-34388	/	_	
50-224	34388-34389	/	_	
50-225	34389-34405	bispl.weebly.com	_	
50-226	34405-34406	/	_	
50-227	34406-34419	nirs-spm.html	_	
50-228	34419-34420	#	_	
50-229	34420-34421	/	_	
50-230	34421-34422	)	_	
50-231	34422-34423	.	_	
50-232	34424-34427	The	_	
50-233	34428-34443	source-detector	_	
50-234	34444-34452	distance	_	
50-235	34453-34456	was	_	
50-236	34457-34459	30	_	
50-237	34460-34462	mm	_	
50-238	34462-34463	,	_	
50-239	34464-34473	measuring	_	
50-240	34474-34477	the	_	
50-241	34478-34483	brain	_	
50-242	34484-34492	activity	_	
50-243	34493-34495	of	_	
50-244	34496-34499	the	_	
50-245	34500-34508	cerebral	_	
50-246	34509-34515	cortex	_	
50-247	34516-34520	with	_	
50-248	34521-34522	a	_	
50-249	34523-34534	penetration	_	
50-250	34535-34540	depth	_	
50-251	34541-34543	of	_	
50-252	34544-34545	2	_	
50-253	34545-34546	–	_	
50-254	34546-34547	3	_	
50-255	34548-34550	cm	_	
50-256	34550-34551	.	_	
50-257	34552-34555	The	_	
50-258	34556-34564	sampling	_	
50-259	34565-34569	rate	_	
50-260	34570-34572	of	_	
50-261	34573-34576	our	_	
50-262	34577-34582	fNIRS	_	
50-263	34583-34589	system	_	
50-264	34590-34593	was	_	
50-265	34594-34596	50	_	
50-266	34597-34599	Hz	_	
50-267	34599-34600	.	_	
50-268	34601-34606	Using	_	
50-269	34607-34613	MATLAB	_	
50-270	34614-34615	(	_	
50-271	34615-34624	MathWorks	_	
50-272	34624-34625	,	_	
50-273	34626-34629	Inc	_	
50-274	34629-34630	.	_	
50-275	34630-34631	,	_	
50-276	34632-34638	Natick	_	
50-277	34638-34639	,	_	
50-278	34640-34642	MA	_	
50-279	34642-34643	,	_	
50-280	34644-34647	USA	_	
50-281	34647-34648	)	_	
50-282	34649-34652	and	_	
50-283	34653-34661	BrainNet	_	
50-284	34662-34668	Viewer	_	
50-285	34669-34670	(	_	
50-286	34670-34675	https	_	
50-287	34675-34676	:	_	
50-288	34676-34677	/	_	
50-289	34677-34678	/	_	
50-290	34678-34691	www.nitrc.org	_	
50-291	34691-34692	/	_	
50-292	34692-34700	projects	_	
50-293	34700-34701	/	_	
50-294	34701-34704	bnv	_	
50-295	34704-34705	)	_	
50-296	34705-34706	,	_	
50-297	34707-34718	statistical	_	
50-298	34719-34727	outcomes	_	
50-299	34728-34731	for	_	
50-300	34732-34736	each	_	
50-301	34737-34744	channel	_	
50-302	34745-34749	were	_	
50-303	34750-34755	shown	_	
50-304	34756-34758	on	_	
50-305	34759-34762	the	_	
50-306	34763-34770	surface	_	
50-307	34771-34773	of	_	
50-308	34774-34775	a	_	
50-309	34776-34786	normalized	_	
50-310	34787-34790	and	_	
50-311	34791-34792	a	_	
50-312	34793-34805	standardized	_	
50-313	34806-34811	brain	_	
50-314	34811-34812	.	_	

#Text=Preprocessing data
51-1	34813-34826	Preprocessing	_	
51-2	34827-34831	data	_	

#Text=All the resting-state fNIRS data were preprocessed using Homer2. For the resting-state data, the first 2-minute measurements were eliminated to generate relatively steady signals and rule out potential effects of unstable signals before rsFC analysis. For the localized task data, the first 30-second recordings were eliminated for the recording signals to reach a steady rate.
52-1	34832-34835	All	_	
52-2	34836-34839	the	_	
52-3	34840-34853	resting-state	_	
52-4	34854-34859	fNIRS	_	
52-5	34860-34864	data	_	
52-6	34865-34869	were	_	
52-7	34870-34882	preprocessed	_	
52-8	34883-34888	using	_	
52-9	34889-34895	Homer2	_	
52-10	34895-34896	.	_	
52-11	34897-34900	For	_	
52-12	34901-34904	the	_	
52-13	34905-34918	resting-state	_	
52-14	34919-34923	data	_	
52-15	34923-34924	,	_	
52-16	34925-34928	the	_	
52-17	34929-34934	first	_	
52-18	34935-34936	2	_	
52-19	34936-34937	-	_	
52-20	34937-34943	minute	_	
52-21	34944-34956	measurements	_	
52-22	34957-34961	were	_	
52-23	34962-34972	eliminated	_	
52-24	34973-34975	to	_	
52-25	34976-34984	generate	_	
52-26	34985-34995	relatively	_	
52-27	34996-35002	steady	_	
52-28	35003-35010	signals	_	
52-29	35011-35014	and	_	
52-30	35015-35019	rule	_	
52-31	35020-35023	out	_	
52-32	35024-35033	potential	_	
52-33	35034-35041	effects	_	
52-34	35042-35044	of	_	
52-35	35045-35053	unstable	_	
52-36	35054-35061	signals	_	
52-37	35062-35068	before	_	
52-38	35069-35073	rsFC	_	
52-39	35074-35082	analysis	_	
52-40	35082-35083	.	_	
52-41	35084-35087	For	_	
52-42	35088-35091	the	_	
52-43	35092-35101	localized	_	
52-44	35102-35106	task	_	
52-45	35107-35111	data	_	
52-46	35111-35112	,	_	
52-47	35113-35116	the	_	
52-48	35117-35122	first	_	
52-49	35123-35125	30	_	
52-50	35125-35126	-	_	
52-51	35126-35132	second	_	
52-52	35133-35143	recordings	_	
52-53	35144-35148	were	_	
52-54	35149-35159	eliminated	_	
52-55	35160-35163	for	_	
52-56	35164-35167	the	_	
52-57	35168-35177	recording	_	
52-58	35178-35185	signals	_	
52-59	35186-35188	to	_	
52-60	35189-35194	reach	_	
52-61	35195-35196	a	_	
52-62	35197-35203	steady	_	
52-63	35204-35208	rate	_	
52-64	35208-35209	.	_	

#Text=The following preprocessing procedures were performed for all the fNIRS data: (1) Conversion of optical density measurements to concentration changes in HbO and Hb at different time points based on the modified Beer-Lambert Law; (2) Bandpass filtering (resting-state: 0.01 < fr < 0.1; task: 0.012 < ft < 0.18 in Hz); (3) Detrending; and (4) Motion correction using the spline interpolation method and a correlation-based signal improvement (CBSI) method.
53-1	35210-35213	The	_	
53-2	35214-35223	following	_	
53-3	35224-35237	preprocessing	_	
53-4	35238-35248	procedures	_	
53-5	35249-35253	were	_	
53-6	35254-35263	performed	_	
53-7	35264-35267	for	_	
53-8	35268-35271	all	_	
53-9	35272-35275	the	_	
53-10	35276-35281	fNIRS	_	
53-11	35282-35286	data	_	
53-12	35286-35287	:	_	
53-13	35288-35289	(	_	
53-14	35289-35290	1	_	
53-15	35290-35291	)	_	
53-16	35292-35302	Conversion	_	
53-17	35303-35305	of	_	
53-18	35306-35313	optical	_	
53-19	35314-35321	density	_	
53-20	35322-35334	measurements	_	
53-21	35335-35337	to	_	
53-22	35338-35351	concentration	_	
53-23	35352-35359	changes	_	
53-24	35360-35362	in	_	
53-25	35363-35366	HbO	_	
53-26	35367-35370	and	_	
53-27	35371-35373	Hb	_	
53-28	35374-35376	at	_	
53-29	35377-35386	different	_	
53-30	35387-35391	time	_	
53-31	35392-35398	points	_	
53-32	35399-35404	based	_	
53-33	35405-35407	on	_	
53-34	35408-35411	the	_	
53-35	35412-35420	modified	_	
53-36	35421-35433	Beer-Lambert	_	
53-37	35434-35437	Law	_	
53-38	35437-35438	;	_	
53-39	35439-35440	(	_	
53-40	35440-35441	2	_	
53-41	35441-35442	)	_	
53-42	35443-35451	Bandpass	_	
53-43	35452-35461	filtering	_	
53-44	35462-35463	(	_	
53-45	35463-35476	resting-state	_	
53-46	35476-35477	:	_	
53-47	35478-35482	0.01	_	
53-48	35483-35484	<	_	
53-49	35485-35487	fr	_	
53-50	35488-35489	<	_	
53-51	35490-35493	0.1	_	
53-52	35493-35494	;	_	
53-53	35495-35499	task	_	
53-54	35499-35500	:	_	
53-55	35501-35506	0.012	_	
53-56	35507-35508	<	_	
53-57	35509-35511	ft	_	
53-58	35512-35513	<	_	
53-59	35514-35518	0.18	_	
53-60	35519-35521	in	_	
53-61	35522-35524	Hz	_	
53-62	35524-35525	)	_	
53-63	35525-35526	;	_	
53-64	35527-35528	(	_	
53-65	35528-35529	3	_	
53-66	35529-35530	)	_	
53-67	35531-35541	Detrending	_	
53-68	35541-35542	;	_	
53-69	35543-35546	and	_	
53-70	35547-35548	(	_	
53-71	35548-35549	4	_	
53-72	35549-35550	)	_	
53-73	35551-35557	Motion	_	
53-74	35558-35568	correction	_	
53-75	35569-35574	using	_	
53-76	35575-35578	the	_	
53-77	35579-35585	spline	_	
53-78	35586-35599	interpolation	_	
53-79	35600-35606	method	_	
53-80	35607-35610	and	_	
53-81	35611-35612	a	_	
53-82	35613-35630	correlation-based	_	
53-83	35631-35637	signal	_	
53-84	35638-35649	improvement	_	
53-85	35650-35651	(	_	
53-86	35651-35655	CBSI	_	
53-87	35655-35656	)	_	
53-88	35657-35663	method	_	
53-89	35663-35664	.	_	

#Text=To ensure high-quality fNIRS data for the rsFC network analyses, motion-induced artifacts and low signal-to-noise ratios (SNRs) were examined with an open-source package, FC_NIRS (https://www.nitrc.org/projects/fcnirs/). Any data with low average signal intensity over five standard deviations of the HbO and Hb concentrations over time (i.e., lower SNRs) were considered to result from poor contact between the optode and scalp and thus were excluded from the rsFC and network analyses. One CG subject’s channel 11 was excluded.
54-1	35665-35667	To	_	
54-2	35668-35674	ensure	_	
54-3	35675-35687	high-quality	_	
54-4	35688-35693	fNIRS	_	
54-5	35694-35698	data	_	
54-6	35699-35702	for	_	
54-7	35703-35706	the	_	
54-8	35707-35711	rsFC	_	
54-9	35712-35719	network	_	
54-10	35720-35728	analyses	_	
54-11	35728-35729	,	_	
54-12	35730-35744	motion-induced	_	
54-13	35745-35754	artifacts	_	
54-14	35755-35758	and	_	
54-15	35759-35762	low	_	
54-16	35763-35778	signal-to-noise	_	
54-17	35779-35785	ratios	_	
54-18	35786-35787	(	_	
54-19	35787-35791	SNRs	_	
54-20	35791-35792	)	_	
54-21	35793-35797	were	_	
54-22	35798-35806	examined	_	
54-23	35807-35811	with	_	
54-24	35812-35814	an	_	
54-25	35815-35826	open-source	_	
54-26	35827-35834	package	_	
54-27	35834-35835	,	_	
54-28	35836-35843	FC_NIRS	_	
54-29	35844-35845	(	_	
54-30	35845-35850	https	_	
54-31	35850-35851	:	_	
54-32	35851-35852	/	_	
54-33	35852-35853	/	_	
54-34	35853-35866	www.nitrc.org	_	
54-35	35866-35867	/	_	
54-36	35867-35875	projects	_	
54-37	35875-35876	/	_	
54-38	35876-35882	fcnirs	_	
54-39	35882-35883	/	_	
54-40	35883-35884	)	_	
54-41	35884-35885	.	_	
54-42	35886-35889	Any	_	
54-43	35890-35894	data	_	
54-44	35895-35899	with	_	
54-45	35900-35903	low	_	
54-46	35904-35911	average	_	
54-47	35912-35918	signal	_	
54-48	35919-35928	intensity	_	
54-49	35929-35933	over	_	
54-50	35934-35938	five	_	
54-51	35939-35947	standard	_	
54-52	35948-35958	deviations	_	
54-53	35959-35961	of	_	
54-54	35962-35965	the	_	
54-55	35966-35969	HbO	_	
54-56	35970-35973	and	_	
54-57	35974-35976	Hb	_	
54-58	35977-35991	concentrations	_	
54-59	35992-35996	over	_	
54-60	35997-36001	time	_	
54-61	36002-36003	(	_	
54-62	36003-36006	i.e	_	
54-63	36006-36007	.	_	
54-64	36007-36008	,	_	
54-65	36009-36014	lower	_	
54-66	36015-36019	SNRs	_	
54-67	36019-36020	)	_	
54-68	36021-36025	were	_	
54-69	36026-36036	considered	_	
54-70	36037-36039	to	_	
54-71	36040-36046	result	_	
54-72	36047-36051	from	_	
54-73	36052-36056	poor	_	
54-74	36057-36064	contact	_	
54-75	36065-36072	between	_	
54-76	36073-36076	the	_	
54-77	36077-36083	optode	_	
54-78	36084-36087	and	_	
54-79	36088-36093	scalp	_	
54-80	36094-36097	and	_	
54-81	36098-36102	thus	_	
54-82	36103-36107	were	_	
54-83	36108-36116	excluded	_	
54-84	36117-36121	from	_	
54-85	36122-36125	the	_	
54-86	36126-36130	rsFC	_	
54-87	36131-36134	and	_	
54-88	36135-36142	network	_	
54-89	36143-36151	analyses	_	
54-90	36151-36152	.	_	
54-91	36153-36156	One	_	
54-92	36157-36159	CG	_	
54-93	36160-36167	subject	_	
54-94	36167-36168	’	_	
54-95	36168-36169	s	_	
54-96	36170-36177	channel	_	
54-97	36178-36180	11	_	
54-98	36181-36184	was	_	
54-99	36185-36193	excluded	_	
54-100	36193-36194	.	_	

#Text=For task-based fNIRS data, the HbO and Hb signals from each channel across all the subjects were extracted for statistical analysis to determine the seed channels for the rsFC analysis.
55-1	36195-36198	For	_	
55-2	36199-36209	task-based	_	
55-3	36210-36215	fNIRS	_	
55-4	36216-36220	data	_	
55-5	36220-36221	,	_	
55-6	36222-36225	the	_	
55-7	36226-36229	HbO	_	
55-8	36230-36233	and	_	
55-9	36234-36236	Hb	_	
55-10	36237-36244	signals	_	
55-11	36245-36249	from	_	
55-12	36250-36254	each	_	
55-13	36255-36262	channel	_	
55-14	36263-36269	across	_	
55-15	36270-36273	all	_	
55-16	36274-36277	the	_	
55-17	36278-36286	subjects	_	
55-18	36287-36291	were	_	
55-19	36292-36301	extracted	_	
55-20	36302-36305	for	_	
55-21	36306-36317	statistical	_	
55-22	36318-36326	analysis	_	
55-23	36327-36329	to	_	
55-24	36330-36339	determine	_	
55-25	36340-36343	the	_	
55-26	36344-36348	seed	_	
55-27	36349-36357	channels	_	
55-28	36358-36361	for	_	
55-29	36362-36365	the	_	
55-30	36366-36370	rsFC	_	
55-31	36371-36379	analysis	_	
55-32	36379-36380	.	_	

#Text=For rsFC and graph analyses, two thresholding strategies were applied: (1) a single threshold representing the absolute connectivity strength was chosen, and (2) the entire range of relative sparsity thresholds and average graph property values over the range were studied. By applying these thresholding strategies together, we hoped to provide a comprehensive way to examine the network organizations of both groups.
56-1	36381-36384	For	_	
56-2	36385-36389	rsFC	_	
56-3	36390-36393	and	_	
56-4	36394-36399	graph	_	
56-5	36400-36408	analyses	_	
56-6	36408-36409	,	_	
56-7	36410-36413	two	_	
56-8	36414-36426	thresholding	_	
56-9	36427-36437	strategies	_	
56-10	36438-36442	were	_	
56-11	36443-36450	applied	_	
56-12	36450-36451	:	_	
56-13	36452-36453	(	_	
56-14	36453-36454	1	_	
56-15	36454-36455	)	_	
56-16	36456-36457	a	_	
56-17	36458-36464	single	_	
56-18	36465-36474	threshold	_	
56-19	36475-36487	representing	_	
56-20	36488-36491	the	_	
56-21	36492-36500	absolute	_	
56-22	36501-36513	connectivity	_	
56-23	36514-36522	strength	_	
56-24	36523-36526	was	_	
56-25	36527-36533	chosen	_	
56-26	36533-36534	,	_	
56-27	36535-36538	and	_	
56-28	36539-36540	(	_	
56-29	36540-36541	2	_	
56-30	36541-36542	)	_	
56-31	36543-36546	the	_	
56-32	36547-36553	entire	_	
56-33	36554-36559	range	_	
56-34	36560-36562	of	_	
56-35	36563-36571	relative	_	
56-36	36572-36580	sparsity	_	
56-37	36581-36591	thresholds	_	
56-38	36592-36595	and	_	
56-39	36596-36603	average	_	
56-40	36604-36609	graph	_	
56-41	36610-36618	property	_	
56-42	36619-36625	values	_	
56-43	36626-36630	over	_	
56-44	36631-36634	the	_	
56-45	36635-36640	range	_	
56-46	36641-36645	were	_	
56-47	36646-36653	studied	_	
56-48	36653-36654	.	_	
56-49	36655-36657	By	_	
56-50	36658-36666	applying	_	
56-51	36667-36672	these	_	
56-52	36673-36685	thresholding	_	
56-53	36686-36696	strategies	_	
56-54	36697-36705	together	_	
56-55	36705-36706	,	_	
56-56	36707-36709	we	_	
56-57	36710-36715	hoped	_	
56-58	36716-36718	to	_	
56-59	36719-36726	provide	_	
56-60	36727-36728	a	_	
56-61	36729-36742	comprehensive	_	
56-62	36743-36746	way	_	
56-63	36747-36749	to	_	
56-64	36750-36757	examine	_	
56-65	36758-36761	the	_	
56-66	36762-36769	network	_	
56-67	36770-36783	organizations	_	
56-68	36784-36786	of	_	
56-69	36787-36791	both	_	
56-70	36792-36798	groups	_	
56-71	36798-36799	.	_	

#Text=Interhemispheric correlation analysis
57-1	36800-36816	Interhemispheric	_	
57-2	36817-36828	correlation	_	
57-3	36829-36837	analysis	_	

#Text=We used interhemispheric correlations to demonstrate the long-range connectivity of the right and left lateral OFC (lOFC) and medial OFC (mOFC) in both the HDs and CGs. All ROIs within the OFC were investigated for local connectivity between the right and left hemispheres (see Supplementary Table S2). The typical patterns observed in the cortical blood flow during brain activation are an increase in HbO and a decrease in Hb. As the regions covered by the channels were very close to each other anatomically, we assume that the long-range activation plays a role in the connectivity because the interhemispheric correlations analysis is designed to study a long-distance brain connectivity that is likely connected to the intravascular (HbO and Hb) events between hemispheres. Therefore both HbO and Hb were considered for the interhemispheric analysis. Pearson’s correlation coefficient between the time course of every channel and the matching symmetrical measurement channel in the other hemisphere from the selected ROI in the OFC system (overall, lOFC and mOFC) was calculated, and the mean correlation coefficient was then calculated for all related channels in each ROI.
58-1	36838-36840	We	_	
58-2	36841-36845	used	_	
58-3	36846-36862	interhemispheric	_	
58-4	36863-36875	correlations	_	
58-5	36876-36878	to	_	
58-6	36879-36890	demonstrate	_	
58-7	36891-36894	the	_	
58-8	36895-36905	long-range	_	
58-9	36906-36918	connectivity	_	
58-10	36919-36921	of	_	
58-11	36922-36925	the	_	
58-12	36926-36931	right	_	
58-13	36932-36935	and	_	
58-14	36936-36940	left	_	
58-15	36941-36948	lateral	_	
58-16	36949-36952	OFC	_	
58-17	36953-36954	(	_	
58-18	36954-36958	lOFC	_	
58-19	36958-36959	)	_	
58-20	36960-36963	and	_	
58-21	36964-36970	medial	_	
58-22	36971-36974	OFC	_	
58-23	36975-36976	(	_	
58-24	36976-36980	mOFC	_	
58-25	36980-36981	)	_	
58-26	36982-36984	in	_	
58-27	36985-36989	both	_	
58-28	36990-36993	the	_	
58-29	36994-36997	HDs	_	
58-30	36998-37001	and	_	
58-31	37002-37005	CGs	_	
58-32	37005-37006	.	_	
58-33	37007-37010	All	_	
58-34	37011-37015	ROIs	_	
58-35	37016-37022	within	_	
58-36	37023-37026	the	_	
58-37	37027-37030	OFC	_	
58-38	37031-37035	were	_	
58-39	37036-37048	investigated	_	
58-40	37049-37052	for	_	
58-41	37053-37058	local	_	
58-42	37059-37071	connectivity	_	
58-43	37072-37079	between	_	
58-44	37080-37083	the	_	
58-45	37084-37089	right	_	
58-46	37090-37093	and	_	
58-47	37094-37098	left	_	
58-48	37099-37110	hemispheres	_	
58-49	37111-37112	(	_	
58-50	37112-37115	see	_	
58-51	37116-37129	Supplementary	_	
58-52	37130-37135	Table	_	
58-53	37136-37138	S2	_	
58-54	37138-37139	)	_	
58-55	37139-37140	.	_	
58-56	37141-37144	The	_	
58-57	37145-37152	typical	_	
58-58	37153-37161	patterns	_	
58-59	37162-37170	observed	_	
58-60	37171-37173	in	_	
58-61	37174-37177	the	_	
58-62	37178-37186	cortical	_	
58-63	37187-37192	blood	_	
58-64	37193-37197	flow	_	
58-65	37198-37204	during	_	
58-66	37205-37210	brain	_	
58-67	37211-37221	activation	_	
58-68	37222-37225	are	_	
58-69	37226-37228	an	_	
58-70	37229-37237	increase	_	
58-71	37238-37240	in	_	
58-72	37241-37244	HbO	_	
58-73	37245-37248	and	_	
58-74	37249-37250	a	_	
58-75	37251-37259	decrease	_	
58-76	37260-37262	in	_	
58-77	37263-37265	Hb	_	
58-78	37265-37266	.	_	
58-79	37267-37269	As	_	
58-80	37270-37273	the	_	
58-81	37274-37281	regions	_	
58-82	37282-37289	covered	_	
58-83	37290-37292	by	_	
58-84	37293-37296	the	_	
58-85	37297-37305	channels	_	
58-86	37306-37310	were	_	
58-87	37311-37315	very	_	
58-88	37316-37321	close	_	
58-89	37322-37324	to	_	
58-90	37325-37329	each	_	
58-91	37330-37335	other	_	
58-92	37336-37348	anatomically	_	
58-93	37348-37349	,	_	
58-94	37350-37352	we	_	
58-95	37353-37359	assume	_	
58-96	37360-37364	that	_	
58-97	37365-37368	the	_	
58-98	37369-37379	long-range	_	
58-99	37380-37390	activation	_	
58-100	37391-37396	plays	_	
58-101	37397-37398	a	_	
58-102	37399-37403	role	_	
58-103	37404-37406	in	_	
58-104	37407-37410	the	_	
58-105	37411-37423	connectivity	_	
58-106	37424-37431	because	_	
58-107	37432-37435	the	_	
58-108	37436-37452	interhemispheric	_	
58-109	37453-37465	correlations	_	
58-110	37466-37474	analysis	_	
58-111	37475-37477	is	_	
58-112	37478-37486	designed	_	
58-113	37487-37489	to	_	
58-114	37490-37495	study	_	
58-115	37496-37497	a	_	
58-116	37498-37511	long-distance	_	
58-117	37512-37517	brain	_	
58-118	37518-37530	connectivity	_	
58-119	37531-37535	that	_	
58-120	37536-37538	is	_	
58-121	37539-37545	likely	_	
58-122	37546-37555	connected	_	
58-123	37556-37558	to	_	
58-124	37559-37562	the	_	
58-125	37563-37576	intravascular	_	
58-126	37577-37578	(	_	
58-127	37578-37581	HbO	_	
58-128	37582-37585	and	_	
58-129	37586-37588	Hb	_	
58-130	37588-37589	)	_	
58-131	37590-37596	events	_	
58-132	37597-37604	between	_	
58-133	37605-37616	hemispheres	_	
58-134	37616-37617	.	_	
58-135	37618-37627	Therefore	_	
58-136	37628-37632	both	_	
58-137	37633-37636	HbO	_	
58-138	37637-37640	and	_	
58-139	37641-37643	Hb	_	
58-140	37644-37648	were	_	
58-141	37649-37659	considered	_	
58-142	37660-37663	for	_	
58-143	37664-37667	the	_	
58-144	37668-37684	interhemispheric	_	
58-145	37685-37693	analysis	_	
58-146	37693-37694	.	_	
58-147	37695-37702	Pearson	_	
58-148	37702-37703	’	_	
58-149	37703-37704	s	_	
58-150	37705-37716	correlation	_	
58-151	37717-37728	coefficient	_	
58-152	37729-37736	between	_	
58-153	37737-37740	the	_	
58-154	37741-37745	time	_	
58-155	37746-37752	course	_	
58-156	37753-37755	of	_	
58-157	37756-37761	every	_	
58-158	37762-37769	channel	_	
58-159	37770-37773	and	_	
58-160	37774-37777	the	_	
58-161	37778-37786	matching	_	
58-162	37787-37798	symmetrical	_	
58-163	37799-37810	measurement	_	
58-164	37811-37818	channel	_	
58-165	37819-37821	in	_	
58-166	37822-37825	the	_	
58-167	37826-37831	other	_	
58-168	37832-37842	hemisphere	_	
58-169	37843-37847	from	_	
58-170	37848-37851	the	_	
58-171	37852-37860	selected	_	
58-172	37861-37864	ROI	_	
58-173	37865-37867	in	_	
58-174	37868-37871	the	_	
58-175	37872-37875	OFC	_	
58-176	37876-37882	system	_	
58-177	37883-37884	(	_	
58-178	37884-37891	overall	_	
58-179	37891-37892	,	_	
58-180	37893-37897	lOFC	_	
58-181	37898-37901	and	_	
58-182	37902-37906	mOFC	_	
58-183	37906-37907	)	_	
58-184	37908-37911	was	_	
58-185	37912-37922	calculated	_	
58-186	37922-37923	,	_	
58-187	37924-37927	and	_	
58-188	37928-37931	the	_	
58-189	37932-37936	mean	_	
58-190	37937-37948	correlation	_	
58-191	37949-37960	coefficient	_	
58-192	37961-37964	was	_	
58-193	37965-37969	then	_	
58-194	37970-37980	calculated	_	
58-195	37981-37984	for	_	
58-196	37985-37988	all	_	
58-197	37989-37996	related	_	
58-198	37997-38005	channels	_	
58-199	38006-38008	in	_	
58-200	38009-38013	each	_	
58-201	38014-38017	ROI	_	
58-202	38017-38018	.	_	

#Text=Functional connectivity measurements: seed-based and whole-brain correlation analyses
59-1	38019-38029	Functional	_	
59-2	38030-38042	connectivity	_	
59-3	38043-38055	measurements	_	
59-4	38055-38056	:	_	
59-5	38057-38067	seed-based	_	
59-6	38068-38071	and	_	
59-7	38072-38083	whole-brain	_	
59-8	38084-38095	correlation	_	
59-9	38096-38104	analyses	_	

#Text=To analyze the rsFC of the HDs and CGs, we used two approaches: (1) a seed-based correlation analysis and (2) a whole-brain correlation analysis. The former approach was used in order to estimate and detect the strength of pairwise relationships between a predefined seed channel and other channels covering other OFC regions. This allowed us to identify intrinsic functional connectivity in different OFC region systems. The second approach aimed to compute a functional connectivity map between any two channel pairs in the entire OFC system, where the measurement channels represented nodes, and the functional connections with correlation coefficients greater than a predefined threshold were considered edges. The change in HbO concentration is recognized to be the most responsive indicator of differences in cortical blood flow. We believe that HbO signals would be responsive enough to indicate changes in the local activity in the regions covered by the channels that were not far apart from each other as abovementioned. For simplicity, HbO was therefore considered for the remainder of the analyses. The Hb data was served as a reference only when needed.
60-1	38105-38107	To	_	
60-2	38108-38115	analyze	_	
60-3	38116-38119	the	_	
60-4	38120-38124	rsFC	_	
60-5	38125-38127	of	_	
60-6	38128-38131	the	_	
60-7	38132-38135	HDs	_	
60-8	38136-38139	and	_	
60-9	38140-38143	CGs	_	
60-10	38143-38144	,	_	
60-11	38145-38147	we	_	
60-12	38148-38152	used	_	
60-13	38153-38156	two	_	
60-14	38157-38167	approaches	_	
60-15	38167-38168	:	_	
60-16	38169-38170	(	_	
60-17	38170-38171	1	_	
60-18	38171-38172	)	_	
60-19	38173-38174	a	_	
60-20	38175-38185	seed-based	_	
60-21	38186-38197	correlation	_	
60-22	38198-38206	analysis	_	
60-23	38207-38210	and	_	
60-24	38211-38212	(	_	
60-25	38212-38213	2	_	
60-26	38213-38214	)	_	
60-27	38215-38216	a	_	
60-28	38217-38228	whole-brain	_	
60-29	38229-38240	correlation	_	
60-30	38241-38249	analysis	_	
60-31	38249-38250	.	_	
60-32	38251-38254	The	_	
60-33	38255-38261	former	_	
60-34	38262-38270	approach	_	
60-35	38271-38274	was	_	
60-36	38275-38279	used	_	
60-37	38280-38282	in	_	
60-38	38283-38288	order	_	
60-39	38289-38291	to	_	
60-40	38292-38300	estimate	_	
60-41	38301-38304	and	_	
60-42	38305-38311	detect	_	
60-43	38312-38315	the	_	
60-44	38316-38324	strength	_	
60-45	38325-38327	of	_	
60-46	38328-38336	pairwise	_	
60-47	38337-38350	relationships	_	
60-48	38351-38358	between	_	
60-49	38359-38360	a	_	
60-50	38361-38371	predefined	_	
60-51	38372-38376	seed	_	
60-52	38377-38384	channel	_	
60-53	38385-38388	and	_	
60-54	38389-38394	other	_	
60-55	38395-38403	channels	_	
60-56	38404-38412	covering	_	
60-57	38413-38418	other	_	
60-58	38419-38422	OFC	_	
60-59	38423-38430	regions	_	
60-60	38430-38431	.	_	
60-61	38432-38436	This	_	
60-62	38437-38444	allowed	_	
60-63	38445-38447	us	_	
60-64	38448-38450	to	_	
60-65	38451-38459	identify	_	
60-66	38460-38469	intrinsic	_	
60-67	38470-38480	functional	_	
60-68	38481-38493	connectivity	_	
60-69	38494-38496	in	_	
60-70	38497-38506	different	_	
60-71	38507-38510	OFC	_	
60-72	38511-38517	region	_	
60-73	38518-38525	systems	_	
60-74	38525-38526	.	_	
60-75	38527-38530	The	_	
60-76	38531-38537	second	_	
60-77	38538-38546	approach	_	
60-78	38547-38552	aimed	_	
60-79	38553-38555	to	_	
60-80	38556-38563	compute	_	
60-81	38564-38565	a	_	
60-82	38566-38576	functional	_	
60-83	38577-38589	connectivity	_	
60-84	38590-38593	map	_	
60-85	38594-38601	between	_	
60-86	38602-38605	any	_	
60-87	38606-38609	two	_	
60-88	38610-38617	channel	_	
60-89	38618-38623	pairs	_	
60-90	38624-38626	in	_	
60-91	38627-38630	the	_	
60-92	38631-38637	entire	_	
60-93	38638-38641	OFC	_	
60-94	38642-38648	system	_	
60-95	38648-38649	,	_	
60-96	38650-38655	where	_	
60-97	38656-38659	the	_	
60-98	38660-38671	measurement	_	
60-99	38672-38680	channels	_	
60-100	38681-38692	represented	_	
60-101	38693-38698	nodes	_	
60-102	38698-38699	,	_	
60-103	38700-38703	and	_	
60-104	38704-38707	the	_	
60-105	38708-38718	functional	_	
60-106	38719-38730	connections	_	
60-107	38731-38735	with	_	
60-108	38736-38747	correlation	_	
60-109	38748-38760	coefficients	_	
60-110	38761-38768	greater	_	
60-111	38769-38773	than	_	
60-112	38774-38775	a	_	
60-113	38776-38786	predefined	_	
60-114	38787-38796	threshold	_	
60-115	38797-38801	were	_	
60-116	38802-38812	considered	_	
60-117	38813-38818	edges	_	
60-118	38818-38819	.	_	
60-119	38820-38823	The	_	
60-120	38824-38830	change	_	
60-121	38831-38833	in	_	
60-122	38834-38837	HbO	_	
60-123	38838-38851	concentration	_	
60-124	38852-38854	is	_	
60-125	38855-38865	recognized	_	
60-126	38866-38868	to	_	
60-127	38869-38871	be	_	
60-128	38872-38875	the	_	
60-129	38876-38880	most	_	
60-130	38881-38891	responsive	_	
60-131	38892-38901	indicator	_	
60-132	38902-38904	of	_	
60-133	38905-38916	differences	_	
60-134	38917-38919	in	_	
60-135	38920-38928	cortical	_	
60-136	38929-38934	blood	_	
60-137	38935-38939	flow	_	
60-138	38939-38940	.	_	
60-139	38941-38943	We	_	
60-140	38944-38951	believe	_	
60-141	38952-38956	that	_	
60-142	38957-38960	HbO	_	
60-143	38961-38968	signals	_	
60-144	38969-38974	would	_	
60-145	38975-38977	be	_	
60-146	38978-38988	responsive	_	
60-147	38989-38995	enough	_	
60-148	38996-38998	to	_	
60-149	38999-39007	indicate	_	
60-150	39008-39015	changes	_	
60-151	39016-39018	in	_	
60-152	39019-39022	the	_	
60-153	39023-39028	local	_	
60-154	39029-39037	activity	_	
60-155	39038-39040	in	_	
60-156	39041-39044	the	_	
60-157	39045-39052	regions	_	
60-158	39053-39060	covered	_	
60-159	39061-39063	by	_	
60-160	39064-39067	the	_	
60-161	39068-39076	channels	_	
60-162	39077-39081	that	_	
60-163	39082-39086	were	_	
60-164	39087-39090	not	_	
60-165	39091-39094	far	_	
60-166	39095-39100	apart	_	
60-167	39101-39105	from	_	
60-168	39106-39110	each	_	
60-169	39111-39116	other	_	
60-170	39117-39119	as	_	
60-171	39120-39134	abovementioned	_	
60-172	39134-39135	.	_	
60-173	39136-39139	For	_	
60-174	39140-39150	simplicity	_	
60-175	39150-39151	,	_	
60-176	39152-39155	HbO	_	
60-177	39156-39159	was	_	
60-178	39160-39169	therefore	_	
60-179	39170-39180	considered	_	
60-180	39181-39184	for	_	
60-181	39185-39188	the	_	
60-182	39189-39198	remainder	_	
60-183	39199-39201	of	_	
60-184	39202-39205	the	_	
60-185	39206-39214	analyses	_	
60-186	39214-39215	.	_	
60-187	39216-39219	The	_	
60-188	39220-39222	Hb	_	
60-189	39223-39227	data	_	
60-190	39228-39231	was	_	
60-191	39232-39238	served	_	
60-192	39239-39241	as	_	
60-193	39242-39243	a	_	
60-194	39244-39253	reference	_	
60-195	39254-39258	only	_	
60-196	39259-39263	when	_	
60-197	39264-39270	needed	_	
60-198	39270-39271	.	_	

#Text=The gambling localizer task data were processed using a general linear model to estimate the task-induced response of each channel from each subject. The run averages of the normalized HbO data were first calculated for each channel, and then grand average results across all subjects by group were calculated and analyzed. A statistical t-test was performed to infer which channel was most significantly (p < 0.05) activated by the localizer task (see Supplementary Figure S3). The channel(s) and the corresponding channel(s) on the other hemisphere were then defined as the seeds for the rsFC analysis.
61-1	39272-39275	The	_	
61-2	39276-39284	gambling	_	
61-3	39285-39294	localizer	_	
61-4	39295-39299	task	_	
61-5	39300-39304	data	_	
61-6	39305-39309	were	_	
61-7	39310-39319	processed	_	
61-8	39320-39325	using	_	
61-9	39326-39327	a	_	
61-10	39328-39335	general	_	
61-11	39336-39342	linear	_	
61-12	39343-39348	model	_	
61-13	39349-39351	to	_	
61-14	39352-39360	estimate	_	
61-15	39361-39364	the	_	
61-16	39365-39377	task-induced	_	
61-17	39378-39386	response	_	
61-18	39387-39389	of	_	
61-19	39390-39394	each	_	
61-20	39395-39402	channel	_	
61-21	39403-39407	from	_	
61-22	39408-39412	each	_	
61-23	39413-39420	subject	_	
61-24	39420-39421	.	_	
61-25	39422-39425	The	_	
61-26	39426-39429	run	_	
61-27	39430-39438	averages	_	
61-28	39439-39441	of	_	
61-29	39442-39445	the	_	
61-30	39446-39456	normalized	_	
61-31	39457-39460	HbO	_	
61-32	39461-39465	data	_	
61-33	39466-39470	were	_	
61-34	39471-39476	first	_	
61-35	39477-39487	calculated	_	
61-36	39488-39491	for	_	
61-37	39492-39496	each	_	
61-38	39497-39504	channel	_	
61-39	39504-39505	,	_	
61-40	39506-39509	and	_	
61-41	39510-39514	then	_	
61-42	39515-39520	grand	_	
61-43	39521-39528	average	_	
61-44	39529-39536	results	_	
61-45	39537-39543	across	_	
61-46	39544-39547	all	_	
61-47	39548-39556	subjects	_	
61-48	39557-39559	by	_	
61-49	39560-39565	group	_	
61-50	39566-39570	were	_	
61-51	39571-39581	calculated	_	
61-52	39582-39585	and	_	
61-53	39586-39594	analyzed	_	
61-54	39594-39595	.	_	
61-55	39596-39597	A	_	
61-56	39598-39609	statistical	_	
61-57	39610-39616	t-test	_	
61-58	39617-39620	was	_	
61-59	39621-39630	performed	_	
61-60	39631-39633	to	_	
61-61	39634-39639	infer	_	
61-62	39640-39645	which	_	
61-63	39646-39653	channel	_	
61-64	39654-39657	was	_	
61-65	39658-39662	most	_	
61-66	39663-39676	significantly	_	
61-67	39677-39678	(	_	
61-68	39678-39679	p	_	
61-69	39680-39681	<	_	
61-70	39682-39686	0.05	_	
61-71	39686-39687	)	_	
61-72	39688-39697	activated	_	
61-73	39698-39700	by	_	
61-74	39701-39704	the	_	
61-75	39705-39714	localizer	_	
61-76	39715-39719	task	_	
61-77	39720-39721	(	_	
61-78	39721-39724	see	_	
61-79	39725-39738	Supplementary	_	
61-80	39739-39745	Figure	_	
61-81	39746-39748	S3	_	
61-82	39748-39749	)	_	
61-83	39749-39750	.	_	
61-84	39751-39754	The	_	
61-85	39755-39762	channel	_	
61-86	39762-39763	(	_	
61-87	39763-39764	s	_	
61-88	39764-39765	)	_	
61-89	39766-39769	and	_	
61-90	39770-39773	the	_	
61-91	39774-39787	corresponding	_	
61-92	39788-39795	channel	_	
61-93	39795-39796	(	_	
61-94	39796-39797	s	_	
61-95	39797-39798	)	_	
61-96	39799-39801	on	_	
61-97	39802-39805	the	_	
61-98	39806-39811	other	_	
61-99	39812-39822	hemisphere	_	
61-100	39823-39827	were	_	
61-101	39828-39832	then	_	
61-102	39833-39840	defined	_	
61-103	39841-39843	as	_	
61-104	39844-39847	the	_	
61-105	39848-39853	seeds	_	
61-106	39854-39857	for	_	
61-107	39858-39861	the	_	
61-108	39862-39866	rsFC	_	
61-109	39867-39875	analysis	_	
61-110	39875-39876	.	_	

#Text=For the resting-state data, functional connectivity was then constructed based on the seed-based and whole-brain correlation methods; thus, functional connectivity matrices and maps were first generated from group adjacencies computed from the individual adjacencies for the brain network analysis. For both the seed-based and whole-brain correlation methods, Pearson’s correlation was used to weigh the strength of functional connectivity of the pairwise relationships between the selected seed channel and other channels and between any two node pairs within the entire OFC system in our study. Prior to any statistical analysis, the correlation values were converted to Fisher z-values using the Fisher z-transformation. Thus, the distribution of the Z to R correlation coefficients pairwise in the OFC can be observed in two groups using the seed-base analysis, and the neural network generated within the entire OFC regions between the groups can be explored using the whole-brain approach.
62-1	39877-39880	For	_	
62-2	39881-39884	the	_	
62-3	39885-39898	resting-state	_	
62-4	39899-39903	data	_	
62-5	39903-39904	,	_	
62-6	39905-39915	functional	_	
62-7	39916-39928	connectivity	_	
62-8	39929-39932	was	_	
62-9	39933-39937	then	_	
62-10	39938-39949	constructed	_	
62-11	39950-39955	based	_	
62-12	39956-39958	on	_	
62-13	39959-39962	the	_	
62-14	39963-39973	seed-based	_	
62-15	39974-39977	and	_	
62-16	39978-39989	whole-brain	_	
62-17	39990-40001	correlation	_	
62-18	40002-40009	methods	_	
62-19	40009-40010	;	_	
62-20	40011-40015	thus	_	
62-21	40015-40016	,	_	
62-22	40017-40027	functional	_	
62-23	40028-40040	connectivity	_	
62-24	40041-40049	matrices	_	
62-25	40050-40053	and	_	
62-26	40054-40058	maps	_	
62-27	40059-40063	were	_	
62-28	40064-40069	first	_	
62-29	40070-40079	generated	_	
62-30	40080-40084	from	_	
62-31	40085-40090	group	_	
62-32	40091-40102	adjacencies	_	
62-33	40103-40111	computed	_	
62-34	40112-40116	from	_	
62-35	40117-40120	the	_	
62-36	40121-40131	individual	_	
62-37	40132-40143	adjacencies	_	
62-38	40144-40147	for	_	
62-39	40148-40151	the	_	
62-40	40152-40157	brain	_	
62-41	40158-40165	network	_	
62-42	40166-40174	analysis	_	
62-43	40174-40175	.	_	
62-44	40176-40179	For	_	
62-45	40180-40184	both	_	
62-46	40185-40188	the	_	
62-47	40189-40199	seed-based	_	
62-48	40200-40203	and	_	
62-49	40204-40215	whole-brain	_	
62-50	40216-40227	correlation	_	
62-51	40228-40235	methods	_	
62-52	40235-40236	,	_	
62-53	40237-40244	Pearson	_	
62-54	40244-40245	’	_	
62-55	40245-40246	s	_	
62-56	40247-40258	correlation	_	
62-57	40259-40262	was	_	
62-58	40263-40267	used	_	
62-59	40268-40270	to	_	
62-60	40271-40276	weigh	_	
62-61	40277-40280	the	_	
62-62	40281-40289	strength	_	
62-63	40290-40292	of	_	
62-64	40293-40303	functional	_	
62-65	40304-40316	connectivity	_	
62-66	40317-40319	of	_	
62-67	40320-40323	the	_	
62-68	40324-40332	pairwise	_	
62-69	40333-40346	relationships	_	
62-70	40347-40354	between	_	
62-71	40355-40358	the	_	
62-72	40359-40367	selected	_	
62-73	40368-40372	seed	_	
62-74	40373-40380	channel	_	
62-75	40381-40384	and	_	
62-76	40385-40390	other	_	
62-77	40391-40399	channels	_	
62-78	40400-40403	and	_	
62-79	40404-40411	between	_	
62-80	40412-40415	any	_	
62-81	40416-40419	two	_	
62-82	40420-40424	node	_	
62-83	40425-40430	pairs	_	
62-84	40431-40437	within	_	
62-85	40438-40441	the	_	
62-86	40442-40448	entire	_	
62-87	40449-40452	OFC	_	
62-88	40453-40459	system	_	
62-89	40460-40462	in	_	
62-90	40463-40466	our	_	
62-91	40467-40472	study	_	
62-92	40472-40473	.	_	
62-93	40474-40479	Prior	_	
62-94	40480-40482	to	_	
62-95	40483-40486	any	_	
62-96	40487-40498	statistical	_	
62-97	40499-40507	analysis	_	
62-98	40507-40508	,	_	
62-99	40509-40512	the	_	
62-100	40513-40524	correlation	_	
62-101	40525-40531	values	_	
62-102	40532-40536	were	_	
62-103	40537-40546	converted	_	
62-104	40547-40549	to	_	
62-105	40550-40556	Fisher	_	
62-106	40557-40565	z-values	_	
62-107	40566-40571	using	_	
62-108	40572-40575	the	_	
62-109	40576-40582	Fisher	_	
62-110	40583-40599	z-transformation	_	
62-111	40599-40600	.	_	
62-112	40601-40605	Thus	_	
62-113	40605-40606	,	_	
62-114	40607-40610	the	_	
62-115	40611-40623	distribution	_	
62-116	40624-40626	of	_	
62-117	40627-40630	the	_	
62-118	40631-40632	Z	_	
62-119	40633-40635	to	_	
62-120	40636-40637	R	_	
62-121	40638-40649	correlation	_	
62-122	40650-40662	coefficients	_	
62-123	40663-40671	pairwise	_	
62-124	40672-40674	in	_	
62-125	40675-40678	the	_	
62-126	40679-40682	OFC	_	
62-127	40683-40686	can	_	
62-128	40687-40689	be	_	
62-129	40690-40698	observed	_	
62-130	40699-40701	in	_	
62-131	40702-40705	two	_	
62-132	40706-40712	groups	_	
62-133	40713-40718	using	_	
62-134	40719-40722	the	_	
62-135	40723-40732	seed-base	_	
62-136	40733-40741	analysis	_	
62-137	40741-40742	,	_	
62-138	40743-40746	and	_	
62-139	40747-40750	the	_	
62-140	40751-40757	neural	_	
62-141	40758-40765	network	_	
62-142	40766-40775	generated	_	
62-143	40776-40782	within	_	
62-144	40783-40786	the	_	
62-145	40787-40793	entire	_	
62-146	40794-40797	OFC	_	
62-147	40798-40805	regions	_	
62-148	40806-40813	between	_	
62-149	40814-40817	the	_	
62-150	40818-40824	groups	_	
62-151	40825-40828	can	_	
62-152	40829-40831	be	_	
62-153	40832-40840	explored	_	
62-154	40841-40846	using	_	
62-155	40847-40850	the	_	
62-156	40851-40862	whole-brain	_	
62-157	40863-40871	approach	_	
62-158	40871-40872	.	_	

#Text=Graph-theory network analysis
63-1	40873-40885	Graph-theory	_	
63-2	40886-40893	network	_	
63-3	40894-40902	analysis	_	

#Text=To quantify rsFC for complex network analysis, powerful graph-theory approach was adopted to compare the fNIRS-based topological properties of the brain networks between the HDs and the CGs. Using the free software, GRETNA (http://www.nitrc.org/projects/gretna), the preprocessed fNIRS data with N nodes were used to form an N-by-N correlation matrix in which each value represented the connectivity strength. The network measures were categorized into global and nodal metrics. The global metrics used included small-world parameters, local efficiency and global efficiency. In the global network analysis, two important small-world parameters, (1) clustering coefficient and (2) characteristic path length, were then calculated and compared with the normalized small-world parameters between the brain networks of both HDs and CGs. These global network metrics provided a global topological framework of the whole-brain network, taking into account all-channel networks in the OFC system. In the nodal network analysis, the nodal degree strength of each channel and efficiency was examined. These nodal metrics provided information on the regional patterns of the functional brain network.
64-1	40903-40905	To	_	
64-2	40906-40914	quantify	_	
64-3	40915-40919	rsFC	_	
64-4	40920-40923	for	_	
64-5	40924-40931	complex	_	
64-6	40932-40939	network	_	
64-7	40940-40948	analysis	_	
64-8	40948-40949	,	_	
64-9	40950-40958	powerful	_	
64-10	40959-40971	graph-theory	_	
64-11	40972-40980	approach	_	
64-12	40981-40984	was	_	
64-13	40985-40992	adopted	_	
64-14	40993-40995	to	_	
64-15	40996-41003	compare	_	
64-16	41004-41007	the	_	
64-17	41008-41019	fNIRS-based	_	
64-18	41020-41031	topological	_	
64-19	41032-41042	properties	_	
64-20	41043-41045	of	_	
64-21	41046-41049	the	_	
64-22	41050-41055	brain	_	
64-23	41056-41064	networks	_	
64-24	41065-41072	between	_	
64-25	41073-41076	the	_	
64-26	41077-41080	HDs	_	
64-27	41081-41084	and	_	
64-28	41085-41088	the	_	
64-29	41089-41092	CGs	_	
64-30	41092-41093	.	_	
64-31	41094-41099	Using	_	
64-32	41100-41103	the	_	
64-33	41104-41108	free	_	
64-34	41109-41117	software	_	
64-35	41117-41118	,	_	
64-36	41119-41125	GRETNA	_	
64-37	41126-41127	(	_	
64-38	41127-41131	http	_	
64-39	41131-41132	:	_	
64-40	41132-41133	/	_	
64-41	41133-41134	/	_	
64-42	41134-41147	www.nitrc.org	_	
64-43	41147-41148	/	_	
64-44	41148-41156	projects	_	
64-45	41156-41157	/	_	
64-46	41157-41163	gretna	_	
64-47	41163-41164	)	_	
64-48	41164-41165	,	_	
64-49	41166-41169	the	_	
64-50	41170-41182	preprocessed	_	
64-51	41183-41188	fNIRS	_	
64-52	41189-41193	data	_	
64-53	41194-41198	with	_	
64-54	41199-41200	N	_	
64-55	41201-41206	nodes	_	
64-56	41207-41211	were	_	
64-57	41212-41216	used	_	
64-58	41217-41219	to	_	
64-59	41220-41224	form	_	
64-60	41225-41227	an	_	
64-61	41228-41234	N-by-N	_	
64-62	41235-41246	correlation	_	
64-63	41247-41253	matrix	_	
64-64	41254-41256	in	_	
64-65	41257-41262	which	_	
64-66	41263-41267	each	_	
64-67	41268-41273	value	_	
64-68	41274-41285	represented	_	
64-69	41286-41289	the	_	
64-70	41290-41302	connectivity	_	
64-71	41303-41311	strength	_	
64-72	41311-41312	.	_	
64-73	41313-41316	The	_	
64-74	41317-41324	network	_	
64-75	41325-41333	measures	_	
64-76	41334-41338	were	_	
64-77	41339-41350	categorized	_	
64-78	41351-41355	into	_	
64-79	41356-41362	global	_	
64-80	41363-41366	and	_	
64-81	41367-41372	nodal	_	
64-82	41373-41380	metrics	_	
64-83	41380-41381	.	_	
64-84	41382-41385	The	_	
64-85	41386-41392	global	_	
64-86	41393-41400	metrics	_	
64-87	41401-41405	used	_	
64-88	41406-41414	included	_	
64-89	41415-41426	small-world	_	
64-90	41427-41437	parameters	_	
64-91	41437-41438	,	_	
64-92	41439-41444	local	_	
64-93	41445-41455	efficiency	_	
64-94	41456-41459	and	_	
64-95	41460-41466	global	_	
64-96	41467-41477	efficiency	_	
64-97	41477-41478	.	_	
64-98	41479-41481	In	_	
64-99	41482-41485	the	_	
64-100	41486-41492	global	_	
64-101	41493-41500	network	_	
64-102	41501-41509	analysis	_	
64-103	41509-41510	,	_	
64-104	41511-41514	two	_	
64-105	41515-41524	important	_	
64-106	41525-41536	small-world	_	
64-107	41537-41547	parameters	_	
64-108	41547-41548	,	_	
64-109	41549-41550	(	_	
64-110	41550-41551	1	_	
64-111	41551-41552	)	_	
64-112	41553-41563	clustering	_	
64-113	41564-41575	coefficient	_	
64-114	41576-41579	and	_	
64-115	41580-41581	(	_	
64-116	41581-41582	2	_	
64-117	41582-41583	)	_	
64-118	41584-41598	characteristic	_	
64-119	41599-41603	path	_	
64-120	41604-41610	length	_	
64-121	41610-41611	,	_	
64-122	41612-41616	were	_	
64-123	41617-41621	then	_	
64-124	41622-41632	calculated	_	
64-125	41633-41636	and	_	
64-126	41637-41645	compared	_	
64-127	41646-41650	with	_	
64-128	41651-41654	the	_	
64-129	41655-41665	normalized	_	
64-130	41666-41677	small-world	_	
64-131	41678-41688	parameters	_	
64-132	41689-41696	between	_	
64-133	41697-41700	the	_	
64-134	41701-41706	brain	_	
64-135	41707-41715	networks	_	
64-136	41716-41718	of	_	
64-137	41719-41723	both	_	
64-138	41724-41727	HDs	_	
64-139	41728-41731	and	_	
64-140	41732-41735	CGs	_	
64-141	41735-41736	.	_	
64-142	41737-41742	These	_	
64-143	41743-41749	global	_	
64-144	41750-41757	network	_	
64-145	41758-41765	metrics	_	
64-146	41766-41774	provided	_	
64-147	41775-41776	a	_	
64-148	41777-41783	global	_	
64-149	41784-41795	topological	_	
64-150	41796-41805	framework	_	
64-151	41806-41808	of	_	
64-152	41809-41812	the	_	
64-153	41813-41824	whole-brain	_	
64-154	41825-41832	network	_	
64-155	41832-41833	,	_	
64-156	41834-41840	taking	_	
64-157	41841-41845	into	_	
64-158	41846-41853	account	_	
64-159	41854-41865	all-channel	_	
64-160	41866-41874	networks	_	
64-161	41875-41877	in	_	
64-162	41878-41881	the	_	
64-163	41882-41885	OFC	_	
64-164	41886-41892	system	_	
64-165	41892-41893	.	_	
64-166	41894-41896	In	_	
64-167	41897-41900	the	_	
64-168	41901-41906	nodal	_	
64-169	41907-41914	network	_	
64-170	41915-41923	analysis	_	
64-171	41923-41924	,	_	
64-172	41925-41928	the	_	
64-173	41929-41934	nodal	_	
64-174	41935-41941	degree	_	
64-175	41942-41950	strength	_	
64-176	41951-41953	of	_	
64-177	41954-41958	each	_	
64-178	41959-41966	channel	_	
64-179	41967-41970	and	_	
64-180	41971-41981	efficiency	_	
64-181	41982-41985	was	_	
64-182	41986-41994	examined	_	
64-183	41994-41995	.	_	
64-184	41996-42001	These	_	
64-185	42002-42007	nodal	_	
64-186	42008-42015	metrics	_	
64-187	42016-42024	provided	_	
64-188	42025-42036	information	_	
64-189	42037-42039	on	_	
64-190	42040-42043	the	_	
64-191	42044-42052	regional	_	
64-192	42053-42061	patterns	_	
64-193	42062-42064	of	_	
64-194	42065-42068	the	_	
64-195	42069-42079	functional	_	
64-196	42080-42085	brain	_	
64-197	42086-42093	network	_	
64-198	42093-42094	.	_	

#Text=Traditionally, a small-world graph is one where the clustering coefficient of a brain network is higher than that of a random network and where the path-length is characteristically similar to that of a random graph. Thus, normalization of clustering coefficients and path-length are traditionally computed with respect to random networks. However, it is not uncommon to compare the brain networks of subject groups to detect connectivity abnormalities in psychiatric disorders. Intuitively, in addition to this tradition, we wanted to explore whether the HD network is “small-world” with respect to the CG network; thus, small-worldness was computed by comparing the HDs with the CGs (i.e., γ = clustering coefficient in the HDs ÷ clustering coefficient in the CGs; λ = characteristic path length in the HDs ÷ characteristic path length in the CGs; γE = local efficiency in the HDs ÷ local efficiency in the CGs; λE = global efficiency in the HDs ÷ global efficiency in the CGs). As such, this preliminary investigation may provide a direct metric to access “small-worldness” in observed real-world networks, which are neither uniformly random nor ordered. A two-sample t-test (α = 0.05) followed by a correction approach with a false discovery rate (FDR) was applied to examine whether the HD brain network acquires significantly non-control and non-random construction. Further, the small-world network measure will be used to characterize differences between the metrics of the traditionally normalized coefficients (i.e., HDnet/Randomnet and CGnet/Randomnet) and compare with the metric of the intuitively normalized ones (i.e., HDnet/CGnet).
65-1	42095-42108	Traditionally	_	
65-2	42108-42109	,	_	
65-3	42110-42111	a	_	
65-4	42112-42123	small-world	_	
65-5	42124-42129	graph	_	
65-6	42130-42132	is	_	
65-7	42133-42136	one	_	
65-8	42137-42142	where	_	
65-9	42143-42146	the	_	
65-10	42147-42157	clustering	_	
65-11	42158-42169	coefficient	_	
65-12	42170-42172	of	_	
65-13	42173-42174	a	_	
65-14	42175-42180	brain	_	
65-15	42181-42188	network	_	
65-16	42189-42191	is	_	
65-17	42192-42198	higher	_	
65-18	42199-42203	than	_	
65-19	42204-42208	that	_	
65-20	42209-42211	of	_	
65-21	42212-42213	a	_	
65-22	42214-42220	random	_	
65-23	42221-42228	network	_	
65-24	42229-42232	and	_	
65-25	42233-42238	where	_	
65-26	42239-42242	the	_	
65-27	42243-42254	path-length	_	
65-28	42255-42257	is	_	
65-29	42258-42276	characteristically	_	
65-30	42277-42284	similar	_	
65-31	42285-42287	to	_	
65-32	42288-42292	that	_	
65-33	42293-42295	of	_	
65-34	42296-42297	a	_	
65-35	42298-42304	random	_	
65-36	42305-42310	graph	_	
65-37	42310-42311	.	_	
65-38	42312-42316	Thus	_	
65-39	42316-42317	,	_	
65-40	42318-42331	normalization	_	
65-41	42332-42334	of	_	
65-42	42335-42345	clustering	_	
65-43	42346-42358	coefficients	_	
65-44	42359-42362	and	_	
65-45	42363-42374	path-length	_	
65-46	42375-42378	are	_	
65-47	42379-42392	traditionally	_	
65-48	42393-42401	computed	_	
65-49	42402-42406	with	_	
65-50	42407-42414	respect	_	
65-51	42415-42417	to	_	
65-52	42418-42424	random	_	
65-53	42425-42433	networks	_	
65-54	42433-42434	.	_	
65-55	42435-42442	However	_	
65-56	42442-42443	,	_	
65-57	42444-42446	it	_	
65-58	42447-42449	is	_	
65-59	42450-42453	not	_	
65-60	42454-42462	uncommon	_	
65-61	42463-42465	to	_	
65-62	42466-42473	compare	_	
65-63	42474-42477	the	_	
65-64	42478-42483	brain	_	
65-65	42484-42492	networks	_	
65-66	42493-42495	of	_	
65-67	42496-42503	subject	_	
65-68	42504-42510	groups	_	
65-69	42511-42513	to	_	
65-70	42514-42520	detect	_	
65-71	42521-42533	connectivity	_	
65-72	42534-42547	abnormalities	_	
65-73	42548-42550	in	_	
65-74	42551-42562	psychiatric	_	
65-75	42563-42572	disorders	_	
65-76	42572-42573	.	_	
65-77	42574-42585	Intuitively	_	
65-78	42585-42586	,	_	
65-79	42587-42589	in	_	
65-80	42590-42598	addition	_	
65-81	42599-42601	to	_	
65-82	42602-42606	this	_	
65-83	42607-42616	tradition	_	
65-84	42616-42617	,	_	
65-85	42618-42620	we	_	
65-86	42621-42627	wanted	_	
65-87	42628-42630	to	_	
65-88	42631-42638	explore	_	
65-89	42639-42646	whether	_	
65-90	42647-42650	the	_	
65-91	42651-42653	HD	_	
65-92	42654-42661	network	_	
65-93	42662-42664	is	_	
65-94	42665-42666	“	_	
65-95	42666-42677	small-world	_	
65-96	42677-42678	”	_	
65-97	42679-42683	with	_	
65-98	42684-42691	respect	_	
65-99	42692-42694	to	_	
65-100	42695-42698	the	_	
65-101	42699-42701	CG	_	
65-102	42702-42709	network	_	
65-103	42709-42710	;	_	
65-104	42711-42715	thus	_	
65-105	42715-42716	,	_	
65-106	42717-42732	small-worldness	_	
65-107	42733-42736	was	_	
65-108	42737-42745	computed	_	
65-109	42746-42748	by	_	
65-110	42749-42758	comparing	_	
65-111	42759-42762	the	_	
65-112	42763-42766	HDs	_	
65-113	42767-42771	with	_	
65-114	42772-42775	the	_	
65-115	42776-42779	CGs	_	
65-116	42780-42781	(	_	
65-117	42781-42784	i.e	_	
65-118	42784-42785	.	_	
65-119	42785-42786	,	_	
65-120	42787-42788	γ	_	
65-121	42789-42790	=	_	
65-122	42791-42801	clustering	_	
65-123	42802-42813	coefficient	_	
65-124	42814-42816	in	_	
65-125	42817-42820	the	_	
65-126	42821-42824	HDs	_	
65-127	42825-42826	÷	_	
65-128	42827-42837	clustering	_	
65-129	42838-42849	coefficient	_	
65-130	42850-42852	in	_	
65-131	42853-42856	the	_	
65-132	42857-42860	CGs	_	
65-133	42860-42861	;	_	
65-134	42862-42863	λ	_	
65-135	42864-42865	=	_	
65-136	42866-42880	characteristic	_	
65-137	42881-42885	path	_	
65-138	42886-42892	length	_	
65-139	42893-42895	in	_	
65-140	42896-42899	the	_	
65-141	42900-42903	HDs	_	
65-142	42904-42905	÷	_	
65-143	42906-42920	characteristic	_	
65-144	42921-42925	path	_	
65-145	42926-42932	length	_	
65-146	42933-42935	in	_	
65-147	42936-42939	the	_	
65-148	42940-42943	CGs	_	
65-149	42943-42944	;	_	
65-150	42945-42947	γE	_	
65-151	42948-42949	=	_	
65-152	42950-42955	local	_	
65-153	42956-42966	efficiency	_	
65-154	42967-42969	in	_	
65-155	42970-42973	the	_	
65-156	42974-42977	HDs	_	
65-157	42978-42979	÷	_	
65-158	42980-42985	local	_	
65-159	42986-42996	efficiency	_	
65-160	42997-42999	in	_	
65-161	43000-43003	the	_	
65-162	43004-43007	CGs	_	
65-163	43007-43008	;	_	
65-164	43009-43011	λE	_	
65-165	43012-43013	=	_	
65-166	43014-43020	global	_	
65-167	43021-43031	efficiency	_	
65-168	43032-43034	in	_	
65-169	43035-43038	the	_	
65-170	43039-43042	HDs	_	
65-171	43043-43044	÷	_	
65-172	43045-43051	global	_	
65-173	43052-43062	efficiency	_	
65-174	43063-43065	in	_	
65-175	43066-43069	the	_	
65-176	43070-43073	CGs	_	
65-177	43073-43074	)	_	
65-178	43074-43075	.	_	
65-179	43076-43078	As	_	
65-180	43079-43083	such	_	
65-181	43083-43084	,	_	
65-182	43085-43089	this	_	
65-183	43090-43101	preliminary	_	
65-184	43102-43115	investigation	_	
65-185	43116-43119	may	_	
65-186	43120-43127	provide	_	
65-187	43128-43129	a	_	
65-188	43130-43136	direct	_	
65-189	43137-43143	metric	_	
65-190	43144-43146	to	_	
65-191	43147-43153	access	_	
65-192	43154-43155	“	_	
65-193	43155-43170	small-worldness	_	
65-194	43170-43171	”	_	
65-195	43172-43174	in	_	
65-196	43175-43183	observed	_	
65-197	43184-43194	real-world	_	
65-198	43195-43203	networks	_	
65-199	43203-43204	,	_	
65-200	43205-43210	which	_	
65-201	43211-43214	are	_	
65-202	43215-43222	neither	_	
65-203	43223-43232	uniformly	_	
65-204	43233-43239	random	_	
65-205	43240-43243	nor	_	
65-206	43244-43251	ordered	_	
65-207	43251-43252	.	_	
65-208	43253-43254	A	_	
65-209	43255-43265	two-sample	_	
65-210	43266-43272	t-test	_	
65-211	43273-43274	(	_	
65-212	43274-43275	α	_	
65-213	43276-43277	=	_	
65-214	43278-43282	0.05	_	
65-215	43282-43283	)	_	
65-216	43284-43292	followed	_	
65-217	43293-43295	by	_	
65-218	43296-43297	a	_	
65-219	43298-43308	correction	_	
65-220	43309-43317	approach	_	
65-221	43318-43322	with	_	
65-222	43323-43324	a	_	
65-223	43325-43330	false	_	
65-224	43331-43340	discovery	_	
65-225	43341-43345	rate	_	
65-226	43346-43347	(	_	
65-227	43347-43350	FDR	_	
65-228	43350-43351	)	_	
65-229	43352-43355	was	_	
65-230	43356-43363	applied	_	
65-231	43364-43366	to	_	
65-232	43367-43374	examine	_	
65-233	43375-43382	whether	_	
65-234	43383-43386	the	_	
65-235	43387-43389	HD	_	
65-236	43390-43395	brain	_	
65-237	43396-43403	network	_	
65-238	43404-43412	acquires	_	
65-239	43413-43426	significantly	_	
65-240	43427-43438	non-control	_	
65-241	43439-43442	and	_	
65-242	43443-43453	non-random	_	
65-243	43454-43466	construction	_	
65-244	43466-43467	.	_	
65-245	43468-43475	Further	_	
65-246	43475-43476	,	_	
65-247	43477-43480	the	_	
65-248	43481-43492	small-world	_	
65-249	43493-43500	network	_	
65-250	43501-43508	measure	_	
65-251	43509-43513	will	_	
65-252	43514-43516	be	_	
65-253	43517-43521	used	_	
65-254	43522-43524	to	_	
65-255	43525-43537	characterize	_	
65-256	43538-43549	differences	_	
65-257	43550-43557	between	_	
65-258	43558-43561	the	_	
65-259	43562-43569	metrics	_	
65-260	43570-43572	of	_	
65-261	43573-43576	the	_	
65-262	43577-43590	traditionally	_	
65-263	43591-43601	normalized	_	
65-264	43602-43614	coefficients	_	
65-265	43615-43616	(	_	
65-266	43616-43619	i.e	_	
65-267	43619-43620	.	_	
65-268	43620-43621	,	_	
65-269	43622-43627	HDnet	_	
65-270	43627-43628	/	_	
65-271	43628-43637	Randomnet	_	
65-272	43638-43641	and	_	
65-273	43642-43647	CGnet	_	
65-274	43647-43648	/	_	
65-275	43648-43657	Randomnet	_	
65-276	43657-43658	)	_	
65-277	43659-43662	and	_	
65-278	43663-43670	compare	_	
65-279	43671-43675	with	_	
65-280	43676-43679	the	_	
65-281	43680-43686	metric	_	
65-282	43687-43689	of	_	
65-283	43690-43693	the	_	
65-284	43694-43705	intuitively	_	
65-285	43706-43716	normalized	_	
65-286	43717-43721	ones	_	
65-287	43722-43723	(	_	
65-288	43723-43726	i.e	_	
65-289	43726-43727	.	_	
65-290	43727-43728	,	_	
65-291	43729-43734	HDnet	_	
65-292	43734-43735	/	_	
65-293	43735-43740	CGnet	_	
65-294	43740-43741	)	_	
65-295	43741-43742	.	_	

#Text=Regression analyses for anxiety scores and seed-based functional connectivity
66-1	43743-43753	Regression	_	
66-2	43754-43762	analyses	_	
66-3	43763-43766	for	_	
66-4	43767-43774	anxiety	_	
66-5	43775-43781	scores	_	
66-6	43782-43785	and	_	
66-7	43786-43796	seed-based	_	
66-8	43797-43807	functional	_	
66-9	43808-43820	connectivity	_	

#Text=Linear regression analysis was conducted to examine the link between anxiety severity (STAI scores) and functional connectivity for all seed channels. Multiple regression analysis was performed for all significant results to statistically account for potential differences in age, years of education, IQ, STAI scores, daily cigarette consumption, years of smoking, and the effect of methadone treatment. The seed-based functional connectivity presented in the correlation coefficient R to Z values between all the selected seed channels and the remainder of the channels were examined with the anxiety scores after controlling for the covariates. To address the issue of multiple comparisons, all results were controlled using the Benjamini–Hochberg procedure at an FDR < 10%.
67-1	43821-43827	Linear	_	
67-2	43828-43838	regression	_	
67-3	43839-43847	analysis	_	
67-4	43848-43851	was	_	
67-5	43852-43861	conducted	_	
67-6	43862-43864	to	_	
67-7	43865-43872	examine	_	
67-8	43873-43876	the	_	
67-9	43877-43881	link	_	
67-10	43882-43889	between	_	
67-11	43890-43897	anxiety	_	
67-12	43898-43906	severity	_	
67-13	43907-43908	(	_	
67-14	43908-43912	STAI	_	
67-15	43913-43919	scores	_	
67-16	43919-43920	)	_	
67-17	43921-43924	and	_	
67-18	43925-43935	functional	_	
67-19	43936-43948	connectivity	_	
67-20	43949-43952	for	_	
67-21	43953-43956	all	_	
67-22	43957-43961	seed	_	
67-23	43962-43970	channels	_	
67-24	43970-43971	.	_	
67-25	43972-43980	Multiple	_	
67-26	43981-43991	regression	_	
67-27	43992-44000	analysis	_	
67-28	44001-44004	was	_	
67-29	44005-44014	performed	_	
67-30	44015-44018	for	_	
67-31	44019-44022	all	_	
67-32	44023-44034	significant	_	
67-33	44035-44042	results	_	
67-34	44043-44045	to	_	
67-35	44046-44059	statistically	_	
67-36	44060-44067	account	_	
67-37	44068-44071	for	_	
67-38	44072-44081	potential	_	
67-39	44082-44093	differences	_	
67-40	44094-44096	in	_	
67-41	44097-44100	age	_	
67-42	44100-44101	,	_	
67-43	44102-44107	years	_	
67-44	44108-44110	of	_	
67-45	44111-44120	education	_	
67-46	44120-44121	,	_	
67-47	44122-44124	IQ	_	
67-48	44124-44125	,	_	
67-49	44126-44130	STAI	_	
67-50	44131-44137	scores	_	
67-51	44137-44138	,	_	
67-52	44139-44144	daily	_	
67-53	44145-44154	cigarette	_	
67-54	44155-44166	consumption	_	
67-55	44166-44167	,	_	
67-56	44168-44173	years	_	
67-57	44174-44176	of	_	
67-58	44177-44184	smoking	_	
67-59	44184-44185	,	_	
67-60	44186-44189	and	_	
67-61	44190-44193	the	_	
67-62	44194-44200	effect	_	
67-63	44201-44203	of	_	
67-64	44204-44213	methadone	_	
67-65	44214-44223	treatment	_	
67-66	44223-44224	.	_	
67-67	44225-44228	The	_	
67-68	44229-44239	seed-based	_	
67-69	44240-44250	functional	_	
67-70	44251-44263	connectivity	_	
67-71	44264-44273	presented	_	
67-72	44274-44276	in	_	
67-73	44277-44280	the	_	
67-74	44281-44292	correlation	_	
67-75	44293-44304	coefficient	_	
67-76	44305-44306	R	_	
67-77	44307-44309	to	_	
67-78	44310-44311	Z	_	
67-79	44312-44318	values	_	
67-80	44319-44326	between	_	
67-81	44327-44330	all	_	
67-82	44331-44334	the	_	
67-83	44335-44343	selected	_	
67-84	44344-44348	seed	_	
67-85	44349-44357	channels	_	
67-86	44358-44361	and	_	
67-87	44362-44365	the	_	
67-88	44366-44375	remainder	_	
67-89	44376-44378	of	_	
67-90	44379-44382	the	_	
67-91	44383-44391	channels	_	
67-92	44392-44396	were	_	
67-93	44397-44405	examined	_	
67-94	44406-44410	with	_	
67-95	44411-44414	the	_	
67-96	44415-44422	anxiety	_	
67-97	44423-44429	scores	_	
67-98	44430-44435	after	_	
67-99	44436-44447	controlling	_	
67-100	44448-44451	for	_	
67-101	44452-44455	the	_	
67-102	44456-44466	covariates	_	
67-103	44466-44467	.	_	
67-104	44468-44470	To	_	
67-105	44471-44478	address	_	
67-106	44479-44482	the	_	
67-107	44483-44488	issue	_	
67-108	44489-44491	of	_	
67-109	44492-44500	multiple	_	
67-110	44501-44512	comparisons	_	
67-111	44512-44513	,	_	
67-112	44514-44517	all	_	
67-113	44518-44525	results	_	
67-114	44526-44530	were	_	
67-115	44531-44541	controlled	_	
67-116	44542-44547	using	_	
67-117	44548-44551	the	_	
67-118	44552-44570	Benjamini–Hochberg	_	
67-119	44571-44580	procedure	_	
67-120	44581-44583	at	_	
67-121	44584-44586	an	_	
67-122	44587-44590	FDR	_	
67-123	44591-44592	<	_	
67-124	44593-44596	10%	_	
67-125	44596-44597	.	_	

#Text=Additional Information
68-1	44598-44608	Additional	_	
68-2	44609-44620	Information	_	

#Text=How to cite this article: Ieong, H.F. and Yuan, Z. Abnormal resting-state functional connectivity in the orbitofrontal cortex of heroin users and its relationship with anxiety: a pilot fNIRS study. Sci. Rep. 7, 46522; doi: 10.1038/srep46522 (2017).
69-1	44621-44624	How	_	
69-2	44625-44627	to	_	
69-3	44628-44632	cite	_	
69-4	44633-44637	this	_	
69-5	44638-44645	article	_	
69-6	44645-44646	:	_	
69-7	44647-44652	Ieong	_	
69-8	44652-44653	,	_	
69-9	44654-44657	H.F	_	
69-10	44657-44658	.	_	
69-11	44659-44662	and	_	
69-12	44663-44667	Yuan	_	
69-13	44667-44668	,	_	
69-14	44669-44670	Z	_	
69-15	44670-44671	.	_	
69-16	44672-44680	Abnormal	_	
69-17	44681-44694	resting-state	_	
69-18	44695-44705	functional	_	
69-19	44706-44718	connectivity	_	
69-20	44719-44721	in	_	
69-21	44722-44725	the	_	
69-22	44726-44739	orbitofrontal	_	
69-23	44740-44746	cortex	_	
69-24	44747-44749	of	_	
69-25	44750-44756	heroin	_	
69-26	44757-44762	users	_	
69-27	44763-44766	and	_	
69-28	44767-44770	its	_	
69-29	44771-44783	relationship	_	
69-30	44784-44788	with	_	
69-31	44789-44796	anxiety	_	
69-32	44796-44797	:	_	
69-33	44798-44799	a	_	
69-34	44800-44805	pilot	_	
69-35	44806-44811	fNIRS	_	
69-36	44812-44817	study	_	
69-37	44817-44818	.	_	
69-38	44819-44822	Sci	_	
69-39	44822-44823	.	_	
69-40	44824-44827	Rep	_	
69-41	44827-44828	.	_	
69-42	44829-44830	7	_	
69-43	44830-44831	,	_	
69-44	44832-44837	46522	_	
69-45	44837-44838	;	_	
69-46	44839-44842	doi	_	
69-47	44842-44843	:	_	
69-48	44844-44851	10.1038	_	
69-49	44851-44852	/	_	
69-50	44852-44861	srep46522	_	
69-51	44862-44863	(	_	
69-52	44863-44867	2017	_	
69-53	44867-44868	)	_	
69-54	44868-44869	.	_	

#Text=Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
70-1	44870-44881	Publisher's	_	
70-2	44882-44886	note	_	
70-3	44886-44887	:	_	
70-4	44888-44896	Springer	_	
70-5	44897-44903	Nature	_	
70-6	44904-44911	remains	_	
70-7	44912-44919	neutral	_	
70-8	44920-44924	with	_	
70-9	44925-44931	regard	_	
70-10	44932-44934	to	_	
70-11	44935-44949	jurisdictional	_	
70-12	44950-44956	claims	_	
70-13	44957-44959	in	_	
70-14	44960-44969	published	_	
70-15	44970-44974	maps	_	
70-16	44975-44978	and	_	
70-17	44979-44992	institutional	_	
70-18	44993-45005	affiliations	_	
70-19	45005-45006	.	_	

#Text=Supplementary Material
71-1	45007-45020	Supplementary	_	
71-2	45021-45029	Material	_	

#Text=Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex
72-1	45030-45039	Addiction	_	
72-2	45039-45040	,	_	
72-3	45041-45042	a	_	
72-4	45043-45050	disease	_	
72-5	45051-45053	of	_	
72-6	45054-45064	compulsion	_	
72-7	45065-45068	and	_	
72-8	45069-45074	drive	_	
72-9	45074-45075	:	_	
72-10	45076-45087	involvement	_	
72-11	45088-45090	of	_	
72-12	45091-45094	the	_	
72-13	45095-45108	orbitofrontal	_	
72-14	45109-45115	cortex	_	

#Text=Recreational drugs of abuse
73-1	45116-45128	Recreational	_	
73-2	45129-45134	drugs	_	
73-3	45135-45137	of	_	
73-4	45138-45143	abuse	_	

#Text=UNDOC, U. N. O. o. D. a. C. World Drug Report. (New York, 2015).
74-1	45144-45149	UNDOC	_	
74-2	45149-45150	,	_	
74-3	45151-45152	U	_	
74-4	45152-45153	.	_	
74-5	45154-45155	N	_	
74-6	45155-45156	.	_	
74-7	45157-45158	O	_	
74-8	45158-45159	.	_	
74-9	45160-45161	o	_	
74-10	45161-45162	.	_	
74-11	45163-45164	D	_	
74-12	45164-45165	.	_	
74-13	45166-45167	a	_	
74-14	45167-45168	.	_	
74-15	45169-45170	C	_	
74-16	45170-45171	.	_	
74-17	45172-45177	World	_	
74-18	45178-45182	Drug	_	
74-19	45183-45189	Report	_	
74-20	45189-45190	.	_	
74-21	45191-45192	(	_	
74-22	45192-45195	New	_	
74-23	45196-45200	York	_	
74-24	45200-45201	,	_	
74-25	45202-45206	2015	_	
74-26	45206-45207	)	_	
74-27	45207-45208	.	_	

#Text=Alcohol abuse by heroin addicts: review of research findings and issues
75-1	45209-45216	Alcohol	_	
75-2	45217-45222	abuse	_	
75-3	45223-45225	by	_	
75-4	45226-45232	heroin	_	
75-5	45233-45240	addicts	_	
75-6	45240-45241	:	_	
75-7	45242-45248	review	_	
75-8	45249-45251	of	_	
75-9	45252-45260	research	_	
75-10	45261-45269	findings	_	
75-11	45270-45273	and	_	
75-12	45274-45280	issues	_	

#Text=Orbitofrontal cortex, decision-making and drug addiction
76-1	45281-45294	Orbitofrontal	_	
76-2	45295-45301	cortex	_	
76-3	45301-45302	,	_	
76-4	45303-45318	decision-making	_	
76-5	45319-45322	and	_	
76-6	45323-45327	drug	_	
76-7	45328-45337	addiction	_	

#Text=Frontal lobe contributions to theory of mind
77-1	45338-45345	Frontal	_	
77-2	45346-45350	lobe	_	
77-3	45351-45364	contributions	_	
77-4	45365-45367	to	_	
77-5	45368-45374	theory	_	
77-6	45375-45377	of	_	
77-7	45378-45382	mind	_	

#Text=Substance use disorders and the orbitofrontal cortex
78-1	45383-45392	Substance	_	
78-2	45393-45396	use	_	
78-3	45397-45406	disorders	_	
78-4	45407-45410	and	_	
78-5	45411-45414	the	_	
78-6	45415-45428	orbitofrontal	_	
78-7	45429-45435	cortex	_	

#Text=Neurocircuitry of Addiction
79-1	45436-45450	Neurocircuitry	_	
79-2	45451-45453	of	_	
79-3	45454-45463	Addiction	_	

#Text=Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
80-1	45464-45475	Dysfunction	_	
80-2	45476-45478	of	_	
80-3	45479-45482	the	_	
80-4	45483-45493	prefrontal	_	
80-5	45494-45500	cortex	_	
80-6	45501-45503	in	_	
80-7	45504-45513	addiction	_	
80-8	45513-45514	:	_	
80-9	45515-45527	neuroimaging	_	
80-10	45528-45536	findings	_	
80-11	45537-45540	and	_	
80-12	45541-45549	clinical	_	
80-13	45550-45562	implications	_	

#Text=Decision-making dysfunctions in psychiatry—altered homeostatic processing?
81-1	45563-45578	Decision-making	_	
81-2	45579-45591	dysfunctions	_	
81-3	45592-45594	in	_	
81-4	45595-45613	psychiatry—altered	_	
81-5	45614-45625	homeostatic	_	
81-6	45626-45636	processing	_	
81-7	45636-45637	?	_	

#Text=An insular view of anxiety
82-1	45638-45640	An	_	
82-2	45641-45648	insular	_	
82-3	45649-45653	view	_	
82-4	45654-45656	of	_	
82-5	45657-45664	anxiety	_	

#Text=Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task
83-1	45665-45678	Orbitofrontal	_	
83-2	45679-45685	cortex	_	
83-3	45686-45697	dysfunction	_	
83-4	45698-45700	in	_	
83-5	45701-45710	abstinent	_	
83-6	45711-45718	cocaine	_	
83-7	45719-45726	abusers	_	
83-8	45727-45737	performing	_	
83-9	45738-45739	a	_	
83-10	45740-45755	decision-making	_	
83-11	45756-45760	task	_	

#Text=Anxiety as a predictor of relapse in detoxified alcohol-dependent patients
84-1	45761-45768	Anxiety	_	
84-2	45769-45771	as	_	
84-3	45772-45773	a	_	
84-4	45774-45783	predictor	_	
84-5	45784-45786	of	_	
84-6	45787-45794	relapse	_	
84-7	45795-45797	in	_	
84-8	45798-45808	detoxified	_	
84-9	45809-45826	alcohol-dependent	_	
84-10	45827-45835	patients	_	

#Text=Amygdala–prefrontal cortex functional connectivity during threat-induced anxiety and goal distraction
85-1	45836-45855	Amygdala–prefrontal	_	
85-2	45856-45862	cortex	_	
85-3	45863-45873	functional	_	
85-4	45874-45886	connectivity	_	
85-5	45887-45893	during	_	
85-6	45894-45908	threat-induced	_	
85-7	45909-45916	anxiety	_	
85-8	45917-45920	and	_	
85-9	45921-45925	goal	_	
85-10	45926-45937	distraction	_	

#Text=Clinical applications of resting state functional connectivity
86-1	45938-45946	Clinical	_	
86-2	45947-45959	applications	_	
86-3	45960-45962	of	_	
86-4	45963-45970	resting	_	
86-5	45971-45976	state	_	
86-6	45977-45987	functional	_	
86-7	45988-46000	connectivity	_	

#Text=Application of functional near-infrared spectroscopy in psychiatry
87-1	46001-46012	Application	_	
87-2	46013-46015	of	_	
87-3	46016-46026	functional	_	
87-4	46027-46040	near-infrared	_	
87-5	46041-46053	spectroscopy	_	
87-6	46054-46056	in	_	
87-7	46057-46067	psychiatry	_	

#Text=Resting state functional connectivity in addiction: Lessons learned and a road ahead
88-1	46068-46075	Resting	_	
88-2	46076-46081	state	_	
88-3	46082-46092	functional	_	
88-4	46093-46105	connectivity	_	
88-5	46106-46108	in	_	
88-6	46109-46118	addiction	_	
88-7	46118-46119	:	_	
88-8	46120-46127	Lessons	_	
88-9	46128-46135	learned	_	
88-10	46136-46139	and	_	
88-11	46140-46141	a	_	
88-12	46142-46146	road	_	
88-13	46147-46152	ahead	_	

#Text=Resting-state functional connectivity reflects structural connectivity in the default mode network
89-1	46153-46166	Resting-state	_	
89-2	46167-46177	functional	_	
89-3	46178-46190	connectivity	_	
89-4	46191-46199	reflects	_	
89-5	46200-46210	structural	_	
89-6	46211-46223	connectivity	_	
89-7	46224-46226	in	_	
89-8	46227-46230	the	_	
89-9	46231-46238	default	_	
89-10	46239-46243	mode	_	
89-11	46244-46251	network	_	

#Text=Greater than the sum of its parts: a review of studies combining structural connectivity and resting-state functional connectivity
90-1	46252-46259	Greater	_	
90-2	46260-46264	than	_	
90-3	46265-46268	the	_	
90-4	46269-46272	sum	_	
90-5	46273-46275	of	_	
90-6	46276-46279	its	_	
90-7	46280-46285	parts	_	
90-8	46285-46286	:	_	
90-9	46287-46288	a	_	
90-10	46289-46295	review	_	
90-11	46296-46298	of	_	
90-12	46299-46306	studies	_	
90-13	46307-46316	combining	_	
90-14	46317-46327	structural	_	
90-15	46328-46340	connectivity	_	
90-16	46341-46344	and	_	
90-17	46345-46358	resting-state	_	
90-18	46359-46369	functional	_	
90-19	46370-46382	connectivity	_	

#Text=Predicting human resting-state functional connectivity from structural connectivity
91-1	46383-46393	Predicting	_	
91-2	46394-46399	human	_	
91-3	46400-46413	resting-state	_	
91-4	46414-46424	functional	_	
91-5	46425-46437	connectivity	_	
91-6	46438-46442	from	_	
91-7	46443-46453	structural	_	
91-8	46454-46466	connectivity	_	

#Text=Enhanced brain correlations during rest are related to memory for recent experiences
92-1	46467-46475	Enhanced	_	
92-2	46476-46481	brain	_	
92-3	46482-46494	correlations	_	
92-4	46495-46501	during	_	
92-5	46502-46506	rest	_	
92-6	46507-46510	are	_	
92-7	46511-46518	related	_	
92-8	46519-46521	to	_	
92-9	46522-46528	memory	_	
92-10	46529-46532	for	_	
92-11	46533-46539	recent	_	
92-12	46540-46551	experiences	_	

#Text=Functional connectivity between task-positive and task-negative brain areas and its relation to working memory performance
93-1	46552-46562	Functional	_	
93-2	46563-46575	connectivity	_	
93-3	46576-46583	between	_	
93-4	46584-46597	task-positive	_	
93-5	46598-46601	and	_	
93-6	46602-46615	task-negative	_	
93-7	46616-46621	brain	_	
93-8	46622-46627	areas	_	
93-9	46628-46631	and	_	
93-10	46632-46635	its	_	
93-11	46636-46644	relation	_	
93-12	46645-46647	to	_	
93-13	46648-46655	working	_	
93-14	46656-46662	memory	_	
93-15	46663-46674	performance	_	

#Text=Competition between functional brain networks mediates behavioral variability
94-1	46675-46686	Competition	_	
94-2	46687-46694	between	_	
94-3	46695-46705	functional	_	
94-4	46706-46711	brain	_	
94-5	46712-46720	networks	_	
94-6	46721-46729	mediates	_	
94-7	46730-46740	behavioral	_	
94-8	46741-46752	variability	_	

#Text=Fusion of fNIRS and fMRI data: identifying when and where hemodynamic signals are changing in human brains
95-1	46753-46759	Fusion	_	
95-2	46760-46762	of	_	
95-3	46763-46768	fNIRS	_	
95-4	46769-46772	and	_	
95-5	46773-46777	fMRI	_	
95-6	46778-46782	data	_	
95-7	46782-46783	:	_	
95-8	46784-46795	identifying	_	
95-9	46796-46800	when	_	
95-10	46801-46804	and	_	
95-11	46805-46810	where	_	
95-12	46811-46822	hemodynamic	_	
95-13	46823-46830	signals	_	
95-14	46831-46834	are	_	
95-15	46835-46843	changing	_	
95-16	46844-46846	in	_	
95-17	46847-46852	human	_	
95-18	46853-46859	brains	_	

#Text=Combining independent component analysis and Granger causality to investigate brain network dynamics with fNIRS measurements
96-1	46860-46869	Combining	_	
96-2	46870-46881	independent	_	
96-3	46882-46891	component	_	
96-4	46892-46900	analysis	_	
96-5	46901-46904	and	_	
96-6	46905-46912	Granger	_	
96-7	46913-46922	causality	_	
96-8	46923-46925	to	_	
96-9	46926-46937	investigate	_	
96-10	46938-46943	brain	_	
96-11	46944-46951	network	_	
96-12	46952-46960	dynamics	_	
96-13	46961-46965	with	_	
96-14	46966-46971	fNIRS	_	
96-15	46972-46984	measurements	_	

#Text=Diffuse optical imaging of brain activation: approaches to optimizing image sensitivity, resolution, and accuracy
97-1	46985-46992	Diffuse	_	
97-2	46993-47000	optical	_	
97-3	47001-47008	imaging	_	
97-4	47009-47011	of	_	
97-5	47012-47017	brain	_	
97-6	47018-47028	activation	_	
97-7	47028-47029	:	_	
97-8	47030-47040	approaches	_	
97-9	47041-47043	to	_	
97-10	47044-47054	optimizing	_	
97-11	47055-47060	image	_	
97-12	47061-47072	sensitivity	_	
97-13	47072-47073	,	_	
97-14	47074-47084	resolution	_	
97-15	47084-47085	,	_	
97-16	47086-47089	and	_	
97-17	47090-47098	accuracy	_	

#Text=Resting-state functional brain connectivity: lessons from functional near-infrared spectroscopy
98-1	47099-47112	Resting-state	_	
98-2	47113-47123	functional	_	
98-3	47124-47129	brain	_	
98-4	47130-47142	connectivity	_	
98-5	47142-47143	:	_	
98-6	47144-47151	lessons	_	
98-7	47152-47156	from	_	
98-8	47157-47167	functional	_	
98-9	47168-47181	near-infrared	_	
98-10	47182-47194	spectroscopy	_	

#Text=A wearable multi-channel fNIRS system for brain imaging in freely moving subjects
99-1	47195-47196	A	_	
99-2	47197-47205	wearable	_	
99-3	47206-47219	multi-channel	_	
99-4	47220-47225	fNIRS	_	
99-5	47226-47232	system	_	
99-6	47233-47236	for	_	
99-7	47237-47242	brain	_	
99-8	47243-47250	imaging	_	
99-9	47251-47253	in	_	
99-10	47254-47260	freely	_	
99-11	47261-47267	moving	_	
99-12	47268-47276	subjects	_	

#Text=State-dependent altered connectivity in late-life depression: a functional near-infrared spectroscopy study
100-1	47277-47292	State-dependent	_	
100-2	47293-47300	altered	_	
100-3	47301-47313	connectivity	_	
100-4	47314-47316	in	_	
100-5	47317-47326	late-life	_	
100-6	47327-47337	depression	_	
100-7	47337-47338	:	_	
100-8	47339-47340	a	_	
100-9	47341-47351	functional	_	
100-10	47352-47365	near-infrared	_	
100-11	47366-47378	spectroscopy	_	
100-12	47379-47384	study	_	

#Text=Atomoxetine treatment strengthens an anti-correlated relationship between functional brain networks in medication-naïve adults with attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled clinical trial
101-1	47385-47396	Atomoxetine	_	
101-2	47397-47406	treatment	_	
101-3	47407-47418	strengthens	_	
101-4	47419-47421	an	_	
101-5	47422-47437	anti-correlated	_	
101-6	47438-47450	relationship	_	
101-7	47451-47458	between	_	
101-8	47459-47469	functional	_	
101-9	47470-47475	brain	_	
101-10	47476-47484	networks	_	
101-11	47485-47487	in	_	
101-12	47488-47504	medication-naïve	_	
101-13	47505-47511	adults	_	
101-14	47512-47516	with	_	
101-15	47517-47534	attention-deficit	_	
101-16	47535-47548	hyperactivity	_	
101-17	47549-47557	disorder	_	
101-18	47557-47558	:	_	
101-19	47559-47560	a	_	
101-20	47561-47571	randomized	_	
101-21	47572-47584	double-blind	_	
101-22	47585-47603	placebo-controlled	_	
101-23	47604-47612	clinical	_	
101-24	47613-47618	trial	_	

#Text=Reduced interhemispheric functional connectivity of children with autism spectrum disorder: evidence from functional near infrared spectroscopy studies
102-1	47619-47626	Reduced	_	
102-2	47627-47643	interhemispheric	_	
102-3	47644-47654	functional	_	
102-4	47655-47667	connectivity	_	
102-5	47668-47670	of	_	
102-6	47671-47679	children	_	
102-7	47680-47684	with	_	
102-8	47685-47691	autism	_	
102-9	47692-47700	spectrum	_	
102-10	47701-47709	disorder	_	
102-11	47709-47710	:	_	
102-12	47711-47719	evidence	_	
102-13	47720-47724	from	_	
102-14	47725-47735	functional	_	
102-15	47736-47740	near	_	
102-16	47741-47749	infrared	_	
102-17	47750-47762	spectroscopy	_	
102-18	47763-47770	studies	_	

#Text=Functional co-activation within the prefrontal cortex supports the maintenance of behavioural performance in fear-relevant situations before an iTBS modulated virtual reality challenge in participants with spider phobia
103-1	47771-47781	Functional	_	
103-2	47782-47795	co-activation	_	
103-3	47796-47802	within	_	
103-4	47803-47806	the	_	
103-5	47807-47817	prefrontal	_	
103-6	47818-47824	cortex	_	
103-7	47825-47833	supports	_	
103-8	47834-47837	the	_	
103-9	47838-47849	maintenance	_	
103-10	47850-47852	of	_	
103-11	47853-47864	behavioural	_	
103-12	47865-47876	performance	_	
103-13	47877-47879	in	_	
103-14	47880-47893	fear-relevant	_	
103-15	47894-47904	situations	_	
103-16	47905-47911	before	_	
103-17	47912-47914	an	_	
103-18	47915-47919	iTBS	_	
103-19	47920-47929	modulated	_	
103-20	47930-47937	virtual	_	
103-21	47938-47945	reality	_	
103-22	47946-47955	challenge	_	
103-23	47956-47958	in	_	
103-24	47959-47971	participants	_	
103-25	47972-47976	with	_	
103-26	47977-47983	spider	_	
103-27	47984-47990	phobia	_	

#Text=Small-world network properties in prefrontal cortex correlate with predictors of psychopathology risk in young children: A NIRS study
104-1	47991-48002	Small-world	_	
104-2	48003-48010	network	_	
104-3	48011-48021	properties	_	
104-4	48022-48024	in	_	
104-5	48025-48035	prefrontal	_	
104-6	48036-48042	cortex	_	
104-7	48043-48052	correlate	_	
104-8	48053-48057	with	_	
104-9	48058-48068	predictors	_	
104-10	48069-48071	of	_	
104-11	48072-48087	psychopathology	_	
104-12	48088-48092	risk	_	
104-13	48093-48095	in	_	
104-14	48096-48101	young	_	
104-15	48102-48110	children	_	
104-16	48110-48111	:	_	
104-17	48112-48113	A	_	
104-18	48114-48118	NIRS	_	
104-19	48119-48124	study	_	

#Text=Functional near-infrared spectroscopy: current status and future prospects
105-1	48125-48135	Functional	_	
105-2	48136-48149	near-infrared	_	
105-3	48150-48162	spectroscopy	_	
105-4	48162-48163	:	_	
105-5	48164-48171	current	_	
105-6	48172-48178	status	_	
105-7	48179-48182	and	_	
105-8	48183-48189	future	_	
105-9	48190-48199	prospects	_	

#Text=Mapping Individual Brain Networks Using Statistical Similarity in Regional Morphology from MRI
106-1	48200-48207	Mapping	_	
106-2	48208-48218	Individual	_	
106-3	48219-48224	Brain	_	
106-4	48225-48233	Networks	_	
106-5	48234-48239	Using	_	
106-6	48240-48251	Statistical	_	
106-7	48252-48262	Similarity	_	
106-8	48263-48265	in	_	
106-9	48266-48274	Regional	_	
106-10	48275-48285	Morphology	_	
106-11	48286-48290	from	_	
106-12	48291-48294	MRI	_	

#Text=Revealing topological organization of human brain functional networks with resting-state functional near infrared spectroscopy
107-1	48295-48304	Revealing	_	
107-2	48305-48316	topological	_	
107-3	48317-48329	organization	_	
107-4	48330-48332	of	_	
107-5	48333-48338	human	_	
107-6	48339-48344	brain	_	
107-7	48345-48355	functional	_	
107-8	48356-48364	networks	_	
107-9	48365-48369	with	_	
107-10	48370-48383	resting-state	_	
107-11	48384-48394	functional	_	
107-12	48395-48399	near	_	
107-13	48400-48408	infrared	_	
107-14	48409-48421	spectroscopy	_	

#Text=Efficient behavior of small-world networks
108-1	48422-48431	Efficient	_	
108-2	48432-48440	behavior	_	
108-3	48441-48443	of	_	
108-4	48444-48455	small-world	_	
108-5	48456-48464	networks	_	

#Text=Complex network measures of brain connectivity: uses and interpretations
109-1	48465-48472	Complex	_	
109-2	48473-48480	network	_	
109-3	48481-48489	measures	_	
109-4	48490-48492	of	_	
109-5	48493-48498	brain	_	
109-6	48499-48511	connectivity	_	
109-7	48511-48512	:	_	
109-8	48513-48517	uses	_	
109-9	48518-48521	and	_	
109-10	48522-48537	interpretations	_	

#Text=Divide and conquer: a defense of functional localizers
110-1	48538-48544	Divide	_	
110-2	48545-48548	and	_	
110-3	48549-48556	conquer	_	
110-4	48556-48557	:	_	
110-5	48558-48559	a	_	
110-6	48560-48567	defense	_	
110-7	48568-48570	of	_	
110-8	48571-48581	functional	_	
110-9	48582-48592	localizers	_	

#Text=The structural and functional connectivity of the amygdala: from normal emotion to pathological anxiety
111-1	48593-48596	The	_	
111-2	48597-48607	structural	_	
111-3	48608-48611	and	_	
111-4	48612-48622	functional	_	
111-5	48623-48635	connectivity	_	
111-6	48636-48638	of	_	
111-7	48639-48642	the	_	
111-8	48643-48651	amygdala	_	
111-9	48651-48652	:	_	
111-10	48653-48657	from	_	
111-11	48658-48664	normal	_	
111-12	48665-48672	emotion	_	
111-13	48673-48675	to	_	
111-14	48676-48688	pathological	_	
111-15	48689-48696	anxiety	_	

#Text=Differential role of the orbital frontal lobe in emotional versus cognitive perspective-taking
112-1	48697-48709	Differential	_	
112-2	48710-48714	role	_	
112-3	48715-48717	of	_	
112-4	48718-48721	the	_	
112-5	48722-48729	orbital	_	
112-6	48730-48737	frontal	_	
112-7	48738-48742	lobe	_	
112-8	48743-48745	in	_	
112-9	48746-48755	emotional	_	
112-10	48756-48762	versus	_	
112-11	48763-48772	cognitive	_	
112-12	48773-48791	perspective-taking	_	

#Text=Frontal dysfunction in neurologically normal chronic alcoholic subjects: metabolic and neuropsychological findings
113-1	48792-48799	Frontal	_	
113-2	48800-48811	dysfunction	_	
113-3	48812-48814	in	_	
113-4	48815-48829	neurologically	_	
113-5	48830-48836	normal	_	
113-6	48837-48844	chronic	_	
113-7	48845-48854	alcoholic	_	
113-8	48855-48863	subjects	_	
113-9	48863-48864	:	_	
113-10	48865-48874	metabolic	_	
113-11	48875-48878	and	_	
113-12	48879-48897	neuropsychological	_	
113-13	48898-48906	findings	_	

#Text=Regional cerebral blood flow changes in chronic alcoholic patients induced by naltrexone challenge during detoxification
114-1	48907-48915	Regional	_	
114-2	48916-48924	cerebral	_	
114-3	48925-48930	blood	_	
114-4	48931-48935	flow	_	
114-5	48936-48943	changes	_	
114-6	48944-48946	in	_	
114-7	48947-48954	chronic	_	
114-8	48955-48964	alcoholic	_	
114-9	48965-48973	patients	_	
114-10	48974-48981	induced	_	
114-11	48982-48984	by	_	
114-12	48985-48995	naltrexone	_	
114-13	48996-49005	challenge	_	
114-14	49006-49012	during	_	
114-15	49013-49027	detoxification	_	

#Text=Regional cerebral blood flow in female cocaine-addicted subjects following limbic activation
115-1	49028-49036	Regional	_	
115-2	49037-49045	cerebral	_	
115-3	49046-49051	blood	_	
115-4	49052-49056	flow	_	
115-5	49057-49059	in	_	
115-6	49060-49066	female	_	
115-7	49067-49083	cocaine-addicted	_	
115-8	49084-49092	subjects	_	
115-9	49093-49102	following	_	
115-10	49103-49109	limbic	_	
115-11	49110-49120	activation	_	

#Text=Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms
116-1	49121-49132	Association	_	
116-2	49133-49135	of	_	
116-3	49136-49144	dopamine	_	
116-4	49145-49156	transporter	_	
116-5	49157-49161	loss	_	
116-6	49162-49164	in	_	
116-7	49165-49168	the	_	
116-8	49169-49182	orbitofrontal	_	
116-9	49183-49186	and	_	
116-10	49187-49199	dorsolateral	_	
116-11	49200-49210	prefrontal	_	
116-12	49211-49219	cortices	_	
116-13	49220-49224	with	_	
116-14	49225-49248	methamphetamine-related	_	
116-15	49249-49260	psychiatric	_	
116-16	49261-49269	symptoms	_	

#Text=Substance use disorders and the orbitofrontal cortex: systematic review of behavioural decision-making and neuroimaging studies
117-1	49270-49279	Substance	_	
117-2	49280-49283	use	_	
117-3	49284-49293	disorders	_	
117-4	49294-49297	and	_	
117-5	49298-49301	the	_	
117-6	49302-49315	orbitofrontal	_	
117-7	49316-49322	cortex	_	
117-8	49322-49323	:	_	
117-9	49324-49334	systematic	_	
117-10	49335-49341	review	_	
117-11	49342-49344	of	_	
117-12	49345-49356	behavioural	_	
117-13	49357-49372	decision-making	_	
117-14	49373-49376	and	_	
117-15	49377-49389	neuroimaging	_	
117-16	49390-49397	studies	_	

#Text=Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users
118-1	49398-49407	Perfusion	_	
118-2	49408-49411	MRI	_	
118-3	49412-49415	and	_	
118-4	49416-49428	computerized	_	
118-5	49429-49438	cognitive	_	
118-6	49439-49443	test	_	
118-7	49444-49457	abnormalities	_	
118-8	49458-49460	in	_	
118-9	49461-49470	abstinent	_	
118-10	49471-49486	methamphetamine	_	
118-11	49487-49492	users	_	

#Text=Addiction related alteration in resting-state brain connectivity
119-1	49493-49502	Addiction	_	
119-2	49503-49510	related	_	
119-3	49511-49521	alteration	_	
119-4	49522-49524	in	_	
119-5	49525-49538	resting-state	_	
119-6	49539-49544	brain	_	
119-7	49545-49557	connectivity	_	

#Text=Dysfunctional connectivity patterns in chronic heroin users: an fMRI study
120-1	49558-49571	Dysfunctional	_	
120-2	49572-49584	connectivity	_	
120-3	49585-49593	patterns	_	
120-4	49594-49596	in	_	
120-5	49597-49604	chronic	_	
120-6	49605-49611	heroin	_	
120-7	49612-49617	users	_	
120-8	49617-49618	:	_	
120-9	49619-49621	an	_	
120-10	49622-49626	fMRI	_	
120-11	49627-49632	study	_	

#Text=The incentive sensitization theory of addiction: some current issues
121-1	49633-49636	The	_	
121-2	49637-49646	incentive	_	
121-3	49647-49660	sensitization	_	
121-4	49661-49667	theory	_	
121-5	49668-49670	of	_	
121-6	49671-49680	addiction	_	
121-7	49680-49681	:	_	
121-8	49682-49686	some	_	
121-9	49687-49694	current	_	
121-10	49695-49701	issues	_	

#Text=Incentive‐sensitization and addiction
122-1	49702-49725	Incentive‐sensitization	_	
122-2	49726-49729	and	_	
122-3	49730-49739	addiction	_	

#Text=Enhanced cue reactivity and fronto-striatal functional connectivity in cocaine use disorders
123-1	49740-49748	Enhanced	_	
123-2	49749-49752	cue	_	
123-3	49753-49763	reactivity	_	
123-4	49764-49767	and	_	
123-5	49768-49783	fronto-striatal	_	
123-6	49784-49794	functional	_	
123-7	49795-49807	connectivity	_	
123-8	49808-49810	in	_	
123-9	49811-49818	cocaine	_	
123-10	49819-49822	use	_	
123-11	49823-49832	disorders	_	

#Text=Left inferior frontal gyrus is critical for response inhibition
124-1	49833-49837	Left	_	
124-2	49838-49846	inferior	_	
124-3	49847-49854	frontal	_	
124-4	49855-49860	gyrus	_	
124-5	49861-49863	is	_	
124-6	49864-49872	critical	_	
124-7	49873-49876	for	_	
124-8	49877-49885	response	_	
124-9	49886-49896	inhibition	_	

#Text=Use of fNIRS to assess resting state functional connectivity
125-1	49897-49900	Use	_	
125-2	49901-49903	of	_	
125-3	49904-49909	fNIRS	_	
125-4	49910-49912	to	_	
125-5	49913-49919	assess	_	
125-6	49920-49927	resting	_	
125-7	49928-49933	state	_	
125-8	49934-49944	functional	_	
125-9	49945-49957	connectivity	_	

#Text=Report of the committee on methods of clinical examination in electroencephalography: 1957
126-1	49958-49964	Report	_	
126-2	49965-49967	of	_	
126-3	49968-49971	the	_	
126-4	49972-49981	committee	_	
126-5	49982-49984	on	_	
126-6	49985-49992	methods	_	
126-7	49993-49995	of	_	
126-8	49996-50004	clinical	_	
126-9	50005-50016	examination	_	
126-10	50017-50019	in	_	
126-11	50020-50042	electroencephalography	_	
126-12	50042-50043	:	_	
126-13	50044-50048	1957	_	

#Text=Anatomical guidance for functional near-infrared spectroscopy: AtlasViewer tutorial
127-1	50049-50059	Anatomical	_	
127-2	50060-50068	guidance	_	
127-3	50069-50072	for	_	
127-4	50073-50083	functional	_	
127-5	50084-50097	near-infrared	_	
127-6	50098-50110	spectroscopy	_	
127-7	50110-50111	:	_	
127-8	50112-50123	AtlasViewer	_	
127-9	50124-50132	tutorial	_	

#Text=Spatial registration of multichannel multi-subject fNIRS data to MNI space without MRI
128-1	50133-50140	Spatial	_	
128-2	50141-50153	registration	_	
128-3	50154-50156	of	_	
128-4	50157-50169	multichannel	_	
128-5	50170-50183	multi-subject	_	
128-6	50184-50189	fNIRS	_	
128-7	50190-50194	data	_	
128-8	50195-50197	to	_	
128-9	50198-50201	MNI	_	
128-10	50202-50207	space	_	
128-11	50208-50215	without	_	
128-12	50216-50219	MRI	_	

#Text=Functional connectivity as revealed by independent component analysis of resting-state fNIRS measurements
129-1	50220-50230	Functional	_	
129-2	50231-50243	connectivity	_	
129-3	50244-50246	as	_	
129-4	50247-50255	revealed	_	
129-5	50256-50258	by	_	
129-6	50259-50270	independent	_	
129-7	50271-50280	component	_	
129-8	50281-50289	analysis	_	
129-9	50290-50292	of	_	
129-10	50293-50306	resting-state	_	
129-11	50307-50312	fNIRS	_	
129-12	50313-50325	measurements	_	

#Text=System for long-term measurement of cerebral blood and tissue oxygenation on newborn infants by near infra-red transillumination
130-1	50326-50332	System	_	
130-2	50333-50336	for	_	
130-3	50337-50346	long-term	_	
130-4	50347-50358	measurement	_	
130-5	50359-50361	of	_	
130-6	50362-50370	cerebral	_	
130-7	50371-50376	blood	_	
130-8	50377-50380	and	_	
130-9	50381-50387	tissue	_	
130-10	50388-50399	oxygenation	_	
130-11	50400-50402	on	_	
130-12	50403-50410	newborn	_	
130-13	50411-50418	infants	_	
130-14	50419-50421	by	_	
130-15	50422-50426	near	_	
130-16	50427-50436	infra-red	_	
130-17	50437-50454	transillumination	_	

#Text=Detecting resting-state functional connectivity in the language system using functional near-infrared spectroscopy
131-1	50455-50464	Detecting	_	
131-2	50465-50478	resting-state	_	
131-3	50479-50489	functional	_	
131-4	50490-50502	connectivity	_	
131-5	50503-50505	in	_	
131-6	50506-50509	the	_	
131-7	50510-50518	language	_	
131-8	50519-50525	system	_	
131-9	50526-50531	using	_	
131-10	50532-50542	functional	_	
131-11	50543-50556	near-infrared	_	
131-12	50557-50569	spectroscopy	_	

#Text=How to detect and reduce movement artifacts in near-infrared imaging using moving standard deviation and spline interpolation
132-1	50570-50573	How	_	
132-2	50574-50576	to	_	
132-3	50577-50583	detect	_	
132-4	50584-50587	and	_	
132-5	50588-50594	reduce	_	
132-6	50595-50603	movement	_	
132-7	50604-50613	artifacts	_	
132-8	50614-50616	in	_	
132-9	50617-50630	near-infrared	_	
132-10	50631-50638	imaging	_	
132-11	50639-50644	using	_	
132-12	50645-50651	moving	_	
132-13	50652-50660	standard	_	
132-14	50661-50670	deviation	_	
132-15	50671-50674	and	_	
132-16	50675-50681	spline	_	
132-17	50682-50695	interpolation	_	

#Text=Functional near infrared spectroscopy (NIRS) signal improvement based on negative correlation between oxygenated and deoxygenated hemoglobin dynamics
133-1	50696-50706	Functional	_	
133-2	50707-50711	near	_	
133-3	50712-50720	infrared	_	
133-4	50721-50733	spectroscopy	_	
133-5	50734-50735	(	_	
133-6	50735-50739	NIRS	_	
133-7	50739-50740	)	_	
133-8	50741-50747	signal	_	
133-9	50748-50759	improvement	_	
133-10	50760-50765	based	_	
133-11	50766-50768	on	_	
133-12	50769-50777	negative	_	
133-13	50778-50789	correlation	_	
133-14	50790-50797	between	_	
133-15	50798-50808	oxygenated	_	
133-16	50809-50812	and	_	
133-17	50813-50825	deoxygenated	_	
133-18	50826-50836	hemoglobin	_	
133-19	50837-50845	dynamics	_	

#Text=The small world of the cerebral cortex
134-1	50847-50850	The	_	
134-2	50851-50856	small	_	
134-3	50857-50862	world	_	
134-4	50863-50865	of	_	
134-5	50866-50869	the	_	
134-6	50870-50878	cerebral	_	
134-7	50879-50885	cortex	_	

#Text=Averaging correlation coefficients: should Fisher’s z transformation be used?
135-1	50886-50895	Averaging	_	
135-2	50896-50907	correlation	_	
135-3	50908-50920	coefficients	_	
135-4	50920-50921	:	_	
135-5	50922-50928	should	_	
135-6	50929-50935	Fisher	_	
135-7	50935-50936	’	_	
135-8	50936-50937	s	_	
135-9	50938-50939	z	_	
135-10	50940-50954	transformation	_	
135-11	50955-50957	be	_	
135-12	50958-50962	used	_	
135-13	50962-50963	?	_	

#Text=GRETNA: a graph theoretical network analysis toolbox for imaging connectomics
136-1	50964-50970	GRETNA	_	
136-2	50970-50971	:	_	
136-3	50972-50973	a	_	
136-4	50974-50979	graph	_	
136-5	50980-50991	theoretical	_	
136-6	50992-50999	network	_	
136-7	51000-51008	analysis	_	
136-8	51009-51016	toolbox	_	
136-9	51017-51020	for	_	
136-10	51021-51028	imaging	_	
136-11	51029-51041	connectomics	_	

#Text=Collective dynamics of ‘small-world’networks
137-1	51042-51052	Collective	_	
137-2	51053-51061	dynamics	_	
137-3	51062-51064	of	_	
137-4	51065-51066	‘	_	
137-5	51066-51077	small-world	_	
137-6	51077-51078	’	_	
137-7	51078-51086	networks	_	

#Text=Efficiency and cost of economical brain functional networks
138-1	51087-51097	Efficiency	_	
138-2	51098-51101	and	_	
138-3	51102-51106	cost	_	
138-4	51107-51109	of	_	
138-5	51110-51120	economical	_	
138-6	51121-51126	brain	_	
138-7	51127-51137	functional	_	
138-8	51138-51146	networks	_	

#Text=Small-World Propensity and Weighted Brain Networks
139-1	51147-51158	Small-World	_	
139-2	51159-51169	Propensity	_	
139-3	51170-51173	and	_	
139-4	51174-51182	Weighted	_	
139-5	51183-51188	Brain	_	
139-6	51189-51197	Networks	_	

#Text=Functional connectivity and brain networks in schizophrenia
140-1	51198-51208	Functional	_	
140-2	51209-51221	connectivity	_	
140-3	51222-51225	and	_	
140-4	51226-51231	brain	_	
140-5	51232-51240	networks	_	
140-6	51241-51243	in	_	
140-7	51244-51257	schizophrenia	_	

#Text=Network ‘small-world-ness’: a quantitative method for determining canonical network equivalence
141-1	51258-51265	Network	_	
141-2	51266-51267	‘	_	
141-3	51267-51283	small-world-ness	_	
141-4	51283-51284	’	_	
141-5	51284-51285	:	_	
141-6	51286-51287	a	_	
141-7	51288-51300	quantitative	_	
141-8	51301-51307	method	_	
141-9	51308-51311	for	_	
141-10	51312-51323	determining	_	
141-11	51324-51333	canonical	_	
141-12	51334-51341	network	_	
141-13	51342-51353	equivalence	_	

#Text=Controlling the false discovery rate: a practical and powerful approach to multiple testing
142-1	51354-51365	Controlling	_	
142-2	51366-51369	the	_	
142-3	51370-51375	false	_	
142-4	51376-51385	discovery	_	
142-5	51386-51390	rate	_	
142-6	51390-51391	:	_	
142-7	51392-51393	a	_	
142-8	51394-51403	practical	_	
142-9	51404-51407	and	_	
142-10	51408-51416	powerful	_	
142-11	51417-51425	approach	_	
142-12	51426-51428	to	_	
142-13	51429-51437	multiple	_	
142-14	51438-51445	testing	_	

#Text=The authors declare no competing financial interests.
143-1	51447-51450	The	_	
143-2	51451-51458	authors	_	
143-3	51459-51466	declare	_	
143-4	51467-51469	no	_	
143-5	51470-51479	competing	_	
143-6	51480-51489	financial	_	
143-7	51490-51499	interests	_	
143-8	51499-51500	.	_	

#Text=Author Contributions H.F.I. conceived and conducted the experiments, analyzed the results and performed the computations. H.F.I. and Z.Y. wrote and reviewed the manuscript.
144-1	51501-51507	Author	_	
144-2	51508-51521	Contributions	_	
144-3	51522-51527	H.F.I	_	
144-4	51527-51528	.	_	
144-5	51529-51538	conceived	_	
144-6	51539-51542	and	_	
144-7	51543-51552	conducted	_	
144-8	51553-51556	the	_	
144-9	51557-51568	experiments	_	
144-10	51568-51569	,	_	
144-11	51570-51578	analyzed	_	
144-12	51579-51582	the	_	
144-13	51583-51590	results	_	
144-14	51591-51594	and	_	
144-15	51595-51604	performed	_	
144-16	51605-51608	the	_	
144-17	51609-51621	computations	_	
144-18	51621-51622	.	_	
144-19	51623-51628	H.F.I	_	
144-20	51628-51629	.	_	
144-21	51630-51633	and	_	
144-22	51634-51637	Z.Y	_	
144-23	51637-51638	.	_	
144-24	51639-51644	wrote	_	
144-25	51645-51648	and	_	
144-26	51649-51657	reviewed	_	
144-27	51658-51661	the	_	
144-28	51662-51672	manuscript	_	
144-29	51672-51673	.	_	

#Text=Interhemispheric correlations in the lateral OFC (lOFC) and medial OFC (mOFC) of abstinent heroin-dependent subjects (HDs, green, n = 8) and control subjects (CGs, blue, n = 7).
145-1	51674-51690	Interhemispheric	_	
145-2	51691-51703	correlations	_	
145-3	51704-51706	in	_	
145-4	51707-51710	the	_	
145-5	51711-51718	lateral	_	
145-6	51719-51722	OFC	_	
145-7	51723-51724	(	_	
145-8	51724-51728	lOFC	_	
145-9	51728-51729	)	_	
145-10	51730-51733	and	_	
145-11	51734-51740	medial	_	
145-12	51741-51744	OFC	_	
145-13	51745-51746	(	_	
145-14	51746-51750	mOFC	_	
145-15	51750-51751	)	_	
145-16	51752-51754	of	_	
145-17	51755-51764	abstinent	_	
145-18	51765-51781	heroin-dependent	_	
145-19	51782-51790	subjects	_	
145-20	51791-51792	(	_	
145-21	51792-51795	HDs	_	
145-22	51795-51796	,	_	
145-23	51797-51802	green	_	
145-24	51802-51803	,	_	
145-25	51804-51805	n	_	
145-26	51806-51807	=	_	
145-27	51808-51809	8	_	
145-28	51809-51810	)	_	
145-29	51811-51814	and	_	
145-30	51815-51822	control	_	
145-31	51823-51831	subjects	_	
145-32	51832-51833	(	_	
145-33	51833-51836	CGs	_	
145-34	51836-51837	,	_	
145-35	51838-51842	blue	_	
145-36	51842-51843	,	_	
145-37	51844-51845	n	_	
145-38	51846-51847	=	_	
145-39	51848-51849	7	_	
145-40	51849-51850	)	_	
145-41	51850-51851	.	_	

#Text=Error bars represent the standard error of the mean over all the subjects. Compared with the CGs, the HDs demonstrated significantly increased interhemispheric HbO correlation values overall (p = 0.016) with the rest of the channels and the lOFC (p = 0.033) as well as greater Hb correlation values overall (p = 0.012) with the rest of the channels, lOFC (p = 0.049), and mOFC (p = 0.012).
146-1	51852-51857	Error	_	
146-2	51858-51862	bars	_	
146-3	51863-51872	represent	_	
146-4	51873-51876	the	_	
146-5	51877-51885	standard	_	
146-6	51886-51891	error	_	
146-7	51892-51894	of	_	
146-8	51895-51898	the	_	
146-9	51899-51903	mean	_	
146-10	51904-51908	over	_	
146-11	51909-51912	all	_	
146-12	51913-51916	the	_	
146-13	51917-51925	subjects	_	
146-14	51925-51926	.	_	
146-15	51927-51935	Compared	_	
146-16	51936-51940	with	_	
146-17	51941-51944	the	_	
146-18	51945-51948	CGs	_	
146-19	51948-51949	,	_	
146-20	51950-51953	the	_	
146-21	51954-51957	HDs	_	
146-22	51958-51970	demonstrated	_	
146-23	51971-51984	significantly	_	
146-24	51985-51994	increased	_	
146-25	51995-52011	interhemispheric	_	
146-26	52012-52015	HbO	_	
146-27	52016-52027	correlation	_	
146-28	52028-52034	values	_	
146-29	52035-52042	overall	_	
146-30	52043-52044	(	_	
146-31	52044-52045	p	_	
146-32	52046-52047	=	_	
146-33	52048-52053	0.016	_	
146-34	52053-52054	)	_	
146-35	52055-52059	with	_	
146-36	52060-52063	the	_	
146-37	52064-52068	rest	_	
146-38	52069-52071	of	_	
146-39	52072-52075	the	_	
146-40	52076-52084	channels	_	
146-41	52085-52088	and	_	
146-42	52089-52092	the	_	
146-43	52093-52097	lOFC	_	
146-44	52098-52099	(	_	
146-45	52099-52100	p	_	
146-46	52101-52102	=	_	
146-47	52103-52108	0.033	_	
146-48	52108-52109	)	_	
146-49	52110-52112	as	_	
146-50	52113-52117	well	_	
146-51	52118-52120	as	_	
146-52	52121-52128	greater	_	
146-53	52129-52131	Hb	_	
146-54	52132-52143	correlation	_	
146-55	52144-52150	values	_	
146-56	52151-52158	overall	_	
146-57	52159-52160	(	_	
146-58	52160-52161	p	_	
146-59	52162-52163	=	_	
146-60	52164-52169	0.012	_	
146-61	52169-52170	)	_	
146-62	52171-52175	with	_	
146-63	52176-52179	the	_	
146-64	52180-52184	rest	_	
146-65	52185-52187	of	_	
146-66	52188-52191	the	_	
146-67	52192-52200	channels	_	
146-68	52200-52201	,	_	
146-69	52202-52206	lOFC	_	
146-70	52207-52208	(	_	
146-71	52208-52209	p	_	
146-72	52210-52211	=	_	
146-73	52212-52217	0.049	_	
146-74	52217-52218	)	_	
146-75	52218-52219	,	_	
146-76	52220-52223	and	_	
146-77	52224-52228	mOFC	_	
146-78	52229-52230	(	_	
146-79	52230-52231	p	_	
146-80	52232-52233	=	_	
146-81	52234-52239	0.012	_	
146-82	52239-52240	)	_	
146-83	52240-52241	.	_	

#Text=Seed-based rsFC Z-R maps of the OFC systems.
147-1	52242-52252	Seed-based	_	
147-2	52253-52257	rsFC	_	
147-3	52258-52261	Z-R	_	
147-4	52262-52266	maps	_	
147-5	52267-52269	of	_	
147-6	52270-52273	the	_	
147-7	52274-52277	OFC	_	
147-8	52278-52285	systems	_	
147-9	52285-52286	.	_	

#Text=(A,B) and (E,F) represent the HDs. (C,D) and (G,H) represent the CGs. The left column indicates the right seed channel OFC regions, and the right column indicates the left seed channel OFC regions. Channels that had enhanced rsFC with OFC seed regions are displayed in warm colors. The selected seed channels are boxed. The seed channels were selected based on the localizer task activation seed channels (i.e., channel 11 with its symmetrical channel 12 for the left side and channel 4 with its symmetrical channel 1 for the right). Each channel is numbered. Color bars represent the HbO-based Z to R correlation coefficient values.
148-1	52287-52288	(	_	
148-2	52288-52289	A	_	
148-3	52289-52290	,	_	
148-4	52290-52291	B	_	
148-5	52291-52292	)	_	
148-6	52293-52296	and	_	
148-7	52297-52298	(	_	
148-8	52298-52299	E	_	
148-9	52299-52300	,	_	
148-10	52300-52301	F	_	
148-11	52301-52302	)	_	
148-12	52303-52312	represent	_	
148-13	52313-52316	the	_	
148-14	52317-52320	HDs	_	
148-15	52320-52321	.	_	
148-16	52322-52323	(	_	
148-17	52323-52324	C	_	
148-18	52324-52325	,	_	
148-19	52325-52326	D	_	
148-20	52326-52327	)	_	
148-21	52328-52331	and	_	
148-22	52332-52333	(	_	
148-23	52333-52334	G	_	
148-24	52334-52335	,	_	
148-25	52335-52336	H	_	
148-26	52336-52337	)	_	
148-27	52338-52347	represent	_	
148-28	52348-52351	the	_	
148-29	52352-52355	CGs	_	
148-30	52355-52356	.	_	
148-31	52357-52360	The	_	
148-32	52361-52365	left	_	
148-33	52366-52372	column	_	
148-34	52373-52382	indicates	_	
148-35	52383-52386	the	_	
148-36	52387-52392	right	_	
148-37	52393-52397	seed	_	
148-38	52398-52405	channel	_	
148-39	52406-52409	OFC	_	
148-40	52410-52417	regions	_	
148-41	52417-52418	,	_	
148-42	52419-52422	and	_	
148-43	52423-52426	the	_	
148-44	52427-52432	right	_	
148-45	52433-52439	column	_	
148-46	52440-52449	indicates	_	
148-47	52450-52453	the	_	
148-48	52454-52458	left	_	
148-49	52459-52463	seed	_	
148-50	52464-52471	channel	_	
148-51	52472-52475	OFC	_	
148-52	52476-52483	regions	_	
148-53	52483-52484	.	_	
148-54	52485-52493	Channels	_	
148-55	52494-52498	that	_	
148-56	52499-52502	had	_	
148-57	52503-52511	enhanced	_	
148-58	52512-52516	rsFC	_	
148-59	52517-52521	with	_	
148-60	52522-52525	OFC	_	
148-61	52526-52530	seed	_	
148-62	52531-52538	regions	_	
148-63	52539-52542	are	_	
148-64	52543-52552	displayed	_	
148-65	52553-52555	in	_	
148-66	52556-52560	warm	_	
148-67	52561-52567	colors	_	
148-68	52567-52568	.	_	
148-69	52569-52572	The	_	
148-70	52573-52581	selected	_	
148-71	52582-52586	seed	_	
148-72	52587-52595	channels	_	
148-73	52596-52599	are	_	
148-74	52600-52605	boxed	_	
148-75	52605-52606	.	_	
148-76	52607-52610	The	_	
148-77	52611-52615	seed	_	
148-78	52616-52624	channels	_	
148-79	52625-52629	were	_	
148-80	52630-52638	selected	_	
148-81	52639-52644	based	_	
148-82	52645-52647	on	_	
148-83	52648-52651	the	_	
148-84	52652-52661	localizer	_	
148-85	52662-52666	task	_	
148-86	52667-52677	activation	_	
148-87	52678-52682	seed	_	
148-88	52683-52691	channels	_	
148-89	52692-52693	(	_	
148-90	52693-52696	i.e	_	
148-91	52696-52697	.	_	
148-92	52697-52698	,	_	
148-93	52699-52706	channel	_	
148-94	52707-52709	11	_	
148-95	52710-52714	with	_	
148-96	52715-52718	its	_	
148-97	52719-52730	symmetrical	_	
148-98	52731-52738	channel	_	
148-99	52739-52741	12	_	
148-100	52742-52745	for	_	
148-101	52746-52749	the	_	
148-102	52750-52754	left	_	
148-103	52755-52759	side	_	
148-104	52760-52763	and	_	
148-105	52764-52771	channel	_	
148-106	52772-52773	4	_	
148-107	52774-52778	with	_	
148-108	52779-52782	its	_	
148-109	52783-52794	symmetrical	_	
148-110	52795-52802	channel	_	
148-111	52803-52804	1	_	
148-112	52805-52808	for	_	
148-113	52809-52812	the	_	
148-114	52813-52818	right	_	
148-115	52818-52819	)	_	
148-116	52819-52820	.	_	
148-117	52821-52825	Each	_	
148-118	52826-52833	channel	_	
148-119	52834-52836	is	_	
148-120	52837-52845	numbered	_	
148-121	52845-52846	.	_	
148-122	52847-52852	Color	_	
148-123	52853-52857	bars	_	
148-124	52858-52867	represent	_	
148-125	52868-52871	the	_	
148-126	52872-52881	HbO-based	_	
148-127	52882-52883	Z	_	
148-128	52884-52886	to	_	
148-129	52887-52888	R	_	
148-130	52889-52900	correlation	_	
148-131	52901-52912	coefficient	_	
148-132	52913-52919	values	_	
148-133	52919-52920	.	_	

#Text=Whole-brain correlation analysis for comparison of the brain networks between the HDs and CGs.
149-1	52921-52932	Whole-brain	_	
149-2	52933-52944	correlation	_	
149-3	52945-52953	analysis	_	
149-4	52954-52957	for	_	
149-5	52958-52968	comparison	_	
149-6	52969-52971	of	_	
149-7	52972-52975	the	_	
149-8	52976-52981	brain	_	
149-9	52982-52990	networks	_	
149-10	52991-52998	between	_	
149-11	52999-53002	the	_	
149-12	53003-53006	HDs	_	
149-13	53007-53010	and	_	
149-14	53011-53014	CGs	_	
149-15	53014-53015	.	_	

#Text=(A,B) Connectivity matrices of the HDs and CGs, respectively. Color bars represent the correlation coefficient values. (C,D) Brain network patterns of the HDs and CGs, respectively. Only the topmost 5% with correlation values greater than 0.87 are shown in the figures. The nodes (red; channels) are numbered by channel, and the weighted edges (gray) are displayed.
150-1	53016-53017	(	_	
150-2	53017-53018	A	_	
150-3	53018-53019	,	_	
150-4	53019-53020	B	_	
150-5	53020-53021	)	_	
150-6	53022-53034	Connectivity	_	
150-7	53035-53043	matrices	_	
150-8	53044-53046	of	_	
150-9	53047-53050	the	_	
150-10	53051-53054	HDs	_	
150-11	53055-53058	and	_	
150-12	53059-53062	CGs	_	
150-13	53062-53063	,	_	
150-14	53064-53076	respectively	_	
150-15	53076-53077	.	_	
150-16	53078-53083	Color	_	
150-17	53084-53088	bars	_	
150-18	53089-53098	represent	_	
150-19	53099-53102	the	_	
150-20	53103-53114	correlation	_	
150-21	53115-53126	coefficient	_	
150-22	53127-53133	values	_	
150-23	53133-53134	.	_	
150-24	53135-53136	(	_	
150-25	53136-53137	C	_	
150-26	53137-53138	,	_	
150-27	53138-53139	D	_	
150-28	53139-53140	)	_	
150-29	53141-53146	Brain	_	
150-30	53147-53154	network	_	
150-31	53155-53163	patterns	_	
150-32	53164-53166	of	_	
150-33	53167-53170	the	_	
150-34	53171-53174	HDs	_	
150-35	53175-53178	and	_	
150-36	53179-53182	CGs	_	
150-37	53182-53183	,	_	
150-38	53184-53196	respectively	_	
150-39	53196-53197	.	_	
150-40	53198-53202	Only	_	
150-41	53203-53206	the	_	
150-42	53207-53214	topmost	_	
150-43	53215-53217	5%	_	
150-44	53218-53222	with	_	
150-45	53223-53234	correlation	_	
150-46	53235-53241	values	_	
150-47	53242-53249	greater	_	
150-48	53250-53254	than	_	
150-49	53255-53259	0.87	_	
150-50	53260-53263	are	_	
150-51	53264-53269	shown	_	
150-52	53270-53272	in	_	
150-53	53273-53276	the	_	
150-54	53277-53284	figures	_	
150-55	53284-53285	.	_	
150-56	53286-53289	The	_	
150-57	53290-53295	nodes	_	
150-58	53296-53297	(	_	
150-59	53297-53300	red	_	
150-60	53300-53301	;	_	
150-61	53302-53310	channels	_	
150-62	53310-53311	)	_	
150-63	53312-53315	are	_	
150-64	53316-53324	numbered	_	
150-65	53325-53327	by	_	
150-66	53328-53335	channel	_	
150-67	53335-53336	,	_	
150-68	53337-53340	and	_	
150-69	53341-53344	the	_	
150-70	53345-53353	weighted	_	
150-71	53354-53359	edges	_	
150-72	53360-53361	(	_	
150-73	53361-53365	gray	_	
150-74	53365-53366	)	_	
150-75	53367-53370	are	_	
150-76	53371-53380	displayed	_	
150-77	53380-53381	.	_	

#Text=Connectivity strength by channel.
151-1	53382-53394	Connectivity	_	
151-2	53395-53403	strength	_	
151-3	53404-53406	by	_	
151-4	53407-53414	channel	_	
151-5	53414-53415	.	_	

#Text=(A) Connectivity strength with the group average of the correlation coefficients in OFC of the HDs (green) and CGs (blue). Error bars indicate the standard error of the mean across the HDs and CGs. Compared with the CGs, the HDs showed significantly greater connectivity strength in almost all the channels, except channel 7, in terms of HbO. (B,C) The size of each node indicates its corresponding nodal strength in the networks of two groups (CG, blue; HD, green). The strength values are shown in Supplementary Table S4. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
152-1	53416-53417	(	_	
152-2	53417-53418	A	_	
152-3	53418-53419	)	_	
152-4	53420-53432	Connectivity	_	
152-5	53433-53441	strength	_	
152-6	53442-53446	with	_	
152-7	53447-53450	the	_	
152-8	53451-53456	group	_	
152-9	53457-53464	average	_	
152-10	53465-53467	of	_	
152-11	53468-53471	the	_	
152-12	53472-53483	correlation	_	
152-13	53484-53496	coefficients	_	
152-14	53497-53499	in	_	
152-15	53500-53503	OFC	_	
152-16	53504-53506	of	_	
152-17	53507-53510	the	_	
152-18	53511-53514	HDs	_	
152-19	53515-53516	(	_	
152-20	53516-53521	green	_	
152-21	53521-53522	)	_	
152-22	53523-53526	and	_	
152-23	53527-53530	CGs	_	
152-24	53531-53532	(	_	
152-25	53532-53536	blue	_	
152-26	53536-53537	)	_	
152-27	53537-53538	.	_	
152-28	53539-53544	Error	_	
152-29	53545-53549	bars	_	
152-30	53550-53558	indicate	_	
152-31	53559-53562	the	_	
152-32	53563-53571	standard	_	
152-33	53572-53577	error	_	
152-34	53578-53580	of	_	
152-35	53581-53584	the	_	
152-36	53585-53589	mean	_	
152-37	53590-53596	across	_	
152-38	53597-53600	the	_	
152-39	53601-53604	HDs	_	
152-40	53605-53608	and	_	
152-41	53609-53612	CGs	_	
152-42	53612-53613	.	_	
152-43	53614-53622	Compared	_	
152-44	53623-53627	with	_	
152-45	53628-53631	the	_	
152-46	53632-53635	CGs	_	
152-47	53635-53636	,	_	
152-48	53637-53640	the	_	
152-49	53641-53644	HDs	_	
152-50	53645-53651	showed	_	
152-51	53652-53665	significantly	_	
152-52	53666-53673	greater	_	
152-53	53674-53686	connectivity	_	
152-54	53687-53695	strength	_	
152-55	53696-53698	in	_	
152-56	53699-53705	almost	_	
152-57	53706-53709	all	_	
152-58	53710-53713	the	_	
152-59	53714-53722	channels	_	
152-60	53722-53723	,	_	
152-61	53724-53730	except	_	
152-62	53731-53738	channel	_	
152-63	53739-53740	7	_	
152-64	53740-53741	,	_	
152-65	53742-53744	in	_	
152-66	53745-53750	terms	_	
152-67	53751-53753	of	_	
152-68	53754-53757	HbO	_	
152-69	53757-53758	.	_	
152-70	53759-53760	(	_	
152-71	53760-53761	B	_	
152-72	53761-53762	,	_	
152-73	53762-53763	C	_	
152-74	53763-53764	)	_	
152-75	53765-53768	The	_	
152-76	53769-53773	size	_	
152-77	53774-53776	of	_	
152-78	53777-53781	each	_	
152-79	53782-53786	node	_	
152-80	53787-53796	indicates	_	
152-81	53797-53800	its	_	
152-82	53801-53814	corresponding	_	
152-83	53815-53820	nodal	_	
152-84	53821-53829	strength	_	
152-85	53830-53832	in	_	
152-86	53833-53836	the	_	
152-87	53837-53845	networks	_	
152-88	53846-53848	of	_	
152-89	53849-53852	two	_	
152-90	53853-53859	groups	_	
152-91	53860-53861	(	_	
152-92	53861-53863	CG	_	
152-93	53863-53864	,	_	
152-94	53865-53869	blue	_	
152-95	53869-53870	;	_	
152-96	53871-53873	HD	_	
152-97	53873-53874	,	_	
152-98	53875-53880	green	_	
152-99	53880-53881	)	_	
152-100	53881-53882	.	_	
152-101	53883-53886	The	_	
152-102	53887-53895	strength	_	
152-103	53896-53902	values	_	
152-104	53903-53906	are	_	
152-105	53907-53912	shown	_	
152-106	53913-53915	in	_	
152-107	53916-53929	Supplementary	_	
152-108	53930-53935	Table	_	
152-109	53936-53938	S4	_	
152-110	53938-53939	.	_	
152-111	53940-53941	*	_	
152-112	53941-53942	p	_	
152-113	53943-53944	<	_	
152-114	53945-53949	0.05	_	
152-115	53949-53950	;	_	
152-116	53951-53952	*	_	
152-117	53952-53953	*	_	
152-118	53953-53954	p	_	
152-119	53955-53956	<	_	
152-120	53957-53961	0.01	_	
152-121	53961-53962	;	_	
152-122	53963-53964	*	_	
152-123	53964-53965	*	_	
152-124	53965-53966	*	_	
152-125	53966-53967	p	_	
152-126	53968-53969	<	_	
152-127	53970-53975	0.001	_	
152-128	53975-53976	;	_	
152-129	53977-53978	*	_	
152-130	53978-53979	*	_	
152-131	53979-53980	*	_	
152-132	53980-53981	*	_	
152-133	53981-53982	p	_	
152-134	53983-53984	<	_	
152-135	53985-53991	0.0001	_	
152-136	53991-53992	.	_	

#Text=Comparison of the HD brain network to the CG brain network: Small-worldness and network efficiency.
153-1	53993-54003	Comparison	_	
153-2	54004-54006	of	_	
153-3	54007-54010	the	_	
153-4	54011-54013	HD	_	
153-5	54014-54019	brain	_	
153-6	54020-54027	network	_	
153-7	54028-54030	to	_	
153-8	54031-54034	the	_	
153-9	54035-54037	CG	_	
153-10	54038-54043	brain	_	
153-11	54044-54051	network	_	
153-12	54051-54052	:	_	
153-13	54053-54068	Small-worldness	_	
153-14	54069-54072	and	_	
153-15	54073-54080	network	_	
153-16	54081-54091	efficiency	_	
153-17	54091-54092	.	_	

#Text=Network parameters were based on the functional networks generated from the HbO measurements over a wide range of sparsity. (A) Clustering coefficient, (B) characteristic path length, (D) local efficiency, and (E), global efficiency, were the network properties under study. For the entire range of sparsity thresholds from 0 to 1, the brain network in the HDs (blue) had greater clustering coefficients and local efficiency values than the brain network in the CGs (red). Normalized clustering coefficients (γ, green) and normalized path lengths (λ, green) with respect to the CG network are shown in (C). Normalized local efficiency (γE, green) and normalized global efficiency (λE, green) with respect to the CG network are shown in (F). The normalized path length and global efficiency values in both groups shared similar patterns, resulting in γ and γE > 1 and λ and λE = ~1. These findings may indicate that the rsFC networks in the HDs carried small-world characteristics with respect to the CG networks. The gray zones represent a significant (pFDR < 0.05) difference between the HD network and the CG network. The asterisk (*) represents a significant (p < 0.025) difference between the small-world network measures from the intuitive normalization method and the traditional normalization one. The comparison of the brain networks to random networks are shown in Supplementary Figure S5. The small-worldness measures from both the intuitive and traditional normalization methods are shown in Supplementary Figure S6.
154-1	54093-54100	Network	_	
154-2	54101-54111	parameters	_	
154-3	54112-54116	were	_	
154-4	54117-54122	based	_	
154-5	54123-54125	on	_	
154-6	54126-54129	the	_	
154-7	54130-54140	functional	_	
154-8	54141-54149	networks	_	
154-9	54150-54159	generated	_	
154-10	54160-54164	from	_	
154-11	54165-54168	the	_	
154-12	54169-54172	HbO	_	
154-13	54173-54185	measurements	_	
154-14	54186-54190	over	_	
154-15	54191-54192	a	_	
154-16	54193-54197	wide	_	
154-17	54198-54203	range	_	
154-18	54204-54206	of	_	
154-19	54207-54215	sparsity	_	
154-20	54215-54216	.	_	
154-21	54217-54218	(	_	
154-22	54218-54219	A	_	
154-23	54219-54220	)	_	
154-24	54221-54231	Clustering	_	
154-25	54232-54243	coefficient	_	
154-26	54243-54244	,	_	
154-27	54245-54246	(	_	
154-28	54246-54247	B	_	
154-29	54247-54248	)	_	
154-30	54249-54263	characteristic	_	
154-31	54264-54268	path	_	
154-32	54269-54275	length	_	
154-33	54275-54276	,	_	
154-34	54277-54278	(	_	
154-35	54278-54279	D	_	
154-36	54279-54280	)	_	
154-37	54281-54286	local	_	
154-38	54287-54297	efficiency	_	
154-39	54297-54298	,	_	
154-40	54299-54302	and	_	
154-41	54303-54304	(	_	
154-42	54304-54305	E	_	
154-43	54305-54306	)	_	
154-44	54306-54307	,	_	
154-45	54308-54314	global	_	
154-46	54315-54325	efficiency	_	
154-47	54325-54326	,	_	
154-48	54327-54331	were	_	
154-49	54332-54335	the	_	
154-50	54336-54343	network	_	
154-51	54344-54354	properties	_	
154-52	54355-54360	under	_	
154-53	54361-54366	study	_	
154-54	54366-54367	.	_	
154-55	54368-54371	For	_	
154-56	54372-54375	the	_	
154-57	54376-54382	entire	_	
154-58	54383-54388	range	_	
154-59	54389-54391	of	_	
154-60	54392-54400	sparsity	_	
154-61	54401-54411	thresholds	_	
154-62	54412-54416	from	_	
154-63	54417-54418	0	_	
154-64	54419-54421	to	_	
154-65	54422-54423	1	_	
154-66	54423-54424	,	_	
154-67	54425-54428	the	_	
154-68	54429-54434	brain	_	
154-69	54435-54442	network	_	
154-70	54443-54445	in	_	
154-71	54446-54449	the	_	
154-72	54450-54453	HDs	_	
154-73	54454-54455	(	_	
154-74	54455-54459	blue	_	
154-75	54459-54460	)	_	
154-76	54461-54464	had	_	
154-77	54465-54472	greater	_	
154-78	54473-54483	clustering	_	
154-79	54484-54496	coefficients	_	
154-80	54497-54500	and	_	
154-81	54501-54506	local	_	
154-82	54507-54517	efficiency	_	
154-83	54518-54524	values	_	
154-84	54525-54529	than	_	
154-85	54530-54533	the	_	
154-86	54534-54539	brain	_	
154-87	54540-54547	network	_	
154-88	54548-54550	in	_	
154-89	54551-54554	the	_	
154-90	54555-54558	CGs	_	
154-91	54559-54560	(	_	
154-92	54560-54563	red	_	
154-93	54563-54564	)	_	
154-94	54564-54565	.	_	
154-95	54566-54576	Normalized	_	
154-96	54577-54587	clustering	_	
154-97	54588-54600	coefficients	_	
154-98	54601-54602	(	_	
154-99	54602-54603	γ	_	
154-100	54603-54604	,	_	
154-101	54605-54610	green	_	
154-102	54610-54611	)	_	
154-103	54612-54615	and	_	
154-104	54616-54626	normalized	_	
154-105	54627-54631	path	_	
154-106	54632-54639	lengths	_	
154-107	54640-54641	(	_	
154-108	54641-54642	λ	_	
154-109	54642-54643	,	_	
154-110	54644-54649	green	_	
154-111	54649-54650	)	_	
154-112	54651-54655	with	_	
154-113	54656-54663	respect	_	
154-114	54664-54666	to	_	
154-115	54667-54670	the	_	
154-116	54671-54673	CG	_	
154-117	54674-54681	network	_	
154-118	54682-54685	are	_	
154-119	54686-54691	shown	_	
154-120	54692-54694	in	_	
154-121	54695-54696	(	_	
154-122	54696-54697	C	_	
154-123	54697-54698	)	_	
154-124	54698-54699	.	_	
154-125	54700-54710	Normalized	_	
154-126	54711-54716	local	_	
154-127	54717-54727	efficiency	_	
154-128	54728-54729	(	_	
154-129	54729-54731	γE	_	
154-130	54731-54732	,	_	
154-131	54733-54738	green	_	
154-132	54738-54739	)	_	
154-133	54740-54743	and	_	
154-134	54744-54754	normalized	_	
154-135	54755-54761	global	_	
154-136	54762-54772	efficiency	_	
154-137	54773-54774	(	_	
154-138	54774-54776	λE	_	
154-139	54776-54777	,	_	
154-140	54778-54783	green	_	
154-141	54783-54784	)	_	
154-142	54785-54789	with	_	
154-143	54790-54797	respect	_	
154-144	54798-54800	to	_	
154-145	54801-54804	the	_	
154-146	54805-54807	CG	_	
154-147	54808-54815	network	_	
154-148	54816-54819	are	_	
154-149	54820-54825	shown	_	
154-150	54826-54828	in	_	
154-151	54829-54830	(	_	
154-152	54830-54831	F	_	
154-153	54831-54832	)	_	
154-154	54832-54833	.	_	
154-155	54834-54837	The	_	
154-156	54838-54848	normalized	_	
154-157	54849-54853	path	_	
154-158	54854-54860	length	_	
154-159	54861-54864	and	_	
154-160	54865-54871	global	_	
154-161	54872-54882	efficiency	_	
154-162	54883-54889	values	_	
154-163	54890-54892	in	_	
154-164	54893-54897	both	_	
154-165	54898-54904	groups	_	
154-166	54905-54911	shared	_	
154-167	54912-54919	similar	_	
154-168	54920-54928	patterns	_	
154-169	54928-54929	,	_	
154-170	54930-54939	resulting	_	
154-171	54940-54942	in	_	
154-172	54943-54944	γ	_	
154-173	54945-54948	and	_	
154-174	54949-54951	γE	_	
154-175	54952-54953	>	_	
154-176	54954-54955	1	_	
154-177	54956-54959	and	_	
154-178	54960-54961	λ	_	
154-179	54962-54965	and	_	
154-180	54966-54968	λE	_	
154-181	54969-54970	=	_	
154-182	54971-54972	~	_	
154-183	54972-54973	1	_	
154-184	54973-54974	.	_	
154-185	54975-54980	These	_	
154-186	54981-54989	findings	_	
154-187	54990-54993	may	_	
154-188	54994-55002	indicate	_	
154-189	55003-55007	that	_	
154-190	55008-55011	the	_	
154-191	55012-55016	rsFC	_	
154-192	55017-55025	networks	_	
154-193	55026-55028	in	_	
154-194	55029-55032	the	_	
154-195	55033-55036	HDs	_	
154-196	55037-55044	carried	_	
154-197	55045-55056	small-world	_	
154-198	55057-55072	characteristics	_	
154-199	55073-55077	with	_	
154-200	55078-55085	respect	_	
154-201	55086-55088	to	_	
154-202	55089-55092	the	_	
154-203	55093-55095	CG	_	
154-204	55096-55104	networks	_	
154-205	55104-55105	.	_	
154-206	55106-55109	The	_	
154-207	55110-55114	gray	_	
154-208	55115-55120	zones	_	
154-209	55121-55130	represent	_	
154-210	55131-55132	a	_	
154-211	55133-55144	significant	_	
154-212	55145-55146	(	_	
154-213	55146-55150	pFDR	_	
154-214	55151-55152	<	_	
154-215	55153-55157	0.05	_	
154-216	55157-55158	)	_	
154-217	55159-55169	difference	_	
154-218	55170-55177	between	_	
154-219	55178-55181	the	_	
154-220	55182-55184	HD	_	
154-221	55185-55192	network	_	
154-222	55193-55196	and	_	
154-223	55197-55200	the	_	
154-224	55201-55203	CG	_	
154-225	55204-55211	network	_	
154-226	55211-55212	.	_	
154-227	55213-55216	The	_	
154-228	55217-55225	asterisk	_	
154-229	55226-55227	(	_	
154-230	55227-55228	*	_	
154-231	55228-55229	)	_	
154-232	55230-55240	represents	_	
154-233	55241-55242	a	_	
154-234	55243-55254	significant	_	
154-235	55255-55256	(	_	
154-236	55256-55257	p	_	
154-237	55258-55259	<	_	
154-238	55260-55265	0.025	_	
154-239	55265-55266	)	_	
154-240	55267-55277	difference	_	
154-241	55278-55285	between	_	
154-242	55286-55289	the	_	
154-243	55290-55301	small-world	_	
154-244	55302-55309	network	_	
154-245	55310-55318	measures	_	
154-246	55319-55323	from	_	
154-247	55324-55327	the	_	
154-248	55328-55337	intuitive	_	
154-249	55338-55351	normalization	_	
154-250	55352-55358	method	_	
154-251	55359-55362	and	_	
154-252	55363-55366	the	_	
154-253	55367-55378	traditional	_	
154-254	55379-55392	normalization	_	
154-255	55393-55396	one	_	
154-256	55396-55397	.	_	
154-257	55398-55401	The	_	
154-258	55402-55412	comparison	_	
154-259	55413-55415	of	_	
154-260	55416-55419	the	_	
154-261	55420-55425	brain	_	
154-262	55426-55434	networks	_	
154-263	55435-55437	to	_	
154-264	55438-55444	random	_	
154-265	55445-55453	networks	_	
154-266	55454-55457	are	_	
154-267	55458-55463	shown	_	
154-268	55464-55466	in	_	
154-269	55467-55480	Supplementary	_	
154-270	55481-55487	Figure	_	
154-271	55488-55490	S5	_	
154-272	55490-55491	.	_	
154-273	55492-55495	The	_	
154-274	55496-55511	small-worldness	_	
154-275	55512-55520	measures	_	
154-276	55521-55525	from	_	
154-277	55526-55530	both	_	
154-278	55531-55534	the	_	
154-279	55535-55544	intuitive	_	
154-280	55545-55548	and	_	
154-281	55549-55560	traditional	_	
154-282	55561-55574	normalization	_	
154-283	55575-55582	methods	_	
154-284	55583-55586	are	_	
154-285	55587-55592	shown	_	
154-286	55593-55595	in	_	
154-287	55596-55609	Supplementary	_	
154-288	55610-55616	Figure	_	
154-289	55617-55619	S6	_	
154-290	55619-55620	.	_	

#Text=Regression analysis of the level of anxiety and functional connectivity.
155-1	55621-55631	Regression	_	
155-2	55632-55640	analysis	_	
155-3	55641-55643	of	_	
155-4	55644-55647	the	_	
155-5	55648-55653	level	_	
155-6	55654-55656	of	_	
155-7	55657-55664	anxiety	_	
155-8	55665-55668	and	_	
155-9	55669-55679	functional	_	
155-10	55680-55692	connectivity	_	
155-11	55692-55693	.	_	

#Text=(A) (top two rows), Connectivity T maps between groups (NHD = 8, NCG = 6) are shown with respect to seed channel 11 (red). The channels are colored by their t values, as scaled in the color bar. The results and channels are displayed on a standardized ICBM152 brain surface from the BrainViewer. (B–E) (bottom rows), Scatter plots by group (HD: green, CG: orange) and population of the sample (pop: black) of the sample show the relationships between the STAI-anxiety score (after controlling for the covariates of age, IQ, education level, and daily cigarette consumption) and the connectivity values for channels 11 and 1 (B), channels 11 and 6 (C), channels 11 and 8 (D), and channels 11 and 9 (E). Each regression line for the population-level sample showed significance (pFDR < 0.05, q-value = 0.09) and depicts the predicted model for the STAI-anxiety score and the left inferior frontal gyrus connectivity, including covariates.
156-1	55694-55695	(	_	
156-2	55695-55696	A	_	
156-3	55696-55697	)	_	
156-4	55698-55699	(	_	
156-5	55699-55702	top	_	
156-6	55703-55706	two	_	
156-7	55707-55711	rows	_	
156-8	55711-55712	)	_	
156-9	55712-55713	,	_	
156-10	55714-55726	Connectivity	_	
156-11	55727-55728	T	_	
156-12	55729-55733	maps	_	
156-13	55734-55741	between	_	
156-14	55742-55748	groups	_	
156-15	55749-55750	(	_	
156-16	55750-55753	NHD	_	
156-17	55754-55755	=	_	
156-18	55756-55757	8	_	
156-19	55757-55758	,	_	
156-20	55759-55762	NCG	_	
156-21	55763-55764	=	_	
156-22	55765-55766	6	_	
156-23	55766-55767	)	_	
156-24	55768-55771	are	_	
156-25	55772-55777	shown	_	
156-26	55778-55782	with	_	
156-27	55783-55790	respect	_	
156-28	55791-55793	to	_	
156-29	55794-55798	seed	_	
156-30	55799-55806	channel	_	
156-31	55807-55809	11	_	
156-32	55810-55811	(	_	
156-33	55811-55814	red	_	
156-34	55814-55815	)	_	
156-35	55815-55816	.	_	
156-36	55817-55820	The	_	
156-37	55821-55829	channels	_	
156-38	55830-55833	are	_	
156-39	55834-55841	colored	_	
156-40	55842-55844	by	_	
156-41	55845-55850	their	_	
156-42	55851-55852	t	_	
156-43	55853-55859	values	_	
156-44	55859-55860	,	_	
156-45	55861-55863	as	_	
156-46	55864-55870	scaled	_	
156-47	55871-55873	in	_	
156-48	55874-55877	the	_	
156-49	55878-55883	color	_	
156-50	55884-55887	bar	_	
156-51	55887-55888	.	_	
156-52	55889-55892	The	_	
156-53	55893-55900	results	_	
156-54	55901-55904	and	_	
156-55	55905-55913	channels	_	
156-56	55914-55917	are	_	
156-57	55918-55927	displayed	_	
156-58	55928-55930	on	_	
156-59	55931-55932	a	_	
156-60	55933-55945	standardized	_	
156-61	55946-55953	ICBM152	_	
156-62	55954-55959	brain	_	
156-63	55960-55967	surface	_	
156-64	55968-55972	from	_	
156-65	55973-55976	the	_	
156-66	55977-55988	BrainViewer	_	
156-67	55988-55989	.	_	
156-68	55990-55991	(	_	
156-69	55991-55994	B–E	_	
156-70	55994-55995	)	_	
156-71	55996-55997	(	_	
156-72	55997-56003	bottom	_	
156-73	56004-56008	rows	_	
156-74	56008-56009	)	_	
156-75	56009-56010	,	_	
156-76	56011-56018	Scatter	_	
156-77	56019-56024	plots	_	
156-78	56025-56027	by	_	
156-79	56028-56033	group	_	
156-80	56034-56035	(	_	
156-81	56035-56037	HD	_	
156-82	56037-56038	:	_	
156-83	56039-56044	green	_	
156-84	56044-56045	,	_	
156-85	56046-56048	CG	_	
156-86	56048-56049	:	_	
156-87	56050-56056	orange	_	
156-88	56056-56057	)	_	
156-89	56058-56061	and	_	
156-90	56062-56072	population	_	
156-91	56073-56075	of	_	
156-92	56076-56079	the	_	
156-93	56080-56086	sample	_	
156-94	56087-56088	(	_	
156-95	56088-56091	pop	_	
156-96	56091-56092	:	_	
156-97	56093-56098	black	_	
156-98	56098-56099	)	_	
156-99	56100-56102	of	_	
156-100	56103-56106	the	_	
156-101	56107-56113	sample	_	
156-102	56114-56118	show	_	
156-103	56119-56122	the	_	
156-104	56123-56136	relationships	_	
156-105	56137-56144	between	_	
156-106	56145-56148	the	_	
156-107	56149-56161	STAI-anxiety	_	
156-108	56162-56167	score	_	
156-109	56168-56169	(	_	
156-110	56169-56174	after	_	
156-111	56175-56186	controlling	_	
156-112	56187-56190	for	_	
156-113	56191-56194	the	_	
156-114	56195-56205	covariates	_	
156-115	56206-56208	of	_	
156-116	56209-56212	age	_	
156-117	56212-56213	,	_	
156-118	56214-56216	IQ	_	
156-119	56216-56217	,	_	
156-120	56218-56227	education	_	
156-121	56228-56233	level	_	
156-122	56233-56234	,	_	
156-123	56235-56238	and	_	
156-124	56239-56244	daily	_	
156-125	56245-56254	cigarette	_	
156-126	56255-56266	consumption	_	
156-127	56266-56267	)	_	
156-128	56268-56271	and	_	
156-129	56272-56275	the	_	
156-130	56276-56288	connectivity	_	
156-131	56289-56295	values	_	
156-132	56296-56299	for	_	
156-133	56300-56308	channels	_	
156-134	56309-56311	11	_	
156-135	56312-56315	and	_	
156-136	56316-56317	1	_	
156-137	56318-56319	(	_	
156-138	56319-56320	B	_	
156-139	56320-56321	)	_	
156-140	56321-56322	,	_	
156-141	56323-56331	channels	_	
156-142	56332-56334	11	_	
156-143	56335-56338	and	_	
156-144	56339-56340	6	_	
156-145	56341-56342	(	_	
156-146	56342-56343	C	_	
156-147	56343-56344	)	_	
156-148	56344-56345	,	_	
156-149	56346-56354	channels	_	
156-150	56355-56357	11	_	
156-151	56358-56361	and	_	
156-152	56362-56363	8	_	
156-153	56364-56365	(	_	
156-154	56365-56366	D	_	
156-155	56366-56367	)	_	
156-156	56367-56368	,	_	
156-157	56369-56372	and	_	
156-158	56373-56381	channels	_	
156-159	56382-56384	11	_	
156-160	56385-56388	and	_	
156-161	56389-56390	9	_	
156-162	56391-56392	(	_	
156-163	56392-56393	E	_	
156-164	56393-56394	)	_	
156-165	56394-56395	.	_	
156-166	56396-56400	Each	_	
156-167	56401-56411	regression	_	
156-168	56412-56416	line	_	
156-169	56417-56420	for	_	
156-170	56421-56424	the	_	
156-171	56425-56441	population-level	_	
156-172	56442-56448	sample	_	
156-173	56449-56455	showed	_	
156-174	56456-56468	significance	_	
156-175	56469-56470	(	_	
156-176	56470-56474	pFDR	_	
156-177	56475-56476	<	_	
156-178	56477-56481	0.05	_	
156-179	56481-56482	,	_	
156-180	56483-56490	q-value	_	
156-181	56491-56492	=	_	
156-182	56493-56497	0.09	_	
156-183	56497-56498	)	_	
156-184	56499-56502	and	_	
156-185	56503-56510	depicts	_	
156-186	56511-56514	the	_	
156-187	56515-56524	predicted	_	
156-188	56525-56530	model	_	
156-189	56531-56534	for	_	
156-190	56535-56538	the	_	
156-191	56539-56551	STAI-anxiety	_	
156-192	56552-56557	score	_	
156-193	56558-56561	and	_	
156-194	56562-56565	the	_	
156-195	56566-56570	left	_	
156-196	56571-56579	inferior	_	
156-197	56580-56587	frontal	_	
156-198	56588-56593	gyrus	_	
156-199	56594-56606	connectivity	_	
156-200	56606-56607	,	_	
156-201	56608-56617	including	_	
156-202	56618-56628	covariates	_	
156-203	56628-56629	.	_	

#Text=The position of the 12 channels on both hemispheres covering the orbitofrontal cortex.
157-1	56630-56633	The	_	
157-2	56634-56642	position	_	
157-3	56643-56645	of	_	
157-4	56646-56649	the	_	
157-5	56650-56652	12	_	
157-6	56653-56661	channels	_	
157-7	56662-56664	on	_	
157-8	56665-56669	both	_	
157-9	56670-56681	hemispheres	_	
157-10	56682-56690	covering	_	
157-11	56691-56694	the	_	
157-12	56695-56708	orbitofrontal	_	
157-13	56709-56715	cortex	_	
157-14	56715-56716	.	_	

#Text=(A–C) Channels were numbered on the right side, frontal and left side of the brain, respectively. (D) Front view of the probe arrangement. (E) The location of the optodes (3 sources: red dots, 8 detectors: blue dots). Each source and each detector were 30 mm apart. A black line connecting a detector and a source represents a measurement channel with a number. There were 6 channels from each side of the brain: 2 channels covering the medial OFC (right hemisphere: channels 5 and 6; left hemisphere: channels 7 and 8) and, 4 channels covering the lateral OFC (right hemisphere: channels 1–4; left hemisphere: channels 9–12). The medial OFC (mOFC) was bounded with the green line and lateral OFC (lOFC) with the red line. The probe was projected on the scalp with the anchor points in the yellow triangle of Fz, F7, and F8 based on the International 10–20 system. The source in the middle of the probe array was located on the Fpz. The locations of the optodes in the both hemispheres were anatomically symmetrical.
158-1	56717-56718	(	_	
158-2	56718-56721	A–C	_	
158-3	56721-56722	)	_	
158-4	56723-56731	Channels	_	
158-5	56732-56736	were	_	
158-6	56737-56745	numbered	_	
158-7	56746-56748	on	_	
158-8	56749-56752	the	_	
158-9	56753-56758	right	_	
158-10	56759-56763	side	_	
158-11	56763-56764	,	_	
158-12	56765-56772	frontal	_	
158-13	56773-56776	and	_	
158-14	56777-56781	left	_	
158-15	56782-56786	side	_	
158-16	56787-56789	of	_	
158-17	56790-56793	the	_	
158-18	56794-56799	brain	_	
158-19	56799-56800	,	_	
158-20	56801-56813	respectively	_	
158-21	56813-56814	.	_	
158-22	56815-56816	(	_	
158-23	56816-56817	D	_	
158-24	56817-56818	)	_	
158-25	56819-56824	Front	_	
158-26	56825-56829	view	_	
158-27	56830-56832	of	_	
158-28	56833-56836	the	_	
158-29	56837-56842	probe	_	
158-30	56843-56854	arrangement	_	
158-31	56854-56855	.	_	
158-32	56856-56857	(	_	
158-33	56857-56858	E	_	
158-34	56858-56859	)	_	
158-35	56860-56863	The	_	
158-36	56864-56872	location	_	
158-37	56873-56875	of	_	
158-38	56876-56879	the	_	
158-39	56880-56887	optodes	_	
158-40	56888-56889	(	_	
158-41	56889-56890	3	_	
158-42	56891-56898	sources	_	
158-43	56898-56899	:	_	
158-44	56900-56903	red	_	
158-45	56904-56908	dots	_	
158-46	56908-56909	,	_	
158-47	56910-56911	8	_	
158-48	56912-56921	detectors	_	
158-49	56921-56922	:	_	
158-50	56923-56927	blue	_	
158-51	56928-56932	dots	_	
158-52	56932-56933	)	_	
158-53	56933-56934	.	_	
158-54	56935-56939	Each	_	
158-55	56940-56946	source	_	
158-56	56947-56950	and	_	
158-57	56951-56955	each	_	
158-58	56956-56964	detector	_	
158-59	56965-56969	were	_	
158-60	56970-56972	30	_	
158-61	56973-56975	mm	_	
158-62	56976-56981	apart	_	
158-63	56981-56982	.	_	
158-64	56983-56984	A	_	
158-65	56985-56990	black	_	
158-66	56991-56995	line	_	
158-67	56996-57006	connecting	_	
158-68	57007-57008	a	_	
158-69	57009-57017	detector	_	
158-70	57018-57021	and	_	
158-71	57022-57023	a	_	
158-72	57024-57030	source	_	
158-73	57031-57041	represents	_	
158-74	57042-57043	a	_	
158-75	57044-57055	measurement	_	
158-76	57056-57063	channel	_	
158-77	57064-57068	with	_	
158-78	57069-57070	a	_	
158-79	57071-57077	number	_	
158-80	57077-57078	.	_	
158-81	57079-57084	There	_	
158-82	57085-57089	were	_	
158-83	57090-57091	6	_	
158-84	57092-57100	channels	_	
158-85	57101-57105	from	_	
158-86	57106-57110	each	_	
158-87	57111-57115	side	_	
158-88	57116-57118	of	_	
158-89	57119-57122	the	_	
158-90	57123-57128	brain	_	
158-91	57128-57129	:	_	
158-92	57130-57131	2	_	
158-93	57132-57140	channels	_	
158-94	57141-57149	covering	_	
158-95	57150-57153	the	_	
158-96	57154-57160	medial	_	
158-97	57161-57164	OFC	_	
158-98	57165-57166	(	_	
158-99	57166-57171	right	_	
158-100	57172-57182	hemisphere	_	
158-101	57182-57183	:	_	
158-102	57184-57192	channels	_	
158-103	57193-57194	5	_	
158-104	57195-57198	and	_	
158-105	57199-57200	6	_	
158-106	57200-57201	;	_	
158-107	57202-57206	left	_	
158-108	57207-57217	hemisphere	_	
158-109	57217-57218	:	_	
158-110	57219-57227	channels	_	
158-111	57228-57229	7	_	
158-112	57230-57233	and	_	
158-113	57234-57235	8	_	
158-114	57235-57236	)	_	
158-115	57237-57240	and	_	
158-116	57240-57241	,	_	
158-117	57242-57243	4	_	
158-118	57244-57252	channels	_	
158-119	57253-57261	covering	_	
158-120	57262-57265	the	_	
158-121	57266-57273	lateral	_	
158-122	57274-57277	OFC	_	
158-123	57278-57279	(	_	
158-124	57279-57284	right	_	
158-125	57285-57295	hemisphere	_	
158-126	57295-57296	:	_	
158-127	57297-57305	channels	_	
158-128	57306-57307	1	_	
158-129	57307-57308	–	_	
158-130	57308-57309	4	_	
158-131	57309-57310	;	_	
158-132	57311-57315	left	_	
158-133	57316-57326	hemisphere	_	
158-134	57326-57327	:	_	
158-135	57328-57336	channels	_	
158-136	57337-57338	9	_	
158-137	57338-57339	–	_	
158-138	57339-57341	12	_	
158-139	57341-57342	)	_	
158-140	57342-57343	.	_	
158-141	57344-57347	The	_	
158-142	57348-57354	medial	_	
158-143	57355-57358	OFC	_	
158-144	57359-57360	(	_	
158-145	57360-57364	mOFC	_	
158-146	57364-57365	)	_	
158-147	57366-57369	was	_	
158-148	57370-57377	bounded	_	
158-149	57378-57382	with	_	
158-150	57383-57386	the	_	
158-151	57387-57392	green	_	
158-152	57393-57397	line	_	
158-153	57398-57401	and	_	
158-154	57402-57409	lateral	_	
158-155	57410-57413	OFC	_	
158-156	57414-57415	(	_	
158-157	57415-57419	lOFC	_	
158-158	57419-57420	)	_	
158-159	57421-57425	with	_	
158-160	57426-57429	the	_	
158-161	57430-57433	red	_	
158-162	57434-57438	line	_	
158-163	57438-57439	.	_	
158-164	57440-57443	The	_	
158-165	57444-57449	probe	_	
158-166	57450-57453	was	_	
158-167	57454-57463	projected	_	
158-168	57464-57466	on	_	
158-169	57467-57470	the	_	
158-170	57471-57476	scalp	_	
158-171	57477-57481	with	_	
158-172	57482-57485	the	_	
158-173	57486-57492	anchor	_	
158-174	57493-57499	points	_	
158-175	57500-57502	in	_	
158-176	57503-57506	the	_	
158-177	57507-57513	yellow	_	
158-178	57514-57522	triangle	_	
158-179	57523-57525	of	_	
158-180	57526-57528	Fz	_	
158-181	57528-57529	,	_	
158-182	57530-57532	F7	_	
158-183	57532-57533	,	_	
158-184	57534-57537	and	_	
158-185	57538-57540	F8	_	
158-186	57541-57546	based	_	
158-187	57547-57549	on	_	
158-188	57550-57553	the	_	
158-189	57554-57567	International	_	
158-190	57568-57570	10	_	
158-191	57570-57571	–	_	
158-192	57571-57573	20	_	
158-193	57574-57580	system	_	
158-194	57580-57581	.	_	
158-195	57582-57585	The	_	
158-196	57586-57592	source	_	
158-197	57593-57595	in	_	
158-198	57596-57599	the	_	
158-199	57600-57606	middle	_	
158-200	57607-57609	of	_	
158-201	57610-57613	the	_	
158-202	57614-57619	probe	_	
158-203	57620-57625	array	_	
158-204	57626-57629	was	_	
158-205	57630-57637	located	_	
158-206	57638-57640	on	_	
158-207	57641-57644	the	_	
158-208	57645-57648	Fpz	_	
158-209	57648-57649	.	_	
158-210	57650-57653	The	_	
158-211	57654-57663	locations	_	
158-212	57664-57666	of	_	
158-213	57667-57670	the	_	
158-214	57671-57678	optodes	_	
158-215	57679-57681	in	_	
158-216	57682-57685	the	_	
158-217	57686-57690	both	_	
158-218	57691-57702	hemispheres	_	
158-219	57703-57707	were	_	
158-220	57708-57720	anatomically	_	
158-221	57721-57732	symmetrical	_	
158-222	57732-57733	.	_	

#Text=Demographic characteristics.
159-1	57734-57745	Demographic	_	
159-2	57746-57761	characteristics	_	
159-3	57761-57762	.	_	

#Text=Variable\tAll participants (n = 15)\tHeroin-dependent Group (HD) (n = 8)\tControl Group (CG) (n = 7)\tp\t \tmean\ts.d.\tmean\ts.d.\tmean\ts.d.\t \tAge (years)\t45.7\t6.8\t47.6\t6.1\t45.7\t6.8\t0.58\t \tEducation (years)\t6.4\t2.7\t5.9\t2.8\t7.0\t2.4\t0.43\t \tIQ\t83.0\t10.5\t82.9\t11.4\t83.1\t9.3\t0.97\t \tCigarettes (mg/per day)\t21.5\t10.3\t22.8\t9.7\t20.0\t10.7\t0.61\t \tHistory of smoking (years)\t31.3\t7.4\t33.6\t6.7\t28.7\t7.3\t0.89\t \tAnxiety\t85.5\t21.9\t95.4\t22.1\t74.1\t15.2\t0.047*\t \tDuration of heroin use (years)\tN/A\tN/A\t29.0\t9.7\tN/A\tN/A\tN/A\t \tDuration of heroin abstinence (years)\tN/A\tN/A\t2.39\t3.4\tN/A\tN/A\tN/A\t \tAverage heroin dosage (g/day)\tN/A\tN/A\t0.6\t0.4\tN/A\tN/A\tN/A\t \tMethadone treatment dosage (mg)\tN/A\tN/A\t30.0\t26.9\tN/A\tN/A\tN/A
160-1	57763-57771	Variable	_	
160-2	57772-57775	All	_	
160-3	57776-57788	participants	_	
160-4	57789-57790	(	_	
160-5	57790-57791	n	_	
160-6	57792-57793	=	_	
160-7	57794-57796	15	_	
160-8	57796-57797	)	_	
160-9	57798-57814	Heroin-dependent	_	
160-10	57815-57820	Group	_	
160-11	57821-57822	(	_	
160-12	57822-57824	HD	_	
160-13	57824-57825	)	_	
160-14	57826-57827	(	_	
160-15	57827-57828	n	_	
160-16	57829-57830	=	_	
160-17	57831-57832	8	_	
160-18	57832-57833	)	_	
160-19	57834-57841	Control	_	
160-20	57842-57847	Group	_	
160-21	57848-57849	(	_	
160-22	57849-57851	CG	_	
160-23	57851-57852	)	_	
160-24	57853-57854	(	_	
160-25	57854-57855	n	_	
160-26	57856-57857	=	_	
160-27	57858-57859	7	_	
160-28	57859-57860	)	_	
160-29	57861-57862	p	_	
160-30	57865-57869	mean	_	
160-31	57870-57873	s.d	_	
160-32	57873-57874	.	_	
160-33	57875-57879	mean	_	
160-34	57880-57883	s.d	_	
160-35	57883-57884	.	_	
160-36	57885-57889	mean	_	
160-37	57890-57893	s.d	_	
160-38	57893-57894	.	_	
160-39	57897-57900	Age	_	
160-40	57901-57902	(	_	
160-41	57902-57907	years	_	
160-42	57907-57908	)	_	
160-43	57909-57913	45.7	_	
160-44	57914-57917	6.8	_	
160-45	57918-57922	47.6	_	
160-46	57923-57926	6.1	_	
160-47	57927-57931	45.7	_	
160-48	57932-57935	6.8	_	
160-49	57936-57940	0.58	_	
160-50	57943-57952	Education	_	
160-51	57953-57954	(	_	
160-52	57954-57959	years	_	
160-53	57959-57960	)	_	
160-54	57961-57964	6.4	_	
160-55	57965-57968	2.7	_	
160-56	57969-57972	5.9	_	
160-57	57973-57976	2.8	_	
160-58	57977-57980	7.0	_	
160-59	57981-57984	2.4	_	
160-60	57985-57989	0.43	_	
160-61	57992-57994	IQ	_	
160-62	57995-57999	83.0	_	
160-63	58000-58004	10.5	_	
160-64	58005-58009	82.9	_	
160-65	58010-58014	11.4	_	
160-66	58015-58019	83.1	_	
160-67	58020-58023	9.3	_	
160-68	58024-58028	0.97	_	
160-69	58031-58041	Cigarettes	_	
160-70	58042-58043	(	_	
160-71	58043-58045	mg	_	
160-72	58045-58046	/	_	
160-73	58046-58049	per	_	
160-74	58050-58053	day	_	
160-75	58053-58054	)	_	
160-76	58055-58059	21.5	_	
160-77	58060-58064	10.3	_	
160-78	58065-58069	22.8	_	
160-79	58070-58073	9.7	_	
160-80	58074-58078	20.0	_	
160-81	58079-58083	10.7	_	
160-82	58084-58088	0.61	_	
160-83	58091-58098	History	_	
160-84	58099-58101	of	_	
160-85	58102-58109	smoking	_	
160-86	58110-58111	(	_	
160-87	58111-58116	years	_	
160-88	58116-58117	)	_	
160-89	58118-58122	31.3	_	
160-90	58123-58126	7.4	_	
160-91	58127-58131	33.6	_	
160-92	58132-58135	6.7	_	
160-93	58136-58140	28.7	_	
160-94	58141-58144	7.3	_	
160-95	58145-58149	0.89	_	
160-96	58152-58159	Anxiety	_	
160-97	58160-58164	85.5	_	
160-98	58165-58169	21.9	_	
160-99	58170-58174	95.4	_	
160-100	58175-58179	22.1	_	
160-101	58180-58184	74.1	_	
160-102	58185-58189	15.2	_	
160-103	58190-58195	0.047	_	
160-104	58195-58196	*	_	
160-105	58199-58207	Duration	_	
160-106	58208-58210	of	_	
160-107	58211-58217	heroin	_	
160-108	58218-58221	use	_	
160-109	58222-58223	(	_	
160-110	58223-58228	years	_	
160-111	58228-58229	)	_	
160-112	58230-58231	N	_	
160-113	58231-58232	/	_	
160-114	58232-58233	A	_	
160-115	58234-58235	N	_	
160-116	58235-58236	/	_	
160-117	58236-58237	A	_	
160-118	58238-58242	29.0	_	
160-119	58243-58246	9.7	_	
160-120	58247-58248	N	_	
160-121	58248-58249	/	_	
160-122	58249-58250	A	_	
160-123	58251-58252	N	_	
160-124	58252-58253	/	_	
160-125	58253-58254	A	_	
160-126	58255-58256	N	_	
160-127	58256-58257	/	_	
160-128	58257-58258	A	_	
160-129	58261-58269	Duration	_	
160-130	58270-58272	of	_	
160-131	58273-58279	heroin	_	
160-132	58280-58290	abstinence	_	
160-133	58291-58292	(	_	
160-134	58292-58297	years	_	
160-135	58297-58298	)	_	
160-136	58299-58300	N	_	
160-137	58300-58301	/	_	
160-138	58301-58302	A	_	
160-139	58303-58304	N	_	
160-140	58304-58305	/	_	
160-141	58305-58306	A	_	
160-142	58307-58311	2.39	_	
160-143	58312-58315	3.4	_	
160-144	58316-58317	N	_	
160-145	58317-58318	/	_	
160-146	58318-58319	A	_	
160-147	58320-58321	N	_	
160-148	58321-58322	/	_	
160-149	58322-58323	A	_	
160-150	58324-58325	N	_	
160-151	58325-58326	/	_	
160-152	58326-58327	A	_	
160-153	58330-58337	Average	_	
160-154	58338-58344	heroin	_	
160-155	58345-58351	dosage	_	
160-156	58352-58353	(	_	
160-157	58353-58354	g	_	
160-158	58354-58355	/	_	
160-159	58355-58358	day	_	
160-160	58358-58359	)	_	
160-161	58360-58361	N	_	
160-162	58361-58362	/	_	
160-163	58362-58363	A	_	
160-164	58364-58365	N	_	
160-165	58365-58366	/	_	
160-166	58366-58367	A	_	
160-167	58368-58371	0.6	_	
160-168	58372-58375	0.4	_	
160-169	58376-58377	N	_	
160-170	58377-58378	/	_	
160-171	58378-58379	A	_	
160-172	58380-58381	N	_	
160-173	58381-58382	/	_	
160-174	58382-58383	A	_	
160-175	58384-58385	N	_	
160-176	58385-58386	/	_	
160-177	58386-58387	A	_	
160-178	58390-58399	Methadone	_	
160-179	58400-58409	treatment	_	
160-180	58410-58416	dosage	_	
160-181	58417-58418	(	_	
160-182	58418-58420	mg	_	
160-183	58420-58421	)	_	
160-184	58422-58423	N	_	
160-185	58423-58424	/	_	
160-186	58424-58425	A	_	
160-187	58426-58427	N	_	
160-188	58427-58428	/	_	
160-189	58428-58429	A	_	
160-190	58430-58434	30.0	_	
160-191	58435-58439	26.9	_	
160-192	58440-58441	N	_	
160-193	58441-58442	/	_	
160-194	58442-58443	A	_	
160-195	58444-58445	N	_	
160-196	58445-58446	/	_	
160-197	58446-58447	A	_	
160-198	58448-58449	N	_	
160-199	58449-58450	/	_	
160-200	58450-58451	A	_	

#Text=The p values are reported for a two-sample t test (for age, years of education, IQ, daily cigarette consumption, years of smoking, and level of anxiety) comparing abstinent heroin-dependent subjects (HDs) with the controls (CGs). IQ was assessed with the Wechsler Adult Intelligence Scale version 4. Anxiety scores were scaled with the adult State-Trait Anxiety Inventory (STAI). Abbreviation: Standard deviation (s.d.). *p < 0.05.
161-1	58455-58458	The	_	
161-2	58459-58460	p	_	
161-3	58461-58467	values	_	
161-4	58468-58471	are	_	
161-5	58472-58480	reported	_	
161-6	58481-58484	for	_	
161-7	58485-58486	a	_	
161-8	58487-58497	two-sample	_	
161-9	58498-58499	t	_	
161-10	58500-58504	test	_	
161-11	58505-58506	(	_	
161-12	58506-58509	for	_	
161-13	58510-58513	age	_	
161-14	58513-58514	,	_	
161-15	58515-58520	years	_	
161-16	58521-58523	of	_	
161-17	58524-58533	education	_	
161-18	58533-58534	,	_	
161-19	58535-58537	IQ	_	
161-20	58537-58538	,	_	
161-21	58539-58544	daily	_	
161-22	58545-58554	cigarette	_	
161-23	58555-58566	consumption	_	
161-24	58566-58567	,	_	
161-25	58568-58573	years	_	
161-26	58574-58576	of	_	
161-27	58577-58584	smoking	_	
161-28	58584-58585	,	_	
161-29	58586-58589	and	_	
161-30	58590-58595	level	_	
161-31	58596-58598	of	_	
161-32	58599-58606	anxiety	_	
161-33	58606-58607	)	_	
161-34	58608-58617	comparing	_	
161-35	58618-58627	abstinent	_	
161-36	58628-58644	heroin-dependent	_	
161-37	58645-58653	subjects	_	
161-38	58654-58655	(	_	
161-39	58655-58658	HDs	_	
161-40	58658-58659	)	_	
161-41	58660-58664	with	_	
161-42	58665-58668	the	_	
161-43	58669-58677	controls	_	
161-44	58678-58679	(	_	
161-45	58679-58682	CGs	_	
161-46	58682-58683	)	_	
161-47	58683-58684	.	_	
161-48	58685-58687	IQ	_	
161-49	58688-58691	was	_	
161-50	58692-58700	assessed	_	
161-51	58701-58705	with	_	
161-52	58706-58709	the	_	
161-53	58710-58718	Wechsler	_	
161-54	58719-58724	Adult	_	
161-55	58725-58737	Intelligence	_	
161-56	58738-58743	Scale	_	
161-57	58744-58751	version	_	
161-58	58752-58753	4	_	
161-59	58753-58754	.	_	
161-60	58755-58762	Anxiety	_	
161-61	58763-58769	scores	_	
161-62	58770-58774	were	_	
161-63	58775-58781	scaled	_	
161-64	58782-58786	with	_	
161-65	58787-58790	the	_	
161-66	58791-58796	adult	_	
161-67	58797-58808	State-Trait	_	
161-68	58809-58816	Anxiety	_	
161-69	58817-58826	Inventory	_	
161-70	58827-58828	(	_	
161-71	58828-58832	STAI	_	
161-72	58832-58833	)	_	
161-73	58833-58834	.	_	
161-74	58835-58847	Abbreviation	_	
161-75	58847-58848	:	_	
161-76	58849-58857	Standard	_	
161-77	58858-58867	deviation	_	
161-78	58868-58869	(	_	
161-79	58869-58872	s.d	_	
161-80	58872-58873	.	_	
161-81	58873-58874	)	_	
161-82	58874-58875	.	_	
161-83	58876-58877	*	_	
161-84	58877-58878	p	_	
161-85	58879-58880	<	_	
161-86	58881-58885	0.05	_	
161-87	58885-58886	.	_	
